This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
Code | Display |
1-8 | Acyclovir [Susceptibility] |
10-9 | Amdinocillin [Susceptibility] by Serum bactericidal titer |
100-8 | Cefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC) |
1000-9 | DBG Ab [Presence] in Serum or Plasma from Blood product unit |
10000-8 | R wave duration in lead AVR |
10001-6 | R wave duration in lead I |
10002-4 | R wave duration in lead II |
10003-2 | R wave duration in lead III |
10004-0 | R wave duration in lead V1 |
10005-7 | R wave duration in lead V2 |
10006-5 | R wave duration in lead V3 |
10007-3 | R wave duration in lead V4 |
10008-1 | R wave duration in lead V5 |
10009-9 | R wave duration in lead V6 |
1001-7 | DBG Ab [Presence] in Serum or Plasma from donor |
10010-7 | R' wave amplitude in lead AVF |
10011-5 | R' wave amplitude in lead AVL |
10012-3 | R' wave amplitude in lead AVR |
10013-1 | R' wave amplitude in lead I |
10014-9 | R' wave amplitude in lead II |
10015-6 | R' wave amplitude in lead III |
10016-4 | R' wave amplitude in lead V1 |
10017-2 | R' wave amplitude in lead V2 |
10018-0 | R' wave amplitude in lead V3 |
10019-8 | R' wave amplitude in lead V4 |
1002-5 | DBG Ab [Presence] in Serum or Plasma |
10020-6 | R' wave amplitude in lead V5 |
10021-4 | R' wave amplitude in lead V6 |
10022-2 | R' wave duration in lead AVF |
10023-0 | R' wave duration in lead AVL |
10024-8 | R' wave duration in lead AVR |
10025-5 | R' wave duration in lead I |
10026-3 | R' wave duration in lead II |
10027-1 | R' wave duration in lead III |
10028-9 | R' wave duration in lead V1 |
10029-7 | R' wave duration in lead V2 |
1003-3 | Indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma |
10030-5 | R' wave duration in lead V3 |
10031-3 | R' wave duration in lead V4 |
10032-1 | R' wave duration in lead V5 |
10033-9 | R' wave duration in lead V6 |
10034-7 | S wave amplitude in lead AVF |
10035-4 | S wave amplitude in lead AVL |
10036-2 | S wave amplitude in lead AVR |
10037-0 | S wave amplitude in lead I |
10038-8 | S wave amplitude in lead II |
10039-6 | S wave amplitude in lead III |
1004-1 | Direct antiglobulin test.complement specific reagent [Presence] on Red Blood Cells |
10040-4 | S wave amplitude in lead V1 |
10041-2 | S wave amplitude in lead V2 |
10042-0 | S wave amplitude in lead V3 |
10043-8 | S wave amplitude in lead V4 |
10044-6 | S wave amplitude in lead V5 |
10045-3 | S wave amplitude in lead V6 |
10046-1 | S wave duration in lead AVF |
10047-9 | S wave duration in lead AVL |
10048-7 | S wave duration in lead AVR |
10049-5 | S wave duration in lead I |
1005-8 | Indirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma |
10050-3 | S wave duration in lead II |
10051-1 | S wave duration in lead III |
10052-9 | S wave duration in lead V1 |
10053-7 | S wave duration in lead V2 |
10054-5 | S wave duration in lead V3 |
10055-2 | S wave duration in lead V4 |
10056-0 | S wave duration in lead V5 |
10057-8 | S wave duration in lead V6 |
10058-6 | S' wave amplitude in lead AVF |
10059-4 | S' wave amplitude in lead AVL |
1006-6 | Direct antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells |
10060-2 | S' wave amplitude in lead AVR |
10061-0 | S' wave amplitude in lead I |
10062-8 | S' wave amplitude in lead II |
10063-6 | S' wave amplitude in lead III |
10064-4 | S' wave amplitude in lead V1 |
10065-1 | S' wave amplitude in lead V2 |
10066-9 | S' wave amplitude in lead V3 |
10067-7 | S' wave amplitude in lead V4 |
10068-5 | S' wave amplitude in lead V5 |
10069-3 | S' wave amplitude in lead V6 |
1007-4 | Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10070-1 | S' wave duration in lead AVF |
10071-9 | S' wave duration in lead AVL |
10072-7 | S' wave duration in lead AVR |
10073-5 | S' wave duration in lead I |
10074-3 | S' wave duration in lead II |
10075-0 | S' wave duration in lead III |
10076-8 | S' wave duration in lead V1 |
10077-6 | S' wave duration in lead V2 |
10078-4 | S' wave duration in lead V3 |
10079-2 | S' wave duration in lead V4 |
1008-2 | Indirect antiglobulin test.poly specific reagent [Presence] in Serum or Plasma |
10080-0 | S' wave duration in lead V5 |
10081-8 | S' wave duration in lead V6 |
10082-6 | ST initial amplitude 6 ms in lead AVF |
10083-4 | ST initial amplitude 6 ms in lead AVL |
10084-2 | ST initial amplitude 6 ms in lead AVR |
10085-9 | ST initial amplitude 6 ms in lead I |
10086-7 | ST initial amplitude 6 ms in lead II |
10087-5 | ST initial amplitude 6 ms in lead III |
10088-3 | ST initial amplitude 6 ms in lead V1 |
10089-1 | ST initial amplitude 6 ms in lead V2 |
1009-0 | Deprecated Direct antiglobulin test.poly specific reagent [Presence] on Red Blood Cells |
10090-9 | ST initial amplitude 6 ms in lead V3 |
10091-7 | ST initial amplitude 6 ms in lead V4 |
10092-5 | ST initial amplitude 6 ms in lead V5 |
10093-3 | ST initial amplitude 6 ms in lead V6 |
10094-1 | ST slope in lead AVF |
10095-8 | ST slope in lead AVL |
10096-6 | ST slope in lead AVR |
10097-4 | ST slope in lead I |
10098-2 | ST slope in lead II |
10099-0 | ST slope in lead III |
101-6 | Cefoperazone [Susceptibility] by Disk diffusion (KB) |
1010-8 | Ew Ab [Presence] in Serum or Plasma from Blood product unit |
10100-6 | ST slope in lead V1 |
10101-4 | ST slope in lead V2 |
10102-2 | ST slope in lead V3 |
10103-0 | ST slope in lead V4 |
10104-8 | ST slope in lead V5 |
10105-5 | ST slope in lead V6 |
10106-3 | ST wave end displacement in lead AVF |
10107-1 | ST wave end displacement in lead AVL |
10108-9 | ST wave end displacement in lead AVR |
10109-7 | ST wave end displacement in lead I |
1011-6 | Ew Ab [Presence] in Serum or Plasma from donor |
10110-5 | ST wave end displacement in lead II |
10111-3 | ST wave end displacement in lead III |
10112-1 | ST wave end displacement in lead V1 |
10113-9 | ST wave end displacement in lead V2 |
10114-7 | ST wave end displacement in lead V3 |
10115-4 | ST wave end displacement in lead V4 |
10116-2 | ST wave end displacement in lead V5 |
10117-0 | ST wave end displacement in lead V6 |
10118-8 | ST wave mid displacement in lead AVF |
10119-6 | ST wave mid displacement in lead AVL |
1012-4 | Ew Ab [Presence] in Serum or Plasma |
10120-4 | ST wave mid displacement in lead AVR |
10121-2 | ST wave mid displacement in lead I |
10122-0 | ST wave mid displacement in lead II |
10123-8 | ST wave mid displacement in lead III |
10124-6 | ST wave mid displacement in lead V1 |
10125-3 | ST wave mid displacement in lead V2 |
10126-1 | ST wave mid displacement in lead V3 |
10127-9 | ST wave mid displacement in lead V4 |
10128-7 | ST wave mid displacement in lead V5 |
10129-5 | ST wave mid displacement in lead V6 |
1013-2 | Ew Ag [Presence] on Red Blood Cells from Blood product unit |
10130-3 | T' wave amplitude in lead AVF |
10131-1 | T' wave amplitude in lead AVL |
10132-9 | T' wave amplitude in lead AVR |
10133-7 | T' wave amplitude in lead I |
10134-5 | T' wave amplitude in lead II |
10135-2 | T' wave amplitude in lead III |
10136-0 | T' wave amplitude in lead V1 |
10137-8 | T' wave amplitude in lead V2 |
10138-6 | T' wave amplitude in lead V3 |
10139-4 | T' wave amplitude in lead V4 |
1014-0 | Ew Ag [Presence] on Red Blood Cells from donor |
10140-2 | T' wave amplitude in lead V5 |
10141-0 | T' wave amplitude in lead V6 |
10142-8 | T wave amplitude in lead AVF |
10143-6 | T wave amplitude in lead AVL |
10144-4 | T wave amplitude in lead AVR |
10145-1 | T wave amplitude in lead I |
10146-9 | T wave amplitude in lead II |
10147-7 | T wave amplitude in lead III |
10148-5 | T wave amplitude in lead V1 |
10149-3 | T wave amplitude in lead V2 |
1015-7 | Ew Ag [Presence] on Red Blood Cells |
10150-1 | T wave amplitude in lead V3 |
10151-9 | T wave amplitude in lead V4 |
10152-7 | T wave amplitude in lead V5 |
10153-5 | T wave amplitude in lead V6 |
10154-3 | Chief complaint Narrative - Reported |
10155-0 | History of allergies, reported |
10156-8 | History of childhood diseases Narrative |
10157-6 | History of family member diseases Narrative |
10158-4 | History of functional status Narrative |
10159-2 | History of industrial exposure Narrative |
1016-5 | E Ab [Presence] in Serum or Plasma from Blood product unit |
10160-0 | History of medication use Narrative |
10161-8 | History of occupational exposure Narrative |
10162-6 | History of pregnancies Narrative |
10163-4 | History of pregnancies |
10164-2 | History of present illness Narrative |
10165-9 | Deprecated History of psychiatric symptoms and diseases Narrative |
10166-7 | History of social function Narrative |
10167-5 | History of surgical procedures Narrative |
10168-3 | History of Cardiovascular system disorders Narrative |
10169-1 | History of Ear disorders Narrative |
1017-3 | E Ab [Presence] in Serum or Plasma from donor |
10170-9 | History of Endocrine system disorders Narrative |
10171-7 | History of Eyes disorders Narrative |
10172-5 | History of Hematologic system disorders Narrative |
10173-3 | History of Musculoskeletal system disorders Narrative |
10174-1 | History of Nose disorders Narrative |
10175-8 | History of Oral cavity disorders Narrative |
10176-6 | History of Reproductive system disorders Narrative |
10177-4 | History of Respiratory system disorders Narrative |
10178-2 | History of Skin disorders Narrative |
10179-0 | History of Throat and Neck disorders Narrative |
1018-1 | E Ab [Presence] in Serum or Plasma |
10180-8 | History of Throat and Neck disorders |
10181-6 | History of Urinary tract disorders Narrative |
10182-4 | History of travel Narrative |
10183-2 | Hospital discharge medications Narrative |
10184-0 | Hospital discharge physical findings Narrative |
10185-7 | Hospital discharge procedures Narrative |
10186-5 | Identifying information Narrative Observed |
10187-3 | Review of systems Narrative - Reported |
10188-1 | Review of systems overview Narrative - Reported |
10189-9 | Review of systems overview - Reported |
1019-9 | E Ag [Presence] on Red Blood Cells from Blood product unit |
10190-7 | Mental status Narrative |
10191-5 | Physical findings of Abdomen Narrative |
10192-3 | Physical findings of Back Narrative |
10193-1 | Physical findings of Breasts Narrative |
10194-9 | Physical findings of Neurologic deep tendon reflexes Narrative |
10195-6 | Physical findings of Ear Narrative |
10196-4 | Physical findings of Extremities Narrative |
10197-2 | Physical findings of Eye Narrative |
10198-0 | Physical findings of Genitourinary tract Narrative |
10199-8 | Physical findings of Head Narrative |
102-4 | Cefoperazone [Susceptibility] by Serum bactericidal titer |
1020-7 | E Ag [Presence] on Red Blood Cells from donor |
10200-4 | Physical findings of Heart Narrative |
10201-2 | Physical findings of Mouth and Throat and Teeth Narrative |
10202-0 | Physical findings of Nervous system Narrative |
10203-8 | Physical findings of Nose Narrative |
10204-6 | Physical findings of Pelvis Narrative |
10205-3 | Physical findings of Rectum Narrative |
10206-1 | Physical findings of Skin Narrative |
10207-9 | Physical findings of Thorax and Lungs Narrative |
10208-7 | Physical findings of Vessels Narrative |
10209-5 | Physical findings of Neurologic balance and Coordination Narrative |
1021-5 | E Ag [Presence] on Red Blood Cells |
10210-3 | Physical findings of General status Narrative |
10211-1 | Physical findings of Sense of touch Narrative |
10212-9 | Physical findings of Strength Narrative |
10213-7 | Surgical operation note anesthesia Narrative |
10214-5 | Surgical operation note anesthesia duration |
10215-2 | Surgical operation note findings Narrative |
10216-0 | Surgical operation note fluids Narrative |
10217-8 | Surgical operation note indications [Interpretation] Narrative |
10218-6 | Surgical operation note postoperative diagnosis Narrative |
10219-4 | Surgical operation note preoperative diagnosis Narrative |
1022-3 | Fy sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10220-2 | Surgical operation note prep time duration |
10221-0 | Surgical operation note specimens taken Narrative |
10222-8 | Surgical operation note surgical complications [Interpretation] Narrative |
10223-6 | Surgical operation note surgical procedure Narrative |
10224-4 | Hemodynamic method special circumstances |
10225-1 | Cardiac measurement device Institution inventory number |
10226-9 | Oxygen content in Intravascular space |
10227-7 | Cardiac measurement device Vendor model number |
10228-5 | Cardiac measurement device Vendor serial number |
10229-3 | Hemodynamic method Type of |
1023-1 | Fy sup(a) Ab [Presence] in Serum or Plasma from donor |
10230-1 | Left ventricular Ejection fraction |
10231-9 | Right ventricular Ejection fraction |
10232-7 | Oxygen content in Aorta root |
10233-5 | Oxygen content in Left atrium |
10234-3 | Oxygen content in Right atrium |
10235-0 | Oxygen content in High right atrium |
10236-8 | Oxygen content in Low right atrium |
10237-6 | Oxygen content in Mid right atrium |
10238-4 | Oxygen content in Left ventricle |
10239-2 | Oxygen content in Right ventricular outflow tract |
1024-9 | Fy sup(a) Ab [Presence] in Serum or Plasma |
10240-0 | Oxygen content in Right ventricle |
10241-8 | Oxygen content in Coronary sinus |
10242-6 | Oxygen content in Ductus arteriosus |
10243-4 | Oxygen content in Inferior vena cava |
10244-2 | Oxygen content in Left pulmonary artery |
10245-9 | Oxygen content in Main pulmonary artery |
10246-7 | Oxygen content in Right pulmonary artery |
10247-5 | Oxygen content in Pulmonary wedge |
10248-3 | Oxygen content in Superior vena cava |
10249-1 | Heart rate device Institution inventory number |
1025-6 | Fy sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10250-9 | Heart rate device Vendor model number |
10251-7 | Heart rate device Vendor serial number |
10252-5 | Biliary drain site |
10253-3 | Type of Biliary drain |
10254-1 | Type of Peritoneal drain |
10255-8 | Type of Subarachnoid drain |
10256-6 | Biliary drain Institution inventory number |
10257-4 | Chest tube Institution inventory number |
10258-2 | Enteral tube Institution inventory number |
10259-0 | Gastrostomy tube Institution inventory number |
1026-4 | Fy sup(a) Ag [Presence] on Red Blood Cells from donor |
10260-8 | GI tube Institution inventory number |
10261-6 | Intravascular tube Institution inventory number |
10262-4 | IO tube Institution inventory number |
10263-2 | Nasogastric tube Institution inventory number |
10264-0 | Oral tube Institution inventory number |
10265-7 | Peritoneal drain Institution inventory number |
10266-5 | Peritoneal tube Institution inventory number |
10267-3 | Rate control device Institution inventory number |
10268-1 | Stool collection device Institution inventory number |
10269-9 | Subarachnoid drain Institution inventory number |
1027-2 | Fy sup(a) Ag [Presence] on Red Blood Cells |
10270-7 | Synovial drain Institution inventory number |
10271-5 | Tube or drain Institution inventory number |
10272-3 | Upper GI tube Institution inventory number |
10273-1 | Bladder irrigation tube Institution inventory number |
10274-9 | Urine tube Institution inventory number |
10275-6 | Wound drain device Institution inventory number |
10276-4 | Peritoneal drain site |
10277-2 | Stool collection site |
10278-0 | Subarachnoid drain site |
10279-8 | Biliary drain Vendor model number |
1028-0 | Fy sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10280-6 | Chest tube Vendor model number |
10281-4 | Enteral tube Vendor model number |
10282-2 | Gastrostomy tube Vendor model number |
10283-0 | GI tube Vendor model number |
10284-8 | Intravascular tube Vendor model number |
10285-5 | IO tube Vendor model number |
10286-3 | Nasogastric tube Vendor model number |
10287-1 | Oral tube Vendor model number |
10288-9 | Peritoneal drain Vendor model number |
10289-7 | Peritoneal tube Vendor model number |
1029-8 | Fy sup(b) Ab [Presence] in Serum or Plasma from donor |
10290-5 | Rate control device Vendor model number |
10291-3 | Stool collection device Vendor model number |
10292-1 | Subarachnoid drain Vendor model number |
10293-9 | Synovial drain Vendor model number |
10294-7 | Tube or drain Vendor model number |
10295-4 | Upper GI tube Vendor model number |
10296-2 | Bladder irrigation tube Vendor model number |
10297-0 | Urine tube Vendor model number |
10298-8 | Wound drain device Vendor model number |
10299-6 | Biliary drain Vendor serial number |
103-2 | Ceforanide [Susceptibility] by Minimum lethal concentration (MLC) |
1030-6 | Fy sup(b) Ab [Presence] in Serum or Plasma |
10300-2 | Chest tube Vendor serial number |
10301-0 | Enteral tube Vendor serial number |
10302-8 | Gastrostomy tube Vendor serial number |
10303-6 | GI tube Vendor serial number |
10304-4 | Intravascular tube Vendor serial number |
10305-1 | IO tube Vendor serial number |
10306-9 | Nasogastric tube Vendor serial number |
10307-7 | Oral tube Vendor serial number |
10308-5 | Peritoneal drain Vendor serial number |
10309-3 | Peritoneal tube Vendor serial number |
1031-4 | Fy sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10310-1 | Rate control device Vendor serial number |
10311-9 | Stool collection device Vendor serial number |
10312-7 | Subarachnoid drain Vendor serial number |
10313-5 | Synovial drain Vendor serial number |
10314-3 | Tube or drain Vendor serial number |
10315-0 | Upper GI tube Vendor serial number |
10316-8 | Bladder irrigation tube Vendor serial number |
10317-6 | Urine tube Vendor serial number |
10318-4 | Wound drain device Vendor serial number |
10319-2 | Enema device Institution inventory number |
1032-2 | Fy sup(b) Ag [Presence] on Red Blood Cells from donor |
10320-0 | Enema device Vendor model number |
10321-8 | Enema device Vendor serial number |
10322-6 | Potassium intake 24 hour |
10323-4 | Wound drain fluid [Appearance] Lower GI tract |
10324-2 | Breath rate device Institution inventory number |
10325-9 | Breath rate device Vendor model number |
10326-7 | Breath rate device Vendor serial number |
10327-5 | Eosinophils/100 leukocytes in Sputum by Manual count |
10328-3 | Lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
10329-1 | Monocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
1033-0 | Fy sup(b) Ag [Presence] on Red Blood Cells |
10330-9 | Monocytes/100 leukocytes in Body fluid by Manual count |
10331-7 | Rh [Type] in Blood |
10332-5 | Cortisol [Mass/volume] in Serum or Plasma --pre 250 ug corticotropin IM |
10333-3 | Appearance of Cerebral spinal fluid |
10334-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma |
10335-8 | Color of Cerebral spinal fluid |
10336-6 | Gonadotropin peptide [Mass/volume] in Urine |
10337-4 | Procollagen type I [Mass/volume] in Serum |
10338-2 | Barbiturates [Mass/volume] in Serum or Plasma |
10339-0 | Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
1034-8 | Fetal cell screen [Interpretation] in Blood |
10340-8 | Molindone [Mass/volume] in Serum or Plasma |
10341-6 | Norpropoxyphene [Mass/volume] in Serum or Plasma |
10342-4 | Sulfamethoxazole [Mass/volume] in Serum or Plasma |
10343-2 | Temazepam [Mass/volume] in Serum or Plasma |
10344-0 | Tranylcypromine [Mass/volume] in Serum or Plasma |
10345-7 | Trihexyphenidyl [Mass/volume] in Urine |
10346-5 | Hemoglobin A [Units/volume] in Blood by Electrophoresis |
10347-3 | Babesia microti identified in Blood by Light microscopy |
10348-1 | Bordetella parapertussis Ab [Presence] in Serum |
10349-9 | Brucella sp Ab [Units/volume] in Serum |
1035-5 | Fresh frozen plasma given [Volume] |
10350-7 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunoassay |
10351-5 | HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
10352-3 | Bacteria identified in Genital specimen by Aerobe culture |
10353-1 | Bacteria identified in Nose by Aerobe culture |
10354-9 | Bacteria identified in Urethra by Culture |
10355-6 | Microscopic observation [Identifier] in Bone marrow by Wright Giemsa stain |
10356-4 | Deprecated Microscopic observation [Identifier] in Stool by Trichrome stain |
10357-2 | Microscopic observation [Identifier] in Wound by Gram stain |
10358-0 | Teichoate Ab [Titer] in Serum by Immune diffusion (ID) |
10359-8 | Asialoganglioside GM1 IgM Ab [Titer] in Serum |
1036-3 | G Ab [Presence] in Serum or Plasma from Blood product unit |
10360-6 | DNA single strand IgG Ab [Units/volume] in Serum |
10361-4 | DNA single strand IgM Ab [Units/volume] in Serum |
10362-2 | Endomysium IgA Ab [Presence] in Serum |
10363-0 | Barbiturates [Presence] in Unspecified specimen |
10364-8 | Cotinine [Mass/mass] in Hair |
10365-5 | Cotinine [Mass/volume] in Serum or Plasma |
10366-3 | Cotinine [Mass/volume] in Urine |
10367-1 | Ethanol [Mass/volume] in Gastric fluid |
10368-9 | Lead [Mass/volume] in Capillary blood |
10369-7 | Opiates [Mass/mass] in Hair |
1037-1 | G Ab [Presence] in Serum or Plasma from donor |
10370-5 | Phencyclidine [Mass/mass] in Hair |
10371-3 | Bite cells [Presence] in Blood by Light microscopy |
10372-1 | Blister cells [Presence] in Blood by Light microscopy |
10373-9 | Fragments [Presence] in Blood by Light microscopy |
10374-7 | Helmet cells [Presence] in Blood by Light microscopy |
10375-4 | Irregularly contracted cells [Presence] in Blood by Light microscopy |
10376-2 | Oval macrocytes [Presence] in Blood by Light microscopy |
10377-0 | Pencil cells [Presence] in Blood by Light microscopy |
10378-8 | Polychromasia [Presence] in Blood by Light microscopy |
10379-6 | Erythrocytes.dual population [Presence] in Blood by Light microscopy |
1038-9 | G Ab [Presence] in Serum or Plasma |
10380-4 | Stomatocytes [Presence] in Blood by Light microscopy |
10381-2 | Target cells [Presence] in Blood by Light microscopy |
10382-0 | A,B variant NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10383-8 | A,B variant NOS Ag [Presence] on Red Blood Cells from donor |
10384-6 | A,B variant NOS Ag [Presence] on Red Blood Cells |
10385-3 | Albumin concentration given |
10386-1 | Albumin given [Volume] |
10387-9 | Autologous erythrocytes given [Volume] |
10388-7 | Autologous whole blood given [Volume] |
10389-5 | Blood product.other [Type] |
1039-7 | G Ag [Presence] on Red Blood Cells from Blood product unit |
10390-3 | Blood product special preparation [Type] |
10391-1 | Cytomegalovirus immune globulin given [Volume] |
10392-9 | Cryoprecipitate given [Volume] |
10393-7 | Factor IX given [Type] |
10394-5 | Factor IX given [Volume] |
10395-2 | Factor VIII given [Type] |
10396-0 | Factor VIII given [Volume] |
10397-8 | Hepatitis B immune globulin given [Volume] |
10398-6 | I Ag [Presence] on Red Blood Cells from Blood product unit |
10399-4 | I Ag [Presence] on Red Blood Cells from donor |
104-0 | Ceforanide [Susceptibility] by Minimum inhibitory concentration (MIC) |
1040-5 | G Ag [Presence] on Red Blood Cells from donor |
10400-0 | I Ag [Presence] on Red Blood Cells |
10401-8 | Immune serum globulin given [Type] |
10402-6 | Immune serum globulin given [Volume] |
10403-4 | Inject immune serum globulin [Volume] |
10404-2 | Inject Rh immune globulin [Volume] |
10405-9 | Inject varicella zoster virus immune globulin [Volume] |
10406-7 | little i Ag [Presence] on Red Blood Cells from Blood product unit |
10407-5 | little i Ag [Presence] on Red Blood Cells from donor |
10408-3 | little i Ag [Presence] on Red Blood Cells |
10409-1 | Pentaspan given [Volume] |
1041-3 | G Ag [Presence] on Red Blood Cells |
10410-9 | Plasma given [Type] |
10411-7 | Plasma given [Volume] |
10412-5 | Platelets given [Type] |
10413-3 | Rh immune globulin given [Volume] |
10414-1 | Transfuse albumin [Volume] |
10415-8 | Transfuse blood exchange transfusion [Volume] |
10416-6 | Transfuse blood product other [Volume] |
10417-4 | Transfuse cryoprecipitate [Volume] |
10418-2 | Transfuse factor IX [Volume] |
10419-0 | Transfuse factor VIII [Volume] |
1042-1 | H Ab [Presence] in Serum or Plasma from Blood product unit |
10420-8 | Transfuse immune serum globulin [Volume] |
10421-6 | Transfuse Pentaspan [Volume] |
10422-4 | Transfuse plasma [Volume] |
10423-2 | Transfuse platelets [Volume] |
10424-0 | Transfuse erythrocytes [Volume] |
10425-7 | Transfuse Rh immune globulin [Volume] |
10426-5 | Transfuse whole blood [Volume] |
10427-3 | Transfuse whole blood autologous [Volume] |
10428-1 | Varicella zoster virus immune globulin given [Volume] |
10429-9 | AE 1 Ag [Presence] in Tissue by Immune stain |
1043-9 | H Ab [Presence] in Serum or Plasma from donor |
10430-7 | AE 3 Ag [Presence] in Tissue by Immune stain |
10431-5 | B-cell Ag [Presence] in Tissue by Immune stain |
10432-3 | CD30 Ag [Presence] in Tissue by Immune stain |
10433-1 | BR-2 Ag [Presence] in Tissue by Immune stain |
10434-9 | Complement C3 Ag [Presence] in Tissue by Immune stain |
10435-6 | C5B-9 Ag [Presence] in Tissue by Immune stain |
10436-4 | CD15 Ag [Presence] in Tissue by Immune stain |
10437-2 | CD16 Ag [Presence] in Tissue by Immune stain |
10438-0 | CD20 Ag [Presence] in Tissue by Immune stain |
10439-8 | CD3 Ag [Presence] in Tissue by Immune stain |
1044-7 | H Ab [Presence] in Serum |
10440-6 | Deprecated CD30 Ag [Presence] in Tissue by Immune stain |
10441-4 | CD34 Ag [Presence] in Tissue by Immune stain |
10442-2 | CD56 Ag [Presence] in Tissue by Immune stain |
10443-0 | CD43 T-cell monocyte+myeloid cell Ag [Presence] in Tissue by Immune stain |
10444-8 | CD57 Ag [Presence] in Tissue by Immune stain |
10445-5 | CD11c Ag [Presence] in Tissue by Immune stain |
10446-3 | Leukocyte common Ag [Presence] in Tissue by Immune stain |
10447-1 | M-5 Ag [Presence] in Tissue by Immune stain |
10448-9 | T-cell Ag [Presence] in Tissue by Immune stain |
10449-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post meal |
1045-4 | H NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10450-5 | Glucose [Mass/volume] in Serum or Plasma --10 hours fasting |
10451-3 | Proinsulin [Moles/volume] in Serum or Plasma --12 hours fasting |
10452-1 | Xylose [Mass/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
10453-9 | Xylose [Mass/volume] in Serum or Plasma --1 hour post dose xylose PO |
10454-7 | Xylose [Mass/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
10455-4 | Xylose [Mass/volume] in Serum or Plasma --30 minutes post 25 g xylose PO |
10456-2 | Xylose [Mass/volume] in Serum or Plasma --6 hours fasting |
10457-0 | Actin Ag [Presence] in Tissue by Immune stain |
10458-8 | Alkaline phosphatase.placental Ag [Presence] in Tissue by Immune stain |
10459-6 | Alpha-1-Fetoprotein Ag [Presence] in Tissue by Immune stain |
1046-2 | H NOS Ab [Presence] in Serum or Plasma from donor |
10460-4 | Lactalbumin alpha Ag [Presence] in Tissue by Immune stain |
10461-2 | Alpha-1-Antichymotrypsin Ag [Presence] in Tissue by Immune stain |
10462-0 | Alpha 1 antitrypsin Ag [Presence] in Tissue by Immune stain |
10463-8 | Amyloid A component Ag [Presence] in Tissue by Immune stain |
10464-6 | Amyloid P component Ag [Presence] in Tissue by Immune stain |
10465-3 | Amyloid.prealbumin Ag [Presence] in Tissue by Immune stain |
10466-1 | Anion gap 3 in Serum or Plasma |
10467-9 | Beta-2-Microglobulin amyloid Ag [Presence] in Tissue by Immune stain |
10468-7 | Calcitonin Ag [Presence] in Tissue by Immune stain |
10469-5 | Carcinoembryonic Ag [Presence] in Tissue by Immune stain |
1047-0 | H NOS Ab [Presence] in Serum or Plasma |
10470-3 | Choriogonadotropin Ag [Presence] in Tissue by Immune stain |
10471-1 | Chromogranin A Ag [Presence] in Tissue by Immune stain |
10472-9 | Chromogranin Ag [Presence] in Tissue by Immune stain |
10473-7 | Chymotrypsin Ag [Presence] in Tissue by Immune stain |
10474-5 | Collagen type 4 Ag [Presence] in Tissue by Immune stain |
10475-2 | Corticotropin Ag [Presence] in Tissue by Immune stain |
10476-0 | Desmin Ag [Presence] in Tissue by Immune stain |
10477-8 | Enolase.neuron specific Ag [Presence] in Tissue by Immune stain |
10478-6 | Eosinophil major basic protein Ag [Presence] in Tissue by Immune stain |
10479-4 | CD227 Ag [Presence] in Tissue by Immune stain |
1048-8 | H NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10480-2 | Estrogen+Progesterone receptor Ag [Presence] in Tissue by Immune stain |
10481-0 | Follitropin.alpha subunit Ag [Presence] in Tissue by Immune stain |
10482-8 | Follitropin.beta subunit Ag [Presence] in Tissue by Immune stain |
10483-6 | Gastrin Ag [Presence] in Tissue by Immune stain |
10484-4 | Glial fibrillary acidic protein Ag [Presence] in Tissue by Immune stain |
10485-1 | Glucagon Ag [Presence] in Tissue by Immune stain |
10486-9 | Hemoglobin Ag [Presence] in Tissue by Immune stain |
10487-7 | HMB-45 Ag [Presence] in Tissue by Immune stain |
10488-5 | IgA Ag [Presence] in Tissue by Immune stain |
10489-3 | IgA.heavy chain Ag [Presence] in Tissue by Immune stain |
1049-6 | H NOS Ag [Presence] on Red Blood Cells from donor |
10490-1 | IgE Ag [Presence] in Tissue by Immune stain |
10491-9 | IgG Ag [Presence] in Tissue by Immune stain |
10492-7 | IgG.heavy chain Ag [Presence] in Tissue by Immune stain |
10493-5 | IgM Ag [Presence] in Tissue by Immune stain |
10494-3 | IgM.heavy chain Ag [Presence] in Tissue by Immune stain |
10495-0 | Insulin Ag [Presence] in Tissue by Immune stain |
10496-8 | Immunoglobulin light chains.kappa Ag [Presence] in Tissue by Immune stain |
10497-6 | Immunoglobulin light chains.kappa amyloid Ag [Presence] in Tissue by Immune stain |
10498-4 | Keratin Ag [Presence] in Tissue by Immune stain |
10499-2 | Immunoglobulin light chains.lambda Ag [Presence] in Tissue by Immune stain |
105-7 | Ceforanide [Susceptibility] by Disk diffusion (KB) |
1050-4 | H NOS Ag [Presence] on Red Blood Cells |
10500-7 | Immunoglobulin light chains.lambda amyloid Ag [Presence] in Tissue by Immune stain |
10501-5 | Lutropin [Units/volume] in Serum or Plasma |
10502-3 | Lutropin Ag [Presence] in Tissue by Immune stain |
10503-1 | Lysozyme Ag [Presence] in Tissue by Immune stain |
10504-9 | Myelin basic protein Ag [Presence] in Tissue by Immune stain |
10505-6 | Myoglobin Ag [Presence] in Tissue by Immune stain |
10506-4 | Peanut agglutinin Ag [Presence] in Tissue by Immune stain |
10507-2 | Prolactin Ag [Presence] in Tissue by Immune stain |
10508-0 | Prostate specific Ag [Presence] in Tissue by Immune stain |
10509-8 | Prostatic acid phosphatase Ag [Presence] in Tissue by Immune stain |
1051-2 | Hemolytic disease of newborn screen [Interpretation] in Blood |
10510-6 | S-100 Ag Ag [Presence] in Tissue by Immune stain |
10511-4 | Serotonin Ag [Presence] in Tissue by Immune stain |
10512-2 | Somatostatin Ag [Presence] in Tissue by Immune stain |
10513-0 | Somatotropin Ag [Presence] in Tissue by Immune stain |
10514-8 | Synaptophysin Ag [Presence] in Tissue by Immune stain |
10515-5 | Thyroglobulin Ag [Presence] in Tissue by Immune stain |
10516-3 | Thyrotropin Ag [Presence] in Tissue by Immune stain |
10517-1 | Trypsin Ag [Presence] in Tissue by Immune stain |
10518-9 | Ulex europaeus I lectin Ag [Presence] in Tissue by Immune stain |
10519-7 | Vimentin Ag [Presence] in Tissue by Immune stain |
1052-0 | Deprecated I (intermediate) subtype [Presence] in Serum or Plasma from Blood product unit |
10520-5 | Coagulation factor VI Ag [Presence] in Tissue by Immune stain |
10521-3 | Coagulation factor VIII Ag [Presence] in Tissue by Immune stain |
10522-1 | Coagulation factor XIII Ag [Presence] in Tissue by Immune stain |
10523-9 | Fibrinogen Ag [Presence] in Tissue by Immune stain |
10524-7 | Microscopic observation [Identifier] in Cervix by Cyto stain |
10525-4 | Microscopic observation [Identifier] in Unspecified specimen by Cyto stain |
10526-2 | Microscopic observation [Identifier] in Sputum by Cyto stain |
10527-0 | Microscopic observation [Identifier] in Tissue by Cyto stain |
10528-8 | Acetophenazine [Mass/volume] in Serum or Plasma |
10529-6 | Amoxapine metabolite [Mass/volume] in Serum or Plasma |
1053-8 | Deprecated I (intermediate) subtype [Presence] in serum or plasma from donor |
10530-4 | Aprobarbital [Mass/volume] in Serum or Plasma |
10531-2 | Bretylium [Mass/volume] in Serum or Plasma |
10532-0 | Deprecated Desethylamiodarone [Mass/volume] in Serum or Plasma |
10533-8 | Propoxyphene+Acetaminophen [Mass/volume] in Serum or Plasma |
10534-6 | Diazoxide [Mass/volume] in Serum or Plasma |
10535-3 | Digoxin [Mass/volume] in Serum or Plasma |
10536-1 | Dipyridamole [Mass/volume] in Serum or Plasma |
10537-9 | Deprecated Doxepin+Nordoxepin [Mass/volume] in Serum or Plasma |
10538-7 | Deprecated Fluoxetine+Norfluoxetine [Mass/volume] in Serum or Plasma |
10539-5 | Glipizide [Mass/volume] in Serum or Plasma |
1054-6 | Deprecated I (intermediate) subtype [Presence] in srum |
10540-3 | Glyburide [Mass/volume] in Serum or Plasma |
10541-1 | Mepivacaine [Mass/volume] in Serum or Plasma |
10542-9 | Metharbital [Mass/volume] in Serum or Plasma |
10543-7 | Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
10544-5 | Normeperidine [Presence] in Serum or Plasma |
10545-2 | Normephenytoin [Mass/volume] in Serum or Plasma |
10546-0 | Normethsuximide [Mass/volume] in Serum or Plasma |
10547-8 | Primidone+Phenobarbital [Mass/volume] in Serum or Plasma |
10548-6 | Phenytoin Free/Phenytoin.total in Serum or Plasma |
10549-4 | Pirmenol [Mass/volume] in Serum or Plasma |
1055-3 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
10550-2 | Deprecated Temazepam [Mass/volume] in Serum or Plasma |
10551-0 | Triamterene [Mass/volume] in Serum or Plasma |
10552-8 | Tricyclic antidepressants [Mass/volume] in Serum or Plasma |
10553-6 | Prostatic acid phosphatase [Enzymatic activity/volume] in Genital fluid |
10554-4 | Deprecated Prostatic acid phosphatase [Enzymatic activity/volume] in Seminal plasma |
10555-1 | Acrosin [Entitic Catalytic Activity] in Spermatozoa |
10556-9 | Deprecated Adenosine triphosphatase [Enzymatic activity/volume] in Seminal plasma |
10557-7 | Adenosine triphosphate [Moles/volume] in Semen |
10558-5 | Albumin [Moles/volume] in Semen |
10559-3 | Deprecated Calcium [Molecules/volume] in Semen |
1056-1 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells from donor |
10560-1 | Carcinoembryonic Ag [Units/volume] in Semen |
10561-9 | Carnitine [Moles/volume] in Semen |
10562-7 | Cells [#/volume] in Cervical mucus |
10563-5 | Cells other than spermatozoa [#/volume] in Semen |
10564-3 | Cervical mucus [Volume] |
10565-0 | Choriogonadotropin [Units/volume] in Semen |
10566-8 | Deprecated Choriogonadotropin [Molecules/volume] in Semen |
10567-6 | Citrate [Moles/volume] in Semen |
10568-4 | Clarity of Semen |
10569-2 | Color of Semen |
1057-9 | Deprecated I (intermediate) subtype [Presence] on Red Blood Cells |
10570-0 | Consistency of Cervical mucus |
10571-8 | Deprecated Consistency of Semen |
10572-6 | Deprecated Duration^post ejaculation |
10573-4 | Ferning [Type] in Cervical mucus |
10574-2 | Fructose [Moles/volume] in Semen |
10575-9 | Deprecated Gamma glutamyl transferase [Enzymatic activity/volume] in Semen |
10576-7 | Germ cells.immature [#/volume] in Semen |
10577-5 | Glucosidase [Enzymatic activity/volume] in Seminal plasma |
10578-3 | Glycerophosphocholine [Moles/volume] in Seminal plasma |
10579-1 | Leukocytes [#/volume] in Semen |
1058-7 | I Ab [Presence] in Serum or Plasma from Blood product unit |
10580-9 | Liquefaction [Time] in Semen |
10581-7 | Deprecated Number of entities [#] in Spermatozoa |
10582-5 | pH of Cervical mucus |
10583-3 | Prostaglandin F1 alpha [Moles/volume] in Semen |
10584-1 | Deprecated Protein [Mass/volume] in Semen |
10585-8 | Round cells [#/volume] in Semen |
10586-6 | Deprecated Volume of Semen |
10587-4 | Sexual abstinence duration |
10588-2 | Spermatogonia [#/volume] in Semen |
10589-0 | Spermatids [#/volume] in Semen by Streptoavidin-biotin method (SAB) |
1059-5 | I Ab [Presence] in Serum or Plasma from donor |
10590-8 | Spermatids [#/volume] in Semen by Sertoli cell barrier method (SCB) |
10591-6 | Primary Spermatocytes [#/volume] in Semen |
10592-4 | Secondary Spermatocytes [#/volume] in Semen |
10593-2 | Spermatozoa Pyriform Head/100 spermatozoa in Semen |
10594-0 | Spermatozoa Tapering Head/100 spermatozoa in Semen |
10595-7 | Deprecated Spermatozoa [#/volume] in Semen |
10596-5 | Deprecated Spermatozoa Ab in cervical mucosa |
10597-3 | Deprecated Spermatozoa Ab in semen |
10598-1 | Deprecated Spermatozoa Ab in serum |
10599-9 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa by Kremer test |
106-5 | Ceforanide [Susceptibility] by Serum bactericidal titer |
1060-3 | I Ab [Presence] in Serum or Plasma |
10600-5 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa |
10601-3 | Spermatozoa penetration [Presence] in Seminal fluid and Cervical mucosa --post coitus |
10602-1 | Spermatozoa Abnormal Head/100 spermatozoa in Semen |
10603-9 | Spermatozoa Abnormal Midpiece/100 spermatozoa in Semen |
10604-7 | Spermatozoa Abnormal Tail/100 spermatozoa in Semen |
10605-4 | Spermatozoa Agglutinated/100 spermatozoa in Semen |
10606-2 | Spermatozoa Amorphous Head/100 spermatozoa in Semen |
10607-0 | Spermatozoa Coiled Tail/100 spermatozoa in Semen |
10608-8 | Spermatozoa Cytoplasmic Droplet/100 spermatozoa in Semen |
10609-6 | Spermatozoa Duplicate Head/100 spermatozoa in Semen |
1061-1 | I NOS Ab [Presence] in Serum or Plasma from Blood product unit |
10610-4 | Spermatozoa Duplicate Tail/100 spermatozoa in Semen |
10611-2 | Spermatozoa Immotile/100 spermatozoa in Semen |
10612-0 | Spermatozoa Large Oval Head/100 spermatozoa in Semen |
10613-8 | Spermatozoa Viable/100 spermatozoa in Semen |
10614-6 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Immunobead |
10615-3 | Spermatozoa Motile w IgA/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10616-1 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Immunobead |
10617-9 | Spermatozoa Motile w IgG/100 spermatozoa in Semen by Mixed antiglobulin reaction |
10618-7 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Immunobead |
10619-5 | Spermatozoa Motile w IgM/100 spermatozoa in Semen by Mixed antiglobulin reaction |
1062-9 | I NOS Ab [Presence] in Serum or Plasma from donor |
10620-3 | Spermatozoa Nonprogressive/100 spermatozoa in Semen |
10621-1 | Spermatozoa Normal Head/100 spermatozoa in Semen |
10622-9 | Spermatozoa Normal/100 spermatozoa in Semen |
10623-7 | Spermatozoa Pin Head/100 spermatozoa in Semen |
10624-5 | Spermatozoa Rapid/100 spermatozoa in Semen |
10625-2 | Spermatozoa Round Head/100 spermatozoa in Semen |
10626-0 | Spermatozoa Slow/100 spermatozoa in Semen |
10627-8 | Spermatozoa Small Oval Head/100 spermatozoa in Semen |
10628-6 | Spermatozoa Tail Swelling/100 spermatozoa in Semen |
10629-4 | Spermatozoa Vacuolated Head/100 spermatozoa in Semen |
1063-7 | I NOS Ab [Presence] in Serum or Plasma |
10630-2 | Spinnbarkeit [Length] in Cervical mucus |
10631-0 | Testosterone [Moles/volume] in Semen |
10632-8 | Time until next menstrual period |
10633-6 | Zinc [Moles/volume] in Semen |
10634-4 | Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma |
10635-1 | Acanthamoeba sp identified in Eye by Organism specific culture |
10636-9 | Acanthamoeba sp identified in Eye by Wet preparation |
10637-7 | Microscopic observation [Identifier] in Tissue by Night blue stain |
10638-5 | Thermophilic Actinomycetes colony count [#/volume] in Unspecified specimen by Organism specific culture |
10639-3 | Thermophilic Actinomycetes identified in Unspecified specimen by Organism specific culture |
1064-5 | I NOS Ag [Presence] on Red Blood Cells from Blood product unit |
10640-1 | Deprecated Adenovirus 40+41 [Identifier] in Stool by Electron microscopy |
10641-9 | Amoeba identified in Aspirate by Immune stain |
10642-7 | Amoeba identified in Aspirate by Wet preparation |
10643-5 | Amoeba identified in Stool by Organism specific culture |
10644-3 | Arthropod identified in Unspecified specimen |
10645-0 | Aspergillus fumigatus Ag [Presence] in Tissue by Immunofluorescence |
10646-8 | Astrovirus [Identifier] in Stool by Electron microscopy |
10647-6 | Babesia sp identified in Blood by Thick film |
10648-4 | Babesia sp identified in Blood by Thin film |
10649-2 | Calicivirus [Identifier] in Stool by Electron microscopy |
1065-2 | I NOS Ag [Presence] on Red Blood Cells from donor |
10650-0 | Candida sp DNA [Presence] in Blood by Probe with amplification |
10651-8 | Chlamydophila pneumoniae Ag [Presence] in Sputum or Bronchial |
10652-6 | Chlamydophila pneumoniae DNA [Presence] in Sputum or Bronchial by Probe with amplification |
10653-4 | Clotrimazole [Susceptibility] by Minimum inhibitory concentration (MIC) |
10654-2 | Clotrimazole [Susceptibility] by Minimum lethal concentration (MLC) |
10655-9 | Coccidia identified in Duodenal fluid by Acid fast stain |
10656-7 | Coccidia identified in Stool by Acid fast stain |
10657-5 | Deprecated Cryptococcus neoformans Ag [Presence] in Tissue by Immunofluorescence |
10658-3 | Cyanobacterium identified in Water by Light microscopy |
10659-1 | Cyclospora sp identified in Stool by Acid fast stain |
1066-0 | I NOS Ag [Presence] on Red Blood Cells |
10660-9 | Cytomegalovirus Ag [Presence] in Tissue by Immune stain |
10661-7 | Dinoflagellate identified in Water by Light microscopy |
10662-5 | Filaria identified in Blood by Concentration |
10663-3 | Filaria identified in Blood by Thick film |
10664-1 | Filaria identified in Blood by Thin film |
10665-8 | Fungus colony count [#/volume] in Unspecified specimen by Environmental culture |
10666-6 | Fungus identified in Tissue by Fontana-Masson stain |
10667-4 | Fungus identified in Unspecified specimen by Animal inoculation |
10668-2 | Fungus identified in Unspecified specimen by Environmental culture |
10669-0 | Fungus identified in Unspecified specimen by Sticky tape for environmental fungus |
1067-8 | Jk sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10670-8 | Giardia lamblia [Presence] in Stool by Organism specific culture |
10671-6 | Helminth identified in Unspecified specimen |
10672-4 | Helminth+Arthropod identified in Unspecified specimen |
10673-2 | Hepatitis B virus core Ag [Presence] in Tissue by Immune stain |
10674-0 | Hepatitis B virus surface Ag [Presence] in Tissue by Immune stain |
10675-7 | Hepatitis B virus surface Ag [Presence] in Tissue by Orcein stain |
10676-5 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification |
10677-3 | Herpes simplex virus 1 Ag [Presence] in Tissue by Immune stain |
10678-1 | Herpes simplex virus 1+2 Ag [Presence] in Tissue by Immune stain |
10679-9 | Herpes simplex virus 2 Ag [Presence] in Tissue by Immune stain |
1068-6 | Jk sup(a) Ab [Presence] in Serum or Plasma from donor |
10680-7 | Herpes simplex virus identified in Cerebral spinal fluid by Electron microscopy |
10681-5 | Herpes simplex virus identified in Tissue by Electron microscopy |
10682-3 | Deprecated HIV 1 RNA [Units/volume] in Serum or Plasma by Probe with amplification |
10683-1 | Hydatid cyst identified in Aspirate by Immune stain |
10684-9 | Hydatid cyst identified in Liver by Wet preparation |
10685-6 | Hydatid cyst identified in Lung tissue by Wet preparation |
10686-4 | Leishmania sp identified in Tissue by Giemsa stain |
10687-2 | Leishmania sp identified in Tissue by Organism specific culture |
10688-0 | Microscopic observation [Identifier] in Hair by KOH preparation |
10689-8 | Microscopic observation [Identifier] in Nail by KOH preparation |
1069-4 | Jk sup(a) Ab [Presence] in Serum or Plasma |
10690-6 | Microsporidia identified in Duodenal fluid by Trichrome stain modified |
10691-4 | Mushroom.toxic identified by Inspection |
10692-2 | Mushroom.toxic identified in Food by Light microscopy |
10693-0 | Mushroom.toxic identified in Vomitus by Light microscopy |
10694-8 | Naegleria sp identified in Tissue by Organism specific culture |
10695-5 | Naegleria sp identified in Tissue by Wet preparation |
10696-3 | Norovirus [Identifier] in Stool by Electron microscopy |
10697-1 | Nystatin [Susceptibility] by Minimum inhibitory concentration (MIC) |
10698-9 | Nystatin [Susceptibility] by Minimum lethal concentration (MLC) |
10699-7 | Onchocerca sp identified in Tissue by Wet preparation |
107-3 | Cefotaxime [Susceptibility] by Minimum lethal concentration (MLC) |
1070-2 | Jk sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10700-3 | Orthopoxvirus [Identifier] in Skin by Electron microscopy |
10701-1 | Ova and parasites identified in Stool by Concentration |
10702-9 | Ova and parasites identified in Stool by Immune stain |
10703-7 | Ova and parasites identified in Stool by Kinyoun iron hematoxylin stain |
10704-5 | Ova and parasites identified in Stool by Light microscopy |
10705-2 | Human papilloma virus Ag [Presence] in Tissue by Immune stain |
10706-0 | Picornavirus [Identifier] in Stool by Electron microscopy |
10707-8 | Toxic Plant identified in plant specimen by Inspection |
10708-6 | Toxic Plant identified in Vomitus by Light microscopy |
10709-4 | Plasmodium falciparum Ag [Units/volume] in Blood by Immunofluorescence |
1071-0 | Jk sup(a) Ag [Presence] on Red Blood Cells from donor |
10710-2 | Plasmodium sp identified in Blood by Thin film |
10711-0 | Plasmodium vivax Ag [Units/volume] in Blood by Immunofluorescence |
10712-8 | Pneumocystis sp identified in Lung tissue |
10713-6 | Prototheca identified in Unspecified specimen by Culture |
10714-4 | Deprecated Rotavirus [Identifier] in Stool by Electron microscopy |
10715-1 | Schistosoma sp identified in Urine sediment by Light microscopy |
10716-9 | Schistosoma sp identified in Unspecified specimen by Organism specific culture |
10717-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Latex agglutination |
10718-5 | Strongyloides sp Ab [Units/volume] in Serum by Immunoassay |
10719-3 | Taenia solium adult Ab [Units/volume] in Serum by Immunoblot (IB) |
1072-8 | Jk sup(a) Ag [Presence] on Red Blood Cells |
10720-1 | Terbinafine [Susceptibility] by Minimum inhibitory concentration (MIC) |
10721-9 | Terbinafine [Susceptibility] by Minimum lethal concentration (MLC) |
10722-7 | Torovirus [Identifier] in Stool by Electron microscopy |
10723-5 | Toxoplasma gondii IgA Ab [Units/volume] in Serum by Immunoassay |
10724-3 | Toxoplasma gondii IgE Ab [Units/volume] in Serum by Immunoassay |
10725-0 | Toxoplasma gondii DNA [Units/volume] in Body fluid by Probe with amplification |
10726-8 | Toxoplasma gondii [Presence] in Tissue by Giemsa stain |
10727-6 | Toxoplasma gondii identified in Tissue |
10728-4 | Trichomonas sp identified in Genital specimen by Organism specific culture |
10729-2 | Trypanosoma sp identified in Blood by Light microscopy |
1073-6 | Jk sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10730-0 | Trypanosoma sp identified in Blood by Organism specific culture |
10731-8 | Trypanosoma sp identified in Blood by Thick film |
10732-6 | Trypanosoma sp identified in Blood by Thin film |
10733-4 | Trypanosoma sp identified in Blood by Wet preparation |
10734-2 | Varicella zoster virus identified in Skin by Electron microscopy |
10735-9 | Viral sequencing [Identifier] in Serum by Sequencing |
10736-7 | Virus identified in Cerebral spinal fluid by Electron microscopy |
10737-5 | Virus identified in Stool by Electron microscopy |
10738-3 | Virus identified in Tissue by Electron microscopy |
10739-1 | Virus identified in Unspecified specimen by Electron microscopy |
1074-4 | Jk sup(b) Ab [Presence] in Serum or Plasma from donor |
10740-9 | Aluminum.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10741-7 | Amyloid.microscopic observation [Identifier] in Brain by Thioflavine-S stain |
10742-5 | Amyloid.microscopic observation [Identifier] in Tissue by Bennhold stain.Putchler modified |
10743-3 | Amyloid.microscopic observation [Identifier] in Tissue by Highman stain |
10744-1 | Amyloid.microscopic observation [Identifier] in Tissue by Vassar-culling stain |
10745-8 | Bile.microscopic observation [Identifier] in Tissue by Fouchet stain |
10746-6 | Calcium.microscopic observation [Identifier] in Tissue by Von Kossa stain |
10747-4 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Lawson-Van Gieson stain |
10748-2 | Collagen fibers+Elastic fibers.microscopic observation [Identifier] in Tissue by Verhoeff-Van Gieson stain |
10749-0 | Collagen fibers.microscopic observation [Identifier] in Tissue by Van Gieson stain |
1075-1 | Jk sup(b) Ab [Presence] in Serum or Plasma |
10750-8 | Connective tissue.microscopic observation [Identifier] in Tissue by Trichrome stain.Masson |
10751-6 | Copper.microscopic observation [Identifier] in Tissue by Rhodamine stain |
10752-4 | Fat.microscopic observation [Identifier] in Milk by Sudan IV stain |
10753-2 | Fat.microscopic observation [Identifier] in Stool by Sudan IV stain |
10754-0 | Fat.microscopic observation [Identifier] in Tissue by Sudan IV stain |
10755-7 | Fungus.microscopic observation [Identifier] in Tissue by Methenamine silver stain.Grocott |
10756-5 | Glial fibers.microscopic observation [Identifier] in Tissue by Holzer stain |
10757-3 | Hematologic+Nuclear elements.microscopic observation [Identifier] in Tissue by Giemsa stain.May-Grunwald |
10758-1 | Iron.microscopic observation [Identifier] in Bone by Histomorphometry stain |
10759-9 | Iron.microscopic observation [Identifier] in Sputum by Gomori stain |
1076-9 | Jk sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10760-7 | Iron.microscopic observation [Identifier] in Tissue by Gomori stain |
10761-5 | Iron.microscopic observation [Identifier] in Tissue by Other stain |
10762-3 | Microscopic observation [Identifier] in Blood by Hemosiderin stain |
10763-1 | Microscopic observation [Identifier] in Body fluid by Sudan black stain |
10764-9 | Microscopic observation [Identifier] in Sputum by Silver stain |
10765-6 | Microscopic observation [Identifier] in Tissue by Acetate esterase stain |
10766-4 | Microscopic observation [Identifier] in Tissue by Alcian blue stain |
10767-2 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.sulfated |
10768-0 | Microscopic observation [Identifier] in Tissue by Alcian blue stain.with periodic acid-Schiff |
10769-8 | Microscopic observation [Identifier] in Tissue by Alizarin red S stain |
1077-7 | Jk sup(b) Ag [Presence] on Red Blood Cells from donor |
10770-6 | Microscopic observation [Identifier] in Tissue by Argentaffin stain |
10771-4 | Deprecated Microscopic observation [Identifier] in Tissue by Rhodamine-auramine fluorochrome stain |
10772-2 | Microscopic observation [Identifier] in Tissue by Azure-eosin stain |
10773-0 | Microscopic observation [Identifier] in Tissue by Basic fuchsin stain |
10774-8 | Microscopic observation [Identifier] in Tissue by Bielschowsky stain |
10775-5 | Microscopic observation [Identifier] in Tissue by Bleach stain |
10776-3 | Microscopic observation [Identifier] in Tissue by Bodian stain |
10777-1 | Microscopic observation [Identifier] in Tissue by Brown and Brenn stain |
10778-9 | Microscopic observation [Identifier] in Tissue by Butyrate esterase stain |
10779-7 | Microscopic observation [Identifier] in Tissue by Carmine stain.Best |
1078-5 | Jk sup(b) Ag [Presence] on Red Blood Cells |
10780-5 | Microscopic observation [Identifier] in Tissue by Chloracetate esterase stain |
10781-3 | Microscopic observation [Identifier] in Tissue by Churukian-Schenk stain |
10782-1 | Microscopic observation [Identifier] in Tissue by Congo red stain |
10783-9 | Microscopic observation [Identifier] in Tissue by Crystal violet stain |
10784-7 | Microscopic observation [Identifier] in Tissue by Esterase stain.non-specific |
10785-4 | Microscopic observation [Identifier] in Tissue by Fite-Faraco stain |
10786-2 | Microscopic observation [Identifier] in Tissue by Giemsa stain.3 micron |
10787-0 | Microscopic observation [Identifier] in Tissue by Gridley stain |
10788-8 | Microscopic observation [Identifier] in Tissue by Hansel stain |
10789-6 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Harris regressive stain |
1079-3 | Js sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10790-4 | Microscopic observation [Identifier] in Tissue by Hematoxylin-eosin-Mayers progressive stain |
10791-2 | Microscopic observation [Identifier] in Tissue by Mallory-Heidenhain stain |
10792-0 | Microscopic observation [Identifier] in Tissue by Methenamine silver stain.Jones |
10793-8 | Microscopic observation [Identifier] in Tissue by Methyl green stain |
10794-6 | Microscopic observation [Identifier] in Tissue by Methyl green-pyronine Y stain |
10795-3 | Microscopic observation [Identifier] in Tissue by Methyl violet stain |
10796-1 | Microscopic observation [Identifier] in Tissue by Mucicarmine stain |
10797-9 | Microscopic observation [Identifier] in Tissue by Neutral red stain |
10798-7 | Microscopic observation [Identifier] in Tissue by Oil red O stain |
10799-5 | Microscopic observation [Identifier] in Tissue by Pentachrome stain.Movat |
108-1 | Cefotaxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
1080-1 | Js sup(a) Ab [Presence] in Serum or Plasma from donor |
10800-1 | Microscopic observation [Identifier] in Tissue by Periodic acid-Schiff stain with diatase digestion |
10801-9 | Microscopic observation [Identifier] in Tissue by Phosphotungstic acid Hematoxylin (PTAH) Stain |
10802-7 | Microscopic observation [Identifier] in Tissue by Prussian blue stain |
10803-5 | Microscopic observation [Identifier] in Tissue by Quinacrine fluorescent stain |
10804-3 | Microscopic observation [Identifier] in Tissue by Reticulin stain |
10805-0 | Microscopic observation [Identifier] in Tissue by Safranin stain |
10806-8 | Microscopic observation [Identifier] in Tissue by Schmorl stain |
10807-6 | Microscopic observation [Identifier] in Tissue by Sevier-Munger stain |
10808-4 | Microscopic observation [Identifier] in Tissue by Silver impregnation stain.Dieterle |
10809-2 | Microscopic observation [Identifier] in Tissue by Silver nitrate stain |
1081-9 | Js sup(a) Ab [Presence] in Serum or Plasma |
10810-0 | Microscopic observation [Identifier] in Tissue by Silver stain.Fontana-Masson |
10811-8 | Microscopic observation [Identifier] in Tissue by Silver stain.Grimelius |
10812-6 | Microscopic observation [Identifier] in Tissue by Steiner stain |
10813-4 | Microscopic observation [Identifier] in Tissue by Sudan black stain |
10814-2 | Microscopic observation [Identifier] in Tissue by Supravital stain |
10815-9 | Microscopic observation [Identifier] in Tissue by Tetrachrome stain |
10816-7 | Deprecated Microscopic observation [Identifier] in Tissue by Toluidine blue O stain |
10817-5 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Gomori-Wheatley |
10818-3 | Microscopic observation [Identifier] in Tissue by Trichrome stain.Masson modified |
10819-1 | Microscopic observation [Identifier] in Tissue by Wade stain |
1082-7 | Js sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
10820-9 | Deprecated Microscopic observation [Identifier] in Tissue by Warthin-Starry stain |
10821-7 | Deprecated Microscopic observation [Identifier] in Tissue by Wright Giemsa stain |
10822-5 | Mucin.microscopic observation [Identifier] in Tissue by Mucicarmine stain.Mayer |
10823-3 | Mucopolysaccharides.microscopic observation [Identifier] in Tissue by Colloidal ferric oxide stain.Hale |
10824-1 | Myelin+Myelin breakdown products.microscopic observation [Identifier] in Tissue by Luxol fast blue/Periodic acid-Schiff stain |
10825-8 | Myelin+Nerve cells.microscopic observation [Identifier] in Tissue by Luxol fast blue/Cresyl violet stain |
10826-6 | Nissel.microscopic observation [Identifier] in Tissue by Cresyl echt violet stain |
10827-4 | Reticulum.microscopic observation [Identifier] in Tissue by Gomori stain |
10828-2 | Urate crystals.microscopic observation [type] in Tissue by De Galantha stain |
10829-0 | Silicon [Mass/volume] in Serum or Plasma |
1083-5 | Js sup(a) Ag [Presence] on Red Blood Cells from donor |
10830-8 | Deprecated Surgical operation note complications |
10831-6 | Surgical operation note complications [Interpretation] |
10832-4 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 50 g lactose PO |
10833-2 | Insulin [Mass/volume] in Serum or Plasma --7 hours post 75 g glucose PO |
10834-0 | Globulin [Mass/volume] in Serum by calculation |
10835-7 | Lipoprotein a [Mass/volume] in Serum or Plasma |
10836-5 | Niacin [Mass/volume] in Blood |
10837-3 | Organic acids [Presence] in Serum or Plasma |
10838-1 | Phosphoserine [Mass/volume] in Serum or Plasma |
10839-9 | Troponin I.cardiac [Mass/volume] in Serum or Plasma |
1084-3 | Js sup(a) Ag [Presence] on Red Blood Cells |
10840-7 | Atropine [Mass/volume] in Urine |
10841-5 | Methazolamide [Mass/volume] in Serum or Plasma |
10842-3 | Deprecated HLA-DQ1 [Presence] |
10843-1 | Deprecated HLA-DQ2 [Presence] |
10844-9 | Deprecated HLA-DQ3 [Presence] |
10845-6 | Deprecated HLA-DQ4 [Presence] |
10846-4 | Borrelia burgdorferi DNA [Presence] in Blood by Probe with amplification |
10847-2 | Borrelia burgdorferi DNA [Presence] in Body fluid by Probe with amplification |
10848-0 | Chlamydia sp IgG Ab [Titer] in Serum by Immunofluorescence |
10849-8 | Chlamydia sp IgM Ab [Titer] in Serum by Immunofluorescence |
1085-0 | Js sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
10850-6 | Cyclospora cayetanensis [Presence] in Unspecified specimen |
10851-4 | Escherichia coli O157:H7 [Presence] in Stool by Organism specific culture |
10852-2 | Deprecated Fungus identified in Blood by Culture |
10853-0 | Isospora belli [Presence] in Unspecified specimen by Acid fast stain.Kinyoun modified |
10854-8 | Deprecated Midrofilaria identified in Blood by Concentration |
10855-5 | Ova and parasites identified in Duodenal fluid or Gastric fluid by Light microscopy |
10856-3 | Microscopic observation [Identifier] in Genital mucus by Gram stain |
10857-1 | Microsporidia identified in Unspecified specimen by Light microscopy |
10858-9 | Teichoate Ab [Presence] in Serum |
10859-7 | Trypanosoma sp [Identifier] in Blood by Acridine Orange + Giemsa Stain |
1086-8 | Js sup(b) Ab [Presence] in Serum or Plasma from donor |
10860-5 | Varicella zoster virus [Presence] in Unspecified specimen by Organism specific culture |
10861-3 | Progesterone receptor [Mass/mass] in Tissue |
10862-1 | Basement membrane Ab [Titer] in Serum |
10863-9 | Endomysium IgA Ab [Titer] in Serum |
10864-7 | Immune complex [Units/volume] in Serum or Plasma by Raji cell assay |
10865-4 | Intercellular substance Ab [Presence] in Serum |
10866-2 | Sulfatide IgG Ab [Titer] in Serum |
10867-0 | Sulfatide IgM Ab [Titer] in Serum |
10868-8 | Bacitracin [Susceptibility] by Disk diffusion (KB) |
10869-6 | Xylose [Mass/volume] in Blood --3 hours post 25 g xylose PO |
1087-6 | Js sup(b) Ab [Presence] in Serum or Plasma |
10870-4 | Xylose [Mass/volume] in Blood --4 hours post 25 g xylose PO |
10871-2 | Xylose [Mass/volume] in Blood --5 hours post 25 g xylose PO |
10872-0 | Xylose [Mass/volume] in Blood --baseline |
10873-8 | Beta-2-Microglobulin [Mass/time] in 24 hour Urine |
10874-6 | Bombesin [Mass/volume] in Plasma |
10875-3 | Carnitine esters [Mass/volume] in Urine |
10876-1 | Carnitine esters [Mass/volume] in Serum or Plasma |
10877-9 | Carnitine free (C0) [Mass/volume] in Urine |
10878-7 | Iodine.protein bound [Mass/volume] in Serum or Plasma |
10879-5 | Isovalerylglycine [Mass/volume] in Urine |
1088-4 | Js sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
10880-3 | Magnesium [Mass/mass] in Stool |
10881-1 | Pentacarboxylporphyrins [Mass/volume] in Red Blood Cells |
10882-9 | Pentacarboxylporphyrins [Mass/volume] in Serum or Plasma |
10883-7 | Phenolphthalein [Mass/mass] in Stool |
10884-5 | Phosphate [Mass/mass] in Stool |
10885-2 | Porphyrins [Mass/time] in 24 hour Urine |
10886-0 | Prostate Specific Ag Free [Mass/volume] in Serum or Plasma |
10887-8 | Pyridinoline [Mass/time] in 24 hour Urine |
10888-6 | Lipase [Enzymatic activity/volume] in Urine |
10889-4 | Bisacodyl [Mass/mass] in Stool |
1089-2 | Js sup(b) Ag [Presence] on Red Blood Cells from donor |
10890-2 | Deprecated Normethsuximide [Mass/volume] in Serum or Plasma |
10891-0 | Oxyphenisatin [Mass/mass] in Stool |
10892-8 | Pentoxifylline [Mass/volume] in Serum or Plasma |
10893-6 | Trenbolone [Mass/volume] in Urine |
10894-4 | Aspergillus niger Ab [Presence] in Serum by Immune diffusion (ID) |
10895-1 | Clostridium difficile toxin B [Presence] in Stool |
10896-9 | Eastern equine encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
10897-7 | Eastern equine encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
10898-5 | Eastern equine encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
10899-3 | Eastern equine encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
109-9 | Cefotaxime [Susceptibility] by Disk diffusion (KB) |
1090-0 | Js sup(b) Ag [Presence] on Red Blood Cells |
10900-9 | Hepatitis B virus surface Ab [Presence] in Serum by Immunoassay |
10901-7 | HIV 2 gp125 Ab [Presence] in Serum by Immunoblot (IB) |
10902-5 | HIV 2 gp36 Ab [Presence] in Serum by Immunoblot (IB) |
10903-3 | Hyaluronidase Ab [Titer] in Serum |
10904-1 | La Crosse virus IgG Ab [Titer] in Serum by Immunofluorescence |
10905-8 | La Crosse virus IgM Ab [Titer] in Serum by Immunofluorescence |
10906-6 | Saint Louis encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
10907-4 | Saint Louis encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
10908-2 | Streptococcus pneumoniae 7 IgG Ab [Units/volume] in Serum by Immunoassay |
10909-0 | Benzidine [Mass/volume] in Urine |
1091-8 | K Ab [Presence] in Serum or Plasma from Blood product unit |
10910-8 | Borate [Mass/volume] in Urine |
10911-6 | Dichlorobenzidine [Mass/volume] in Urine |
10912-4 | Lead [Mass/volume] in Serum or Plasma |
10913-2 | 4,4'-Methylene bis(2-Chloroaniline) [Mass/volume] in Urine |
10914-0 | Methylenediamine [Mass/volume] in Urine |
10915-7 | Phencyclidine [Mass/volume] in Unspecified specimen |
10916-5 | Platinum [Mass/volume] in Blood |
10917-3 | Zinc [Mass/mass] in Stool |
10918-1 | Zinc [Mass/volume] in Unspecified specimen |
10919-9 | Anisakis IgE Ab [Units/volume] in Serum |
1092-6 | K Ab [Presence] in Serum or Plasma from donor |
10920-7 | Bamboo shoot IgE Ab [Units/volume] in Serum |
10921-5 | Blomia tropicalis IgE Ab [Units/volume] in Serum |
10922-3 | Bovine serum albumin (BSA) IgE Ab [Units/volume] in Serum |
10923-1 | Bromelin IgE Ab [Units/volume] in Serum |
10924-9 | Starfruit IgE Ab [Units/volume] in Serum |
10925-6 | Chub Mackerel IgE Ab [Units/volume] in Serum |
10926-4 | Deer epithelium IgE Ab [Units/volume] in Serum |
10927-2 | Elk or Moose Meat IgE Ab [Units/volume] in Serum |
10928-0 | Fennel Fresh IgE Ab [Units/volume] in Serum |
10929-8 | Fennel Seed IgE Ab [Units/volume] in Serum |
1093-4 | K Ab [Presence] in Serum or Plasma |
10930-6 | Fish Feed IgE Ab [Units/volume] in Serum |
10931-4 | Daphnia (fish feed) IgE Ab [Units/volume] in Serum |
10932-2 | Tetramin IgE Ab [Units/volume] in Serum |
10933-0 | Guar gum IgE Ab [Units/volume] in Serum |
10934-8 | Guava IgE Ab [Units/volume] in Serum |
10935-5 | Horse serum proteins IgE Ab [Units/volume] in Serum |
10936-3 | Mare milk IgE Ab [Units/volume] in Serum |
10937-1 | Marjoram IgE Ab [Units/volume] in Serum |
10938-9 | Mediterranean flour moth IgE Ab [Units/volume] in Serum |
10939-7 | Whiff IgE Ab [Units/volume] in Serum |
1094-2 | K Ag [Presence] on Red Blood Cells from Blood product unit |
10940-5 | Cow milk boiled IgE Ab [Units/volume] in Serum |
10941-3 | Milk powder IgE Ab [Units/volume] in Serum |
10942-1 | Cockspur IgE Ab [Units/volume] in Serum |
10943-9 | Mink epithelium IgE Ab [Units/volume] in Serum |
10944-7 | Octopus IgE Ab [Units/volume] in Serum |
10945-4 | Papain IgE Ab [Units/volume] in Serum |
10946-2 | Passion fruit IgE Ab [Units/volume] in Serum |
10947-0 | Persimmon IgE Ab [Units/volume] in Serum |
10948-8 | Pigeon feather IgE Ab [Units/volume] in Serum |
10949-6 | Malassezia furfur IgE Ab [Units/volume] in Serum |
1095-9 | K Ag [Presence] on Red Blood Cells from donor |
10950-4 | Reindeer epithelium IgE Ab [Units/volume] in Serum |
10951-2 | Sericin IgE Ab [Units/volume] in Serum |
10952-0 | Swine urine proteins IgE Ab [Units/volume] in Serum |
10953-8 | Timothy IgG Ab [Units/volume] in Serum |
10954-6 | Pine Nut IgE Ab [Units/volume] in Serum |
10955-3 | Long Leaf Pine IgE Ab [Units/volume] in Serum |
10956-1 | Short Leaf Pine IgE Ab [Units/volume] in Serum |
10957-9 | Slash Pine IgE Ab [Units/volume] in Serum |
10958-7 | Virginia Scrub Pine IgE Ab [Units/volume] in Serum |
10959-5 | Plaice IgE Ab [Units/volume] in Serum |
1096-7 | K Ag [Presence] on Red Blood Cells |
10960-3 | Rabbit serum proteins IgE Ab [Units/volume] in Serum |
10961-1 | Rabbit urine proteins IgE Ab [Units/volume] in Serum |
10962-9 | Deprecated Sagebrush tridenda IgE Ab [Units/volume] in Serum |
10963-7 | Spondylocladium citrovirens IgE Ab [Units/volume] in Serum |
10964-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
10965-2 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
10966-0 | Glucose [Presence] in Urine by Test strip --2.5 hours post 75 g glucose PO |
10967-8 | Glucose [Presence] in Urine by Test strip --3.5 hours post 75 g glucose PO |
10968-6 | Glucose [Presence] in Urine by Test strip --4.5 hours post 75 g glucose PO |
10969-4 | Cystine+Homocysteine [Presence] in Urine |
1097-5 | Kp sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
10970-2 | Galactose 1 phosphate uridyl transferase [Enzymatic activity/volume] in Blood |
10971-0 | Lysozyme [Mass/volume] in Urine |
10972-8 | Organic acids [Mass/volume] in Urine |
10973-6 | 3 methoxy O desmethylencainide [Mass/volume] in Serum or Plasma |
10974-4 | 5-Fluorocytosine [Mass/volume] in Urine |
10975-1 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Urine |
10976-9 | 6-Monoacetylmorphine (6-MAM) [Presence] in Urine |
10977-7 | Alprazolam [Mass/volume] in Blood |
10978-5 | Amitriptyline+Nortriptyline [Mass/volume] in Urine |
10979-3 | Carisoprodol [Mass/volume] in Urine |
1098-3 | Kp sup(a) Ab [Presence] in Serum or Plasma from donor |
10980-1 | Cephapirin [Mass/volume] in Serum or Plasma |
10981-9 | Clonidine [Mass/volume] in Urine |
10982-7 | Demeclocycline [Mass/volume] in Serum or Plasma |
10983-5 | Norparamethadione [Mass/volume] in Serum or Plasma |
10984-3 | Dicloxacillin [Mass/volume] in Serum or Plasma |
10985-0 | Doxapram [Mass/volume] in Serum or Plasma |
10986-8 | Doxycycline [Mass/volume] in Serum or Plasma |
10987-6 | Fluconazole [Mass/volume] in Serum or Plasma |
10988-4 | Fluvoxamine [Mass/volume] in Serum or Plasma |
10989-2 | Itraconazole [Mass/volume] in Serum or Plasma |
1099-1 | Kp sup(a) Ab [Presence] in Serum or Plasma |
10990-0 | Ketoconazole [Mass/volume] in Serum or Plasma |
10991-8 | Metronidazole [Mass/volume] in Serum or Plasma |
10992-6 | Norclozapine [Mass/volume] in Serum or Plasma |
10993-4 | Nafcillin [Mass/volume] in Serum or Plasma |
10994-2 | Naltrexone [Mass/volume] in Serum or Plasma |
10995-9 | Neomycin [Mass/volume] in Serum or Plasma |
10996-7 | Normeperidine [Mass/volume] in Serum or Plasma |
10997-5 | O-desmethylencainide [Mass/volume] in Serum or Plasma |
10998-3 | Oxycodone [Presence] in Urine |
10999-1 | Paramethadione [Mass/volume] in Serum or Plasma |
11-7 | Amikacin [Susceptibility] by Minimum lethal concentration (MLC) |
110-7 | Cefotaxime [Susceptibility] by Serum bactericidal titer |
1100-7 | Kp sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
11000-7 | Promethazine [Presence] in Urine |
11001-5 | Pyrazinamide [Mass/volume] in Serum or Plasma |
11002-3 | Scopolamine [Presence] in Urine |
11003-1 | Ticlopidine [Mass/volume] in Serum or Plasma |
11004-9 | Tricyclic antidepressants [Presence] in Urine |
11005-6 | Trimethoprim [Mass/volume] in Serum or Plasma |
11006-4 | Borrelia burgdorferi Ab [Presence] in Serum |
11007-2 | Borrelia burgdorferi Ag [Units/volume] in Urine |
11008-0 | Cytomegalovirus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
11009-8 | Epstein Barr virus capsid IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
1101-5 | Kp sup(a) Ag [Presence] on Red Blood Cells from donor |
11010-6 | Epstein Barr virus capsid IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
11011-4 | Hepatitis C virus RNA [Units/volume] (viral load) in Serum or Plasma by Probe and target amplification method |
11012-2 | Reovirus Ab [Titer] in Serum by Complement fixation |
11013-0 | DNA double strand Ab [Titer] in Serum |
11014-8 | Somatotropin Ab [Titer] in Serum or Plasma |
11015-5 | Somatotropin binding protein [Moles/volume] in Serum or Plasma |
11016-3 | Microscopic observation [Identifier] in Blood or Marrow by Esterase stain.non-specific |
11017-1 | Microscopic observation [Identifier] in Blood or Marrow by Chloracetate esterase stain |
11018-9 | Microscopic observation [Identifier] in Blood or Marrow by Peroxidase stain |
11019-7 | Microscopic observation [Identifier] in Blood or Marrow by Sudan black B stain |
1102-3 | Kp sup(a) Ag [Presence] on Red Blood Cells |
11020-5 | Microscopic observation [Identifier] in Blood or Marrow by Tartrate-resistant acid phosphatase stain |
11021-3 | Microscopic observation [Identifier] in Blood or Marrow by Terminal deoxynucleotidyl transferase stain |
11022-1 | Barbiturates [Mass/volume] in Meconium |
11023-9 | Benzodiazepines [Mass/volume] in Meconium |
11024-7 | Benzodiazepines [Mass/volume] in Serum or Plasma |
11025-4 | Methadone [Mass/volume] in Meconium |
11026-2 | Methaqualone [Mass/volume] in Meconium |
11027-0 | Propoxyphene [Mass/volume] in Meconium |
11028-8 | Zinc [Mass/volume] in Body fluid |
11029-6 | Consistency of Stool |
1103-1 | Kp sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
11030-4 | Aspergillus fumigatus+Aspergillus niger IgE Ab [Units/volume] in Serum |
11031-2 | Lymphocytes/100 leukocytes in Body fluid |
11032-0 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 50 g lactose PO |
11033-8 | Thyrotropin [Mass/volume] in Serum or Plasma --45 minutes post dose TRH IV |
11034-6 | Acetylcholine receptor binding Ab [Moles/volume] in Serum |
11035-3 | Adenylate kinase [Enzymatic activity/volume] in Red Blood Cells |
11036-1 | Deprecated Aldolase [Enzymatic activity/volume] in Red Blood Cells |
11037-9 | Alpha-N-acetylgalactosaminidase [Enzymatic activity/volume] in Serum or Plasma |
11038-7 | Beta+gamma tocopherol [Mass/volume] in Serum or Plasma |
11039-5 | C reactive protein [Presence] in Serum or Plasma |
1104-9 | Kp sup(b) Ab [Presence] in Serum or Plasma from donor |
11040-3 | Cortisol Free [Mass/volume] in Urine |
11041-1 | Creatinine [Mass/volume] in Serum or Plasma --post dialysis |
11042-9 | Creatinine [Mass/volume] in Serum or Plasma --pre dialysis |
11043-7 | Cryofibrinogen [Presence] in Plasma |
11044-5 | Diphosphoglycerate mutase [Enzymatic activity/volume] in Red Blood Cells |
11045-2 | Enolase [Enzymatic activity/volume] in Red Blood Cells |
11046-0 | Epinephrine [Mass/volume] in Urine |
11047-8 | Glucose phosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
11048-6 | Glyceraldehyde 3 phosphate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
11049-4 | Deprecated Hydroxyproline [Mass/volume] in Urine |
1105-6 | Kp sup(b) Ab [Presence] in Serum or Plasma |
11050-2 | Immunoglobulin light chains.kappa [Mass/volume] in Serum or Plasma |
11051-0 | Immunoglobulin light chains.lambda [Mass/volume] in Serum or Plasma |
11052-8 | Ketamine [Mass/volume] in Urine |
11053-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
11054-4 | Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma |
11055-1 | Melatonin [Mass/volume] in Serum or Plasma |
11056-9 | Melatonin [Flow] in 24 hour Urine |
11057-7 | Monophosphoglyceromutase [Enzymatic activity/volume] in Red Blood Cells |
11058-5 | Phosphofructokinase [Enzymatic activity/volume] in Red Blood Cells |
11059-3 | Phosphoglycerate kinase [Enzymatic activity/volume] in Red Blood Cells |
1106-4 | Kp sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
11060-1 | Reducing substances [Presence] in Stool |
11061-9 | Thromboxane beta 2 [Mass/time] in 24 hour Urine |
11062-7 | Thyroxine (T4).albumin bound [Mass/volume] in Serum or Plasma |
11063-5 | Triosephosphate isomerase [Enzymatic activity/volume] in Red Blood Cells |
11064-3 | Urea nitrogen [Mass/volume] in Serum or Plasma --post dialysis |
11065-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --pre dialysis |
11066-8 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Red Blood Cells |
11067-6 | Bleeding time |
11068-4 | Microscopic observation [Identifier] in Body fluid by Cyto stain |
11069-2 | Microscopic observation [Identifier] in Gastric fluid by Cyto stain |
1107-2 | Kp sup(b) Ag [Presence] on Red Blood Cells from donor |
11070-0 | Microscopic observation [Identifier] in Urine by Cyto stain |
11071-8 | Butalbital [Mass/volume] in Urine |
11072-6 | Despropionylfentanyl [Mass/volume] in Serum or Plasma |
11073-4 | Despropionylfentanyl [Mass/volume] in Urine |
11074-2 | Norfentanyl [Mass/volume] in Serum or Plasma |
11075-9 | Norfentanyl [Mass/volume] in Urine |
11076-7 | Hepatitis C virus 5-1-1 Ab [Presence] in Serum by Immunoblot (IB) |
11077-5 | Hepatitis C virus superoxide dismutase Ab [Presence] in Serum by Immunoblot (IB) |
11078-3 | HIV 2 gp80 Ab [Presence] in Serum by Immunoblot (IB) |
11079-1 | HIV 2 p26 Ab [Presence] in Serum by Immunoblot (IB) |
1108-0 | Kp sup(b) Ag [Presence] on Red Blood Cells |
11080-9 | HIV 2 p53 Ab [Presence] in Serum by Immunoblot (IB) |
11081-7 | HIV 2 p56 Ab [Presence] in Serum by Immunoblot (IB) |
11082-5 | HIV 2 p68 Ab [Presence] in Serum by Immunoblot (IB) |
11083-3 | Human papilloma virus identified in Cervix |
11084-1 | Reagin Ab [Titer] in Serum |
11085-8 | Schistosoma sp identified in Stool by Concentration |
11086-6 | Streptococcus pneumoniae Ag [Presence] in Serum |
11087-4 | Insulin Ab [Titer] in Serum |
11088-2 | Neuronal nuclear Ab [Presence] in Serum |
11089-0 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid |
1109-8 | Deprecated L little b |
11090-8 | Smith extractable nuclear Ab [Units/volume] in Serum |
11091-6 | Alpha chlordane [Mass/volume] in Serum or Plasma |
11092-4 | Barbiturates [Mass/mass] in Hair |
11093-2 | Dichlorodiphenyldichloroethylene [Mass/volume] in Serum or Plasma |
11094-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Serum or Plasma |
11095-7 | Dieldrin [Mass/volume] in Serum or Plasma |
11096-5 | Gamma chlordane [Mass/volume] in Serum or Plasma |
11097-3 | Lindane [Mass/volume] in Serum or Plasma |
11098-1 | Malaoxon [Mass/volume] in Serum or Plasma |
11099-9 | Methoxychlor [Mass/volume] in Serum or Plasma |
111-5 | Cefotetan [Susceptibility] by Minimum lethal concentration (MLC) |
1110-6 | Le sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
11100-5 | Tetrachloroethylene [Mass/volume] in Blood |
11101-3 | Bacteria [#/area] in Synovial fluid by Microscopy high power field |
11102-1 | Charcot-leyden crystals [type] in Unspecified specimen by Trichrome stain |
11103-9 | Band form neutrophils/100 cells in Bone marrow by Manual count |
11104-7 | Normoblasts Basophilic/100 cells in Bone marrow by Manual count |
11105-4 | Basophils/100 cells in Bone marrow by Manual count |
11106-2 | Eosinophils/100 cells in Bone marrow by Manual count |
11107-0 | Variant lymphocytes/100 cells in Bone marrow by Manual count |
11108-8 | Lymphocytes/100 cells in Bone marrow by Manual count |
11109-6 | Mast cells/100 cells in Bone marrow by Manual count |
1111-4 | Le sup(a) Ab [Presence] in Serum or Plasma from donor |
11110-4 | Megakaryocytes/100 cells in Bone marrow by Manual count |
11111-2 | Metamyelocytes/100 cells in Bone marrow by Manual count |
11112-0 | Monocytes/100 cells in Bone marrow by Manual count |
11113-8 | Myeloblasts/100 cells in Bone marrow by Manual count |
11114-6 | Myelocytes/100 cells in Bone marrow by Manual count |
11115-3 | Neutrophils/100 cells in Bone marrow by Manual count |
11116-1 | Normoblasts Orthochromic/100 cells in Bone marrow by Manual count |
11117-9 | Plasma cells immature/100 cells in Bone marrow by Manual count |
11118-7 | Plasma cells/100 cells in Bone marrow by Manual count |
11119-5 | Normoblasts Polychromatophilic/100 cells in Bone marrow by Manual count |
1112-2 | Le sup(a) Ab [Presence] in Serum or Plasma |
11120-3 | Promyelocytes/100 cells in Bone marrow by Manual count |
11121-1 | Prolymphocytes/100 cells in Bone marrow by Manual count |
11122-9 | Promonocytes/100 cells in Bone marrow by Manual count |
11123-7 | Deprecated Promyelocytes/100 cells in Bone marrow by Microscopy |
11124-5 | Pronormoblasts/100 cells in Bone marrow by Manual count |
11125-2 | Platelet morphology finding [Identifier] in Blood |
11126-0 | Platelets [Morphology] in Bone marrow |
11127-8 | Erythrocytes [Morphology] in Bone marrow |
11128-6 | Segmented neutrophils/100 cells in Bone marrow |
11129-4 | Pronormoblasts [#/volume] in Blood |
1113-0 | Le sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
11130-2 | B lymphocytes [#/volume] in Blood |
11131-0 | Deprecated Normoblasts Basophilic/100 cells in Bone marrow by Microscopy |
11132-8 | Deprecated Bilirubin [Mass/volume] in Body fluid |
11133-6 | Catecholamines Free [Mass/volume] in Urine |
11134-4 | Appearance of Spun Body fluid |
11135-1 | Appearance of Spun Cerebral spinal fluid |
11136-9 | Deprecated Normoblasts Orthochromic/100 cells in Bone marrow by Microscopy |
11137-7 | Deprecated Normoblasts Polychromatophilic/100 cells in Bone marrow by Microscopy |
11138-5 | Myeloid cells/Erythroid cells [# Ratio] in Bone marrow |
11139-3 | Metanephrine [Mass/volume] in Urine |
1114-8 | Le sup(a) Ag [Presence] on Red Blood Cells from donor |
11140-1 | Metanephrine [Moles/time] in 24 hour Urine |
11141-9 | Phosphate/Creatinine [Mass Ratio] in Urine |
11142-7 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post 100 g glucose PO |
11143-5 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post 100 g glucose PO |
11144-3 | Homovanillate [Mass/volume] in Urine |
11145-0 | 5-Hydroxyindoleacetate/Creatinine [Mass Ratio] in Urine |
11146-8 | Homovanillate/Creatinine [Mass Ratio] in Urine |
11147-6 | Myoglobin/Creatinine [Mass Ratio] in Urine |
11148-4 | Potassium/Creatinine [Mass Ratio] in Urine |
11149-2 | Sodium/Creatinine [Mass Ratio] in Urine |
1115-5 | Le sup(a) Ag [Presence] on Red Blood Cells |
11150-0 | Blasts/100 cells in Bone marrow |
11151-8 | Hematocrit [Volume Fraction] of Cord blood |
11152-6 | Eosinophils/100 cells in Bone marrow |
11153-4 | Hematocrit [Volume Fraction] of Body fluid |
11154-2 | Cholinesterase [Enzymatic activity/volume] in Blood |
11155-9 | Cortisol/Creatinine [Mass Ratio] in Urine |
11156-7 | Leukocyte morphology finding [Identifier] in Blood |
11157-5 | Leukocytes [Morphology] in Bone marrow |
11158-3 | Appearance of Serum |
11159-1 | Alkalase IgE Ab [Units/volume] in Serum |
1116-3 | Le sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
11160-9 | Beta lactoglobulin IgG Ab [Units/volume] in Serum |
11161-7 | Wheat Bran IgE Ab [Units/volume] in Serum |
11162-5 | Deprecated Cocoa IgE Ab [Units/volume] in Serum |
11163-3 | Carageenan IgE Ab [Units/volume] in Serum |
11164-1 | Cream Cheese IgE Ab [Units/volume] in Serum |
11165-8 | Chinchilla IgE Ab [Units/volume] in Serum |
11166-6 | Chortoglyphus arcuatus IgE Ab [Units/volume] in Serum |
11167-4 | Cockatiel feather IgE Ab [Units/volume] in Serum |
11168-2 | Arizona Cypress IgE Ab [Units/volume] in Serum |
11169-0 | Deer hair IgE Ab [Units/volume] in Serum |
1117-1 | Le sup(b) Ab [Presence] in Serum or Plasma from donor |
11170-8 | Dematiaceae IgE Ab [Units/volume] in Serum |
11171-6 | Erythromycin IgE Ab [Units/volume] in Serum |
11172-4 | Ferret epithelium IgE Ab [Units/volume] in Serum |
11173-2 | Fig IgE Ab [Units/volume] in Serum |
11174-0 | Grain weevel IgE Ab [Units/volume] in Serum |
11175-7 | Helminthosporium sativum IgE Ab [Units/volume] in Serum |
11176-5 | Lactalbumin alpha IgG Ab [Units/volume] in Serum |
11177-3 | Lactalbumin beta IgE Ab [Units/volume] in Serum |
11178-1 | Beta galactosidase IgE Ab [Units/volume] in Serum |
11179-9 | Linden IgE Ab [Units/volume] in Serum |
1118-9 | Le sup(b) Ab [Presence] in Serum or Plasma |
11180-7 | Lupin IgE Ab [Units/volume] in Serum |
11181-5 | Lycopodium spp IgE Ab [Units/volume] in Serum |
11182-3 | Lysozyme IgE Ab [Units/volume] in Serum |
11183-1 | Macadamia IgE Ab [Units/volume] in Serum |
11184-9 | Scad IgE Ab [Units/volume] in Serum |
11185-6 | Maxatase IgE Ab [Units/volume] in Serum |
11186-4 | Foxtail Millet IgE Ab [Units/volume] in Serum |
11187-2 | Penicillium frequentans IgE Ab [Units/volume] in Serum |
11188-0 | Cayenne IgE Ab [Units/volume] in Serum |
11189-8 | Jalepeno Pepper IgE Ab [Units/volume] in Serum |
1119-7 | Le sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
11190-6 | Mint IgE Ab [Units/volume] in Serum |
11191-4 | Pollock IgE Ab [Units/volume] in Serum |
11192-2 | Protamine IgE Ab [Units/volume] in Serum |
11193-0 | Pumpkin Seed IgE Ab [Units/volume] in Serum |
11194-8 | Rape Pollen IgE Ab [Units/volume] in Serum |
11195-5 | Rapeseed IgE Ab [Units/volume] in Serum |
11196-3 | Orange roughy IgE Ab [Units/volume] in Serum |
11197-1 | Sardine (pilchard) IgE Ab [Units/volume] in Serum |
11198-9 | Shark IgE Ab [Units/volume] in Serum |
11199-7 | Silver IgE Ab [Units/volume] in Serum |
112-3 | Cefotetan [Susceptibility] by Minimum inhibitory concentration (MIC) |
1120-5 | Le sup(b) Ag [Presence] on Red Blood Cells from donor |
11200-3 | Escargot IgE Ab [Units/volume] in Serum |
11201-1 | Succinylcholine IgE Ab [Units/volume] in Serum |
11202-9 | Tarragon IgE Ab [Units/volume] in Serum |
11203-7 | Trichosporon pullulans IgE Ab [Units/volume] in Serum |
11204-5 | Ulocladium chartarum IgE Ab [Units/volume] in Serum |
11205-2 | Deprecated Paper Wasp IgE Ab [Units/volume] in Serum |
11206-0 | 18-Hydroxydeoxycorticosterone [Mass/volume] in Serum or Plasma |
11207-8 | Alpha-1-Fetoprotein [Mass/volume] in Body fluid |
11208-6 | Atrial natriuretic factor [Mass/volume] in Plasma |
11209-4 | Beta glucuronidase [Enzymatic activity/volume] in Cerebral spinal fluid |
1121-3 | Le sup(b) Ag [Presence] on Red Blood Cells |
11210-2 | Cancer Ag 125 [Units/volume] in Body fluid |
11211-0 | Carbon dioxide, total [Moles/volume] in Body fluid |
11212-8 | Coproporphyrin [Mass/volume] in Urine |
11213-6 | Corticotropin releasing hormone [Mass/volume] in Serum or Plasma |
11214-4 | Deprecated Creatinine |
11215-1 | Delta aminolevulinate [Mass/volume] in Urine |
11216-9 | Deoxypyridinoline [Mass/volume] in Urine |
11217-7 | Deprecated Hexaporphyrin [Mass/time] in 24 hour Urine |
11218-5 | Microalbumin [Mass/volume] in Urine by Test strip |
11219-3 | Immunoglobulin light chains [Presence] in Serum |
1122-1 | Le sup(x) Ab [Presence] in Serum or Plasma from Blood product unit |
11220-1 | Iodine Free [Mass/time] in 24 hour Urine |
11221-9 | Pentacarboxylporphyrins [Mass/volume] in Urine |
11222-7 | Pentacarboxylporphyrins [Presence] in Urine |
11223-5 | Deprecated Phenolphthalein |
11224-3 | Phosphoethanolamine [Mass/volume] in Cerebral spinal fluid |
11225-0 | Porphyrins [Mass/volume] in Urine |
11226-8 | Prorenin [Units/volume] in Plasma |
11227-6 | Pyruvate kinase [Presence] in Blood |
11228-4 | Uroporphyrin [Mass/volume] in Urine |
11229-2 | 3-O-Methyldopa [Mass/volume] in Serum or Plasma |
1123-9 | Le sup(x) Ab [Presence] in Serum or Plasma from donor |
11230-0 | Amobarbital [Mass/volume] in Urine |
11231-8 | Astemizole [Mass/volume] in Serum or Plasma |
11232-6 | Bromocriptine [Mass/volume] in Serum or Plasma |
11233-4 | Brompheniramine [Mass/volume] in Serum or Plasma |
11234-2 | Propoxyphene [Mass/mass] in Hair |
11235-9 | Fentanyl [Presence] in Urine |
11236-7 | Gemfibrozil [Mass/volume] in Serum or Plasma |
11237-5 | Hydralazine [Mass/volume] in Serum or Plasma |
11238-3 | Hydroxyalprazolam [Mass/volume] in Urine |
11239-1 | Deprecated Hydroxyzine |
1124-7 | Le sup(x) Ab [Presence] in Serum or Plasma |
11240-9 | Hydroxyzine [Mass/volume] in Urine |
11241-7 | Hyoscyamine [Mass/volume] in Serum or Plasma |
11242-5 | Mercaptopurine [Mass/volume] in Serum or Plasma |
11243-3 | Methadone [Mass/mass] in Hair |
11244-1 | Morphine Free [Mass/volume] in Serum or Plasma |
11245-8 | Deprecated Orphenadrine |
11246-6 | Oxycodone [Mass/volume] in Urine |
11247-4 | Oxymorphone [Presence] in Urine |
11248-2 | Pergolide [Mass/volume] in Serum or Plasma |
11249-0 | Phenacemide [Mass/volume] in Serum or Plasma |
1125-4 | Le Ab [Presence] in Serum or Plasma from Blood product unit |
11250-8 | Phenylethylmalonate [Mass/volume] in Serum or Plasma |
11251-6 | Piroxicam [Mass/volume] in Serum or Plasma |
11252-4 | Scopolamine [Mass/volume] in Serum or Plasma |
11253-2 | Tacrolimus [Mass/volume] in Blood |
11254-0 | Chlamydophila pneumoniae Ab [Titer] in Serum |
11255-7 | Haemophilus ducreyi [Presence] in Unspecified specimen by Organism specific culture |
11256-5 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum |
11257-3 | Haemophilus influenzae B IgG Ab [Mass/volume] in Serum by Immunoassay |
11258-1 | Hepatitis B virus DNA [Units/volume] in Serum |
11259-9 | Hepatitis C virus RNA [Presence] in Serum or Plasma by Probe and target amplification method |
1126-2 | Le Ab [Presence] in Serum or Plasma from donor |
11260-7 | HTLV I Ab [Presence] in Serum by Immunoassay |
11261-5 | Bacteria identified in Vaginal fluid by Aerobe culture |
11262-3 | Parainfluenza virus 3 IgG Ab [Titer] in Serum |
11263-1 | Parainfluenza virus 3 IgM Ab [Titer] in Serum |
11264-9 | Salmonella paratyphi A Ab [Presence] in Serum by Agglutination |
11265-6 | Salmonella paratyphi B Ab [Presence] in Serum by Agglutination |
11266-4 | Streptococcus agalactiae Ag [Presence] in Unspecified specimen |
11267-2 | Streptococcus.beta-hemolytic [Presence] in Genital specimen by Organism specific culture |
11268-0 | Streptococcus pyogenes [Presence] in Throat by Organism specific culture |
11269-8 | Streptococcus pyogenes Ag [Presence] in Serum by Agglutination |
1127-0 | Le NOS Ab [Presence] in Serum or Plasma from Blood product unit |
11270-6 | Viral inclusion bodies [Identifier] in Unspecified specimen by Cyto stain |
11271-4 | Hematocrit [Volume Fraction] of Cord blood by Automated count |
11272-2 | Erythrocyte mean corpuscular volume [Entitic volume] in Cord blood by Automated count |
11273-0 | Erythrocytes [Morphology] in Blood by Automated count |
11274-8 | Elliptocytes [Presence] in Blood by Light microscopy |
11275-5 | Large granular lymphocytes/100 leukocytes in Blood by Manual count |
11276-3 | Tubular cells [Presence] in Urine sediment by Light microscopy |
11277-1 | Epithelial cells.squamous [#/area] in Urine sediment by Microscopy high power field |
11278-9 | Bladder cells [#/area] in Urine sediment by Microscopy high power field |
11279-7 | Urine sediment comments by Light microscopy Narrative |
1128-8 | Le NOS Ab [Presence] in Serum or Plasma from donor |
11280-5 | Cabot rings [Presence] in Blood by Light microscopy |
11281-3 | Auer rods [Presence] in Blood by Light microscopy |
11282-1 | Cells Counted Total [#] in Blood |
11283-9 | Acuity assessment [Function] at First encounter |
11284-7 | Acuity assessment practitioner identification |
11285-4 | Acuity assessment practitioner profession |
11286-2 | Alcohol binge episodes per month - Reported |
11287-0 | Alcoholic drinks per drinking day - Reported |
11288-8 | Arrival time documented |
11289-6 | Body temperature at First encounter |
1129-6 | Le NOS Ab [Presence] in Serum or Plasma |
11290-4 | Body temperature measurement site at First encounter |
11291-2 | Respiratory rate at First encounter |
11292-0 | Deprecated Chief complaint: Prid: Pt: ^Patient: Nom: Reported |
11293-8 | Type of Referral source |
11294-6 | Current employment Narrative - Reported |
11295-3 | Current employment - Reported |
11296-1 | ED clinical finding practitioner identifier |
11297-9 | ED clinical finding practitioner profession |
11298-7 | ED consultant practitioner identifier |
11299-5 | ED consultant practitioner profession |
113-1 | Cefotetan [Susceptibility] by Disk diffusion (KB) |
1130-4 | Le NOS Ag [Presence] on Red Blood Cells from Blood product unit |
11300-1 | ED diagnosis |
11301-9 | ED diagnosis type |
11302-7 | ED discharge disposition |
11303-5 | ED disposition consult/referral |
11304-3 | ED disposition diagnosis practitioner identification |
11305-0 | ED disposition diagnosis practitioner profession |
11306-8 | ED medication practitioner identification |
11307-6 | ED medication practitioner profession |
11308-4 | ED outcome observation practitioner identification |
11309-2 | ED outcome observation practitioner profession |
1131-2 | Le NOS Ag [Presence] on Red Blood Cells from donor |
11310-0 | ED patient satisfaction report type |
11311-8 | ED procedure practitioner profession |
11312-6 | ED procedure practitioner identifier |
11313-4 | ED procedure result observation [Interpretation] |
11314-2 | ED procedure result type |
11315-9 | ED service level |
11316-7 | ED service level practitioner profession |
11317-5 | ED service level practitioner identification |
11318-3 | Ambulance transport agency EMS system |
11319-1 | Ambulance transport unit [Identifier] EMS system |
1132-0 | Le NOS Ag [Presence] on Red Blood Cells |
11320-9 | Feeding and dietary status Narrative - Reported |
11321-7 | Feeding and dietary status - Reported |
11322-5 | History of general health Narrative |
11323-3 | General health - Reported |
11324-1 | Glasgow coma score eye opening at First encounter |
11325-8 | Glasgow coma score motor at First encounter |
11326-6 | Glasgow coma score verbal at First encounter |
11327-4 | Heart rate method at First encounter |
11328-2 | Heart rate at First encounter |
11329-0 | History general Narrative - Reported |
1133-8 | Lu sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
11330-8 | History of alcohol use Narrative |
11331-6 | History of alcohol use |
11332-4 | History of cognitive function Narrative |
11333-2 | History of cognitive function |
11334-0 | History of growth+Development Narrative |
11335-7 | History of growth+Development |
11336-5 | History of hospitalizations Narrative |
11337-3 | History of hospitalizations |
11338-1 | History of major illnesses and injuries Narrative |
11339-9 | History of major illnesses and injuries |
1134-6 | Lu sup(a) Ab [Presence] in Serum or Plasma from donor |
11340-7 | History of occupation Narrative |
11341-5 | History of occupation |
11342-3 | History of other nonmedical drug use Narrative |
11343-1 | History of other nonmedical drug use |
11344-9 | History of other social factors Narrative |
11345-6 | History of other social factors |
11346-4 | History of outpatient visits Narrative |
11347-2 | History of outpatient visits |
11348-0 | History of past illness Narrative |
11349-8 | History of past illness |
1135-3 | Lu sup(a) Ab [Presence] in Serum or Plasma |
11350-6 | History of sexual behavior Narrative |
11351-4 | History of sexual behavior |
11352-2 | History of Allergenic and Immunologic disorders Narrative |
11353-0 | History of Breasts disorders Narrative |
11354-8 | History of Ears and Nose and Sinuses and Mouth and Throat disorders Narrative |
11355-5 | History of Gastrointestinal system disorders Narrative |
11356-3 | History of Genitourinary systems disorders Narrative |
11357-1 | History of Integumentary system disorders Narrative |
11358-9 | History of Psychiatric disorders Narrative |
11359-7 | History of Allergenic and Immunologic disorders |
1136-1 | Lu sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
11360-5 | History of Breasts disorders |
11361-3 | History of Ears and Nose and Sinuses and Mouth and Throat disorders |
11362-1 | History of Gastrointestinal system disorders |
11363-9 | History of Genitourinary systems disorders |
11364-7 | History of Integumentary system disorders |
11365-4 | History of Psychiatric disorders |
11366-2 | History of tobacco use Narrative |
11367-0 | History of tobacco use |
11368-8 | Illness or injury onset date and time |
11369-6 | History of immunization Narrative |
1137-9 | Lu sup(a) Ag [Presence] on Red Blood Cells from donor |
11370-4 | Immunization status - Reported |
11371-2 | Initial visit for chief complaint |
11372-0 | Injury associated activity |
11373-8 | Injury cause |
11374-6 | Injury incident description Narrative |
11375-3 | Injury intent |
11376-1 | Injury location |
11377-9 | Diastolic blood pressure at First encounter |
11378-7 | Systolic blood pressure at First encounter |
11379-5 | Level of education - Reported |
1138-7 | Lu sup(a) Ag [Presence] on Red Blood Cells |
11380-3 | Marital status and living arrangements Narrative - Reported |
11381-1 | Marital status and living arrangements - Reported |
11382-9 | Medication allergy - Reported |
11383-7 | Patient problem outcome Narrative |
11384-5 | Physical examination by organ systems |
11385-2 | Physical findings of Ankle Narrative |
11386-0 | Physical findings of Upper arm Narrative |
11387-8 | Physical findings of Axilla Narrative |
11388-6 | Physical findings of Buttocks Narrative |
11389-4 | Physical findings of Calf Narrative |
1139-5 | Lu sup(ab) Ab [Presence] in Serum or Plasma from Blood product unit |
11390-2 | Physical findings of Cardiovascular system Narrative |
11391-0 | Physical findings of Chest Narrative |
11392-8 | Physical findings of Chest wall Narrative |
11393-6 | Physical findings of Ears and Nose and Mouth and Throat Narrative |
11394-4 | Physical findings of Elbow Narrative |
11395-1 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed |
11396-9 | Deprecated Physical findings: Find: Pt: Extremities: Nar: Observed. |
11397-7 | Physical findings of Foot Narrative |
11398-5 | Physical findings of Forearm Narrative |
11399-3 | Physical findings of Gastrointestinal system Narrative |
114-9 | Cefotetan [Susceptibility] by Serum bactericidal titer |
1140-3 | Lu sup(ab) Ab [Presence] in Serum or Plasma from donor |
11400-9 | Physical findings of Genitalia Narrative |
11401-7 | Physical findings of Female genitalia Narrative |
11402-5 | Physical findings of Male genitalia Narrative |
11403-3 | Physical findings of Groin Narrative |
11404-1 | Physical findings of Hand Narrative |
11405-8 | Deprecated Physical findings: Find: Pt: Heart: Nar: Observed |
11406-6 | Physical findings of Hip Narrative |
11407-4 | Physical findings of Knee Narrative |
11408-2 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed |
11409-0 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nar: Observed. |
1141-1 | Lu sup(ab) Ab [Presence] in Serum or Plasma |
11410-8 | Physical findings of Musculoskeletal system Narrative |
11411-6 | Physical findings of Neck Narrative |
11412-4 | Physical findings of Respiratory system Narrative |
11413-2 | Physical findings of Shoulder Narrative |
11414-0 | Physical findings of Thigh Narrative |
11415-7 | Physical findings of Wrist Narrative |
11416-5 | Physical findings of Ankle |
11417-3 | Physical findings of Upper arm |
11418-1 | Physical findings of Axilla |
11419-9 | Physical findings of Buttocks |
1142-9 | Lu sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
11420-7 | Physical findings of Calf |
11421-5 | Physical findings of Cardiovascular system |
11422-3 | Physical findings of Chest |
11423-1 | Physical findings of Chest wall |
11424-9 | Physical findings of Ears and Nose and Mouth and Throat |
11425-6 | Physical findings of Elbow |
11426-4 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed |
11427-2 | Deprecated Physical findings: Find: Pt: Extremities: Nom: Observed. |
11428-0 | Physical findings of Foot |
11429-8 | Physical findings of Forearm |
1143-7 | Lu sup(b) Ab [Presence] in Serum or Plasma from donor |
11430-6 | Physical findings of Gastrointestinal system |
11431-4 | Physical findings of Genitalia |
11432-2 | Physical findings of Female genitalia |
11433-0 | Physical findings of Male genitalia |
11434-8 | Physical findings of Groin |
11435-5 | Physical findings of Hand |
11436-3 | Deprecated Physical findings: Find: Pt: Heart: Nom: Observed |
11437-1 | Physical findings of Hip |
11438-9 | Physical findings of Knee |
11439-7 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed. |
1144-5 | Lu sup(b) Ab [Presence] in Serum or Plasma |
11440-5 | Deprecated Physical findings: Find: Pt: Mouth & Throat & Teeth: Nom: Observed |
11441-3 | Physical findings of Musculoskeletal system |
11442-1 | Physical findings of Neck |
11443-9 | Physical findings of Respiratory system |
11444-7 | Physical findings of Shoulder |
11445-4 | Physical findings of Thigh |
11446-2 | Physical findings of Wrist |
11447-0 | Physical findings of Hematologic and Lymphatic and Immunologic System Narrative |
11448-8 | Physical findings of Hematologic and Lymphatic and Immunologic System |
11449-6 | Pregnancy status [Interpretation] - Reported |
1145-2 | Lu sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
11450-4 | Problem list - Reported |
11451-2 | Psychiatric findings Narrative |
11452-0 | Psychiatric findings |
11453-8 | Receiving facility EMS system |
11454-6 | Responsiveness assessment at First encounter |
11455-3 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nar: Reported |
11456-1 | Deprecated Review of symptoms and diseases: Find: Pt: ^Patient: Nom: Reported |
11457-9 | Safety equipment used |
11458-7 | Clostridium tetani immunization status |
11459-5 | Transport mode EMS system |
1146-0 | Lu sup(b) Ag [Presence] on Red Blood Cells from donor |
11467-8 | Bacillus anthracis Ab [Units/volume] in Serum by Immunoblot (IB) |
11468-6 | Bacillus anthracis Ab [Units/volume] in Unspecified specimen by Immunofluorescence |
11469-4 | Bacillus anthracis [Presence] in Unspecified specimen by Organism specific culture |
1147-8 | Lu sup(b) Ag [Presence] on Red Blood Cells |
11470-2 | Clostridium botulinum toxin [Units/volume] in Stool |
11471-0 | Deprecated Cryptococcus neoformans Ag [Titer] in Unspecified specimen |
11472-8 | Deprecated Cryptococcus neoformans Ag [Presence] in Unspecified specimen |
11473-6 | Cryptococcus sp Ag [Titer] in Unspecified specimen |
11474-4 | Hydatid cyst identified in Unspecified specimen by Wet preparation |
11475-1 | Microorganism identified in Unspecified specimen by Culture |
11476-9 | Microscopic observation [Identifier] in Gastric fluid by Acid fast stain |
11477-7 | Microscopic observation [Identifier] in Sputum by Acid fast stain |
11478-5 | Microscopic observation [Identifier] in Stool by Acid fast stain |
11479-3 | Microscopic observation [Identifier] in Tissue by Acid fast stain |
1148-6 | Lu NOS Ab [Presence] in Serum or Plasma from Blood product unit |
11480-1 | Microscopic observation [Identifier] in Urine by Acid fast stain |
11481-9 | Human papilloma virus identified in Unspecified specimen |
11482-7 | Rickettsia rickettsii RNA [Presence] in Tissue by Probe and target amplification method |
11483-5 | Varicella zoster virus DNA [Presence] in Unspecified specimen by Probe and target amplification method |
11484-3 | Virus identified in Amniotic fluid by Culture |
11485-0 | Anesthesia records |
11486-8 | Chemotherapy records |
11487-6 | Consultation request (narrative) |
11488-4 | Consult note |
11489-2 | Dictating practitioner identifier |
1149-4 | Lu NOS Ab [Presence] in Serum or Plasma from donor |
11490-0 | Physician Discharge summary |
11491-6 | Deprecated Provider-unspecified ED visit note |
11492-6 | Provider-unspecifed, History and physical note |
11493-4 | Hospital discharge studies summary Narrative |
11494-2 | Deprecated Physician Initial assessment note at First encounter |
11495-9 | Deprecated Physical therapy Initial assessment note at First encounter |
11496-7 | Deprecated Podiatry Initial assessment note at First encounter |
11497-5 | Deprecated Psychology Initial assessment note at First encounter |
11498-3 | Deprecated Social work Initial assessment note at First encounter |
11499-1 | Deprecated Speech therapy Initial assessment note at First encounter |
115-6 | Cefoxitin [Susceptibility] by Minimum lethal concentration (MLC) |
1150-2 | Lu NOS Ab [Presence] in Serum or Plasma |
11500-6 | Deprecated Occupational therapy Initial assessment note at First encounter |
11501-6 | Deprecated Labor and delivery records |
11502-2 | Laboratory report |
11503-0 | Medical records |
11504-8 | Provider-unspecified Operation note |
11505-5 | Physician Procedure note |
11506-3 | Provider-unspecified Progress note |
11507-1 | Occupational therapy Progress note |
11508-9 | Physical therapy Progress note |
11509-7 | Podiatry Progress note |
1151-0 | Lu NOS Ag [Presence] on Red Blood Cells from Blood product unit |
11510-5 | Psychology Progress note |
11511-3 | Deprecated Provider-unspecified progress note |
11512-1 | Speech-language pathology Progress note |
11513-9 | Provider.signing [Identifier] Report |
11514-7 | Chiropractic Records total Encounter |
11515-4 | Physical therapy Records total Encounter |
11516-2 | Physician Records total Encounter |
11517-0 | Podiatry Records total Encounter |
11518-8 | Psychology Records total Encounter |
11519-6 | Social service Records total Encounter |
1152-8 | Lu NOS Ag [Presence] on Red Blood Cells from donor |
11520-4 | Speech therapy Records total Encounter |
11521-2 | Occupational therapy Records total Encounter |
11522-0 | Deprecated Cardiac echo study |
11523-8 | EEG study |
11524-6 | EKG Study |
11525-3 | US Pelvis and Fetus for pregnancy |
11526-1 | Pathology study |
11527-9 | Psychiatry study |
11528-7 | Deprecated Radiology Unspecified site and modality Study |
11529-5 | Surgical pathology study |
1153-6 | Lu NOS Ag [Presence] on Red Blood Cells |
11530-3 | Surgeon.assisting [Identifier] |
11531-1 | Surgeon.resident [Identifier] |
11532-9 | Surgeon.staff [Identifier] |
11533-7 | Surgical drains |
11534-5 | Temperature charts |
11535-2 | Hospital discharge Dx Narrative |
11536-0 | Nurse Notes |
11537-8 | Surgical drains Narrative |
11538-6 | Deprecated CT Chest study |
11539-4 | Deprecated CT Head study |
1154-4 | little c Ab [Presence] in Serum or Plasma from Blood product unit |
11540-2 | Deprecated CT Abdomen study |
11541-0 | Deprecated MRI Brain study |
11542-8 | Deprecated Provider-unspecified visit note |
11543-6 | Nursery records |
11544-4 | Hospital discharge follow-up Narrative |
11545-1 | Microscopic observation [Identifier] in Unspecified specimen by Acid fast stain |
11546-9 | Microscopic observation [Identifier] in Unspecified specimen by Other stain |
1155-1 | little c Ab [Presence] in Serum or Plasma from donor |
11550-1 | Borrelia burgdorferi [Presence] in Unspecified specimen by Organism specific culture |
11551-9 | Borrelia burgdorferi DNA [Presence] in Cerebral spinal fluid by Probe with amplification |
11552-7 | Microscopic exam [Interpretation] of Tissue fine needle aspirate by Cytology |
11553-5 | Microscopic exam [Interpretation] of Sputum by Cytology |
11554-3 | Deprecated Magnesium [Molecules/volume] in Serum or Plasma |
11555-0 | Base excess in Blood by calculation |
11556-8 | Oxygen [Partial pressure] in Blood |
11557-6 | Carbon dioxide [Partial pressure] in Blood |
11558-4 | pH of Blood |
11559-2 | Fractional oxyhemoglobin in Blood |
1156-9 | little c Ab [Presence] in Serum or Plasma |
11560-0 | Acetylcholine receptor binding Ab [Units/volume] in Serum |
11561-8 | Acetylcholine receptor blocking Ab [Units/volume] in Serum |
11562-6 | Acetylcholine receptor modulation Ab [Units/volume] in Serum |
11563-4 | Deprecated DNA double strand Ab [Units/volume] in Serum |
11564-2 | Intrinsic factor Ab [Units/volume] in Serum |
11565-9 | Jo-1 extractable nuclear Ab [Units/volume] in Serum |
11566-7 | Liver kidney microsomal Ab [Units/volume] in Serum |
11567-5 | Deprecated Neutrophil cytoplasmic Ab [Units/volume] in Serum |
11568-3 | Phosphatidylserine IgG Ab [Presence] in Serum |
11569-1 | Phosphatidylserine IgM Ab [Presence] in Serum |
1157-7 | little c Ag [Presence] on Red Blood Cells from Blood product unit |
11570-9 | Platelet IgG Ab [Units/volume] in Serum |
11571-7 | Rheumatoid arthritis nuclear Ab [Units/volume] in Serum |
11572-5 | Rheumatoid factor [Units/volume] in Serum or Plasma |
11573-3 | Rheumatoid factor IgM [Units/volume] in Serum |
11574-1 | Deprecated Thyroperoxidase Ab [Units/volume] in Serum |
11575-8 | Cefmetazole [Susceptibility] by Gradient strip (E-test) |
11576-6 | Erythromycin+Sulfisoxazole [Susceptibility] by Gradient strip (E-test) |
11577-4 | Sulfamethoxazole [Susceptibility] by Gradient strip (E-test) |
11578-2 | Sulfisoxazole [Susceptibility] by Gradient strip (E-test) |
11579-0 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L |
1158-5 | little c Ag [Presence] on Red Blood Cells from donor |
11580-8 | Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.005 mIU/L |
11581-6 | Ebola virus Ab [Units/volume] in Serum |
11582-4 | Wuchereria bancrofti Ab [Units/volume] in Serum |
11583-2 | Aspergillus fumigatus 1 Ab [Presence] in Serum |
11584-0 | Aureobasidium pullulans Ab [Presence] in Serum |
11585-7 | Bordetella pertussis Ab [Units/volume] in Serum |
11586-5 | Brucella abortus Ab [Units/volume] in Serum |
11587-3 | Brucella canis Ab [Units/volume] in Serum |
11588-1 | Brucella melitensis Ab [Units/volume] in Serum |
11589-9 | Brucella suis Ab [Units/volume] in Serum |
1159-3 | little c Ag [Presence] on Red Blood Cells |
11590-7 | Coxsackievirus A10 Ab [Units/volume] in Serum |
11591-5 | Coxsackievirus A2 Ab [Units/volume] in Serum |
11592-3 | Aspergillus fumigatus 6 Ab [Presence] in Serum |
11593-1 | Coxsackievirus A4 Ab [Units/volume] in Serum |
11594-9 | Echovirus 16 Ab [Units/volume] in Serum |
11595-6 | Echovirus 18 Ab [Units/volume] in Serum |
11596-4 | Shigella dysenteriae Ab [Units/volume] in Serum |
11597-2 | Treponema pallidum Ab [Units/volume] in Serum |
11598-0 | Toxoplasma gondii Ab [Units/volume] in Serum |
11599-8 | Coxsackievirus A21 Ab [Units/volume] in Serum |
116-4 | Cefoxitin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1160-1 | little e Ab [Presence] in Serum or Plasma from Blood product unit |
11600-4 | Shigella flexneri Ab [Units/volume] in Serum |
11601-2 | Echovirus 7 Ab [Units/volume] in Serum |
11602-0 | Shigella boydii Ab [Units/volume] in Serum |
11603-8 | Salmonella sp Ab [Units/volume] in Serum |
11604-6 | Burkholderia pseudomallei Ab [Units/volume] in Serum |
11605-3 | Lymphocytic choriomeningitis virus Ab [Units/volume] in Serum |
11606-1 | Leptospira interrogans Ab [Units/volume] in Serum |
11607-9 | Junin virus Ab [Units/volume] in Serum |
11608-7 | Japanese encephalitis virus Ab [Units/volume] in Serum |
11609-5 | HTLV I Ab [Units/volume] in Serum |
1161-9 | little e Ab [Presence] in Serum or Plasma from donor |
11610-3 | Heterophile Ab [Units/volume] in Serum |
11611-1 | Shigella sonnei Ab [Units/volume] in Serum |
11612-9 | [#] Abortions |
11613-7 | [#] Abortions.induced |
11614-5 | [#] Abortions.spontaneous |
11615-2 | Fetal Heart Activity US |
11616-0 | Fetal Heart Narrative Activity US |
11617-8 | Fetal Limbs Activity US |
11618-6 | Fetal Limbs Narrative Activity US |
11619-4 | Fetal Respiratory Activity US |
1162-7 | little e Ab [Presence] in Serum or Plasma |
11620-2 | Fetal Respiratory Narrative Activity US |
11621-0 | Fetal Trunk Activity US |
11622-8 | Fetal Trunk Narrative Activity US |
11623-6 | Fetal Quadrant four Amniotic fluid index derived by US |
11624-4 | Fetal Quadrant four one Amniotic fluid index derived by US |
11625-1 | Fetal Quadrant three Amniotic fluid index derived by US |
11626-9 | Fetal Quadrant two Amniotic fluid index derived by US |
11627-7 | Fetal Amniotic fluid index.sum derived by US |
11628-5 | Fetal Head Binocular distance estimated from Biparietal diameter on US |
11629-3 | Fetal Head Binocular distance US |
1163-5 | little e Ag [Presence] on Red Blood Cells from Blood product unit |
11630-1 | Fetal Biophysical profile.amniotic fluid volume US |
11631-9 | Fetal Biophysical profile.body movement US |
11632-7 | Fetal Biophysical profile.breathing movement US |
11633-5 | Fetal Biophysical profile.heart rate reactivity US |
11634-3 | Fetal Biophysical profile.sum Derived |
11635-0 | Fetal Biophysical profile.tone US |
11636-8 | [#] Births.live |
11637-6 | [#] Births.preterm |
11638-4 | [#] Births.still living |
11639-2 | [#] Births.term |
1164-3 | little e Ag [Presence] on Red Blood Cells from donor |
11640-0 | [#] Births total |
11641-8 | Fetal Mitral valve Peak A wave US.doppler |
11642-6 | Deprecated Mitral valve Blood flow.diastolic.atrial wave.max by US.doppler |
11643-4 | Fetal Tricuspid valve Peak A wave US.doppler |
11644-2 | Deprecated Tricuspid valve Peak A velocity US.doppler |
11645-9 | Fetal Mitral valve Peak E wave US.doppler |
11646-7 | Deprecated Mitral valve Peak E velocity US.doppler |
11647-5 | Fetal Tricuspid valve Peak E wave US.doppler |
11648-3 | Deprecated Tricuspid valve Peak E velocity US.doppler |
11649-1 | Fetal Mitral valve E-wave/A-wave US.doppler |
1165-0 | little e Ag [Presence] on Red Blood Cells |
11650-9 | Deprecated Mitral valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured |
11651-7 | Fetal Tricuspid valve E-wave/A-wave US.doppler |
11652-5 | Deprecated Tricuspid valve Blood flow.diastolic.early wave/Atrial wave Doppler.measured |
11653-3 | Circulatory system End diastolic blood flow US.doppler |
11654-1 | Fetal Cerebral artery anterior Minimal flow velocity US.doppler |
11655-8 | Cerebral artery anterior Minimal flow velocity US.doppler |
11656-6 | Fetal Cerebral artery middle Minimal flow velocity US.doppler |
11657-4 | Cerebral artery middle Minimal flow velocity US.doppler |
11658-2 | Ovarian artery - left Minimal flow velocity US.doppler |
11659-0 | Ovarian artery - right Minimal flow velocity US.doppler |
1166-8 | little f Ab [Presence] in Serum or Plasma from Blood product unit |
11660-8 | Fetal Umbilical artery at fetus Minimal flow velocity US.doppler |
11661-6 | Fetal Umbilical artery at placenta Minimal flow velocity US.doppler |
11662-4 | Fetal Umbilical artery between fetus and placenta Minimal flow velocity US.doppler |
11663-2 | Uterine artery - left Minimal flow velocity US.doppler |
11664-0 | Uterine artery - right Minimal flow velocity US.doppler |
11665-7 | Circulatory system Minimal flow velocity US.doppler |
11666-5 | Fetal Aorta ascending Mean blood flow US.doppler |
11667-3 | Aorta ascending Mean blood flow US.doppler |
11668-1 | Fetal Aorta descending Mean blood flow US.doppler |
11669-9 | Aorta descending Mean blood flow US.doppler |
1167-6 | little f Ab [Presence] in Serum or Plasma from donor |
11670-7 | Fetal Aortic arch Mean blood flow US.doppler |
11671-5 | Aortic arch Mean blood flow US.doppler |
11672-3 | Fetal Cerebral artery anterior Mean blood flow US.doppler |
11673-1 | Cerebral artery anterior Mean blood flow US.doppler |
11674-9 | Cerebral artery middle Mean blood flow US.doppler |
11675-6 | Fetal Ductus arteriosus Mean blood flow US.doppler |
11676-4 | Ductus arteriosus Mean blood flow US.doppler |
11677-2 | Fetal Pulmonary valve Mean blood flow US.doppler |
11678-0 | Pulmonary valve Mean blood flow by US.doppler |
11679-8 | Fetal Left ventricular outflow tract Mean blood flow US.doppler |
1168-4 | little f Ab [Presence] in Serum or Plasma |
11680-6 | Deprecated Left ventricular outflow tract Mean blood flow Doppler.measured |
11681-4 | Fetal Right ventricular outflow tract Mean blood flow US.doppler |
11682-2 | Deprecated Right ventricular outflow tract Mean blood flow Doppler.measured |
11683-0 | Ovarian artery - left Mean blood flow US.doppler |
11684-8 | Ovarian artery - right Mean blood flow US.doppler |
11685-5 | Fetal Main pulmonary artery Mean blood flow US.doppler |
11686-3 | Main pulmonary artery Mean blood flow US.doppler |
11687-1 | Fetal Umbilical artery at fetus Mean blood flow US.doppler |
11688-9 | Fetal Umbilical artery at placenta Mean blood flow US.doppler |
11689-7 | Fetal Umbilical artery between fetus and placenta Mean blood flow US.doppler |
1169-2 | little f Ag [Presence] on Red Blood Cells from Blood product unit |
11690-5 | Uterine artery - left Mean blood flow US.doppler |
11691-3 | Uterine artery - right Mean blood flow US.doppler |
11692-1 | Circulatory system Maximum blood flow mean US.doppler |
11693-9 | Fetal Aorta ascending Peak systolic flow US.doppler |
11694-7 | Aorta ascending Peak systolic flow US.doppler |
11695-4 | Fetal Aorta descending Peak systolic flow US.doppler |
11696-2 | Aorta descending Peak systolic flow US.doppler |
11697-0 | Fetal Aortic arch Peak systolic flow US.doppler |
11698-8 | Aortic arch Peak systolic flow US.doppler |
11699-6 | Fetal Cerebral artery anterior Peak systolic flow US.doppler |
117-2 | Cefoxitin [Susceptibility] by Disk diffusion (KB) |
1170-0 | little f Ag [Presence] on Red Blood Cells from donor |
11700-2 | Cerebral artery anterior Peak systolic flow US.doppler |
11701-0 | Fetal Cerebral artery middle Peak systolic flow US.doppler |
11702-8 | Cerebral artery middle Peak systolic flow US.doppler |
11703-6 | Fetal Ductus arteriosus Peak systolic flow US.doppler |
11704-4 | Ductus arteriosus Peak systolic flow US.doppler |
11705-1 | Fetal Aortic valve Peak systolic flow US.doppler |
11706-9 | Aortic valve Peak systolic flow by US.doppler |
11707-7 | Fetal Mitral valve Peak systolic flow US.doppler |
11708-5 | Mitral valve Peak systolic flow by US.doppler |
11709-3 | Fetal Pulmonary valve Peak systolic flow US.doppler |
1171-8 | little f Ag [Presence] on Red Blood Cells |
11710-1 | Pulmonary valve Peak systolic flow by US.doppler |
11711-9 | Fetal Tricuspid valve Peak systolic flow US.doppler |
11712-7 | Tricuspid valve Peak systolic flow by US.doppler |
11713-5 | Fetal Left ventricular outflow tract Peak systolic flow US.doppler |
11714-3 | Deprecated Left ventricular outflow tract Peak systolic flow Doppler.measured |
11715-0 | Fetal Right ventricular outflow tract Peak systolic flow US.doppler |
11716-8 | Deprecated Right ventricular outflow tract Peak systolic flow Doppler.measured |
11717-6 | Ovarian artery - left Peak systolic flow US.doppler |
11718-4 | Ovarian artery - right Peak systolic flow US.doppler |
11719-2 | Fetal Main pulmonary artery Peak systolic flow US.doppler |
1172-6 | Deprecated little i-1 subtype [Presence] in Serum or Plasma from Blood product unit |
11720-0 | Main pulmonary artery Peak systolic flow US.doppler |
11721-8 | Fetal Umbilical artery at fetus Peak systolic flow US.doppler |
11722-6 | Fetal Umbilical artery at placenta Peak systolic flow US.doppler |
11723-4 | Fetal Umbilical artery between fetus and placenta Peak systolic flow US.doppler |
11724-2 | Uterine artery - left Peak systolic flow US.doppler |
11725-9 | Uterine artery - right Peak systolic flow US.doppler |
11726-7 | Circulatory system Peak systolic flow US.doppler |
11727-5 | Fetal Body weight estimated by US |
11728-3 | Fetal Body weight estimated from Abdominal circumference on US |
11729-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US |
1173-4 | Deprecated little i-1 subtype [Presence] in serum or plasma from donor |
11730-9 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US |
11731-7 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US |
11732-5 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Hadlock 1985 method |
11733-3 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length and Head circumference on US by Roberts 1985 method |
11734-1 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1984 method |
11735-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Hadlock 1985 method |
11736-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter and Femur length on US by Woo 1985 method |
11737-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Eik-Nes 1982 method |
11738-2 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Hadlock 1984 method |
11739-0 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Shepard 1982 method |
1174-2 | Deprecated little i-1 subtype [Presence] in serum |
11740-8 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Thurnau 1983 method |
11741-6 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Warsof 1977 method |
11742-4 | Fetal Body weight estimated from Abdominal circumference and Biparietal diameter on US by Weinberger 1984 method |
11743-2 | Fetal Body weight estimated from Abdominal circumference and Femur length on US |
11744-0 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US |
11745-7 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1984 method |
11746-5 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Hadlock 1985 method |
11747-3 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Ott 1986 method |
11748-1 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Vintzileos 1987 method |
11749-9 | Fetal Body weight estimated from Abdominal circumference and Femur length and Head circumference on US by Weiner 1985 method |
1175-9 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
11750-7 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1984 method |
11751-5 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Hadlock 1985 method |
11752-3 | Fetal Body weight estimated from Abdominal circumference and Femur length on US by Woo 1985 method |
11753-1 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US |
11754-9 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Hadlock 1984 method |
11755-6 | Fetal Body weight estimated from Abdominal circumference and Head circumference on US by Jordaan 1983 method |
11756-4 | Fetal Body weight estimated from Abdominal circumference on US by Campbell 1975 method |
11757-2 | Fetal Body weight estimated from Abdominal circumference on US by Vintzileos 1987 method |
11758-0 | Fetal Body weight estimated from Abdominal circumference on US by Warsof 1977 method |
11759-8 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US |
1176-7 | Deprecated little i-1 subtype [Presence] on Red Blood Cells from donor |
11760-6 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US |
11761-4 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter and Femur length on US by Rose 1987 method |
11762-2 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Rose 1987 method |
11763-0 | Fetal Body weight estimated from Abdominal diameter and Biparietal diameter on US by Vintzileos 1987 method |
11764-8 | Fetal Body weight estimated from Abdominal diameter and Femur length on US |
11765-5 | Fetal Body weight estimated from Abdominal diameter and Femur length on US by Rose 1987 method |
11766-3 | Fetal Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
11767-1 | Body weight percentile Comparison of estimated fetal weight with standard population distribution at same estimated gestational age |
11768-9 | Fetal Body weight percentile range Categorization by comparison with standards |
11769-7 | Body weight percentile range Categorization by comparison with standards |
1177-5 | Deprecated little i-1 subtype [Presence] on Red Blood Cells |
11770-5 | [Percentile] Body weight.10th Estimated.pop birth wgt gestational age corr.ref |
11771-3 | [Percentile] Body weight.25th Estimated.pop birth wgt gestational age corr.ref |
11772-1 | [Percentile] Body weight.50th Estimated.pop birth wgt gestational age corr.ref |
11773-9 | [Percentile] Body weight.75th Estimated.pop birth wgt gestational age corr.ref |
11774-7 | [Percentile] Body weight.90th Estimated.pop birth wgt gestational age corr.ref |
11775-4 | Fetal body weight estimation formula Narrative [Bibliographic Citation] Citation |
11776-2 | Gestational age estimation formula Narrative [Bibliographic Citation] Citation |
11777-0 | Fetal Abdomen [Area] Cross section derived by US |
11778-8 | Delivery date Estimated |
11779-6 | Delivery date Estimated from last menstrual period |
1178-3 | Deprecated little i-2 subtype [Presence] in Serum or Plasma from Blood product unit |
11780-4 | Delivery date Estimated from ovulation date |
11781-2 | Delivery date US composite estimate |
11782-0 | Fetal Bowel Diameter US |
11783-8 | Bowel Diameter US |
11784-6 | Cervical canal external os Diameter palpation |
11785-3 | Cervical canal external os Diameter US |
11786-1 | Cervical canal internal os Diameter palpation |
11787-9 | Cervical canal internal os Diameter US |
11788-7 | Cervical canal Diameter Probe insertion.Hagar |
11789-5 | Cervical canal Diameter Probe insertion.Pratt |
1179-1 | Deprecated little i-2 subtype [Presence] in serum or plasmafrom donor |
11790-3 | Fetal Colon lumen Diameter US |
11791-1 | Colon lumen Diameter US |
11792-9 | Fetal Eye Diameter US |
11793-7 | Follicle Diameter US |
11794-5 | Fetal Aortic valve Diameter US |
11795-2 | Aortic valve Diameter by US |
11796-0 | Fetal Mitral valve Diameter US |
11797-8 | Deprecated Mitral valve Diameter by US |
11798-6 | Fetal Pulmonary valve Diameter US |
11799-4 | Pulmonary valve Diameter by US |
118-0 | Cefoxitin [Susceptibility] by Serum bactericidal titer |
1180-9 | Deprecated little i-2 subtype [Presence] in serum |
11800-0 | Fetal Tricuspid valve Diameter US |
11801-8 | Tricuspid valve Diameter by US |
11802-6 | Fetal Left ventricular outflow tract Diameter US.doppler |
11803-4 | Left ventricular outflow tract Diameter US.doppler |
11804-2 | Fetal Right ventricular outflow tract Diameter US |
11805-9 | Right ventricular outflow tract Diameter US |
11806-7 | Fetal Pulmonary artery Diameter US |
11807-5 | Pulmonary artery Diameter US |
11808-3 | Fetal Renal pelvis - left Diameter US |
11809-1 | Renal pelvis - left Diameter US |
1181-7 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
11810-9 | Fetal Renal pelvis - right Diameter US |
11811-7 | Renal pelvis - right Diameter US |
11812-5 | Fetal Small bowel Diameter US |
11813-3 | Small bowel Diameter US |
11814-1 | Fetal Umbilical vein Diameter US |
11815-8 | Fetal Urinary bladder Diameter US |
11816-6 | Fetal Yolk sac Diameter US |
11817-4 | Fetal Amniotic fluid space Diameter largest pocket US |
11818-2 | Fetal Abdomen Diameter.anterior-posterior US |
11819-0 | Fetal Thorax Diameter.anterior-posterior US |
1182-5 | Deprecated little i-2 subtype [Presence] on Red Blood Cells from donor |
11820-8 | Fetal Head Diameter.biparietal US |
11821-6 | Fetal Head Mean biparietal diameter Estimated from gestational age |
11822-4 | Fetal Head Mean biparietal diameter estimated from Cerebellar diameter (US) |
11823-2 | Fetal Head Diameter.biparietal/Diameter.occipital derived by US |
11824-0 | Fetal Head Diameter.BPD.area-corrected derived by US |
11825-7 | Fetal Kidney - left Hilum-cortex diameter US |
11826-5 | Kidney - left Hilum-cortex diameter US |
11827-3 | Fetal Kidney - right Hilum-cortex diameter US |
11828-1 | Kidney - right Hilum-cortex diameter US |
11829-9 | Ovary - left Hilum-cortex diameter US |
1183-3 | Deprecated little i-2 subtype [Presence] on Red Blood Cells |
11830-7 | Ovary - right Hilum-cortex diameter US |
11831-5 | Fetal Kidney Mean width Estimated from gestational age |
11832-3 | Fetal Amniotic fluid space Maximum diameter largest pocket US |
11833-1 | Fetal Amniotic fluid space Mean diameter largest pocket US |
11834-9 | Fetal Kidney - left Longitudinal diameter US |
11835-6 | Kidney - left Longitudinal diameter US |
11836-4 | Fetal Kidney - right Longitudinal diameter US |
11837-2 | Kidney - right Longitudinal diameter US |
11838-0 | Fetal Liver Longitudinal diameter US |
11839-8 | Liver Longitudinal diameter US |
1184-1 | little i Ab [Presence] in Serum or Plasma from Blood product unit |
11840-6 | Ovary - left Longitudinal diameter US |
11841-4 | Ovary - right Longitudinal diameter US |
11842-2 | Uterus Longitudinal diameter US |
11843-0 | Fetal Kidney Mean longitudinal diameter Estimated from gestational age |
11844-8 | Fetal Liver Mean longitudinal diameter Estimated from abdominal circumference |
11845-5 | Fetal Liver Mean longitudinal diameter Estimated from gestational age |
11846-3 | Ovary largest follicle Maximum diameter US |
11847-1 | Ovary - left largest follicle Maximum diameter US |
11848-9 | Ovary - right largest follicle Maximum diameter US |
11849-7 | Fetal Abdomen Mean diameter Estimated from gestational age |
1185-8 | little i Ab [Presence] in Serum or Plasma from donor |
11850-5 | Gestational sac Mean diameter US |
11851-3 | Fetal Head Diameter.occipito-frontal US |
11852-1 | Fetal Head Diameter.outer to outer US |
11853-9 | Fetal Kidney - left Thickeness US |
11854-7 | Kidney - left Thickeness US |
11855-4 | Fetal Kidney - right Thickeness US |
11856-2 | Kidney - right Thickeness US |
11857-0 | Ovary - left Thickeness US |
11858-8 | Ovary - right Thickeness US |
11859-6 | Uterus Thickeness US |
1186-6 | little i Ab [Presence] in Serum or Plasma |
11860-4 | Fetal Cisterna magna Diameter.sagittal US |
11861-2 | Fetal Cisterna magna Mean sagittal diameter Estimated from gestational age |
11862-0 | Fetal Abdomen Diameter transverse US |
11863-8 | Fetal Cerebellum Diameter transverse US |
11864-6 | Fetal Thorax Diameter transverse US |
11865-3 | Uterus Diameter transverse US |
11866-1 | Fetal Cerebellum Mean transverse diameter Estimated from gestational age |
11867-9 | Effacement Cervix |
11868-7 | Fetal body weight estimation formula Narrative [Equation] Equation |
11869-5 | Gestational age estimation formula Narrative [Equation] Equation |
1187-4 | little i NOS Ag [Presence] on Red Blood Cells from Blood product unit |
11870-3 | Examination level ultrasound |
11871-1 | Fetal Femur length/Abdominal circumference derived by US |
11872-9 | Fetal Femur length/Biparietal diameter derived by US |
11873-7 | Fetal Femur length/Head circumference derived by US |
11874-5 | Fetal position palpation |
11875-2 | Fetal position US |
11876-0 | Fetal presentation palpation |
11877-8 | Fetal presentation US |
11878-6 | Number of fetuses by US |
11879-4 | Ovary - left [#] Follicles US |
1188-2 | little i NOS Ag [Presence] on Red Blood Cells from donor |
11880-2 | Ovary - right [#] Follicles US |
11881-0 | Uterus Fundal height Tape measure |
11882-8 | Fetal Sex US |
11883-6 | Fetal Narrative Sex US |
11884-4 | Gestational age Estimated |
11885-1 | Gestational age Estimated from last menstrual period |
11886-9 | Gestational age Estimated from ovulation date |
11887-7 | Gestational age Estimated from selected delivery date |
11888-5 | Gestational age US composite estimate |
11889-3 | Gestational age estimated from Abdominal circumference on US |
1189-0 | little i NOS Ag [Presence] on Red Blood Cells |
11890-1 | Gestational age estimated from Abdominal circumference on US by Campbell 1975 method |
11891-9 | Gestational age estimated from Abdominal circumference on US by Hadlock 1982 method |
11892-7 | Gestational age estimated from Abdominal circumference on US by Hadlock 1984 method |
11893-5 | Gestational age estimated from Abdominal circumference on US by Jeanty 1984 method |
11894-3 | Gestational age estimated from area corrected Biparietal circumference (US) |
11895-0 | Gestational age estimated from Binocular distance on US |
11896-8 | Gestational age estimated from Binocular distance on US by Jeanty 1984 method |
11897-6 | Gestational age estimated from Biparietal circumference (US) |
11898-4 | Gestational age estimated from Biparietal diameter on US |
11899-2 | Gestational age estimated from Biparietal diameter on US by Campbell 1975 method |
119-8 | Cefpodoxime [Susceptibility] by Minimum lethal concentration (MLC) |
1190-8 | little k Ab [Presence] in Serum or Plasma from Blood product unit |
11900-8 | Gestational age estimated from Biparietal diameter on US by Doubilet 1993 method |
11901-6 | Gestational age estimated from Biparietal diameter on US by Hadlock 1982 method |
11902-4 | Gestational age estimated from Biparietal diameter on US by Hadlock 1984 method |
11903-2 | Gestational age estimated from Biparietal diameter on US by Hansmann 1985 method |
11904-0 | Gestational age estimated from Biparietal diameter on US by Hobbins 1983 method |
11905-7 | Gestational age estimated from Biparietal diameter on US by Jeanty 1984 method |
11906-5 | Gestational age estimated from Biparietal diameter on US by Kurtz 1980 method |
11907-3 | Gestational age estimated from Biparietal diameter on US by Sabbagha 1978 method |
11908-1 | Gestational age estimated from Cerebellar diameter by method of Goldstein 1987 (US) |
11909-9 | Gestational age estimated from Crown rump length on US |
1191-6 | little k Ab [Presence] in Serum or Plasma from donor |
11910-7 | Gestational age estimated from Crown rump length on US by Hadlock 1992 method |
11911-5 | Gestational age estimated from Crown rump length on US by Hansmann 1985 method |
11912-3 | Gestational age estimated from Crown rump length on US by Jeanty 1984 method |
11913-1 | Gestational age estimated from Crown rump length on US by Nelson 1981 method |
11914-9 | Gestational age estimated from Crown rump length on US by Robinson 1975 method |
11915-6 | Gestational age estimated from Crown rump length on US by Yeh 1988 method |
11916-4 | Gestational age estimated from Fibula length (US) |
11917-2 | Gestational age estimated from Fibula length by method of Jeanty 1984 (US) |
11918-0 | Gestational age estimated from Fibula length by method of Merz 1987 (US) |
11919-8 | Gestational age estimated from Femur length on US |
1192-4 | little k Ab [Presence] in Serum or Plasma |
11920-6 | Gestational age estimated from Femur length on US by Hadlock 1984 method |
11921-4 | Gestational age estimated from Femur length on US by Hansmann 1985 method |
11922-2 | Gestational age estimated from Femur length on US by Hohler 1982 method |
11923-0 | Gestational age estimated from Femur length on US by Jeanty 1984 method |
11924-8 | Gestational age estimated from Femur length on US by Merz 1987 method |
11925-5 | Gestational age estimated from Femur length on US by Obrien 1982 method |
11926-3 | Gestational age estimated from Foot length on US by Mercer 1987 method |
11927-1 | Gestational age estimated from Gestational sac diameter on US |
11928-9 | Gestational age estimated from Gestational sac diameter on US by Hellman 1969 method |
11929-7 | Gestational age estimated from Gestational sac diameter on US by Rempen 1991 method |
1193-2 | little k Ag [Presence] on Red Blood Cells from Blood product unit |
11930-5 | Gestational age estimated from Head circumference on US |
11931-3 | Gestational age estimated from Head circumference on US by Hadlock 1982 method |
11932-1 | Gestational age estimated from Head circumference on US by Hadlock 1984 method |
11933-9 | Gestational age estimated from Head circumference on US by Hoffbauer 1979 method |
11934-7 | Gestational age estimated from Head circumference on US by Jeanty 1984 method |
11935-4 | Gestational age estimated from Humerus length on US |
11936-2 | Gestational age estimated from Humerus length on US by Jeanty 1984 method |
11937-0 | Gestational age estimated from Humerus length on US by Merz 1987 method |
11938-8 | Gestational age estimated from Radius length (US) |
11939-6 | Gestational age estimated from Radius length by method of Merz 1987 (US) |
1194-0 | little k Ag [Presence] on Red Blood Cells from donor |
11940-4 | Gestational age estimated from Tibia length on US |
11941-2 | Gestational age estimated from Tibia length on US by Jeanty 1984 method |
11942-0 | Gestational age estimated from Tibia length on US by Merz 1987 method |
11943-8 | Gestational age estimated from Ulna length (US) |
11944-6 | Gestational age estimated from Ulna length by method of Jeanty 1984 (US) |
11945-3 | Gestational age estimated from Ulna length by method of Merz 1987 (US) |
11946-1 | Fetal Placenta Grade US |
11947-9 | Head circumference/Abdominal circumference derived by US |
11948-7 | Fetal Heart rate US |
11949-5 | Fetal Identification criteria US |
1195-7 | little k Ag [Presence] on Red Blood Cells |
11950-3 | Fetal Narrative Identification criteria US |
11951-1 | Fetal [Identifier] Identifier |
11952-9 | Fetal Umbilical cord.placenta Narrative Insertion site US |
11953-7 | OB ultrasound imaging device Institution inventory number |
11954-5 | Fetal Kidney length/Abdominal circumference derived by US |
11955-2 | Deprecated Last menstrual period |
11956-0 | Fetal Head Lateral ventricular body width/Hemispheric width derived by US |
11957-8 | Fetal Crown Rump length US |
11958-6 | Cervical canal [Length] palpation |
11959-4 | Cervical canal [Length] US |
1196-5 | Little NOS Ab [Presence] in Serum or Plasma from Blood product unit |
11960-2 | Cervix externally palpable surface [Length] palpation |
11961-0 | Cervix [Length] US |
11962-8 | Fetal Clavicle diaphysis [Length] US |
11963-6 | Fetal Femur diaphysis [Length] US |
11964-4 | Fetal Fibula diaphysis [Length] US |
11965-1 | Fetal Foot [Length] US |
11966-9 | Fetal Humerus diaphysis [Length] US |
11967-7 | Fetal Radius diaphysis [Length] US |
11968-5 | Fetal Tibia diaphysis [Length] US |
11969-3 | Fetal Ulna diaphysis [Length] US |
1197-3 | Little NOS Ab [Presence] in Serum or Plasma from donor |
11970-1 | Fetal Femur diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11971-9 | Fetal Fibula diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11972-7 | Fetal Humerus diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11973-5 | Fetal Radius diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11974-3 | Fetal Tibia diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11975-0 | Fetal Ulna diaphysis [Length] mean Estimated from gestational age.Merz. 1987 |
11976-8 | Ovulation date |
11977-6 | [#] Parity |
11978-4 | Fetal Abdomen Circumference derived by US |
11979-2 | Fetal Abdomen Circumference US |
1198-1 | Little NOS Ab [Presence] in Serum or Plasma |
11980-0 | Fetal Abdomen Circumference measured by ellipse overlay (US) |
11981-8 | Fetal Abdomen Circumference US.traced |
11982-6 | Fetal Head Circumference derived from occipital-frontal diameter and outer-outer transaxial diameter (US) |
11983-4 | Fetal Head Circumference derived from occipital-frontal diameter and outer-inner biparietal diameter (US) |
11984-2 | Fetal Head Circumference US |
11985-9 | Fetal Head Circumference measured by ellipse overlay (US) |
11986-7 | Fetal Head Circumference US.traced |
11987-5 | Fetal Thorax Circumference derived by US |
11988-3 | Fetal Thorax Circumference US |
11989-1 | Fetal Thorax Circumference measured by ellipse overlay (US) |
1199-9 | pk Ab [Presence] in Serum or Plasma from Blood product unit |
11990-9 | Fetal Thorax Circumference US.traced |
11991-7 | Fetal Abdomen Mean perimeter Estimated from gestational age |
11992-5 | Fetal Heart position US |
11993-3 | Fetal Narrative Heart position US |
11994-1 | Placenta position US |
11995-8 | Narrative Placenta position US |
11996-6 | [#] Pregnancies |
11997-4 | Fetal Cerebral artery anterior Pulsatility index US.doppler |
11998-2 | Cerebral artery anterior Pulsatility index US.doppler |
11999-0 | Fetal Cerebral artery middle Pulsatility index US.doppler |
12-5 | Amikacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
120-6 | Cefpodoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
1200-5 | pk Ab [Presence] in Serum or Plasma from donor |
12000-6 | Cerebral artery middle Pulsatility index US.doppler |
12001-4 | Ovarian artery - left Pulsatility index US.doppler |
12002-2 | Ovarian artery - right Pulsatility index US.doppler |
12003-0 | Fetal Umbilical artery at fetus Pulsatility index US.doppler |
12004-8 | Fetal Umbilical artery at placenta Pulsatility index US.doppler |
12005-5 | Fetal Umbilical artery between fetus and placenta Pulsatility index US.doppler |
12006-3 | Uterine artery - left Pulsatility index US.doppler |
12007-1 | Uterine artery - right Pulsatility index US.doppler |
12008-9 | Pulsatility index US.doppler |
12009-7 | Fetal Heart R-R duration US |
1201-3 | pk Ab [Presence] in Serum or Plasma |
12010-5 | R-R duration US |
12011-3 | Replicate summarization |
12012-1 | Fetal Cerebral artery anterior Resistivity index US.doppler |
12013-9 | Deprecated Fetal Cerebral artery anterior Resistivity index Doppler.calculated |
12014-7 | Cerebral artery middle Resistivity index US.doppler |
12015-4 | Deprecated Resistivity index of Cerebral artery middle Doppler.calculated |
12016-2 | Ovarian artery - left Resistivity index US.doppler |
12017-0 | Ovarian artery - right Resistivity index US.doppler |
12018-8 | Fetal Umbilical artery at fetus Resistivity index US.doppler |
12019-6 | Fetal Umbilical artery at placenta Resistivity index US.doppler |
1202-1 | pk Ag [Presence] on Red Blood Cells from Blood product unit |
12020-4 | Fetal Umbilical artery between fetus and placenta Resistivity index US.doppler |
12021-2 | Uterine artery - left Resistivity index US.doppler |
12022-0 | Uterine artery - right Resistivity index US.doppler |
12023-8 | Resistivity index US.doppler |
12024-6 | Left ventricle [Length] Short axis during diastole US.M-mode+Measured |
12025-3 | Left ventricle [Length] Short axis during diastole Measured by real time two dimension US |
12026-1 | Left ventricle [Length] Short axis during systole US.M-mode+Measured |
12027-9 | Left ventricle [Length] Short axis during systole Measured by real time two dimension US |
12028-7 | Fetal Abdomen Study observation US |
12029-5 | Fetal Abdomen Narrative Study observation US |
1203-9 | pk Ag [Presence] on Red Blood Cells from donor |
12030-3 | Fetal Abdominal wall Study observation US |
12031-1 | Fetal Abdominal wall Narrative Study observation US |
12032-9 | Fetal Aorta ascending Study observation US |
12033-7 | Fetal Aorta ascending Narrative Study observation US |
12034-5 | Fetal Aorta descending Study observation US |
12035-2 | Fetal Aorta descending Narrative Study observation US |
12036-0 | Fetal Aorta Study observation US |
12037-8 | Fetal Aorta Narrative Study observation US |
12038-6 | Fetal Aortic arch Study observation US |
12039-4 | Fetal Aortic arch Narrative Study observation US |
1204-7 | pk Ag [Presence] on Red Blood Cells |
12040-2 | Fetal Cerebellum Study observation US |
12041-0 | Fetal Cerebellum Narrative Study observation US |
12042-8 | Fetal Cerebrum Study observation US |
12043-6 | Fetal Cerebrum Narrative Study observation US |
12044-4 | Inspection Cervix Study observation |
12045-1 | palpation Cervix Study observation |
12046-9 | US Cervix Study observation |
12047-7 | Fetal Colon Study observation US |
12048-5 | Fetal Colon Narrative Study observation US |
12049-3 | Fetal Cranium Study observation US |
1205-4 | little p Ag [Presence] on Red Blood Cells from Blood product unit |
12050-1 | Fetal Cranium Narrative Study observation US |
12051-9 | Fetal Diaphragm Study observation US |
12052-7 | Fetal Diaphragm Narrative Study observation US |
12053-5 | Fetal ductal arch Study observation US |
12054-3 | Fetal ductal arch Narrative Study observation US |
12055-0 | Fetal Face Study observation US |
12056-8 | Fetal Face Narrative Study observation US |
12057-6 | Fetal Choroid plexus Study observation US |
12058-4 | Fetal Choroid plexus Narrative Study observation US |
12059-2 | Fetal Fourth ventricle Study observation US |
1206-2 | little p Ag [Presence] on Red Blood Cells from donor |
12060-0 | Fetal Fourth ventricle Narrative Study observation US |
12061-8 | Fetal Intracranial anatomy Study observation US |
12062-6 | Fetal Intracranial anatomy Narrative Study observation US |
12063-4 | Fetal Lateral cerebral ventricles Study observation US |
12064-2 | Fetal Lateral cerebral ventricles Narrative Study observation US |
12065-9 | Fetal Posterior fossa Study observation US |
12066-7 | Fetal Posterior fossa Narrative Study observation US |
12067-5 | Fetal Head Third Ventricle Study observation US |
12068-3 | Fetal Head Third Ventricle Narrative Study observation US |
12069-1 | Fetal Head Study observation US |
1207-0 | little p Ag [Presence] on Red Blood Cells |
12070-9 | Fetal Head Narrative Study observation US |
12071-7 | Fetal Aortic valve Study observation US |
12072-5 | Fetal Aortic valve Narrative Study observation US |
12073-3 | Fetal Atrium Study observation US |
12074-1 | Fetal Atrium Narrative Study observation US |
12075-8 | Fetal Heart chambers Study observation US |
12076-6 | Fetal Heart chambers Narrative Study observation US |
12077-4 | Fetal Heart great vessels Study observation US |
12078-2 | Fetal Heart great vessels Narrative Study observation US |
12079-0 | Fetal Interventricular septum Study observation US |
1208-8 | little s Ab [Presence] in Serum or Plasma from Blood product unit |
12080-8 | Fetal Interventricular septum Narrative Study observation US |
12081-6 | Fetal Mitral valve Study observation US |
12082-4 | Fetal Mitral valve Narrative Study observation US |
12083-2 | Fetal Pulmonary valve Study observation US |
12084-0 | Fetal Tricuspid valve Study observation US |
12085-7 | Fetal Tricuspid valve Narrative Study observation US |
12086-5 | Fetal Heart valves Study observation US |
12087-3 | Fetal Heart valves Narrative Study observation US |
12088-1 | Fetal Left ventricular outflow tract Study observation US |
12089-9 | Fetal Left ventricular outflow tract Narrative Study observation US |
1209-6 | little s Ab [Presence] in Serum or Plasma from donor |
12090-7 | Fetal Right ventricular outflow tract Study observation US |
12091-5 | Fetal Right ventricular outflow tract Narrative Study observation US |
12092-3 | Fetal Intestine Study observation US |
12093-1 | Fetal Intestine Narrative Study observation US |
12094-9 | Fetal Kidney - left Study observation US |
12095-6 | Fetal Kidney - left Narrative Study observation US |
12096-4 | Fetal Kidney - right Study observation US |
12097-2 | Fetal Kidney - right Narrative Study observation US |
12098-0 | Fetal Kidney Study observation US |
12099-8 | Fetal Kidney Narrative Study observation US |
121-4 | Cefpodoxime [Susceptibility] by Disk diffusion (KB) |
1210-4 | little s Ab [Presence] in Serum or Plasma |
12100-4 | Fetal Limbs Study observation US |
12101-2 | Fetal Limbs Narrative Study observation US |
12102-0 | Fetal Nuchal fold Study observation US |
12103-8 | Fetal Nuchal fold Narrative Study observation US |
12104-6 | Fetal Pulmonary artery Study observation US |
12105-3 | Fetal Pulmonary artery Narrative Study observation US |
12106-1 | Fetal Pulmonary vein Study observation US |
12107-9 | Fetal Pulmonary vein Narrative Study observation US |
12108-7 | Fetal Small bowel Study observation US |
12109-5 | Fetal Small bowel Narrative Study observation US |
1211-2 | little s Ag [Presence] on Red Blood Cells from Blood product unit |
12110-3 | Fetal Spine Study observation US |
12111-1 | Fetal Spine Narrative Study observation US |
12112-9 | Fetal Stomach Study observation US |
12113-7 | Fetal Stomach Narrative Study observation US |
12114-5 | Fetal Thorax Study observation US |
12115-2 | Fetal Thorax Narrative Study observation US |
12116-0 | Fetal Umbilical cord Study observation US |
12117-8 | Fetal Umbilical cord Narrative Study observation US |
12118-6 | Fetal Urinary bladder Study observation US |
12119-4 | Fetal Urinary bladder Narrative Study observation US |
1212-0 | little s Ag [Presence] on Red Blood Cells from donor |
12120-2 | Fetal Inferior vena cava Study observation US |
12121-0 | Fetal Inferior vena cava Narrative Study observation US |
12122-8 | Fetal Superior vena cava Study observation US |
12123-6 | Fetal Superior vena cava Narrative Study observation US |
12124-4 | Fetal Vena cava Study observation US |
12125-1 | Fetal Vena cava Narrative Study observation US |
12126-9 | US Unspecified body region Study observation Narrative |
12127-7 | Deprecated Fetal Yolk sac Quantitative Study observation US |
12128-5 | Fetal Yolk sac Narrative Study observation US |
12129-3 | Fetal [Interpretation] Study observation general US |
1213-8 | little s Ag [Presence] on Red Blood Cells |
12130-1 | Fetal Narrative [Interpretation] Study observation general US |
12131-9 | US Study observation general [Interpretation] |
12132-7 | US Study observation general [Interpretation] Narrative |
12133-5 | Fetal Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
12134-3 | Cerebral artery anterior Systolic flow/Diastolic flow US.doppler |
12135-0 | Fetal Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
12136-8 | Cerebral artery middle Systolic flow/Diastolic flow US.doppler |
12137-6 | Ovarian artery - left Systolic flow/Diastolic flow US.doppler |
12138-4 | Ovarian artery - right Systolic flow/Diastolic flow US.doppler |
12139-2 | Fetal Umbilical artery at fetus Systolic flow/Diastolic flow US.doppler |
1214-6 | LW Ab [Presence] in Serum or Plasma from Blood product unit |
12140-0 | Fetal Umbilical artery at placenta Systolic flow/Diastolic flow US.doppler |
12141-8 | Fetal Umbilical artery between fetus and placenta Systolic flow/Diastolic flow US.doppler |
12142-6 | Uterine artery - left Systolic flow/Diastolic flow US.doppler |
12143-4 | Uterine artery - right Systolic flow/Diastolic flow US.doppler |
12144-2 | Systolic flow/Diastolic flow US.doppler |
12145-9 | Endometrium Thickness US |
12146-7 | Fetal Nuchal fold Thickness US |
12147-5 | Fetal Placenta Thickness US |
12148-3 | Fetal Interventricular septum Thickness diastolic US.M-mode+Measured |
12149-1 | Fetal Interventricular septum Thickness diastolic Measured by real time two dimension US |
1215-3 | LW Ab [Presence] in Serum or Plasma from donor |
12150-9 | Fetal Left ventricular posterior wall Thickness diastolic US.M-mode+Measured |
12151-7 | Fetal Left ventricular posterior wall Thickness diastolic Measured by real time two dimension US |
12152-5 | Fetal Interventricular septum Thickness.systolic US.M-mode+Measured |
12153-3 | Fetal Interventricular septum Thickness.systolic Measured by real time two dimension US |
12154-1 | Fetal Left ventricular posterior wall Thickness.systolic US.M-mode+Measured |
12155-8 | Fetal Left ventricular posterior wall Thickness.systolic Measured by real time two dimension US |
12156-6 | Transducer site |
12157-4 | Ultrasonographer gravidity number |
12158-2 | OB ultrasound imaging device Class |
12159-0 | Ultrasound scan quality |
1216-1 | LW Ab [Presence] in Serum or Plasma |
12160-8 | OB ultrasound imaging device Vendor model number |
12161-6 | OB ultrasound imaging device Vendor serial number |
12162-4 | Fetal Kidney - left Volume derived by US |
12163-2 | Fetal Kidney - right Volume derived by US |
12164-0 | Ovary - left Volume derived by US |
12165-7 | Ovary - right Volume derived by US |
12166-5 | Fetal Yolk sac Volume US |
12167-3 | Fetal Amniotic fluid space [Interpretation] Volume.amniotic fluid US |
12168-1 | Fetal Urinary bladder Volume post void US |
12169-9 | Fetal Urinary bladder Volume.pre void US |
1217-9 | LW Ag [Presence] on Red Blood Cells from Blood product unit |
12170-7 | Fetal Head Hemisphere width US |
12171-5 | Fetal Lateral cerebral ventricles Transverse width US |
12172-3 | 5-Hydroxyindoleacetate [Presence] in 24 hour Urine |
12173-1 | Non prostatic acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
12174-9 | Albumin/Globulin [Mass Ratio] in Body fluid |
12175-6 | Deprecated Albumin/Globulin [Mass ratio] in Serum |
12176-4 | Amino acids [Moles/volume] in Serum or Plasma |
12177-2 | Amino acids/Creatinine [Ratio] in Urine |
12178-0 | Bacteria [Presence] in Genital specimen by Wet preparation |
12179-8 | Basophils/100 leukocytes in Body fluid by Manual count |
1218-7 | LW Ag [Presence] on Red Blood Cells from donor |
12180-6 | Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
12181-4 | Calcium [Moles/volume] in Body fluid |
12182-2 | Cells [#/volume] in Body fluid by Manual count |
12183-0 | Cholesterol [Mass/volume] in Body fluid |
12184-8 | Choriogonadotropin [Presence] in Body fluid |
12185-5 | aPTT in control Blood by Coagulation assay |
12186-3 | Colloid oncotic pressure [Partial pressure] in Plasma |
12187-1 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
12188-9 | Deprecated Creatine kinase.MB/Creatine kinase.total |
12189-7 | Creatine kinase.MB/Creatine kinase.total in Serum or Plasma by calculation |
1219-5 | LW Ag [Presence] on Red Blood Cells |
12190-5 | Creatinine [Mass/volume] in Body fluid |
12191-3 | Creatinine [Mass/volume] in Peritoneal fluid |
12192-1 | Creatinine [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
12193-9 | Creatinine [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
12194-7 | Creatinine [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
12195-4 | Creatinine renal clearance/1.73 sq M in 24 hour |
12196-2 | Cryofibrinogen [Presence] in Plasma by 4 hour cold incubation |
12197-0 | Cryofibrinogen [Presence] in Plasma by 1 day cold incubation |
12198-8 | Cryofibrinogen [Presence] in Plasma by 2 day cold incubation |
12199-6 | Cryofibrinogen [Presence] in Plasma by 3 day cold incubation |
122-2 | Cefpodoxime [Susceptibility] by Serum bactericidal titer |
1220-3 | Mg Ab [Presence] in Serum or Plasma from Blood product unit |
12200-2 | Cryoglobulin [Presence] in Serum by 4 hour cold incubation |
12201-0 | Cryoglobulin [Presence] in Serum by 1 day cold incubation |
12202-8 | Cryoglobulin [Presence] in Serum by 2 day cold incubation |
12203-6 | Cryoglobulin [Presence] in Serum by 3 day cold incubation |
12204-4 | Cryoglobulin [Presence] in Serum by 4 day cold incubation |
12205-1 | Cryoglobulin [Presence] in Serum by 5 day cold incubation |
12206-9 | Cryoglobulin [Presence] in Serum by 6 day cold incubation |
12207-7 | Cryoglobulin [Presence] in Serum by 1 week cold incubation |
12208-5 | Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
12209-3 | Eosinophils/100 leukocytes in Body fluid by Manual count |
1221-1 | Mg Ab [Presence] in Serum or Plasma from donor |
12210-1 | Eosinophils/100 leukocytes in Urine sediment by Manual count |
12211-9 | Epithelial cells [Presence] in Vaginal fluid by Wet preparation |
12212-7 | Epstein Barr virus nuclear IgG Ab [Titer] in Serum by Immunofluorescence |
12213-5 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by RIA |
12214-3 | Deprecated Estradiol [Mass/volume] in Serum or Plasma by MEIA |
12215-0 | Fatty acids.very long chain [Moles/volume] in Serum or Plasma |
12216-8 | Deprecated Gastrin [Mass/volume] in Serum or Plasma |
12217-6 | Globulin [Mass/volume] in Body fluid |
12218-4 | Glucose [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
12219-2 | Glucose [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
1222-9 | Mg Ab [Presence] in Serum or Plasma |
12220-0 | Glucose [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
12221-8 | Heterophile Ab [Presence] in Serum by Sheep Cell Agglutination |
12222-6 | Human papilloma virus Ag [Presence] in Genital specimen |
12223-4 | Human papilloma virus 16+18 Ag [Presence] in Genital specimen |
12224-2 | Leukocytes [#/area] in Nose by Microscopy high power field |
12225-9 | Leukocytes [#/area] in Sputum by Microscopy high power field |
12226-7 | Leukocytes [Presence] in Vaginal fluid by Wet preparation |
12227-5 | Leukocytes [#/volume] corrected for nucleated erythrocytes in Blood |
12228-3 | Triglyceride [Mass/volume] in Body fluid |
12229-1 | Macrophages/100 leukocytes in Cerebral spinal fluid by Manual count |
1223-7 | Mg Ag [Presence] on Red Blood Cells from Blood product unit |
12230-9 | Macrophages/100 leukocytes in Body fluid by Manual count |
12231-7 | Prolactin [Mass/volume] in Serum or Plasma --baseline |
12232-5 | Measles virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
12233-3 | Mesothelial cells/100 leukocytes in Cerebral spinal fluid by Manual count |
12234-1 | Mesothelial cells/100 leukocytes in Body fluid by Manual count |
12235-8 | Microscopic observation [Identifier] in Urine sediment by Light microscopy |
12236-6 | Mononuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
12237-4 | Mumps virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
12238-2 | Neutrophils/100 leukocytes in Body fluid by Manual count |
12239-0 | Oligosaccharides [Presence] in Urine |
1224-5 | Mg Ag [Presence] on Red Blood Cells from donor |
12240-8 | Orotidine [Moles/volume] in Urine |
12241-6 | Osmotic fragility of Red Blood Cells by Diluted RBC |
12242-4 | Phosphate [Mass/volume] in Body fluid |
12243-2 | Deprecated Platelets [Morphology] in Blood |
12244-0 | Polymorphonuclear cells/100 leukocytes in Cerebral spinal fluid by Manual count |
12245-7 | Porphobilinogen [Presence] in 24 hour Urine |
12246-5 | Porphyrins [Presence] in 24 hour Urine |
12247-3 | Pyruvate [Mass/volume] in Serum or Plasma |
12248-1 | Epithelial cells.renal [Presence] in Urine sediment by Light microscopy |
12249-9 | Deprecated Renin [Enzymatic activity/volume] in Plasma |
1225-2 | Mg Ag [Presence] on Red Blood Cells |
12250-7 | Reticulocytes/1000 erythrocytes hematocrit adjusted in Blood |
12251-5 | Rubella virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
12252-3 | Deprecated Insulin-Like growth factor-I [Mass/volume] in Serum or Plasma |
12253-1 | Somatotropin [Mass/volume] in Serum or Plasma --baseline |
12254-9 | Volume of Body fluid |
12255-6 | Volume of 5 hour Urine |
12256-4 | Spermatozoa [#/area] in Semen by Microscopy high power field --post vasectomy |
12257-2 | Spermatozoa Motile/100 spermatozoa in Semen by Microscopy high power field --post vasectomy |
12258-0 | Epithelial cells.squamous [Presence] in Urine sediment by Light microscopy |
12259-8 | Streptococcus pyogenes enzyme Ab [Presence] in Serum by Sheep Cell Agglutination |
1226-0 | M Ab [Presence] in Serum or Plasma from Blood product unit |
12260-6 | Sucrose hemolysis [Presence] of Red Blood Cells |
12261-4 | Toxoplasma gondii IgG Ab [Titer] in Serum by Immunoassay |
12262-2 | Toxoplasma gondii IgM Ab [Titer] in Serum by Immunoassay |
12263-0 | Deprecated EBV [Presence] in Cerebral spinal fluid by Immunofluorescence |
12264-8 | Deprecated Epstein Barr virus early restricted Ab [Mass/volume] in Body fluid |
12265-5 | Urea nitrogen [Mass/volume] in Peritoneal fluid |
12266-3 | Urea nitrogen [Mass/volume] in Peritoneal fluid --2 hours post peritoneal dialysis |
12267-1 | Urea nitrogen [Mass/volume] in Peritoneal fluid --4 hours post peritoneal dialysis |
12268-9 | Urea nitrogen [Mass/volume] in Peritoneal fluid --12 hours post peritoneal dialysis |
12269-7 | Urobilinogen [Presence] in 24 hour Urine |
1227-8 | M Ab [Presence] in Serum or Plasma from donor |
12270-5 | Uroporphyrin [Presence] in 24 hour Urine |
12271-3 | Varicella zoster virus Ab [Presence] in Serum by Latex agglutination |
12272-1 | Virus identified in Unspecified specimen by Immunofluorescence |
12273-9 | Xanthochromia of Body fluid Qualitative |
12274-7 | Xylose [Mass/time] in 5 hour Urine |
12275-4 | Yeast [Presence] in Genital specimen by Wet preparation |
12276-2 | Deprecated Escherichia coli O157:H7 identified in Stool by Organism specific culture |
12277-0 | DNA double strand Ab [Presence] in Serum by Farr method |
12278-8 | Band form neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
12279-6 | Deprecated Spermatozoa Ab [Units/volume] in Semen |
1228-6 | M Ab [Presence] in Serum or Plasma |
12280-4 | Alanine [Mass/volume] in Amniotic fluid |
12281-2 | Bacteria identified in Cervix by Anaerobe culture |
12282-0 | Warfarin [Presence] in Urine |
12283-8 | Corticotropin releasing hormone [Units/volume] in Serum or Plasma |
12284-6 | Growth hormone-releasing hormone [Units/volume] in Serum or Plasma |
12285-3 | HLA-DP [Type] |
12286-1 | Drugs identified in Urine by Screen method |
12287-9 | Drugs identified in Gastric fluid by Screen method |
12288-7 | Diuretics [Identifier] in Urine |
12289-5 | Drugs identified in Vitreous fluid by Screen method |
1229-4 | M Ag [Presence] on Red Blood Cells from Blood product unit |
12290-3 | Procyclidine [Presence] in Urine |
12291-1 | Mephentermine [Presence] in Urine |
12292-9 | Dimethyltryptamine [Presence] in Urine |
12293-7 | Cotinine [Presence] in Urine |
12294-5 | Nicotine [Presence] in Urine |
12295-2 | Hallucinogens [Identifier] in Urine |
12296-0 | Mescaline [Presence] in Urine |
12297-8 | Chlorate [Presence] in Blood |
12298-6 | Erythromycin [Presence] in Urine |
12299-4 | Ethinamate [Presence] in Urine |
123-0 | Cefprozil [Susceptibility] by Minimum lethal concentration (MLC) |
1230-2 | M Ag [Presence] on Red Blood Cells from donor |
12300-0 | Polythiazide [Presence] in Urine |
12301-8 | Procaine [Presence] in Urine |
12302-6 | Theobromine [Presence] in Serum or Plasma |
12303-4 | Theobromine [Presence] in Urine |
12304-2 | Benzyl alcohol [Presence] in Serum or Plasma |
12305-9 | Chlordecone [Presence] in Blood |
12306-7 | Cyclohexane [Mass/volume] in Blood |
12307-5 | Dichloroethane [Mass/volume] in Blood |
12308-3 | Hydrocodone [Presence] in Urine |
12309-1 | Naltrexone [Presence] in Urine |
1231-0 | M Ag [Presence] on Red Blood Cells |
12310-9 | Phenytoin [Presence] in Urine |
12311-7 | Prazepam [Mass/volume] in Urine |
12312-5 | Cyclopropane [Mass/volume] in Blood |
12313-3 | Aprobarbital [Presence] in Urine |
12314-1 | Clorazepate [Presence] in Urine |
12315-8 | Mephobarbital [Presence] in Urine |
12316-6 | Deprecated Methapyrilene [Presence] in Urine |
12317-4 | Phenolphthalein [Presence] in Urine |
12318-2 | Spironolactone [Presence] in Urine |
12319-0 | Thioridazine [Presence] in Urine |
1232-8 | Mi sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
12320-8 | Thiothixene [Presence] in Urine |
12321-6 | Trifluoperazine [Presence] in Urine |
12322-4 | Triflupromazine [Presence] in Urine |
12323-2 | Trimeprazine [Presence] in Urine |
12324-0 | Hydroxyzine [Presence] in Urine |
12325-7 | Tetrahydrocortisone [Presence] in Urine |
12326-5 | Diamorphine [Presence] in Unknown substance |
12327-3 | Ketamine [Presence] in Urine |
12328-1 | Beta blockers [Identifier] in Urine |
12329-9 | Chlorpropamide [Presence] in Urine |
1233-6 | Mi sup(a) Ag [Presence] on Red Blood Cells from donor |
12330-7 | Hypoglycemics.oral [Identifier] in Urine |
12331-5 | Phenethylamine [Presence] in Urine |
12332-3 | Antihistamines [Identifier] in Urine |
12333-1 | Butorphanol [Presence] in Urine |
12334-9 | Para aminophenol [Mass/volume] in Urine |
12335-6 | Halothane [Presence] in Blood |
12336-4 | Hydralazine [Presence] in Serum or Plasma |
12337-2 | Dimethylsulfoxide [Presence] in Serum or Plasma |
12338-0 | Pentachlorophenol [Presence] in Serum or Plasma |
12339-8 | Diquat [Presence] in Urine |
1234-4 | Mi sup(a) Ag [Presence] on Red Blood Cells |
12340-6 | Ethylene [Presence] in Blood |
12341-4 | Mazindol [Presence] in Serum or Plasma |
12342-2 | Oxymorphone [Presence] in Serum or Plasma |
12343-0 | Thiazides [Identifier] in Urine |
12344-8 | Antipsychotics [Identifier] in Serum or Plasma |
12345-5 | Cyclothiazide [Presence] in Urine |
12346-3 | Methyclothiazide [Presence] in Urine |
12347-1 | Metolazone [Presence] in Urine |
12348-9 | Quinethazone [Presence] in Urine |
12349-7 | Trichlormethiazide [Presence] in Urine |
1235-1 | Mi sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
12350-5 | Amphetamines [Presence] in Stool |
12351-3 | Tetrahydrocannabinol [Presence] in Stool |
12352-1 | Benzoylecgonine [Presence] in Stool |
12353-9 | Methaqualone [Presence] in Stool |
12354-7 | Opiates [Presence] in Stool |
12355-4 | Phencyclidine [Presence] in Stool |
12356-2 | Methadone [Presence] in Stool |
12357-0 | Propoxyphene [Presence] in Stool |
12358-8 | Barbiturates [Presence] in Stool |
12359-6 | Benzodiazepines [Presence] in Stool |
1236-9 | Mi sup(a) Ab [Presence] in Serum or Plasma from donor |
12360-4 | Barbital [Presence] in Urine |
12361-2 | Oxazepam [Presence] in Urine |
12362-0 | Oxazepam [Presence] in Serum or Plasma |
12363-8 | Carbamazepine [Presence] in Urine |
12364-6 | Benzodiazepines [Presence] in Gastric fluid |
12365-3 | Dimenhydrinate [Presence] in Urine |
12366-1 | Disopyramide [Presence] in Urine |
12367-9 | Mesoridazine [Presence] in Urine |
12368-7 | Phenacetin [Presence] in Urine |
12369-5 | Sympathomimetics [Identifier] in Urine |
1237-7 | Mi sup(a) Ab [Presence] in Serum or Plasma |
12370-3 | Thiopental [Mass/volume] in Urine |
12371-1 | Isopropyl ether [Mass/volume] in Blood |
12372-9 | Dimethylacetamide [Mass/volume] in Urine |
12373-7 | Deprecated Norchlordiazepoxide [Mass/volume] in Serum or Plasma |
12374-5 | Clobazam [Mass/volume] in Urine |
12375-2 | Clozapine+Norclozapine [Mass/volume] in Serum or Plasma |
12376-0 | Deprecated Norclozapine [Mass/volume] in Serum or Plasma |
12377-8 | Demoxepam [Mass/volume] in Serum or Plasma |
12378-6 | Diazepam [Presence] in Stool |
12379-4 | Halazepam [Mass/volume] in Serum or Plasma |
1238-5 | M NOS Ab [Presence] in Serum or Plasma from Blood product unit |
12380-2 | Lorazepam [Presence] in Stool |
12381-0 | Oxazepam [Presence] in Stool |
12382-8 | Temazepam [Mass/volume] in Urine |
12383-6 | Hydroxytriazolam [Presence] in Stool |
12384-4 | Triazolam [Presence] in Stool |
12385-1 | Deprecated Nordoxepin [Mass/volume] in Serum or Plasma |
12386-9 | Nordoxepin [Mass/volume] in Urine |
12387-7 | Primidone [Mass/volume] in Urine |
12388-5 | Phenylethylmalonamide [Mass/volume] in Serum or Plasma |
12389-3 | Olanzapine [Mass/volume] in Serum or Plasma |
1239-3 | M NOS Ab [Presence] in Serum or Plasma from donor |
12390-1 | Sulfasalazine [Mass/volume] in Serum or Plasma |
12391-9 | Dimenhydrinate [Mass/volume] in Serum or Plasma |
12392-7 | Deprecated Itraconazole [Mass/volume] in Serum or Plasma |
12393-5 | Deprecated Ketoconazole [Mass/volume] in Serum or Plasma |
12394-3 | Butorphanol [Mass/volume] in Serum or Plasma |
12395-0 | Butorphanol [Mass/volume] in Urine |
12396-8 | Chlorpropamide [Mass/volume] in Urine |
12397-6 | Colchicine [Mass/volume] in Serum or Plasma |
12398-4 | Diphenoxylate [Mass/volume] in Serum or Plasma |
12399-2 | Emetine [Mass/volume] in Serum or Plasma |
124-8 | Cefprozil [Susceptibility] by Minimum inhibitory concentration (MIC) |
1240-1 | M NOS Ab [Presence] in Serum or Plasma |
12400-8 | Emetine [Mass/volume] in Urine |
12401-6 | Ethinamate [Mass/volume] in Serum or Plasma |
12402-4 | Griseofulvin [Mass/volume] in Serum or Plasma |
12403-2 | Mephentermine [Mass/volume] in Blood |
12404-0 | Nitroglycerin [Mass/volume] in Serum or Plasma |
12405-7 | Nabumetone [Mass/volume] in Serum or Plasma |
12406-5 | Nadolol [Mass/volume] in Serum or Plasma |
12407-3 | 6-Beta naltrexone [Mass/volume] in Serum or Plasma |
12408-1 | Oxybutynin [Mass/volume] in Serum or Plasma |
12409-9 | Deprecated Pentoxyfylline [Mass/volume] in Serum or Plasma |
1241-9 | M NOS Ag [Presence] on Red Blood Cells from Blood product unit |
12410-7 | Pimozide [Mass/volume] in Serum or Plasma |
12411-5 | Promazine [Mass/volume] in Serum or Plasma |
12412-3 | Pyridine [Mass/volume] in Serum or Plasma |
12413-1 | Resperine [Mass/volume] in Serum or Plasma |
12414-9 | Resperine [Mass/volume] in Urine |
12415-6 | Selegiline [Mass/volume] in Serum or Plasma |
12416-4 | Sotalol [Mass/volume] in Serum or Plasma |
12417-2 | Sulindac [Mass/volume] in Serum or Plasma |
12418-0 | Terfenadine [Mass/volume] in Serum or Plasma |
12419-8 | Terfenadine [Mass/volume] in Urine |
1242-7 | M NOS Ag [Presence] on Red Blood Cells from donor |
12420-6 | Thiosulfate [Mass/volume] in Urine |
12421-4 | Thiosulfate/Creatinine [Mass Ratio] in Urine |
12422-2 | Triflupromazine [Mass/volume] in Serum or Plasma |
12423-0 | Trimeprazine [Mass/volume] in Serum or Plasma |
12424-8 | Triprolidine [Mass/volume] in Serum or Plasma |
12425-5 | Chlorzoxazone [Mass/volume] in Serum or Plasma |
12426-3 | Brodifacoum [Mass/volume] in Serum or Plasma |
12427-1 | Chlormezanone [Mass/volume] in Serum or Plasma |
12428-9 | Flurbiprofen [Mass/volume] in Serum or Plasma |
12429-7 | Succinylcholine [Mass/volume] in Urine |
1243-5 | M NOS Ag [Presence] on Red Blood Cells |
12430-5 | Cumene [Mass/volume] in Serum or Plasma |
12431-3 | Norfenfluramine [Mass/volume] in Serum or Plasma |
12432-1 | Hydroxytriazolam [Mass/volume] in Urine |
12433-9 | Bufotenine [Mass/volume] in Serum or Plasma |
12434-7 | Prednisone [Mass/volume] in Serum or Plasma |
12435-4 | Naphthalene [Mass/volume] in Serum or Plasma |
12436-2 | Naphthol [Mass/volume] in Serum or Plasma |
12437-0 | Tramadol [Mass/volume] in Serum or Plasma |
12438-8 | Nortramadol [Mass/volume] in Serum or Plasma |
12439-6 | Fluoxetine [Mass/volume] in Urine |
1244-3 | M1 Ab [Presence] in Serum or Plasma from Blood product unit |
12440-4 | Midazolam [Presence] in Stool |
12441-2 | Tolmetin [Mass/volume] in Serum or Plasma |
12442-0 | Acetaminophen [Mass/volume] in Unspecified specimen |
12443-8 | Trimipramine [Mass/volume] in Urine |
12444-6 | Nortrimipramine [Mass/volume] in Urine |
12445-3 | Norfluoxetine [Mass/volume] in Urine |
12446-1 | Halogenated organic molecules [Identifier] in Urine |
12447-9 | Deprecated Phenylethylmalonamide |
12448-7 | Ketones [Mass/volume] in Urine by Test strip --fasting |
12449-5 | Ketones [Mass/volume] in Urine by Test strip --1 hour post XXX challenge |
1245-0 | M1 Ab [Presence] in Serum or Plasma from donor |
12450-3 | Ketones [Mass/volume] in Urine by Test strip --2 hours post XXX challenge |
12451-1 | Ketones [Mass/volume] in Urine by Test strip --3 hours post XXX challenge |
12452-9 | Epithelial cells [Presence] in Semen by Light microscopy |
12453-7 | Phosphate crystals amorphous [Presence] in Urine sediment by Light microscopy |
12454-5 | Urate crystals amorphous [Presence] in Urine sediment by Light microscopy |
12455-2 | Histoplasma capsulatum yeast phase Ab [Presence] in Cerebral spinal fluid |
12456-0 | Histoplasma capsulatum mycelial phase Ab [Presence] in Cerebral spinal fluid |
12457-8 | Volume of Dialysis fluid |
12458-6 | Corticotropin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
12459-4 | Corticotropin [Mass/volume] in Plasma --3rd specimen post XXX challenge |
1246-8 | M1 Ab [Presence] in Serum or Plasma |
12460-2 | Corticotropin [Mass/volume] in Plasma --4th specimen post XXX challenge |
12461-0 | Corticotropin [Mass/volume] in Plasma --5th specimen post XXX challenge |
12462-8 | Corticotropin [Mass/volume] in Plasma --6th specimen post XXX challenge |
12463-6 | Corticotropin [Mass/volume] in Plasma --7th specimen post XXX challenge |
12464-4 | Corticotropin [Mass/volume] in Plasma --8th specimen post XXX challenge |
12465-1 | Ethanol [Mass/volume] in Vitreous fluid |
12466-9 | Alpha 1 antitrypsin [Mass/volume] in Amniotic fluid by Nephlometry |
12467-7 | Amino acids [Identifier] in Urine |
12468-5 | Amino acids [Identifier] in Serum or Plasma |
12469-3 | Cystine crystals [type] in Stone by Light microscopy |
1247-6 | M1 Ag [Presence] on Red Blood Cells from Blood product unit |
12470-1 | Homocysteine [Mass/volume] in Urine |
12471-9 | Amino beta guanidinopropionate [Mass/volume] in Urine |
12472-7 | Amino beta guanidinopropionate [Mass/volume] in 24 hour Urine |
12473-5 | Phosphoethanolamine [Mass/time] in Urine |
12474-3 | Carnosine [Mass/volume] in 24 hour Urine |
12475-0 | Delta aminolevulinate [Mass/time] in Urine |
12476-8 | Bilirubin.total [Mass/volume] in Amniotic fluid by Spectrophotometry direct |
12477-6 | Dextromethamphetamine [Mass/volume] in Urine |
12478-4 | Levomethamphetamine [Mass/volume] in Urine |
12479-2 | Androsterone [Mass/time] in Urine |
1248-4 | M1 Ag [Presence] on Red Blood Cells from donor |
12480-0 | Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid |
12481-8 | Arsenic.inorganic [Mass/volume] in Urine |
12482-6 | Ascorbate [Mass/volume] in Leukocytes |
12483-4 | Tungsten [Presence] in Serum or Plasma |
12484-2 | Phenobarbital [Presence] in Gastric fluid |
12485-9 | Amobarbital [Presence] in Gastric fluid |
12486-7 | Butabarbital [Presence] in Gastric fluid |
12487-5 | Butalbital [Presence] in Gastric fluid |
12488-3 | Pentobarbital [Presence] in Gastric fluid |
12489-1 | Secobarbital [Presence] in Gastric fluid |
1249-2 | M1 Ag [Presence] on Red Blood Cells |
12490-9 | Allyl-sec-butyl-barbiturate [Mass/volume] in Serum or Plasma |
12491-7 | Methohexital [Presence] in Serum or Plasma |
12492-5 | Thiamylal [Presence] in Serum or Plasma |
12493-3 | Hexobarbital [Mass/volume] in Serum or Plasma |
12494-1 | Amobarbital [Presence] in Stool |
12495-8 | Barbital [Presence] in Stool |
12496-6 | Butabarbital [Presence] in Stool |
12497-4 | Butalbital [Presence] in Stool |
12498-2 | Metharbital [Presence] in Stool |
12499-0 | Pentobarbital [Presence] in Stool |
125-5 | Cefprozil [Susceptibility] by Disk diffusion (KB) |
1250-0 | Major crossmatch [Interpretation] |
12500-5 | Secobarbital [Presence] in Stool |
12501-3 | Phenobarbital [Presence] in Stool |
12502-1 | Allobarbital [Presence] in Stool |
12503-9 | Hemoglobin.gastrointestinal [Presence] in Stool --4th specimen |
12504-7 | Hemoglobin.gastrointestinal [Presence] in Stool --5th specimen |
12505-4 | Cadmium [Mass/volume] in Red Blood Cells |
12506-2 | Calcitonin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12507-0 | Calcitonin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12508-8 | Calcitonin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12509-6 | Calcitonin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
1251-8 | Major crossmatch [Interpretation] by Immediate spin |
12510-4 | Calcitonin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12511-2 | Calcium [Mass/volume] in 4 hour Urine |
12512-0 | Calcium hydrogen phosphate dihydrate crystals [Presence] in Urine sediment by Light microscopy |
12513-8 | Bicarbonate [Moles/volume] in Water |
12514-6 | Bicarbonate [Moles/volume] in Dialysis fluid |
12515-3 | Carcinoembryonic Ag [Mass/volume] in Body fluid |
12516-1 | Catecholamines [Mass/volume] in Urine --2nd specimen post XXX challenge |
12517-9 | Catecholamines [Mass/volume] in Urine --3rd specimen post XXX challenge |
12518-7 | Catecholamines [Mass/volume] in Urine --4th specimen post XXX challenge |
12519-5 | Catecholamines [Mass/volume] in Urine --5th specimen post XXX challenge |
1252-6 | Major crossmatch [Interpretation] --post immediate spin |
12520-3 | Catecholamines [Mass/volume] in Urine --6th specimen post XXX challenge |
12521-1 | Catecholamines [Mass/volume] in Urine --7th specimen post XXX challenge |
12522-9 | Catecholamines [Mass/volume] in Plasma --2nd specimen post XXX challenge |
12523-7 | Catecholamines [Mass/volume] in Plasma --3rd specimen post XXX challenge |
12524-5 | Catecholamines [Mass/volume] in Plasma --4th specimen post XXX challenge |
12525-2 | Norepinephrine [Mass/volume] in Plasma --1 hour post XXX challenge |
12526-0 | Norepinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
12527-8 | Norepinephrine [Mass/volume] in Plasma --3 hours post XXX challenge |
12528-6 | Norepinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
12529-4 | Epinephrine [Mass/volume] in Plasma --2 hours post XXX challenge |
1253-4 | Major crossmatch [Interpretation] by Prewarmed |
12530-2 | Chloride [Moles/volume] in Water |
12531-0 | Deprecated Cholesterol [Mass/volume] in Body fluid |
12532-8 | Meclizine [Presence] in Serum or Plasma |
12533-6 | Thiazolidine-2-Thione-4-Carboxylic acid [Mass/volume] in Urine |
12534-4 | Thiazolidine-2-Thione-4-Carboxylic acid/Creatinine [Mass Ratio] in Urine |
12535-1 | Amyl nitrite [Presence] in Blood |
12536-9 | Butyl nitrate [Presence] in Blood |
12537-7 | Phenylglyoxylate [Mass/volume] in Urine |
12538-5 | Nitrate [Mass/volume] in Blood |
12539-3 | 2-Methylcitrate [Mass/volume] in Urine |
1254-2 | Major crossmatch.re-crossmatch [Interpretation] |
12540-1 | 2-Methylcitrate [Mass/volume] in Serum or Plasma |
12541-9 | Meta methylhippurate+Para methylhippurate [Mass/volume] in Urine |
12542-7 | N-methylacetamide [Mass/volume] in Urine |
12543-5 | Methyl formamide [Mass/volume] in Urine |
12544-3 | Nefazodone [Mass/volume] in Serum or Plasma |
12545-0 | Zomepirac [Mass/volume] in Serum or Plasma |
12546-8 | Quinethazone [Presence] in Serum or Plasma |
12547-6 | Phorate [Mass/volume] in Serum or Plasma |
12548-4 | Tybamate [Mass/volume] in Serum or Plasma |
12549-2 | Turpentine [Mass/volume] in Serum or Plasma |
1255-9 | Minor crossmatch [Interpretation] |
12550-0 | Papaverine [Mass/volume] in Serum or Plasma |
12551-8 | Isocarboxazid [Mass/volume] in Serum or Plasma |
12552-6 | Propylene glycol [Mass/volume] in Serum or Plasma |
12553-4 | Stimulants [Identifier] in Urine |
12554-2 | Narcotics and opioids [Identifier] in Urine |
12555-9 | Turpentine [Mass/volume] in Urine |
12556-7 | Copper [Mass/volume] in Blood |
12557-5 | Cortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12558-3 | Cortisol [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12559-1 | Cortisol [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
1256-7 | N Ab [Presence] in Serum or Plasma from Blood product unit |
12560-9 | Cortisol [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12561-7 | Cortisol [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12562-5 | Cortisol [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
12563-3 | Cortisol [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
12564-1 | Cortisol [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
12565-8 | Cortisol [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
12566-6 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
12567-4 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12568-2 | Cortisol [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
12569-0 | Cortisol [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
1257-5 | N Ab [Presence] in Serum or Plasma from donor |
12570-8 | Cortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
12571-6 | Deprecated Creatinine [Mass/volume] in Body fluid |
12572-4 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
12573-2 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
12574-0 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
12575-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --baseline |
12576-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
12577-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
12578-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
12579-9 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
1258-3 | N Ab [Presence] in Serum or Plasma |
12580-7 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
12581-5 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
12582-3 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
12583-1 | Creatinine [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
12584-9 | Creatinine [Mass/volume] in Vitreous fluid |
12585-6 | Creatinine [Mass/time] in 2 hour Urine |
12586-4 | Creatinine [Mass/time] in 4 hour Urine |
12587-2 | Creatinine [Mass/time] in 6 hour Urine |
12588-0 | Creatinine [Mass/time] in 8 hour Urine |
12589-8 | Creatinine [Mass/time] in 12 hour Urine |
1259-1 | N Ag [Presence] on Red Blood Cells from Blood product unit |
12590-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12591-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12592-2 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12593-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12594-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12595-5 | Estradiol (E2) [Mass/volume] in Urine |
12596-3 | Estradiol (E2) [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
12597-1 | Estrogen [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12598-9 | Fat.neutral [Presence] in Stool |
12599-7 | Pristanate (C15:0(CH3)4) [Mass/volume] in Serum or Plasma |
126-3 | Cefprozil [Susceptibility] by Serum bactericidal titer |
1260-9 | N Ag [Presence] on Red Blood Cells from donor |
12600-3 | Pristanate (C15:0(CH3)4)/Phytanate (C16:0(CH3)4) [Mass Ratio] in Serum or Plasma |
12601-1 | Fluoride [Mass/volume] in Dialysis fluid |
12602-9 | Hydroxyethylflurazepam [Mass/volume] in Urine |
12603-7 | N-desalkylflurazepam [Presence] in Stool |
12604-5 | Hydroxyethylflurazepam [Presence] in Stool |
12605-2 | Flurazepam [Presence] in Stool |
12606-0 | Dolichol [Mass/volume] in Serum or Plasma |
12607-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --pre dialysis |
12608-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
12609-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
1261-7 | N Ag [Presence] on Red Blood Cells |
12610-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
12611-0 | Glucose [Mass/volume] in Serum or Plasma --4 hour specimen |
12612-8 | Glucose [Mass/volume] in Dialysis fluid --2 hour specimen |
12613-6 | Glucose [Mass/volume] in Dialysis fluid --4 hour specimen |
12614-4 | Glucose [Mass/volume] in Serum or Plasma --7 hours post meal |
12615-1 | Glucose [Mass/volume] in Serum or Plasma --1st specimen post XXX challenge |
12616-9 | Glucose [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12617-7 | Glucose [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12618-5 | Glucose [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12619-3 | Glucose [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
1262-5 | N NOS Ab [Presence] in Serum or Plasma from Blood product unit |
12620-1 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12621-9 | Glucose [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
12622-7 | Glucose [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
12623-5 | Glucose [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
12624-3 | Glucose [Mass/volume] in Serum or Plasma --12th specimen post XXX challenge |
12625-0 | Glucose [Mass/volume] in Serum or Plasma --13th specimen post XXX challenge |
12626-8 | Glucose [Mass/volume] in Serum or Plasma --14th specimen post XXX challenge |
12627-6 | Glucose [Mass/volume] in Serum or Plasma --15th specimen post XXX challenge |
12628-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid |
12629-2 | Glucose [Mass/volume] in 24 hour Peritoneal dialysis fluid |
1263-3 | N NOS Ab [Presence] in Serum or Plasma from donor |
12630-0 | Glucose [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
12631-8 | Glucose [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
12632-6 | Glucose [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
12633-4 | Glucose [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
12634-2 | Glucose [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
12635-9 | Glucose [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
12636-7 | Glucose [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
12637-5 | Glucose [Mass/volume] in Peritoneal dialysis fluid --8th specimen post XXX challenge |
12638-3 | Glucose [Mass/volume] in Serum or Plasma --pre dose lactose PO |
12639-1 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
1264-1 | N NOS Ab [Presence] in Serum or Plasma |
12640-9 | Glucose [Mass/volume] in Serum or Plasma --6.5 hours post XXX challenge |
12641-7 | Glucose [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
12642-5 | Glucose [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
12643-3 | Glucose [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
12644-1 | Glucose [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
12645-8 | Glucose [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
12646-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12647-4 | Glucose [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
12648-2 | Glucose [Mass/volume] in Serum or Plasma --15 minutes post dose lactose PO |
12649-0 | Glucose [Mass/volume] in Serum or Plasma --6th specimen post dose lactose |
1265-8 | N NOS Ag [Presence] on Red Blood Cells from Blood product unit |
12650-8 | Glucose [Mass/volume] in Serum or Plasma --3.5 hours post dose lactose PO |
12651-6 | Glucose [Mass/volume] in Serum or Plasma --10 minutes pre XXX challenge |
12652-4 | Glucose [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
12653-2 | Glucose [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
12654-0 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
12655-7 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
12656-5 | Glucose [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
12657-3 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
12658-1 | Glucose [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
12659-9 | Glucose [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
1266-6 | N NOS Ag [Presence] on Red Blood Cells from donor |
12660-7 | Follitropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
12661-5 | Follitropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
12662-3 | Follitropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
12663-1 | Follitropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
12664-9 | Follitropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12665-6 | Follitropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12666-4 | Follitropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
12667-2 | Follitropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
12668-0 | Follitropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
12669-8 | Follitropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
1267-4 | N NOS Ag [Presence] on Red Blood Cells |
12670-6 | Follitropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
12671-4 | Follitropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
12672-2 | Lutropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
12673-0 | Lutropin [Moles/volume] in Serum or Plasma --3 hours post XXX challenge |
12674-8 | Lutropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
12675-5 | Lutropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
12676-3 | Lutropin [Moles/volume] in Serum or Plasma --40 minutes post XXX challenge |
12677-1 | Lutropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12678-9 | Lutropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12679-7 | Lutropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
1268-2 | Not otherwise specified Ab [Presence] in Serum or Plasma from Blood product unit |
12680-5 | Lutropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
12681-3 | Lutropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
12682-1 | Lutropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
12683-9 | Lutropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
12684-7 | Lutropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
12685-4 | Somatotropin [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12686-2 | Somatotropin [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12687-0 | Somatotropin [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
12688-8 | Somatotropin [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
12689-6 | Somatotropin [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
1269-0 | Not otherwise specified Ab [Presence] in Serum or Plasma from donor |
12690-4 | Somatotropin [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
12691-2 | Somatotropin [Moles/volume] in Serum or Plasma --8th specimen post XXX challenge |
12692-0 | Somatotropin [Moles/volume] in Serum or Plasma --9th specimen post XXX challenge |
12693-8 | Somatotropin [Moles/volume] in Serum or Plasma --10th specimen post XXX challenge |
12694-6 | Somatotropin [Moles/volume] in Serum or Plasma --post XXX challenge |
12695-3 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes pre XXX challenge |
12696-1 | Somatotropin [Moles/volume] in Serum or Plasma --pre XXX challenge |
12697-9 | Somatotropin [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
12698-7 | Somatotropin [Moles/volume] in Serum or Plasma --15 minutes post XXX challenge |
12699-5 | Somatotropin [Moles/volume] in Serum or Plasma --20 minutes post XXX challenge |
127-1 | Cefsulodin [Susceptibility] by Minimum lethal concentration (MLC) |
1270-8 | Unidentified Ab [Presence] in Serum or Plasma |
12700-1 | Somatotropin [Moles/volume] in Serum or Plasma --45 minutes post XXX challenge |
12701-9 | Somatotropin [Moles/volume] in Serum or Plasma --2.5 hours post XXX challenge |
12702-7 | Antimony [Presence] in Serum or Plasma |
12703-5 | Gallium [Mass/volume] in Serum or Plasma |
12704-3 | Length of Hair |
12705-0 | Strontium [Mass/volume] in Urine |
12706-8 | Tellurium [Mass/volume] in Serum or Plasma |
12707-6 | Thorium [Mass/volume] in Serum or Plasma |
12708-4 | Tin [Mass/volume] in Urine |
12709-2 | Norastemizole [Mass/volume] in Serum or Plasma |
1271-6 | Deprecated O group [Presence] [Presence] in Serum or Plasma from Blood product unit |
12710-0 | Hemoglobin pattern [Interpretation] in Blood |
12711-8 | Hemoglobin A region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
12712-6 | Hemoglobin S+D+G region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
12713-4 | Hemoglobin C+E+O+A2 region [Presence] in Blood by Electrophoresis alkaline (pH 8.9) |
12714-2 | N-methylhistamine [Mass/volume] in Urine |
12715-9 | Homovanillate [Mass/time] in Urine |
12716-7 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12717-5 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12718-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12719-1 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
1272-4 | Deprecated O group [Presence] in serum or plasma from donor |
12720-9 | Hydroxyproline [Mass/volume] in 2 hour Urine |
12721-7 | Melatonin [Units/volume] in Serum or Plasma |
12722-5 | Insulin-like growth factor binding protein 1 [Mass/volume] in Serum or Plasma |
12723-3 | Insulin-like growth factor binding protein 2 [Mass/volume] in Serum or Plasma |
12724-1 | Voltage-gated calcium channel IgG Ab [Units/volume] in Serum |
12725-8 | IgA.secretory [Units/volume] in Serum or Plasma |
12726-6 | Leucine-enkephalin [Units/volume] in Serum or Plasma |
12727-4 | Prednisolone [Mass/volume] in Serum or Plasma |
12728-2 | Alpha subunit [Units/volume] in Serum or Plasma |
12729-0 | Interferon gamma [Units/volume] in Serum or Plasma |
1273-2 | Deprecated O group [Presence] in serum |
12730-8 | Interferon beta [Units/volume] in Serum or Plasma |
12731-6 | Interferon alpha [Units/volume] in Serum or Plasma |
12732-4 | Interleukin 12 [Units/volume] in Serum or Plasma |
12733-2 | Tryptase [Enzymatic activity/volume] in Serum or Plasma |
12734-0 | Cytokeratin Ab [Units/volume] in Serum |
12735-7 | Collagen Ab [Units/volume] in Urine |
12736-5 | Hyaluronate [Mass/volume] in Serum or Plasma |
12737-3 | Endothelin [Units/volume] in Serum or Plasma |
12738-1 | Insulin [Mass/volume] in Serum or Plasma --pre XXX challenge |
12739-9 | Insulin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
1274-0 | Deprecated O group [Presence] on Red Blood Cells from Blood product unit |
12740-7 | Insulin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12741-5 | Insulin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12742-3 | Insulin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12743-1 | Insulin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12744-9 | Insulin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
12745-6 | Insulin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
12746-4 | Insulin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
12747-2 | Insulin [Mass/volume] in Serum or Plasma --3.5 hours post XXX challenge |
12748-0 | Insulin [Mass/volume] in Serum or Plasma --4.5 hours post XXX challenge |
12749-8 | Insulin [Mass/volume] in Serum or Plasma --5.5 hours post XXX challenge |
1275-7 | Deprecated O group [Presence] on Red Blood Cells from donor |
12750-6 | Insulin [Mass/volume] in Serum or Plasma --7 hours post XXX challenge |
12751-4 | Insulin [Mass/volume] in Serum or Plasma --7.5 hours post XXX challenge |
12752-2 | Insulin [Mass/volume] in Serum or Plasma --8 hours post XXX challenge |
12753-0 | Insulin [Mass/volume] in Serum or Plasma --9 hours post XXX challenge |
12754-8 | Insulin [Mass/volume] in Serum or Plasma --10 hours post XXX challenge |
12755-5 | Insulin [Mass/volume] in Serum or Plasma --11 hour post XXX challenge |
12756-3 | Insulin [Mass/volume] in Serum or Plasma --12 hours post XXX challenge |
12757-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes pre XXX challenge |
12758-9 | Insulin [Mass/volume] in Serum or Plasma --15 minutes pre XXX challenge |
12759-7 | Insulin [Mass/volume] in Serum or Plasma --2 minutes post XXX challenge |
1276-5 | Deprecated O group [Presence] on Red Blood Cells |
12760-5 | Insulin [Mass/volume] in Serum or Plasma --4 minutes post XXX challenge |
12761-3 | Insulin [Mass/volume] in Serum or Plasma --8 minutes post XXX challenge |
12762-1 | Insulin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
12763-9 | Insulin [Mass/volume] in Serum or Plasma --19 minutes post XXX challenge |
12764-7 | Insulin [Mass/volume] in Serum or Plasma --22 minutes post XXX challenge |
12765-4 | Insulin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
12766-2 | Insulin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
12767-0 | Insulin [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
12768-8 | Insulin [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
12769-6 | 17-Ketosteroids.total neutral [Mass/time] in 24 hour Urine |
1277-3 | P Ab [Presence] in Serum or Plasma from Blood product unit |
12770-4 | Lead [Mass/mass] in Tissue |
12771-2 | Cholesterol in HDL [Presence] in Serum or Plasma by Electrophoresis |
12772-0 | Cholesterol in HDL [Units/volume] in Serum or Plasma by Electrophoresis |
12773-8 | Cholesterol in LDL [Units/volume] in Serum or Plasma by Electrophoresis |
12774-6 | Mercury [Mass/volume] in Red Blood Cells |
12775-3 | Mercury [Mass/volume] in Dentin |
12776-1 | Mucin-like carcinoma associated Ag [Units/volume] in Serum or Plasma |
12777-9 | Immunoglobulin light chains.kappa.free [Units/volume] in Urine |
12778-7 | Immunoglobulin light chains.lambda.free [Units/volume] in Urine |
12779-5 | Nickel [Mass/time] in Urine |
1278-1 | P Ab [Presence] in Serum or Plasma from donor |
12780-3 | Nickel [Mass/volume] in Red Blood Cells |
12781-1 | Borrelia burgdorferi Ab band pattern [Interpretation] in Serum by Immunoblot (IB) |
12782-9 | Oligoclonal bands [Interpretation] in Cerebral spinal fluid by Electrophoresis |
12783-7 | Oligoclonal bands [Interpretation] in Serum or Plasma |
12784-5 | Codeine Free [Mass/volume] in Serum or Plasma |
12785-2 | Dihydrocodeine Free [Mass/volume] in Serum or Plasma |
12786-0 | Hydrocodone Free [Mass/volume] in Serum or Plasma |
12787-8 | Hydromorphone Free [Mass/volume] in Serum or Plasma |
12788-6 | 6-Monoacetylmorphine (6-MAM) [Mass/volume] in Serum or Plasma |
12789-4 | Oxycodone Free [Mass/volume] in Serum or Plasma |
1279-9 | P Ab [Presence] in Serum or Plasma |
12790-2 | Oxalate [Mass/volume] in Urine --2nd specimen post XXX challenge |
12791-0 | Oxalate [Mass/volume] in Urine --3rd specimen post XXX challenge |
12792-8 | Oxalate [Mass/volume] in Urine --4th specimen post XXX challenge |
12793-6 | Oxalate [Mass/volume] in Urine --5th specimen post XXX challenge |
12794-4 | Oxalate [Mass/volume] in Urine --6th specimen post XXX challenge |
12795-1 | Oxalate [Mass/volume] in Urine --7th specimen post XXX challenge |
12796-9 | Oxalate [Mass/volume] in Urine --8th specimen post XXX challenge |
12797-7 | Oxalate [Mass/volume] in Urine --9th specimen post XXX challenge |
12798-5 | Oxalate [Mass/volume] in Urine --10th specimen post XXX challenge |
12799-3 | Parathyrin Ab [Units/volume] in Serum |
128-9 | Cefsulodin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1280-7 | P NOS Ab [Presence] in Serum or Plasma from Blood product unit |
12800-9 | Deprecated Trimeprazine |
12801-7 | Methdilazine [Mass/volume] in Serum or Plasma |
12802-5 | Propiomazine [Mass/volume] in Serum or Plasma |
12803-3 | Phenylalanine [Presence] in Blood by Guthrie test |
12804-1 | Acid phosphatase [Enzymatic activity/volume] in Body fluid |
12805-8 | Alkaline phosphatase isoenzyme [Units/volume] in Serum or Plasma |
12806-6 | Alkaline phosphatase.lung [Enzymatic activity/volume] in Serum or Plasma |
12807-4 | Phosphoserine [Mass/volume] in Cerebral spinal fluid |
12808-2 | Uroporphyrin [Mass/time] in Urine |
12809-0 | Coproporphyrin [Mass/time] in Urine |
1281-5 | P NOS Ab [Presence] in Serum or Plasma from donor |
12810-8 | Porphobilinogen deaminase [Enzymatic activity/volume] in Blood |
12811-6 | Uroporphyrinogen III synthase [Enzymatic activity/volume] in Blood |
12812-4 | Potassium [Moles/volume] in Serum or Plasma --2nd specimen |
12813-2 | Potassium [Moles/volume] in Serum or Plasma --3rd specimen |
12814-0 | Potassium [Moles/volume] in Vitreous fluid |
12815-7 | Progesterone [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12816-5 | Progesterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12817-3 | Progesterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12818-1 | Progesterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12819-9 | Progesterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
1282-3 | P NOS Ab [Presence] in Serum or Plasma |
12820-7 | Progesterone [Mass/volume] in 24 hour Urine |
12821-5 | Progesterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
12822-3 | Progesterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12823-1 | Prolactin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12824-9 | Prolactin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12825-6 | Prolactin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12826-4 | Prolactin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12827-2 | Prolactin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12828-0 | Prolactin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
12829-8 | Prolactin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
1283-1 | P NOS Ag [Presence] on Red Blood Cells from Blood product unit |
12830-6 | Prolactin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
12831-4 | Prolactin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
12832-2 | Prolactin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
12833-0 | Prolactin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
12834-8 | Prolactin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
12835-5 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
12836-3 | Prostaglandin E2 [Mass/volume] in 24 hour Urine |
12837-1 | Prostaglandin E1 [Mass/volume] in 24 hour Urine |
12838-9 | Prostaglandin D2 [Mass/volume] in Urine |
12839-7 | Prostaglandin D2 [Mass/volume] in Serum or Plasma |
1284-9 | P NOS Ag [Presence] on Red Blood Cells from donor |
12840-5 | Prostaglandin F2 alpha [Moles/volume] in Urine |
12841-3 | Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
12842-1 | Protein [Mass/volume] in 12 hour Urine |
12843-9 | Protein [Mass/volume] in Peritoneal dialysis fluid |
12844-7 | Protein [Mass/volume] in Peritoneal dialysis fluid --2nd specimen |
12845-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
12846-2 | Protein [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
12847-0 | Protein [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
12848-8 | Protein [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
12849-6 | Protein [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
1285-6 | P NOS Ag [Presence] on Red Blood Cells |
12850-4 | Protein [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
12851-2 | Protein Fractions [Interpretation] in Serum or Plasma by Electrophoresis |
12852-0 | Bovine inner ear Ag [Presence] in Serum or Plasma by Immunoblot (IB) |
12853-8 | Purkinje cells Ab [Presence] in Serum by Immunoblot (IB) |
12854-6 | Neuronal nuclear type 1 Ab [Units/volume] in Serum |
12855-3 | HIV 1 p23 Ab [Presence] in Serum by Immunoblot (IB) |
12856-1 | HIV 1 p65 Ab [Presence] in Serum by Immunoblot (IB) |
12857-9 | HIV 1 p28 Ab [Presence] in Serum by Immunoblot (IB) |
12858-7 | HIV 1 p32 Ab [Presence] in Serum by Immunoblot (IB) |
12859-5 | HIV 1 p18 Ab [Presence] in Serum by Immunoblot (IB) |
1286-4 | P1 Ab [Presence] in Serum or Plasma from Blood product unit |
12860-3 | Borrelia burgdorferi 39kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12861-1 | Borrelia burgdorferi 88kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12862-9 | Borrelia burgdorferi 66kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12863-7 | Borrelia burgdorferi 41kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12864-5 | Borrelia burgdorferi 25kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12865-2 | Borrelia burgdorferi 29kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12866-0 | Borrelia burgdorferi 18kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12867-8 | Borrelia burgdorferi 58kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12868-6 | Borrelia burgdorferi 47kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12869-4 | Borrelia burgdorferi 30kD Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
1287-2 | P1 Ab [Presence] in Serum or Plasma from donor |
12870-2 | HIV 1 gp34 Ab [Presence] in Serum by Immunoblot (IB) |
12871-0 | HIV 1 p26 Ab [Presence] in Serum by Immunoblot (IB) |
12872-8 | HIV 1 p15 Ab [Presence] in Serum by Immunoblot (IB) |
12873-6 | Borrelia burgdorferi 88kD Ab [Presence] in Serum by Immunoblot (IB) |
12874-4 | Borrelia burgdorferi 93kD Ab [Presence] in Serum by Immunoblot (IB) |
12875-1 | HIV 1 p64 Ab [Presence] in Serum by Immunoblot (IB) |
12876-9 | HIV 1 p53 Ab [Presence] in Serum by Immunoblot (IB) |
12877-7 | Borrelia burgdorferi 47kD Ab [Presence] in Serum by Immunoblot (IB) |
12878-5 | Borrelia burgdorferi 29kD Ab [Presence] in Serum by Immunoblot (IB) |
12879-3 | Borrelia burgdorferi 25kD Ab [Presence] in Serum by Immunoblot (IB) |
1288-0 | P1 Ab [Presence] in Serum or Plasma |
12880-1 | Borrelia burgdorferi 58kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12881-9 | Borrelia burgdorferi 47kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12882-7 | Borrelia burgdorferi 29kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12883-5 | Borrelia burgdorferi 18kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12884-3 | Borrelia burgdorferi 39kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12885-0 | Borrelia burgdorferi 88kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12886-8 | Borrelia burgdorferi 66kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12887-6 | Borrelia burgdorferi 41kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12888-4 | Borrelia burgdorferi 25kD Ab [Presence] in Body fluid by Immunoblot (IB) |
12889-2 | Borrelia burgdorferi 30kD Ab [Presence] in Body fluid by Immunoblot (IB) |
1289-8 | P1 Ag [Presence] on Red Blood Cells from Blood product unit |
12890-0 | Borrelia burgdorferi 45kD Ab [Presence] in Serum by Immunoblot (IB) |
12891-8 | Borrelia burgdorferi 41kD Ab [Presence] in Serum by Immunoblot (IB) |
12892-6 | Borrelia burgdorferi 30kD Ab [Presence] in Serum by Immunoblot (IB) |
12893-4 | HIV 1 gp105 Ab [Presence] in Serum by Immunoblot (IB) |
12894-2 | HIV 1 p68 Ab [Presence] in Serum by Immunoblot (IB) |
12895-9 | HIV 1 p58 Ab [Presence] in Serum by Immunoblot (IB) |
12896-7 | Borrelia burgdorferi 58kD Ab [Presence] in Serum by Immunoblot (IB) |
12897-5 | Myelin associated glycoprotein Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
12898-3 | Chloride [Moles/volume] in Vitreous fluid |
12899-1 | Acetylene [Mass/volume] in Serum or Plasma |
129-7 | Cefsulodin [Susceptibility] by Disk diffusion (KB) |
1290-6 | P1 Ag [Presence] on Red Blood Cells from donor |
12900-7 | Renin [Enzymatic activity/volume] in Plasma --2nd specimen post XXX challenge |
12901-5 | Renin [Enzymatic activity/volume] in Plasma --3rd specimen post XXX challenge |
12902-3 | Renin [Enzymatic activity/volume] in Plasma --4th specimen post XXX challenge |
12903-1 | Renin [Enzymatic activity/volume] in Plasma --5th specimen post XXX challenge |
12904-9 | Renin [Enzymatic activity/volume] in Plasma --6th specimen post XXX challenge |
12905-6 | Renin [Enzymatic activity/volume] in Plasma --7th specimen post XXX challenge |
12906-4 | Renin [Enzymatic activity/volume] in Plasma --8th specimen post XXX challenge |
12907-2 | Sodium [Moles/volume] in Red Blood Cells |
12908-0 | Sodium [Moles/volume] in Vitreous fluid |
12909-8 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
1291-4 | P1 Ag [Presence] on Red Blood Cells |
12910-6 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12911-4 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
12912-2 | Lipids [Mass/volume] in Body fluid |
12913-0 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Leukocytes |
12914-8 | Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total in Serum |
12915-5 | Beta galactosidase [Enzymatic activity/volume] in Leukocytes |
12916-3 | Porphobilinogen synthase [Enzymatic activity/volume] in Blood |
12917-1 | Porphobilinogen synthase [Enzymatic activity/volume] in Serum or Plasma |
12918-9 | Monoamine oxidase [Enzymatic activity/volume] in Platelet rich plasma |
12919-7 | Monoamine oxidase [Enzymatic activity/volume] in Blood |
1292-2 | Deprecated P2 Ab [Presence] in Serum or Plasma from Blood product unit |
12920-5 | Sulfate [Mass/volume] in 24 hour Urine |
12921-3 | Testosterone [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
12922-1 | Testosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12923-9 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12924-7 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12925-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12926-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12927-0 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12928-8 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
12929-6 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
1293-0 | Deprecated P2 Ab [Presence] on Red Blood Cells from donor |
12930-4 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
12931-2 | Thyroxine (T4) [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12932-0 | Thyrotropin [Units/volume] in Serum or Plasma --post XXX challenge |
12933-8 | Thyrotropin [Units/volume] in Serum or Plasma --10 minutes post XXX challenge |
12934-6 | Thyrotropin [Units/volume] in Serum or Plasma --15 minutes post XXX challenge |
12935-3 | Thyrotropin [Units/volume] in Serum or Plasma --20 minutes post XXX challenge |
12936-1 | Thyrotropin [Units/volume] in Serum or Plasma --40 minutes post XXX challenge |
12937-9 | Thyrotropin [Units/volume] in Serum or Plasma --45 minutes post XXX challenge |
12938-7 | Thyrotropin [Units/volume] in Serum or Plasma --1.5 hours post XXX challenge |
12939-5 | Thyrotropin [Units/volume] in Serum or Plasma --2 hours post XXX challenge |
1294-8 | Deprecated P2 Ab |
12940-3 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes pre XXX challenge |
12941-1 | Thyrotropin [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12942-9 | Thyrotropin [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12943-7 | Thyrotropin [Units/volume] in Serum or Plasma --4th specimen post XXX challenge |
12944-5 | Thyrotropin [Units/volume] in Serum or Plasma --5th specimen post XXX challenge |
12945-2 | Thyrotropin [Units/volume] in Serum or Plasma --6th specimen post XXX challenge |
12946-0 | Thyrotropin [Units/volume] in Serum or Plasma --7th specimen post XXX challenge |
12947-8 | Thyrotropin [Units/volume] in Serum or Plasma --8th specimen post XXX challenge |
12948-6 | Thyrotropin [Units/volume] in Serum or Plasma --9th specimen post XXX challenge |
12949-4 | Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma |
1295-5 | P2 Ag [Presence] on Red Blood Cells from Blood product unit |
12950-2 | Deprecated Triglyceride [Mass/volume] in Body fluid |
12951-0 | Triglyceride [Mass/volume] in Serum or Plasma by calculation |
12952-8 | Deprecated Thyroxine (T4) uptake [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
12953-6 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
12954-4 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
12955-1 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
12956-9 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
12957-7 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
12958-5 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
12959-3 | Triiodothyronine (T3) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
1296-3 | P2 Ag [Presence] on Red Blood Cells from donor |
12960-1 | Alpha 1 antitrypsin fecal clearance |
12961-9 | Urea nitrogen [Mass/volume] in Arterial blood |
12962-7 | Urea nitrogen [Mass/volume] in Venous blood |
12963-5 | Urea nitrogen [Mass/volume] in Peripheral blood |
12964-3 | Urea nitrogen [Mass/volume] in Blood --baseline |
12965-0 | Urea nitrogen [Mass/volume] in Serum or Plasma --70 minute specimen |
12966-8 | Urea nitrogen [Mass/volume] in Serum or Plasma --2 hour specimen |
12967-6 | Urea nitrogen [Mass/volume] in 24 hour Urine |
12968-4 | Urea nitrogen [Mass/volume] in Dialysis fluid --4 hour specimen |
12969-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --baseline |
1297-1 | P2 Ag [Presence] on Red Blood Cells |
12970-0 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --2 hour dwell specimen |
12971-8 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4 hour dwell specimen |
12972-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --1st specimen |
12973-4 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --4th specimen |
12974-2 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --3rd specimen |
12975-9 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --5th specimen |
12976-7 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --6th specimen |
12977-5 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --8th specimen |
12978-3 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --7th specimen |
12979-1 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid --24 hour specimen |
1298-9 | Packed erythrocytes given [Volume] |
12980-9 | Deprecated Urate [Mass/volume] in Body fluid |
12981-7 | Urea nitrogen [Mass Ratio] in Peritoneal dialysis fluid --post dialysis/pre dialysis |
12982-5 | Vasopressin [Mass/volume] in Plasma --2nd specimen post XXX challenge |
12983-3 | Volatiles and gases [Identifier] in Urine |
12984-1 | 2,4 toluenediamine [Mass/volume] in Blood |
12985-8 | 2,6 toluenediamine [Mass/volume] in Blood |
12986-6 | 2,5-Hexanedione [Mass/volume] in Blood |
12987-4 | Acetonitrile [Mass/volume] in Urine |
12988-2 | Acrylamide [Mass/volume] in Blood |
12989-0 | Allyl alcohol [Mass/volume] in Serum or Plasma |
1299-7 | Platelets given [Volume] |
12990-8 | Polychlorinated biphenyl.Aroclor 1260 [Mass/volume] in Serum or Plasma |
12991-6 | Polychlorinated biphenyl.Aroclor 1254 [Mass/volume] in Serum or Plasma |
12992-4 | Isobutane [Mass/volume] in Blood |
12993-2 | Hydrocarbons.chlorinated [Identifier] in Blood |
12994-0 | Oxychlordane [Mass/volume] in Blood |
12995-7 | Cyclohexanone [Mass/volume] in Blood |
12996-5 | Dichlorodifluoroethane [Mass/volume] in Blood |
12997-3 | 1,4-Dioxane [Mass/volume] in Serum or Plasma |
12998-1 | Methylene chloride [Mass/volume] in Blood |
12999-9 | Epichlorohydrin [Mass/volume] in Serum or Plasma |
13-3 | Amikacin [Susceptibility] by Disk diffusion (KB) |
130-5 | Cefsulodin [Susceptibility] by Serum bactericidal titer |
1300-3 | Deprecated PP1 Ab [Presence] in Serum or Plasma from Blood product unit |
13000-5 | Mandelate [Mass/volume] in Urine |
13001-3 | Mandelate/Creatinine [Mass Ratio] in Urine |
13002-1 | Mesityl oxide [Mass/volume] in Blood |
13003-9 | Halogenated organic molecules [Identifier] in Blood |
13004-7 | Hydrocarbons.halogenated.volatile [Identifier] in Blood |
13005-4 | 2,4,5-Trichlorophenoxyacetate [Type] in Serum or Plasma |
13006-2 | 1,4-Dichlorobenzene [Mass/volume] in Serum or Plasma |
13007-0 | Ethane [Mass/volume] in Blood |
13008-8 | Methyl propyl ketone [Mass/volume] in Blood |
13009-6 | Methyl ethyl ketone [Mass/volume] in Urine |
1301-1 | Deprecated PP1 Ab [Presence] serum or plasma from donor |
13010-4 | Methyl amyl ketone [Mass/volume] in Blood |
13011-2 | Methyl ethyl ketone [Mass/volume] in Blood |
13012-0 | Methyl isoamyl ketone [Mass/volume] in Blood |
13013-8 | Methyl isobutyl ketone [Mass/volume] in Blood |
13014-6 | Methyl butyl ketone [Mass/volume] in Blood |
13015-3 | Diisobutylketone [Mass/volume] in Blood |
13016-1 | Nitrophenol [Units/volume] in Blood |
13017-9 | Deprecated Tetrachloroethylene [Mass/volume] in Blood |
13018-7 | Pesticides [Identifier] in Urine |
13019-5 | Pesticides [Identifier] in Serum or Plasma |
1302-9 | Deprecated PP1 Ab |
13020-3 | Pesticides [Identifier] in Blood |
13021-1 | Pesticides [Identifier] in Gastric fluid |
13022-9 | Propane [Mass/volume] in Blood |
13023-7 | Trichlorofluoromethane [Mass/volume] in Blood |
13024-5 | Trichlorofluoroethane [Mass/volume] in Blood |
13025-2 | Trichlorotrifluoroethane [Mass/volume] in Blood |
13026-0 | Orthocresol [Mass/volume] in Urine |
13027-8 | Ethyl acetate [Mass/volume] in Serum or Plasma |
13028-6 | Xylose [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
13029-4 | Xylose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
1303-7 | Reverse ABO group [Type] |
13030-2 | Xylose [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
13031-0 | Xylose [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
13032-8 | C peptide [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
13033-6 | C peptide [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
13034-4 | C peptide [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
13035-1 | C peptide [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
13036-9 | C peptide [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
13037-7 | C peptide [Mass/volume] in Serum or Plasma --fasting |
13038-5 | C peptide [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
13039-3 | C peptide [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
1304-5 | D Ab [Titer] in Serum or Plasma |
13040-1 | C peptide [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
13041-9 | C peptide [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
13042-7 | C peptide [Mass/volume] in Serum or Plasma --2.5 hours post XXX challenge |
13043-5 | C peptide [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
13044-3 | C peptide [Mass/volume] in Serum or Plasma --5 hours post XXX challenge |
13045-0 | C peptide [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
13046-8 | Variant lymphocytes/100 leukocytes in Blood |
13047-6 | Plasma cells/100 leukocytes in Blood |
13048-4 | Sezary cells [Presence] in Blood by Light microscopy |
13049-2 | Deprecated von Willebrand factor (vWf) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
1305-2 | D Ag [Presence] in Blood |
13050-0 | Protein C/Coagulation factor IX [Mass Ratio] in Platelet poor plasma |
13051-8 | Deprecated Protein S [Units/volume] in Platelet poor plasma |
13052-6 | Protein S/Coagulation factor IX [Mass Ratio] in Platelet poor plasma by Coagulation assay |
13053-4 | Kaolin activated time [Units/volume] in Platelet poor plasma |
13054-2 | Fibrin+Fibrinogen fragments [Units/volume] in Urine |
13055-9 | Heparin [Units/volume] in Platelet poor plasma |
13056-7 | Platelets [#/volume] in Plasma by Automated count |
13057-5 | Platelets [Units/volume] in Dialysis fluid |
13058-3 | aPTT in Platelet poor plasma by Coagulation assay --2nd specimen |
13059-1 | aPTT in Platelet poor plasma by Coagulation assay --3rd specimen |
1306-0 | D NOS Ab [Presence] in Serum or Plasma |
13060-9 | aPTT in Platelet poor plasma by Coagulation assay --4th specimen |
13061-7 | Platelet IgM Ab [Units/volume] in Serum |
13062-5 | Platelet IgA Ab [Units/volume] in Serum |
13063-3 | Drug induced platelet Ab [Units/volume] in Serum |
13064-1 | Platelet associated IgA Ab [Units/volume] in Blood |
13065-8 | Deprecated Platelet Ab [Units/volume] in Serum |
13066-6 | Nuclear Ab [Units/volume] in Body fluid by Immunofluorescence |
13067-4 | Nuclear Ab pattern [Interpretation] in Body fluid by Immunofluorescence |
13068-2 | Nuclear Ab pattern [Interpretation] in Serum by Immunofluorescence |
13069-0 | Phosphatidylserine IgA Ab [Units/volume] in Serum |
1307-8 | D NOS Ab [Presence] in Serum or Plasma from Blood product unit |
13070-8 | Phosphatidate IgG Ab [Units/volume] in Serum |
13071-6 | Phosphatidate IgM Ab [Units/volume] in Serum |
13072-4 | Phosphatidate IgA Ab [Units/volume] in Serum |
13073-2 | Phosphatidylcholine IgG Ab [Units/volume] in Serum |
13074-0 | Phosphatidylcholine IgM Ab [Units/volume] in Serum |
13075-7 | Phosphatidylcholine IgA Ab [Units/volume] in Serum |
13076-5 | Phosphatidylethanolamine IgG Ab [Units/volume] in Serum |
13077-3 | Phosphatidylethanolamine IgM Ab [Units/volume] in Serum |
13078-1 | Phosphatidylethanolamine IgA Ab [Units/volume] in Serum |
13079-9 | Phosphatidylglycerol IgG Ab [Units/volume] in Serum |
1308-6 | D NOS Ab [Presence] in Serum or Plasma from donor |
13080-7 | Phosphatidylglycerol IgM Ab [Units/volume] in Serum |
13081-5 | Phosphatidylglycerol IgA Ab [Units/volume] in Serum |
13082-3 | Phosphatidylinositol IgG Ab [Units/volume] in Serum |
13083-1 | Phosphatidylinositol IgM Ab [Units/volume] in Serum |
13084-9 | Phosphatidylinositol IgA Ab [Units/volume] in Serum |
13085-6 | Complement C4 Nephritic [Mass/volume] in Serum or Plasma |
13086-4 | Complement C3 Nephritic [Mass/volume] in Serum or Plasma |
13087-2 | Complement alternate pathway AH50 [Units/volume] in Serum or Plasma |
13088-0 | Complement total hemolytic CH100 [Units/volume] in Serum or Plasma |
13089-8 | Deprecated Asialoganglioside GM1 Ab |
1309-4 | Deprecated D NOS Ab [Presence] in Serum or Plasma |
13090-6 | Deprecated Asialoganglioside GM1 Ab.IgG |
13091-4 | Deoxyribonucleoprotein Ab [Units/volume] in Serum |
13092-2 | Endomysium Ab [Units/volume] in Serum |
13093-0 | Deprecated Monosialoganglioside GM1 Ab.IgM |
13094-8 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum |
13095-5 | Deprecated Monosialoganglioside GM1 Ab.IgA in serum or plasma |
13096-3 | Deprecated Myelin associated glycoprotein Ab.IgM in serum |
13097-1 | Deprecated PM-SCL extractable nuclear Ab |
13098-9 | Deprecated Sulfatide Ab.IgG |
13099-7 | Deprecated Sulfatide Ab.IgM in serum |
131-3 | Cefsulodin [Mass/volume] in Serum or Plasma |
1310-2 | D NOS Ag [Presence] on Red Blood Cells from Blood product unit |
13100-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in serum |
13101-1 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab.IgM in CSF |
13102-9 | Deprecated Disialylganglioside GD1b Ab in serum |
13103-7 | Deprecated Disialylganglioside GD1b Ab.IgG |
13104-5 | Deprecated Disialylganglioside GD1b Ab.IgM |
13105-2 | Deprecated Tetrasialylganglioside GQ1b Ab.IgG |
13106-0 | Deprecated Tetrasialylganglioside GQ1b Ab in serum |
13107-8 | Deprecated Disialylganglioside GD1a Ab |
13108-6 | Deprecated Tetrasialylganglioside GQ1b Ab in serum or plasma |
13109-4 | Deprecated Disialylganglioside GD1b Ab in serum or plasma |
1311-0 | D NOS Ag [Presence] on Red Blood Cells from donor |
13110-2 | Deprecated Beta tubulin Ab.IgM |
13111-0 | Deprecated Nuclear Ab by Immunofluorescence |
13112-8 | Deprecated Nuclear Ab Immunofluorescence (rat kidney substrate) |
13113-6 | Deprecated Myelin associated glycoprotein Ab.IgM in serum or plasma |
13114-4 | Deprecated Neuronal nuclear type 2 Ab |
13115-1 | Deprecated Neuronal nuclear type 1 Ab |
13116-9 | Deprecated Reticulin Ab.IgG |
13117-7 | Complement Sc5b-9 Ab [Units/volume] in Serum or Plasma |
13118-5 | Deprecated Myelin associated glycoprotein Ab |
13119-3 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunoblot (IB) |
1312-8 | D NOS Ag [Presence] on Red Blood Cells |
13120-1 | Ovary Ab [Units/volume] in Serum |
13121-9 | Deprecated Ribosomal P protein Ab |
13122-7 | Deprecated Sulfatide Ab.IgM in serum or plasma |
13123-5 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum |
13124-3 | Deprecated Sulfate-3-Glucuronyl paragloboside Ab in serum or plasma |
13125-0 | Deprecated Hepatitis C virus c33c Ab [Presence] in Serum by Immunoblot (IB) |
13126-8 | Deprecated Hepatitis B virus DNA [Presence] in Blood by Immunoblot (IB) |
13127-6 | Cancer Ag DM/70K [Units/volume] in Serum or Plasma |
13128-4 | Protein.immunoacidic [Units/volume] in Serum or Plasma |
13129-2 | Pancreatic oncofetal Ag [Units/volume] in Serum or Plasma |
1313-6 | Rh immune globulin dosage.vials recommended [#] |
13130-0 | Motilin [Units/volume] in Serum or Plasma |
13131-8 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum |
13132-6 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum |
13133-4 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum |
13134-2 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum |
13135-9 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum |
13136-7 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum |
13137-5 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum |
13138-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum |
13139-1 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen |
1314-4 | Rh immune globulin screen [interpretation] |
13140-9 | Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen |
13141-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen |
13142-5 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen |
13143-3 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen |
13144-1 | Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen |
13145-8 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen |
13146-6 | Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen |
13147-4 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --1st specimen |
13148-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum --2nd specimen |
13149-0 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --1st specimen |
1315-1 | S Ab [Presence] in Serum or Plasma from Blood product unit |
13150-8 | Streptococcus pneumoniae 8 Ab [Units/volume] in Serum --2nd specimen |
13151-6 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --1st specimen |
13152-4 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum --2nd specimen |
13153-2 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen |
13154-0 | Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen |
13155-7 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum --1st specimen |
13156-5 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum --2nd specimen/1st specimen |
13157-3 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen |
13158-1 | Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen |
13159-9 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --1st specimen |
1316-9 | S Ab [Presence] in Serum or Plasma from donor |
13160-7 | Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen |
13161-5 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen |
13162-3 | Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen |
13163-1 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum |
13164-9 | Human antimouse Ab [Units/volume] in Serum |
13165-6 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum |
13166-4 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum |
13167-2 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum |
13168-0 | Streptococcus pneumoniae 6+26 Ab [Units/volume] in Serum |
13169-8 | Immunoelectrophoresis for Serum or Plasma |
1317-7 | S Ab [Presence] in Serum or Plasma |
13170-6 | Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
13171-4 | Immune complex [Units/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
13172-2 | Complement C1q Ag [Units/volume] in Serum or Plasma by Raji cell assay |
13173-0 | Fibronectin aggregate IgA Ab [Units/volume] in Serum |
13174-8 | Immunofixation for Cerebral spinal fluid |
13175-5 | Liver cytosol Ab [Presence] in Serum |
13176-3 | Wasp venom IgE Ab [Units/volume] in Serum |
13177-1 | Russian olive IgE Ab [Units/volume] in Serum |
13178-9 | Wasp venom IgG Ab [Units/volume] in Serum |
13179-7 | English Walnut IgG Ab [Units/volume] in Serum |
1318-5 | S Ag [Presence] on Red Blood Cells from Blood product unit |
13180-5 | Formaldehyde IgG Ab [Units/volume] in Serum |
13181-3 | Bahia grass IgG Ab [Units/volume] in Serum |
13182-1 | Mesquite IgG Ab [Units/volume] in Serum |
13183-9 | White Elm IgG Ab [Units/volume] in Serum |
13184-7 | Cottonwood IgG Ab [Units/volume] in Serum |
13185-4 | Nettle IgG Ab [Units/volume] in Serum |
13186-2 | Yellow Dock IgG Ab [Units/volume] in Serum |
13187-0 | False ragweed IgG Ab [Units/volume] in Serum |
13188-8 | Mugwort IgG Ab [Units/volume] in Serum |
13189-6 | English Plantain IgG Ab [Units/volume] in Serum |
1319-3 | S Ag [Presence] on Red Blood Cells from donor |
13190-4 | Formaldehyde IgM Ab [Units/volume] in Serum or Plasma |
13191-2 | Deprecated Rheumatoid factor [Units/volume] in Serum |
13192-0 | Adenovirus Ab [Units/volume] in Cerebral spinal fluid |
13193-8 | Aspergillus flavus Ab [Units/volume] in Cerebral spinal fluid |
13194-6 | Aspergillus glaucus Ab [Units/volume] in Serum |
13195-3 | Ehrlichia chaffeensis Ab [Units/volume] in Serum |
13196-1 | Ehrlichia sp IgG Ab [Presence] in Serum |
13197-9 | Ehrlichia sp IgM Ab [Presence] in Serum |
13198-7 | Thermoactinomyces Ab [Units/volume] in Serum |
13199-5 | Rickettsia conorii IgG Ab [Units/volume] in Serum |
132-1 | Ceftazidime [Susceptibility] by Minimum lethal concentration (MLC) |
1320-1 | S Ag [Presence] on Red Blood Cells |
13200-1 | Rickettsia conorii IgM Ab [Units/volume] in Serum |
13201-9 | Blastomyces dermatitidis Ab [Units/volume] in Cerebral spinal fluid |
13202-7 | Borrelia burgdorferi IgG Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
13203-5 | Borrelia burgdorferi IgM Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
13204-3 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
13205-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
13206-8 | Borrelia burgdorferi IgG Ab [Presence] in Synovial fluid by Immunoblot (IB) |
13207-6 | Borrelia burgdorferi IgM Ab [Presence] in Synovial fluid by Immunoblot (IB) |
13208-4 | Borrelia hermsii IgG Ab [Units/volume] in Serum |
13209-2 | Borrelia hermsii IgM Ab [Units/volume] in Serum |
1321-9 | Transfusion duration |
13210-0 | Brucella sp IgG Ab [Units/volume] in Serum |
13211-8 | Brucella sp IgA Ab [Units/volume] in Serum |
13212-6 | Brucella abortus IgG Ab [Units/volume] in Cerebral spinal fluid |
13213-4 | Brucella abortus IgM Ab [Units/volume] in Cerebral spinal fluid |
13214-2 | Brucella canis IgG Ab [Units/volume] in Cerebral spinal fluid |
13215-9 | Brucella canis IgM Ab [Units/volume] in Cerebral spinal fluid |
13216-7 | Candida albicans immune complex [Units/volume] in Serum or Plasma |
13217-5 | Chlamydia trachomatis B Ab [Units/volume] in Serum |
13218-3 | Chlamydia trachomatis C Ab [Units/volume] in Serum |
13219-1 | Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
1322-7 | Transfusion volume |
13220-9 | Chlamydia trachomatis C IgM Ab [Units/volume] in Serum |
13221-7 | Chlamydia trachomatis G+F+K IgM Ab [Units/volume] in Serum |
13222-5 | Deprecated Chlamydia trachomatis C Ab [Units/volume] in Serum |
13223-3 | Deprecated Chlamydia trachomatis B Ab [Units/volume] in Serum |
13224-1 | Deprecated Chlamydia trachomatis G+F+K Ab [Units/volume] in Serum |
13225-8 | Cytomegalovirus IgG Ab [Units/volume] in Serum --1st specimen |
13226-6 | Cytomegalovirus IgM Ab [Units/volume] in Cerebral spinal fluid |
13227-4 | Corynebacterium diphtheriae IgG Ab [Units/volume] in Serum |
13228-2 | Eastern equine encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
13229-0 | Eastern equine encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
1323-5 | U Ab [Presence] in Serum or Plasma from Blood product unit |
13230-8 | Saint Louis encephalitis virus IgG Ab [Units/volume] in Cerebral spinal fluid |
13231-6 | Saint Louis encephalitis virus IgM Ab [Units/volume] in Cerebral spinal fluid |
13232-4 | Coxsackievirus A Ab [Units/volume] in Cerebral spinal fluid |
13233-2 | Coxsackievirus A2 Ab [Units/volume] in Cerebral spinal fluid |
13234-0 | Coxsackievirus A4 Ab [Units/volume] in Cerebral spinal fluid |
13235-7 | Coxsackievirus A16 Ab [Units/volume] in Cerebral spinal fluid |
13236-5 | Epstein Barr virus early diffuse Ab [Presence] in Serum by Immunofluorescence |
13237-3 | Epstein Barr virus early restricted Ab [Presence] in Serum by Immunofluorescence |
13238-1 | Epstein Barr virus Ab [Units/volume] in Serum |
13239-9 | Deprecated Epstein Barr virus nuclear IgG Ab [Presence] in Serum |
1324-3 | U Ab [Presence] in Serum or Plasma from donor |
13240-7 | Phoma herbarum IgE Ab [Units/volume] in Serum |
13241-5 | Sporothrix schenckii IgG Ab [Units/volume] in Serum |
13242-3 | Sporothrix schenckii IgM Ab [Units/volume] in Serum |
13243-1 | Sporothrix schenckii IgA Ab [Units/volume] in Serum |
13244-9 | Filaria IgG Ab [Units/volume] in Serum |
13245-6 | Filaria IgM Ab [Units/volume] in Serum |
13246-4 | Haemophilus influenzae B Ab [Units/volume] in Serum |
13247-2 | HTLV I+II Ab [Units/volume] in Cerebral spinal fluid |
13248-0 | Hepatitis D virus Ab [Presence] in Serum |
13249-8 | Herpes simplex virus 1+2 IgG Ab [Units/volume] in Cerebral spinal fluid |
1325-0 | U Ab [Presence] in Serum or Plasma |
13250-6 | Herpes virus 6 IgG+IgM Ab [Units/volume] in Serum |
13251-4 | Herpes simplex virus 1 IgM Ab [Units/volume] in Cerebral spinal fluid |
13252-2 | Herpes simplex virus 2 IgM Ab [Units/volume] in Cerebral spinal fluid |
13253-0 | Legionella non-pneumophila Ab [Presence] in Serum |
13254-8 | Legionella pneumophila atypical Ab [Presence] in Serum |
13255-5 | Legionella longbeachae 1+2 Ab [Presence] in Serum |
13256-3 | Leishmania donovani IgG Ab [Units/volume] in Serum |
13257-1 | Leishmania donovani IgM Ab [Units/volume] in Serum |
13258-9 | Leishmania brasilensis IgG Ab [Units/volume] in Serum |
13259-7 | Leishmania brasilensis IgM Ab [Units/volume] in Serum |
1326-8 | U Ag [Presence] on Red Blood Cells from Blood product unit |
13260-5 | Leishmania mexicana IgG Ab [Units/volume] in Serum |
13261-3 | Leishmania mexicana IgM Ab [Units/volume] in Serum |
13262-1 | Leishmania tropica IgG Ab [Units/volume] in Serum |
13263-9 | Leishmania tropica IgM Ab [Units/volume] in Serum |
13264-7 | Leptospira sp IgG Ab [Titer] in Serum |
13265-4 | Leptospira sp IgM Ab [Titer] in Serum |
13266-2 | Mumps virus IgG Ab [Units/volume] in Cerebral spinal fluid |
13267-0 | Mumps virus IgM Ab [Units/volume] in Cerebral spinal fluid |
13268-8 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --1st specimen |
13269-6 | Mycoplasma pneumoniae Ab [Units/volume] in Serum --2nd specimen |
1327-6 | U Ag [Presence] on Red Blood Cells from donor |
13270-4 | Mycoplasma pneumoniae IgA Ab [Units/volume] in Serum |
13271-2 | Neisseria meningitidis A Ab [Units/volume] in Serum |
13272-0 | Neisseria meningitidis C Ab [Units/volume] in Serum |
13273-8 | Sporothrix schenckii Ab [Presence] in Serum |
13274-6 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid |
13275-3 | Toxocara canis IgM Ab [Units/volume] in Serum |
13276-1 | Toxocara canis IgA Ab [Units/volume] in Serum |
13277-9 | Schistosoma sp IgG Ab [Units/volume] in Serum |
13278-7 | Schistosoma sp IgM Ab [Units/volume] in Serum |
13279-5 | Rubella virus IgG Ab [Units/volume] in Serum --1st specimen |
1328-4 | U Ag [Presence] on Red Blood Cells |
13280-3 | Rubella virus IgG Ab [Units/volume] in Serum --2nd specimen |
13281-1 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid |
13282-9 | Rubella virus IgM Ab [Units/volume] in Cerebral spinal fluid |
13283-7 | Measles virus IgM Ab [Units/volume] in Cerebral spinal fluid |
13284-5 | Salmonella typhi H D Ab [Presence] in Serum |
13285-2 | Salmonella typhi O D Ab [Presence] in Serum |
13286-0 | Toxoplasma gondii IgG Ab [Units/volume] in Serum --2nd specimen |
13287-8 | Toxoplasma gondii Ab [Units/volume] in Cerebral spinal fluid |
13288-6 | Treponema pallidum Ab [Units/volume] in Blood by Immunofluorescence |
13289-4 | Hantavirus hantaan Ab [Units/volume] in Serum |
1329-2 | V Ab [Presence] in Serum or Plasma from Blood product unit |
13290-2 | Trypanosoma cruzi IgM Ab [Units/volume] in Serum |
13291-0 | Trypanosoma cruzi IgG Ab [Units/volume] in Serum |
13292-8 | Colorado tick fever virus IgG Ab [Units/volume] in Serum |
13293-6 | Colorado tick fever virus IgM Ab [Units/volume] in Serum |
13294-4 | Hepatitis E virus Ab [Presence] in Serum |
13295-1 | Coxsackievirus A10 Ab [Units/volume] in Cerebral spinal fluid |
13296-9 | Deprecated Coxsackievirus A10 Ab [Units/volume] in Serum |
13297-7 | Coxsackievirus A1 Ab [Units/volume] in Serum |
13298-5 | HLA-A [Type] |
13299-3 | HLA-B [Type] |
133-9 | Ceftazidime [Susceptibility] by Minimum inhibitory concentration (MIC) |
1330-0 | V Ab [Presence] in Serum or Plasma from donor |
13300-9 | HLA-A+B [Type] |
13301-7 | HLA-A+B+Bw [Type] |
13302-5 | HLA-C [Type] |
13303-3 | HLA-A+B+C (class I) [Type] |
13304-1 | HLA-DR [Type] |
13305-8 | HLA-DQ [Type] |
13306-6 | HLA-DR beta [Type] |
13307-4 | HLA-DQ alpha [Type] |
13308-2 | Deprecated DNA |
13309-0 | Duffy group Ag [Type] on Red Blood Cells |
1331-8 | V Ab [Presence] in Serum or Plasma |
13310-8 | Kell group Ag [Type] on Red Blood Cells |
13311-6 | MNS group Ag [Type] on Red Blood Cells |
13312-4 | IgA IgG Ab [Units/volume] in Serum or Plasma |
13313-2 | IgM IgM Ab [Units/volume] in Serum or Plasma |
13314-0 | Bacteria identified in Semen |
13315-7 | Bacteria identified in 24 hour Urine by Culture |
13316-5 | Vancomycin resistant enterococcus [Presence] in Unspecified specimen by Organism specific culture |
13317-3 | Methicillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific culture |
13318-1 | Escherichia coli enteroinvasive identified in Stool by Organism specific culture |
13319-9 | Ova and parasites identified in Stool by Light microscopy--2nd specimen |
1332-6 | V Ag [Presence] on Red Blood Cells from Blood product unit |
13320-7 | Ova and parasites identified in Stool by Light microscopy--3rd specimen |
13321-5 | Human papilloma virus IgG Ab [Presence] in Serum |
13322-3 | Human papilloma virus IgM Ab [Presence] in Serum |
13323-1 | Herpes simplex virus 2 Ab [Units/volume] in Serum by Immunofluorescence |
13324-9 | Herpes simplex virus 1 Ab [Units/volume] in Serum by Immunofluorescence |
13325-6 | Bartonella sp identified in Blood by Light microscopy |
13326-4 | Pneumocystis sp identified in Unspecified specimen by Light microscopy |
13327-2 | Parainfluenza virus Ag [Presence] in Unspecified specimen by Immunofluorescence |
13328-0 | Measles virus Ag [Presence] in Serum or Plasma by Immunofluorescence |
13329-8 | Escherichia coli labile toxin [Presence] in Unspecified specimen |
1333-4 | V Ag [Presence] on Red Blood Cells from donor |
13330-6 | Barr bodies [Presence] in Cervix by Light microscopy |
13331-4 | CD2+CD26+ cells/100 cells in Blood |
13332-2 | CD4+CD25+ cells/100 cells in Blood |
13333-0 | CD3+CD25+ cells/100 cells in Blood |
13334-8 | CD8+CD25+ cells/100 cells in Blood |
13335-5 | CD4+CD29+ cells/100 cells in Blood |
13336-3 | CD4+CD45RA+ cells/100 cells in Blood |
13337-1 | CD8+HLA-DR+ cells/100 cells in Blood |
13338-9 | CD8+CD57+ cells/100 cells in Blood |
13339-7 | CD8+CD56+ cells/100 cells in Blood |
1334-2 | V Ag [Presence] on Red Blood Cells |
13340-5 | CD3+CD38+ cells/100 cells in Blood |
13341-3 | CD3+CD25+ cells/100 cells in Tissue |
13342-1 | CD3+CD26+ cells/100 cells in Blood |
13343-9 | CD4+HLA-DR+ cells/100 cells in Blood |
13344-7 | CD8+CD38+ cells/100 cells in Blood |
13345-4 | CD8+CD11b+ cells/100 cells in Blood |
13346-2 | CD35 cells/100 cells in Blood |
13347-0 | RNA polymerase I+II+III Ab [Presence] in Serum |
13348-8 | Monoclonal band observed [Identifier] in Serum or Plasma |
13349-6 | Leukocytes [#/volume] in Stool by Manual count |
1335-9 | Whole blood given [Volume] |
13350-4 | Deprecated Eosinophils/100 leukocytes in Cerebral spinal fluid by Manual count |
13351-2 | Leukocytes other [#/volume] in Cerebral spinal fluid by Manual count |
13352-0 | Deprecated Neutrophils/100 leukocytes in Body fluid by Manual count |
13353-8 | Deprecated Eosinophils/100 leukocytes in Body fluid by Manual count |
13354-6 | Band form neutrophils/100 leukocytes in Body fluid by Manual count |
13355-3 | Unspecified cells/100 leukocytes in Body fluid by Manual count |
13356-1 | Fat [Presence] in Body fluid |
13357-9 | Synovial cells [Units/volume] in Body fluid |
13358-7 | Collection time of Semen |
13359-5 | Character of Semen |
1336-7 | Xg sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
13360-3 | Deprecated Color of Semen - impression |
13361-1 | Semen analysis panel |
13362-9 | Collection duration of Urine |
13363-7 | Collection duration of Stool |
13364-5 | Amino beta guanidinopropionate [Mass/volume] in Plasma |
13365-2 | Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
13366-0 | Alpha aminoadipate [Mass/volume] in Cerebral spinal fluid |
13367-8 | Beta aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
13368-6 | Beta alanine [Mass/volume] in Cerebral spinal fluid |
13369-4 | Carnosine [Mass/volume] in Cerebral spinal fluid |
1337-5 | Xg sup(a) Ab [Presence] in Serum or Plasma from donor |
13370-2 | Cystathionine [Mass/volume] in Cerebral spinal fluid |
13371-0 | Cystine [Mass/volume] in Cerebral spinal fluid |
13372-8 | Homocystine [Mass/volume] in Cerebral spinal fluid |
13373-6 | Hydroxylysine [Mass/volume] in Cerebral spinal fluid |
13374-4 | Hydroxyproline [Mass/volume] in Cerebral spinal fluid |
13375-1 | Lysine [Mass/volume] in Cerebral spinal fluid |
13376-9 | Methionine [Mass/volume] in Cerebral spinal fluid |
13377-7 | 1-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
13378-5 | 3-Methylhistidine [Mass/volume] in Cerebral spinal fluid |
13379-3 | Ornithine [Mass/volume] in Cerebral spinal fluid |
1338-3 | Xg sup(a) Ab [Presence] in Serum or Plasma |
13380-1 | Sarcosine [Mass/volume] in Cerebral spinal fluid |
13381-9 | Tyrosine [Mass/volume] in Cerebral spinal fluid |
13382-7 | Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
13383-5 | Alpha aminobutyrate [Mass/volume] in Amniotic fluid |
13384-3 | Alpha aminoadipate [Mass/volume] in Amniotic fluid |
13385-0 | Beta aminoisobutyrate [Mass/volume] in Amniotic fluid |
13386-8 | Anserine [Mass/volume] in Amniotic fluid |
13387-6 | Arginine [Mass/volume] in Amniotic fluid |
13388-4 | Asparagine [Mass/volume] in Amniotic fluid |
13389-2 | Aspartate [Mass/volume] in Amniotic fluid |
1339-1 | Xg sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
13390-0 | Beta alanine [Mass/volume] in Amniotic fluid |
13391-8 | Carnosine [Mass/volume] in Amniotic fluid |
13392-6 | Citrulline [Mass/volume] in Amniotic fluid |
13393-4 | Cystathionine [Mass/volume] in Amniotic fluid |
13394-2 | Cystine [Mass/volume] in Amniotic fluid |
13395-9 | Glutamate [Mass/volume] in Amniotic fluid |
13396-7 | Glutamine [Mass/volume] in Amniotic fluid |
13397-5 | Glycine [Mass/volume] in Amniotic fluid |
13398-3 | Histidine [Mass/volume] in Amniotic fluid |
13399-1 | Homocystine [Mass/volume] in Amniotic fluid |
134-7 | Ceftazidime [Susceptibility] by Disk diffusion (KB) |
1340-9 | Xg sup(a) Ag [Presence] on Red Blood Cells from donor |
13400-7 | Hydroxylysine [Mass/volume] in Amniotic fluid |
13401-5 | Hydroxyproline [Mass/volume] in Amniotic fluid |
13402-3 | Isoleucine [Mass/volume] in Amniotic fluid |
13403-1 | Leucine [Mass/volume] in Amniotic fluid |
13404-9 | Lysine [Mass/volume] in Amniotic fluid |
13405-6 | Methionine [Mass/volume] in Amniotic fluid |
13406-4 | 1-Methylhistidine [Mass/volume] in Amniotic fluid |
13407-2 | 3-Methylhistidine [Mass/volume] in Amniotic fluid |
13408-0 | Ornithine [Mass/volume] in Amniotic fluid |
13409-8 | Phenylalanine [Mass/volume] in Amniotic fluid |
1341-7 | Xg sup(a) Ag [Presence] on Red Blood Cells |
13410-6 | Phosphoethanolamine [Mass/volume] in Amniotic fluid |
13411-4 | Phosphoserine [Mass/volume] in Amniotic fluid |
13412-2 | Proline [Mass/volume] in Amniotic fluid |
13413-0 | Sarcosine [Mass/volume] in Amniotic fluid |
13414-8 | Serine [Mass/volume] in Amniotic fluid |
13415-5 | Taurine [Mass/volume] in Amniotic fluid |
13416-3 | Threonine [Mass/volume] in Amniotic fluid |
13417-1 | Tyrosine [Mass/volume] in Amniotic fluid |
13418-9 | Tryptophan [Mass/volume] in Amniotic fluid |
13419-7 | Valine [Mass/volume] in Amniotic fluid |
1342-5 | Yt sup(a) Ab [Presence] in Serum or Plasma from Blood product unit |
13420-5 | Epinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
13421-3 | Epinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
13422-1 | Epinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
13423-9 | Epinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
13424-7 | Epinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
13425-4 | Epinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
13426-2 | Norepinephrine [Mass/volume] in Plasma --2nd specimen post XXX challenge |
13427-0 | Norepinephrine [Mass/volume] in Plasma --3rd specimen post XXX challenge |
13428-8 | Norepinephrine [Mass/volume] in Plasma --4th specimen post XXX challenge |
13429-6 | Norepinephrine [Mass/volume] in Plasma --5th specimen post XXX challenge |
1343-3 | Yt sup(a) Ab [Presence] in Serum or Plasma from donor |
13430-4 | Norepinephrine [Mass/volume] in Plasma --6th specimen post XXX challenge |
13431-2 | Norepinephrine [Mass/volume] in Plasma --7th specimen post XXX challenge |
13432-0 | Dopamine [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
13433-8 | Dopamine [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
13434-6 | Dopamine [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
13435-3 | Dopamine [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
13436-1 | Dopamine [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
13437-9 | Dopamine [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
13438-7 | Protein Fractions [Interpretation] in Urine by Electrophoresis |
13439-5 | Protein Fractions [Interpretation] in Cerebral spinal fluid by Electrophoresis |
1344-1 | Yt sup(a) Ab [Presence] in Serum or Plasma |
13440-3 | Immunofixation for Urine |
13441-1 | Creatinine renal clearance in 4 hour |
13442-9 | Creatinine renal clearance in 6 hour |
13443-7 | Creatinine renal clearance in 8 hour |
13444-5 | Calcium/Albumin [Mass Ratio] in Serum or Plasma |
13445-2 | Deprecated Creatinine renal clearance/1.73 sq M in 24 hour |
13446-0 | Creatinine renal clearance/1.73 sq M in 4 hour |
13447-8 | Creatinine renal clearance/1.73 sq M in 6 hour |
13448-6 | Calcium/Osmolality [Mass Ratio] in Serum or Plasma |
13449-4 | Creatinine renal clearance/1.73 sq M in 8 hour |
1345-8 | Yt sup(a) Ag [Presence] on Red Blood Cells from Blood product unit |
13450-2 | Creatinine renal clearance/1.73 sq M in 12 hour |
13451-0 | Creatinine dialysis fluid clearance |
13452-8 | Iron/Transferrin [Mass Ratio] in Serum or Plasma |
13453-6 | Deprecated Glucose mean value |
13454-4 | Calcium-phosphorus product [(Moles/volume)*2] in Serum or Plasma |
13455-1 | Lithium.plasma/Lithium.RBC [Mass Ratio] in Blood |
13456-9 | IgG synthesis rate [Units/volume] in Serum and CSF |
13457-7 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation |
13458-5 | Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation |
13459-3 | Cholesterol in LDL/Cholesterol.total [Mass Ratio] in Serum or Plasma |
1346-6 | Yt sup(a) Ag [Presence] on Red Blood Cells from donor |
13460-1 | Deprecated Cholesterol.in LDL/Cholesterol.in HDL [Mass ratio] in Serum or Plasma |
13461-9 | Monoacetyldapsone/Dapsone [Mass Ratio] in Serum or Plasma |
13462-7 | Apolipoprotein A-I/Apolipoprotein B [Mass Ratio] in Serum or Plasma |
13463-5 | Arsenic/Creatinine [Mass Ratio] in Urine |
13464-3 | Chromium/Creatinine [Mass Ratio] in Urine |
13465-0 | Mercury/Creatinine [Mass Ratio] in Urine |
13466-8 | Lead/Creatinine [Mass Ratio] in Urine |
13467-6 | Selenium/Creatinine [Mass Ratio] in Urine |
13468-4 | Cobalt/Creatinine [Mass Ratio] in Urine |
13469-2 | Thallium/Creatinine [Mass Ratio] in Urine |
1347-4 | Yt sup(a) Ag [Presence] on Red Blood Cells |
13470-0 | Aluminum/Creatinine [Mass Ratio] in Urine |
13471-8 | Cadmium/Creatinine [Mass Ratio] in Urine |
13472-6 | Nickel/Creatinine [Mass Ratio] in Urine |
13473-4 | Zinc/Creatinine [Mass Ratio] in Urine |
13474-2 | Magnesium/Creatinine [Mass Ratio] in Urine |
13475-9 | Fluoride/Creatinine [Mass Ratio] in Urine |
13476-7 | Silver/Creatinine [Mass Ratio] in Urine |
13477-5 | Orthocresol/Creatinine [Mass Ratio] in Urine |
13478-3 | Tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
13479-1 | Benzoylecgonine/Creatinine [Mass Ratio] in Urine |
1348-2 | Yt sup(b) Ab [Presence] in Serum or Plasma from Blood product unit |
13480-9 | 18-Hydroxydeoxycortisol/Creatinine [Mass Ratio] in Urine |
13481-7 | Gonadotropin peptide/Creatinine [Mass Ratio] in Urine |
13482-5 | Aldosterone/Creatinine [Mass Ratio] in Urine |
13483-3 | Oxalate/Creatinine [Mass Ratio] in Urine |
13484-1 | Creatine/Creatinine [Mass Ratio] in Urine |
13485-8 | Beta-2-Microglobulin/Creatinine [Mass Ratio] in Urine |
13486-6 | Testosterone/Creatinine [Mass Ratio] in Urine |
13487-4 | Phenol/Creatinine [Mass Ratio] in Urine |
13488-2 | aPTT in control Platelet poor plasma by Coagulation assay |
13489-0 | Follitropin/Creatinine [Mass Ratio] in Urine |
1349-0 | Yt sup(b) Ab [Presence] in Serum or Plasma from donor |
13490-8 | Lutropin/Creatinine [Mass Ratio] in Urine |
13491-6 | Deprecated CD4+CD25+ cells/100 cells in Blood |
13492-4 | Deprecated CD4+HLA-DR+ cells/100 cells in Blood |
13493-2 | Deprecated CD8+CD25+ cells/100 cells in Blood |
13494-0 | Volume of 4 hour Dialysis fluid |
13495-7 | Volume of 24 hour Dialysis fluid |
13496-5 | Triple phosphate crystals [type] in Stone by Light microscopy |
13497-3 | Dextroamphetamine/Levoamphetamine [Mass Ratio] in Urine |
13498-1 | Dextromethamphetamine/Levomethamphetamine [Mass Ratio] in Urine |
13499-9 | HIV 1 Ab band pattern [Interpretation] in Serum by Immunoblot (IB) |
135-4 | Ceftazidime [Susceptibility] by Serum bactericidal titer |
1350-8 | Yt sup(b) Ab [Presence] in Serum or Plasma |
13500-4 | Amino acid pattern [Interpretation] in Serum or Plasma |
13501-2 | Herpes simplex virus 2 Ab pattern [Interpretation] in Serum |
13502-0 | Borrelia burgdorferi Ab.IgG band pattern [Interpretation] in Serum by Immunoblot (IB) |
13503-8 | Borrelia burgdorferi Ab.IgM band pattern [Interpretation] in Serum by Immunoblot (IB) |
13504-6 | Deprecated Borrelia burgdorferi Ab [interpretation] in Serum |
13505-3 | Herpes simplex virus 1+2 Ab pattern [Interpretation] in Serum |
13506-1 | Urea nitrogen renal clearance |
13507-9 | Lupus erythematosus cells [Presence] in Blood |
13508-7 | Hematocrit [Volume Fraction] of Cerebral spinal fluid by Centrifugation |
13509-5 | Microscopic observation [Identifier] in Blood by Crystal violet stain |
1351-6 | Yt sup(b) Ag [Presence] on Red Blood Cells from Blood product unit |
13510-3 | Microscopic observation [Identifier] in Bone marrow by Myeloperoxidase stain |
13511-1 | Cyanide ascorbate screen [Presence] in Blood |
13512-9 | Microscopic observation [Identifier] in Bone marrow by Butyrate esterase stain |
13513-7 | Iron.microscopic observation [Identifier] in Bone marrow by Potassium ferrocyanide stain |
13514-5 | Hemoglobin pattern [Interpretation] in Blood by Electrophoresis Narrative |
13515-2 | Hemoglobin pattern [Interpretation] in Blood by Electrophesis citrate agar Narrative |
13516-0 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
13517-8 | Variant lymphocytes/100 leukocytes in Cerebral spinal fluid by Manual count |
13518-6 | Variant lymphocytes/100 leukocytes in Body fluid by Manual count |
13519-4 | Basophils/100 leukocytes in Cerebral spinal fluid by Manual count |
1352-4 | Yt sup(b) Ag [Presence] on Red Blood Cells from donor |
13520-2 | Deprecated Basophils/100 leukocytes in Body fluid by Manual count |
13521-0 | Blasts/100 leukocytes in Cerebral spinal fluid by Manual count |
13522-8 | Blasts/100 leukocytes in Body fluid by Manual count |
13523-6 | Leukocytes other/100 leukocytes in Cerebral spinal fluid by Manual count |
13524-4 | Leukocytes other/100 leukocytes in Body fluid by Manual count |
13525-1 | Nonhematic cells/100 leukocytes in Cerebral spinal fluid by Manual count |
13526-9 | Nonhematic cells/100 leukocytes in Body fluid by Manual count |
13527-7 | Unidentified cells/100 leukocytes in Cerebral spinal fluid by Manual count |
13528-5 | Unidentified cells/100 leukocytes in Body fluid by Manual count |
13529-3 | Nucleated erythrocytes [#/volume] in Cerebral spinal fluid by Manual count |
1353-2 | Yt sup(b) Ag [Presence] on Red Blood Cells |
13530-1 | Nucleated erythrocytes [#/volume] in Body fluid by Manual count |
13531-9 | Fat.microscopic observation [Presence] in Sputum by Sudan III stain |
13532-7 | Xanthochromia [Presence] of Cerebral spinal fluid Qualitative |
13533-5 | Acid hemolysis [Presence] of Blood |
13534-3 | Sucrose hemolysis [Presence] of Blood |
13535-0 | Sucrose hemolysis of Red Blood Cells |
13536-8 | Globulin [Mass/volume] in Plasma |
13537-6 | Deprecated Protein [Mass/volume] in Plasma. |
13538-4 | Carbon dioxide, total [Moles/volume] in Urine |
13539-2 | Phosphate [Moles/volume] in Urine |
1354-0 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --9 hours post 3 g metyrapone PO overnight |
13540-0 | Carbon dioxide, total [Moles/volume] in Cerebral spinal fluid |
13541-8 | Deprecated Carbon dioxide [Molecules/volume] in Body fluid |
13542-6 | Phosphate [Mass/volume] in Cerebral spinal fluid |
13543-4 | Deprecated Phosphate [Mass/volume] in Body fluid |
13544-2 | 4-Hydroxyglutethimide [Presence] in Serum or Plasma |
13545-9 | Alprazolam [Presence] in Serum or Plasma |
13546-7 | Amikacin [Mass/volume] in Body fluid |
13547-5 | Butriptyline [Presence] in Serum or Plasma |
13548-3 | Chlorpromazine [Presence] in Serum or Plasma |
13549-1 | Clomipramine [Presence] in Serum or Plasma |
1355-7 | 11-Deoxycorticosteroids [Mass/volume] in Plasma --pre 3 g metyrapone PO overnight |
13550-9 | Clonazepam [Presence] in Serum or Plasma |
13551-7 | Clorazepate [Presence] in Serum or Plasma |
13552-5 | Clozapine [Presence] in Serum or Plasma |
13553-3 | Cocaethylene [Presence] in Serum or Plasma |
13554-1 | Cyclobenzaprine [Presence] in Serum or Plasma |
13555-8 | D-pseudoephedrine [Presence] in Serum or Plasma |
13556-6 | Demoxepam [Presence] in Serum or Plasma |
13557-4 | Norsertraline [Presence] in Serum or Plasma |
13558-2 | Disopyramide [Presence] in Serum or Plasma |
13559-0 | Flecainide [Presence] in Serum or Plasma |
1356-5 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO |
13560-8 | Fluvoxamine [Presence] in Serum or Plasma |
13561-6 | Gentamicin [Mass/volume] in Cerebral spinal fluid |
13562-4 | Gentamicin [Mass/volume] in Body fluid |
13563-2 | Glutethimide [Presence] in Serum or Plasma |
13564-0 | Ibuprofen [Presence] in Serum or Plasma |
13565-7 | Lorazepam [Presence] in Serum or Plasma |
13566-5 | Mesoridazine [Presence] in Serum or Plasma |
13567-3 | Mexiletine [Presence] in Serum or Plasma |
13568-1 | N-desalkylflurazepam [Presence] in Serum or Plasma |
13569-9 | Norchlordiazepoxide [Presence] in Serum or Plasma |
1357-3 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post 750 mg metyrapone q4h X 6 |
13570-7 | Norclomipramine [Presence] in Serum or Plasma |
13571-5 | Norclozapine [Presence] in Serum or Plasma |
13572-3 | Nordiazepam [Presence] in Serum or Plasma |
13573-1 | Nordoxepin [Presence] in Serum or Plasma |
13574-9 | Norfluoxetine [Presence] in Serum or Plasma |
13575-6 | Normaprotiline [Presence] in Serum or Plasma |
13576-4 | Oxycodone [Presence] in Serum or Plasma |
13577-2 | Paroxetine [Presence] in Serum or Plasma |
13578-0 | Promazine [Presence] in Serum or Plasma |
13579-8 | Sertraline [Presence] in Serum or Plasma |
1358-1 | Corticotropin [Mass/volume] in Plasma --1.5 hours post dose insulin IV |
13580-6 | Temazepam [Presence] in Serum or Plasma |
13581-4 | Theophylline [Mass/volume] in Cerebral spinal fluid |
13582-2 | Theophylline [Mass/volume] in Body fluid |
13583-0 | Thioridazine [Presence] in Serum or Plasma |
13584-8 | Tobramycin [Mass/volume] in Body fluid |
13585-5 | Trifluoperazine [Presence] in Serum or Plasma |
13586-3 | Vancomycin [Mass/volume] in Cerebral spinal fluid |
13587-1 | Vancomycin [Mass/volume] in Body fluid |
13588-9 | Venlafaxine [Presence] in Serum or Plasma |
13589-7 | Activated protein C resistance [Presence] in Blood by Probe and target amplification method |
1359-9 | Corticotropin [Mass/volume] in Plasma --1 hour post 1 ug/kg CRH IV |
13590-5 | Activated protein C resistance [Time Ratio] in Platelet poor plasma by Coagulation assay |
13591-3 | Factor inhibitor XXX [Units/volume] in Platelet poor plasma by Coagulation assay |
13592-1 | Platelet aggregation XXX induced in Platelet rich plasma |
13593-9 | Platelet aggregation prostaglandin induced in Platelet rich plasma |
13594-7 | Prekallikrein (Fletcher Factor) [Presence] in Platelet poor plasma |
13595-4 | Basophils/100 leukocytes in Nose |
13596-2 | Histiocytes [Presence] in Nose by Light microscopy |
13597-0 | Neutrophils/100 leukocytes in Nose |
13598-8 | Deprecated Promyelocytes/100 leukocytes in Blood by Manual count |
13599-6 | Promonocytes/100 leukocytes in Blood by Manual count |
136-2 | Ceftizoxime [Susceptibility] by Minimum lethal concentration (MLC) |
1360-7 | Corticotropin [Mass/volume] in Plasma --1 hour post dose insulin IV |
13600-2 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
13601-0 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
13602-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
13603-6 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
13604-4 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
13605-1 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
13606-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 50 g lactose PO |
13607-7 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 50 g lactose PO |
13608-5 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
13609-3 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post 75 g glucose PO |
1361-5 | Corticotropin [Mass/volume] in Plasma --1 minute post 1 ug/kg CRH IV |
13610-1 | 3-Beta-Androstanediol [Mass/volume] in Serum or Plasma |
13611-9 | 6-Beta-Hydroxycortisol [Mass/time] in 24 hour Urine |
13612-7 | Dehydroepiandrosterone (DHEA) [Mass/time] in 24 hour Urine |
13613-5 | Ethanolamine [Mass/volume] in Cerebral spinal fluid |
13614-3 | Etiocholanolone [Mass/volume] in Serum or Plasma |
13615-0 | Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid |
13616-8 | Nitrite [Mass/volume] in Water |
13617-6 | Deprecated Prostaglandin D2 [Mass/volume] in Serum or Plasma |
13618-4 | Tetrahydroaldosterone [Mass/time] in 24 hour Urine |
13619-2 | Volume of 2 hour Urine |
1362-3 | Corticotropin [Mass/volume] in Plasma --30 minutes post 1 ug/kg CRH IV |
13620-0 | Volume of 12 hour Urine |
13621-8 | Deprecated Thrombin time in Platelet poor plasma from control by Coagulation assay |
13622-6 | Acetaminophen [Mass/volume] in Urine |
13623-4 | Dextromethorphan [Mass/volume] in Serum or Plasma |
13624-2 | Doxorubicin [Mass/volume] in Serum or Plasma |
13625-9 | Methoxsalen [Mass/volume] in Serum or Plasma |
13626-7 | Mitotane [Mass/volume] in Serum or Plasma |
13627-5 | Erythrocytes [Presence] in Semen by Light microscopy |
13628-3 | Deprecated Spermatozoa Motile/100 spermatozoa in Semen |
13629-1 | Interleukin 1 beta [Mass/volume] in Serum or Plasma |
1363-1 | Corticotropin [Mass/volume] in Plasma --30 minutes post dose insulin IV |
13630-9 | Deprecated Immune complex [Units/volume] in Serum or Plasma by Conglutinin assay |
13631-7 | Immune complex [Mass/volume] in Serum or Plasma by Polyethylene glycol (PEG) assay |
13632-5 | Insulin receptor Ab [Titer] in Serum |
13633-3 | Insulin receptor Ab [Presence] in Serum |
13634-1 | Rheumatoid factor [Units/volume] in Synovial fluid |
13635-8 | Ribosomal Ab [Titer] in Serum |
13636-6 | Ribosomal P Ab [Units/volume] in Serum |
13637-4 | Trichloroethane [Mass/volume] in Serum or Plasma |
13638-2 | Chlordecone [Mass/volume] in Blood |
13639-0 | Chlordecone [Mass/volume] in Serum or Plasma |
1364-9 | Corticotropin [Mass/volume] in Plasma --45 minutes post 1 ug/kg CRH IV |
13640-8 | Vinyl chloride [Mass/volume] in Urine |
13641-6 | Codeine [Presence] in Urine by SAMHSA confirm method |
13642-4 | Deprecated Ethylene glycol |
13643-2 | Lindane [Mass/volume] in Urine |
13644-0 | 1,3-Dimethylbenzene [Mass/volume] in Blood |
13645-7 | Manganese [Mass/volume] in Water |
13646-5 | Methaqualone [Mass/mass] in Hair |
13647-3 | Deprecated Methylene chloride [Mass/volume] in Blood |
13648-1 | Morphine [Presence] in Urine by SAMHSA confirm method |
13649-9 | Nickel [Mass/volume] in Water |
1365-6 | Corticotropin [Mass/volume] in Plasma --45 minutes post dose insulin IV |
13650-7 | 1,2-Dimethylbenzene [Mass/volume] in Blood |
13651-5 | 1,4-Dimethylbenzene [Mass/volume] in Blood |
13652-3 | Zinc [Mass/mass] in Hair |
13653-1 | Epithelial cells.renal [#/volume] in Urine sediment |
13654-9 | Epithelial cells.squamous [#/volume] in Urine sediment |
13655-6 | Leukocytes [Presence] in Stool by Light microscopy |
13656-4 | Phosphate crystals amorphous [#/volume] in Urine sediment |
13657-2 | Urate crystals amorphous [#/volume] in Urine sediment |
13658-0 | Urobilinogen [Presence] in Urine |
13659-8 | Epidermal growth factor receptor [Mass/mass] in Tissue |
1366-4 | Corticotropin [Mass/volume] in Plasma --5 minutes post 1 ug/kg CRH IV |
13660-6 | Gonadotropin releasing hormone [Mass/volume] in Serum or Plasma |
13661-4 | Ganglioside GD1b IgM Ab [Titer] in Serum |
13662-2 | Ganglioside GD1b IgG Ab [Titer] in Serum |
13663-0 | Asialoganglioside GM1 IgG Ab [Titer] in Serum |
13664-8 | Myelin associated glycoprotein/Sulfated glucuronic paragloboside IgM Ab [Titer] in Serum |
13665-5 | 1-Methylhistidine/Creatinine [Mass Ratio] in Urine |
13666-3 | Alpha aminoadipate/Creatinine [Mass Ratio] in Urine |
13667-1 | Alpha aminobutyrate/Creatinine [Mass Ratio] in Urine |
13668-9 | 2-Ethyl-3-Hydroxypropionate/Creatinine [Mass Ratio] in Urine |
13669-7 | 2-Hydroxy-3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
1367-2 | Corticotropin [Mass/volume] in Plasma --pre 1 ug/kg CRH IV |
13670-5 | 2-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
13671-3 | Alpha hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
13672-1 | 2-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
13673-9 | 2-Hydroxyisocaproate/Creatinine [Mass Ratio] in Urine |
13674-7 | 2-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
13675-4 | 2-methyl-3-hydroxybutyrate (C5-OH)/Creatinine [Mass Ratio] in Urine |
13676-2 | 2-Oxo,3-Methylvalerate/Creatinine [Mass Ratio] in Urine |
13677-0 | 2-Oxoadipate/Creatinine [Mass Ratio] in Urine |
13678-8 | Alpha ketoglutarate/Creatinine [Mass Ratio] in Urine |
13679-6 | 2-Oxoisocaproate/Creatinine [Mass Ratio] in Urine |
1368-0 | Corticotropin [Mass/volume] in Plasma --pre dose insulin IV |
13680-4 | 2-Oxoisovalerate/Creatinine [Mass Ratio] in Urine |
13681-2 | Beta aminoisobutyrate/Creatinine [Mass Ratio] in Urine |
13682-0 | 3-Hydroxy,3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
13683-8 | 3-Hydroxyadipate/Creatinine [Mass Ratio] in Urine |
13684-6 | Beta hydroxybutyrate/Creatinine [Mass Ratio] in Urine |
13685-3 | 3-Hydroxyglutarate/Creatinine [Mass Ratio] in Urine |
13686-1 | 3-Hydroxyisobutyrate/Creatinine [Mass Ratio] in Urine |
13687-9 | 3-Hydroxyisovalerate/Creatinine [Mass Ratio] in Urine |
13688-7 | 3-Hydroxypropionate (3-OH-C3)/Creatinine [Mass Ratio] in Urine |
13689-5 | 3-Hydroxyvalerate/Creatinine [Mass Ratio] in Urine |
1369-8 | Ascorbate [Mass/time] in 24 hour Urine --post dose PO |
13690-3 | Deprecated Vanillylmandelate/Creatinine [Mass ratio] in Urine |
13691-1 | 3-Methylcrotonylglycine/Creatinine [Mass Ratio] in Urine |
13692-9 | 3-Methylglutaconate/Creatinine [Mass Ratio] in Urine |
13693-7 | 3-Methylglutarate/Creatinine [Mass Ratio] in Urine |
13694-5 | 3-Methylhistidine/Creatinine [Mass Ratio] in Urine |
13695-2 | Gamma aminobutyrate/Creatinine [Mass Ratio] in Urine |
13696-0 | 4-Hydroxyphenylacetate/Creatinine [Mass Ratio] in Urine |
13697-8 | 4-Hydroxyphenyllactate/Creatinine [Mass Ratio] in Urine |
13698-6 | 4-Hydroxyphenylpyruvate/Creatinine [Mass Ratio] in Urine |
13699-4 | 5-Hydroxyhexanoate/Creatinine [Mass Ratio] in Urine |
137-0 | Ceftizoxime [Susceptibility] by Minimum inhibitory concentration (MIC) |
1370-6 | Carotene [Mass/volume] in Serum --post 15000 U carotene QDx3 for 3 day poly |
13700-0 | 5-Oxoproline/Creatinine [Mass Ratio] in Urine |
13701-8 | Acetoacetate/Creatinine [Mass Ratio] in Urine |
13702-6 | Aconitate/Creatinine [Mass Ratio] in Urine |
13703-4 | Adipate/Creatinine [Mass Ratio] in Urine |
13704-2 | Alanine/Creatinine [Mass Ratio] in Urine |
13705-9 | Albumin/Creatinine [Mass Ratio] in 24 hour Urine |
13706-7 | Amylase/Creatinine [Mass Ratio] in Urine |
13707-5 | Anserine/Creatinine [Mass Ratio] in Urine |
13708-3 | Arginine/Creatinine [Mass Ratio] in Urine |
13709-1 | Argininosuccinate/Creatinine [Mass Ratio] in Urine |
1371-4 | Bromsulphthalein [Mass/volume] in Serum or Plasma |
13710-9 | Asparagine/Creatinine [Mass Ratio] in Urine |
13711-7 | Aspartate/Creatinine [Mass Ratio] in Urine |
13712-5 | Azelate/Creatinine [Mass Ratio] in Urine |
13713-3 | Benzoate/Creatinine [Mass Ratio] in Urine |
13714-1 | Beta alanine/Creatinine [Mass Ratio] in Urine |
13715-8 | C peptide/Creatinine [Mass Ratio] in 24 hour Urine |
13716-6 | C peptide/Creatinine [Mass Ratio] in Urine |
13717-4 | Calcium/Creatinine [Mass Ratio] in 24 hour Urine |
13718-2 | Carnitine free (C0)/Creatinine [Mass Ratio] in Urine |
13719-0 | Carnitine/Creatinine [Mass Ratio] in Urine |
1372-2 | Calcitonin [Mass/volume] in Serum or Plasma --90 seconds post 0.5 ug/kg pentagastrin IV |
13720-8 | Carnosine/Creatinine [Mass Ratio] in Urine |
13721-6 | Chloride/Creatinine [Mass Ratio] in 24 hour Urine |
13722-4 | Citrate/Creatinine [Mass Ratio] in Urine |
13723-2 | Citrulline/Creatinine [Mass Ratio] in Urine |
13724-0 | Cystathionine/Creatinine [Mass Ratio] in Urine |
13725-7 | Cystine/Creatinine [Mass Ratio] in Urine |
13726-5 | Decadienediate/Creatinine [Mass Ratio] in Urine |
13727-3 | Decenedioate/Creatinine [Mass Ratio] in Urine |
13728-1 | Delta aminolevulinate/Creatinine [Mass Ratio] in Urine |
13729-9 | Deoxypyridinoline/Creatinine [Mass Ratio] in Urine |
1373-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
13730-7 | Deoxypyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
13731-5 | Deoxypyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
13732-3 | Dodecanedioate/Creatinine [Mass Ratio] in Urine |
13733-1 | Dopamine/Creatinine [Mass Ratio] in Urine |
13734-9 | Epinephrine/Creatinine [Mass Ratio] in Urine |
13735-6 | Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine |
13736-4 | Estradiol (E2)/Creatinine [Mass Ratio] in 24 hour Urine |
13737-2 | Estriol (E3)/Creatinine [Mass Ratio] in 24 hour Urine |
13738-0 | Estrogen/Creatinine [Mass Ratio] in 24 hour Urine |
13739-8 | Estrone (E1)/Creatinine [Mass Ratio] in 24 hour Urine |
1374-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post 15 mg/kg calcium gluconate IV |
13740-6 | Ethanolamine/Creatinine [Mass Ratio] in Urine |
13741-4 | Ethylmalonate/Creatinine [Mass Ratio] in Urine |
13742-2 | Formate/Creatinine [Mass Ratio] in Urine |
13743-0 | Fumarate/Creatinine [Mass Ratio] in Urine |
13744-8 | Galactose/Creatinine [Mass Ratio] in Urine |
13745-5 | Glutaconate/Creatinine [Mass Ratio] in Urine |
13746-3 | Glutamate/Creatinine [Mass Ratio] in Urine |
13747-1 | Glutamine/Creatinine [Mass Ratio] in Urine |
13748-9 | Glutarate/Creatinine [Mass Ratio] in Urine |
13749-7 | Glycerate/Creatinine [Mass Ratio] in Urine |
1375-5 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post 15 mg/kg calcium gluconate IV |
13750-5 | Glycine/Creatinine [Mass Ratio] in Urine |
13751-3 | Glycolate/Creatinine [Mass Ratio] in Urine |
13752-1 | Glyoxylate/Creatinine [Mass Ratio] in Urine |
13753-9 | Hexanoylglycine/Creatinine [Mass Ratio] in Urine |
13754-7 | Hippurate/Creatinine [Mass Ratio] in Urine |
13755-4 | Histamine/Creatinine [Mass Ratio] in Urine |
13756-2 | Histamine/Creatinine [Mass Ratio] in 24 hour Urine |
13757-0 | Histidine/Creatinine [Mass Ratio] in Urine |
13758-8 | Homocysteine/Creatinine [Mass Ratio] in Urine |
13759-6 | Homocystine/Creatinine [Mass Ratio] in Urine |
1376-3 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 0.5 ug/kg pentagastrin IV |
13760-4 | Homovanillate/Creatinine [Mass Ratio] in 24 hour Urine |
13761-2 | Hydroxydecanedioate/Creatinine [Mass Ratio] in Urine |
13762-0 | Hydroxylysine/Creatinine [Mass Ratio] in Urine |
13763-8 | Hydroxyproline/Creatinine [Mass Ratio] in Urine |
13764-6 | Isocitrate/Creatinine [Mass Ratio] in Urine |
13765-3 | Isoleucine/Creatinine [Mass Ratio] in Urine |
13766-1 | Isovalerylglycine/Creatinine [Mass Ratio] in Urine |
13767-9 | Lactate/Creatinine [Mass Ratio] in Urine |
13768-7 | Leucine/Creatinine [Mass Ratio] in Urine |
13769-5 | Lysine/Creatinine [Mass Ratio] in Urine |
1377-1 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
13770-3 | Malate/Creatinine [Mass Ratio] in Urine |
13771-1 | Metanephrines/Creatinine [Mass Ratio] in Urine |
13772-9 | Methionine/Creatinine [Mass Ratio] in Urine |
13773-7 | 2-Methylcitrate/Creatinine [Mass Ratio] in Urine |
13774-5 | Methylhippurate/Creatinine [Mass Ratio] in Urine |
13775-2 | Methylmalonate/Creatinine [Mass Ratio] in 24 hour Urine |
13776-0 | Methylmalonate/Creatinine [Mass Ratio] in Urine |
13777-8 | Methylsuccinate/Creatinine [Mass Ratio] in Urine |
13778-6 | Mevalonate/Creatinine [Mass Ratio] in Urine |
13779-4 | N-acetyl-L-aspartate/Creatinine [Mass Ratio] in Urine |
1378-9 | Calcitonin [Mass/volume] in Serum or Plasma --pre 0.5 ug/kg pentagastrin IV |
13780-2 | N-acetyltyrosine/Creatinine [Mass Ratio] in Urine |
13781-0 | N-methylhistamine/Creatinine [Mass Ratio] in Urine |
13782-8 | Norepinephrine/Creatinine [Mass Ratio] in Urine |
13783-6 | Normetanephrine/Creatinine [Mass Ratio] in Urine |
13784-4 | Octanoate (C8:0)/Creatinine [Mass Ratio] in Urine |
13785-1 | Octenedioate (C8:1)/Creatinine [Mass Ratio] in Urine |
13786-9 | Ornithine/Creatinine [Mass Ratio] in Urine |
13787-7 | Orotate/Creatinine [Mass Ratio] in Urine |
13788-5 | Oxalate/Creatinine [Mass Ratio] in 24 hour Urine |
13789-3 | Phosphoethanolamine/Creatinine [Mass Ratio] in Urine |
1379-7 | Calcitonin [Mass/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
13790-1 | Para nitrophenol/Creatinine [Mass Ratio] in Urine |
13791-9 | Phenylacetate/Creatinine [Mass Ratio] in Urine |
13792-7 | Phenyllactate/Creatinine [Mass Ratio] in Urine |
13793-5 | Phenylpropionylglycine/Creatinine [Mass Ratio] in Urine |
13794-3 | Phenylpyruvate/Creatinine [Mass Ratio] in Urine |
13795-0 | Phosphate/Creatinine [Mass Ratio] in 24 hour Urine |
13796-8 | Phosphoserine/Creatinine [Mass Ratio] in Urine |
13797-6 | Porphobilinogen/Creatinine [Mass Ratio] in Urine |
13798-4 | Potassium/Creatinine [Mass Ratio] in 24 hour Urine |
13799-2 | Proline/Creatinine [Mass Ratio] in Urine |
138-8 | Ceftizoxime [Susceptibility] by Disk diffusion (KB) |
1380-5 | Calcium/Phosphate parathyroid-challenge test [Mass Ratio] in Serum |
13800-8 | Propionylglycine/Creatinine [Mass Ratio] in Urine |
13801-6 | Protein/Creatinine [Mass Ratio] in 24 hour Urine |
13802-4 | Pyridinoline/Creatinine [Mass Ratio] in Urine |
13803-2 | Pyridinoline/Creatinine [Mass Ratio] in 24 hour Urine |
13804-0 | Pyridinoline/Creatinine [Mass Ratio] in 2 hour Urine |
13805-7 | Pyruvate/Creatinine [Mass Ratio] in Urine |
13806-5 | Sarcosine/Creatinine [Mass Ratio] in Urine |
13807-3 | Sebacate (C8)/Creatinine [Mass Ratio] in Urine |
13808-1 | Serine/Creatinine [Mass Ratio] in Urine |
13809-9 | Sodium/Creatinine [Mass Ratio] in 24 hour Urine |
1381-3 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post 2.4 mg/kg calcium short IV |
13810-7 | Suberate/Creatinine [Mass Ratio] in Urine |
13811-5 | Suberylglycine/Creatinine [Mass Ratio] in Urine |
13812-3 | Succinate/Creatinine [Mass Ratio] in Urine |
13813-1 | Succinylacetone/Creatinine [Mass Ratio] in Urine |
13814-9 | Taurine/Creatinine [Mass Ratio] in Urine |
13815-6 | Threonine/Creatinine [Mass Ratio] in Urine |
13816-4 | Tiglylglycine/Creatinine [Mass Ratio] in Urine |
13817-2 | Tryptophan/Creatinine [Mass Ratio] in Urine |
13818-0 | Tyrosine/Creatinine [Mass Ratio] in Urine |
13819-8 | Uracil/Creatinine [Mass Ratio] in Urine |
1382-1 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post 2.4 mg/kg calcium short IV |
13820-6 | Urate/Creatinine [Mass Ratio] in 24 hour Urine |
13821-4 | Urea nitrogen/Creatinine [Mass Ratio] in 24 hour Urine |
13822-2 | Valine/Creatinine [Mass Ratio] in Urine |
13823-0 | Antimony/Creatinine [Mass Ratio] in Urine |
13824-8 | Arsenic/Creatinine [Mass Ratio] in 24 hour Urine |
13825-5 | Arsenic.inorganic/Creatinine [Mass Ratio] in Urine |
13826-3 | Barium/Creatinine [Mass Ratio] in Urine |
13827-1 | Beryllium/Creatinine [Mass Ratio] in Urine |
13828-9 | Cadmium/Creatinine [Mass Ratio] in 24 hour Urine |
13829-7 | Copper/Creatinine [Mass Ratio] in Urine |
1383-9 | Calcium [Moles/volume] in Serum or Plasma --pre 2.4 mg/kg calcium short IV |
13830-5 | Phenylglyoxylate/Creatinine [Mass Ratio] in Urine |
13831-3 | Vanadium/Creatinine [Mass Ratio] in Urine |
13832-1 | Dimethylbenzene/Creatinine [Mass Ratio] in Urine |
13833-9 | Finch feather IgE Ab [Units/volume] in Serum |
13834-7 | Total IgE [Units/volume] in Serum by Radioallergosorbent test (RAST) |
13835-4 | Monocytes/100 leukocytes in Peritoneal fluid by Manual count |
13836-2 | Neutrophils/100 leukocytes in Peritoneal fluid by Manual count |
13837-0 | CD10 blasts/100 blasts in Blood |
13838-8 | CD13 blasts/100 blasts in Blood |
13839-6 | CD14 blasts/100 blasts in Blood |
1384-7 | Calcium [Moles/volume] in Blood --post calcium infusion |
13840-4 | CD19 blasts/100 blasts in Blood |
13841-2 | CD2 blasts/100 blasts in Blood |
13842-0 | CD20 blasts/100 blasts in Blood |
13843-8 | CD33 blasts/100 blasts in Blood |
13844-6 | CD34 blasts/100 blasts in Blood |
13845-3 | CD5 blasts/100 blasts in Blood |
13846-1 | CD7 blasts/100 blasts in Blood |
13847-9 | Terminal Deoxyribonucleotidyl Transferase blasts/100 blasts in Blood by Immunoperoxidase stain |
13848-7 | CD3+CD26+ cells [#/volume] in Blood |
13849-5 | Deprecated CD3+CD26+ cells/100 cells in Blood |
1385-4 | Catecholamines Free fractionated [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
13850-3 | CD5+CD25+ cells [#/volume] in Blood |
13851-1 | CD5+CD25+ cells/100 cells in Blood |
13852-9 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
13853-7 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post 25 mg captopril PO |
13854-5 | Aldosterone [Mass/volume] in Serum or Plasma --2 hours post 25 mg captopril PO |
13855-2 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
13856-0 | Androstenedione [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin IM |
13857-8 | Androstenedione [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
13858-6 | Androstenedione [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
13859-4 | C peptide [Mass/volume] in Serum or Plasma --10 minutes post 1 mg glucagon IV |
1386-2 | Catecholamines Free fractionated [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
13860-2 | C peptide [Mass/volume] in Serum or Plasma --15 minutes post 1 mg glucagon IV |
13861-0 | C peptide [Mass/volume] in Serum or Plasma --5 minutes post 1 mg glucagon IV |
13862-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --15 minutes post 250 ug corticotropin |
13863-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin |
13864-4 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin |
13865-1 | Glucose [Mass/volume] in Serum or Plasma --2.5 hours post 50 g lactose PO |
13866-9 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 50 g lactose PO |
13867-7 | Renin [Enzymatic activity/volume] in Plasma --1 hour post 25 mg captopril PO |
13868-5 | Renin [Enzymatic activity/volume] in Plasma --2 hours post 25 mg captopril PO |
13869-3 | Thyrotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose TRH IV |
1387-0 | Catecholamines Free fractionated [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
13870-1 | Thyrotropin [Mass/volume] in Serum or Plasma --15 minutes post dose TRH IV |
13871-9 | Thyrotropin [Mass/volume] in Serum or Plasma --2 hours post dose TRH IV |
13872-7 | 11-Deoxycortisol [Mass/time] in 24 hour Urine |
13873-5 | Albumin.glycated/Albumin.total in Serum or Plasma |
13874-3 | Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma |
13875-0 | Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma |
13876-8 | Beta-2 transferrin [Presence] in Body fluid |
13877-6 | Bilirubin.total [Presence] in Amniotic fluid |
13878-4 | Collagen type 1 IgG Ab [Units/volume] in Serum |
13879-2 | Collagen type 2 IgG Ab [Units/volume] in Serum |
1388-8 | Catecholamines Free fractionated [Mass/volume] in Plasma --pre 300 ug clonidine PO |
13880-0 | Collagen type 4 IgG Ab [Units/volume] in Serum |
13881-8 | Deoxypyridinoline Free/Creatinine [Molar ratio] in Urine |
13882-6 | Androstanolone Free/Androstanolone.total in Serum or Plasma |
13883-4 | Estradiol (E2).bioavailable/Estradiol (E2).total in Serum or Plasma |
13884-2 | Estradiol (E2).bioavailable [Mass/volume] in Serum or Plasma |
13885-9 | Deprecated Estrogen/Creatinine [Mass ratio] in 24 hour Urine |
13886-7 | Lactate dehydrogenase 1/Lactate dehydrogenase.total in Urine by Electrophoresis |
13887-5 | Lactate dehydrogenase 2/Lactate dehydrogenase.total in Urine by Electrophoresis |
13888-3 | Lactate dehydrogenase 3/Lactate dehydrogenase.total in Urine by Electrophoresis |
13889-1 | Lactate dehydrogenase 4/Lactate dehydrogenase.total in Urine by Electrophoresis |
1389-6 | Cortisol Free [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
13890-9 | Lactate dehydrogenase 5/Lactate dehydrogenase.total in Urine by Electrophoresis |
13891-7 | Motilin [Mass/volume] in Serum or Plasma |
13892-5 | Nitrosonaphthol [Presence] in Urine |
13893-3 | Phenylalanine [Presence] in Urine |
13894-1 | Pregnenolone [Mass/time] in 24 hour Urine |
13895-8 | Sodium [Moles/volume] in Milk |
13896-6 | Insulin-like growth factor-I [Units/volume] in Blood |
13897-4 | Thyrotropin.beta subunit [Mass/volume] in Serum or Plasma |
13898-2 | Trichloroacetate [Mass/volume] in Serum or Plasma |
13899-0 | Deprecated Triglyceride [Mass/volume] in fluid |
139-6 | Ceftizoxime [Susceptibility] by Serum bactericidal titer |
1390-4 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
13900-6 | Deprecated Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma |
13901-4 | Tyrosine [Presence] in Urine |
13902-2 | Urate [Mass/volume] in Cerebral spinal fluid |
13903-0 | Vasopressin [Mass/volume] in Urine |
13904-8 | Meclizine [Mass/volume] in Serum or Plasma |
13905-5 | Meclofenamate [Mass/volume] in Serum or Plasma |
13906-3 | Deprecated Mesoridazine |
13907-1 | Norethindrone [Mass/volume] in Serum or Plasma |
13908-9 | Oxipurinol [Mass/volume] in Serum or Plasma |
13909-7 | Tamoxifen [Mass/volume] in Serum or Plasma |
1391-2 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
13910-5 | Deprecated HLA-B22 [Presence] |
13911-3 | HLA-B27 related Ag [Presence] |
13912-1 | Deprecated HLA-B42 [Presence] |
13913-9 | Adenovirus Ab [Titer] in Serum by Immunofluorescence |
13914-7 | Adenovirus IgG Ab [Units/volume] in Serum |
13915-4 | Adenovirus IgM Ab [Titer] in Serum |
13916-2 | Bordetella parapertussis Ag [Presence] in Unspecified specimen by Immunofluorescence |
13917-0 | Coccidioides immitis Ab [Titer] in Cerebral spinal fluid by Complement fixation |
13918-8 | Eastern equine encephalitis virus Ab [Titer] in Serum by Immunofluorescence |
13919-6 | Hepatitis B virus core IgG Ab [Units/volume] in Serum by Immunoassay |
1392-0 | Cortisol Free [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
13920-4 | HIV 2 p41 Ab [Presence] in Serum by Immunoblot (IB) |
13921-2 | Mumps virus [Presence] in Unspecified specimen by Organism specific culture |
13922-0 | Trichinella spiralis IgA Ab [Presence] in Serum by Immunoassay |
13923-8 | Trichinella spiralis IgM Ab [Presence] in Serum by Immunoassay |
13924-6 | Calcitonin Ab [Presence] in Serum |
13925-3 | Cytokeratin Ab [Presence] in Serum |
13926-1 | Glutamate decarboxylase 65 Ab [Units/volume] in Serum |
13927-9 | Pancreatic islet cell Ab [Titer] in Serum |
13928-7 | Parathyrin Ab [Presence] in Serum |
13929-5 | Rheumatoid factor [Titer] in Synovial fluid by Sheep Cell Agglutination |
1393-8 | Cortisol Free [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
13930-3 | Rheumatoid factor [Titer] in Synovial fluid by Agglutination |
13931-1 | Striated muscle Ab [Presence] in Serum |
13932-9 | Testes IgG Ab [Titer] in Serum |
13933-7 | Benzodiazepines [Mass/mass] in Hair |
13934-5 | Butanol [Mass/volume] in Blood |
13935-2 | Dichlorodifluoromethane [Mass/volume] in Blood |
13936-0 | Diethyl ether [Mass/volume] in Blood |
13937-8 | Ethyl acetate [Mass/volume] in Blood |
13938-6 | Trichloroethane [Mass/volume] in Blood |
13939-4 | Deprecated Trichlorotrifluoroethane [Mass/volume] in Blood |
1394-6 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
13940-2 | Dimethylbenzene [Mass/volume] in Blood |
13941-0 | Lymphocytes/100 leukocytes in Body fluid by Manual count |
13942-8 | Spermatozoa Motile [Presence] in Semen by Light microscopy |
13943-6 | Fructose [Presence] in Semen |
13944-4 | Leukocyte phosphatase [Enzymatic activity/volume] in control Leukocytes by Light microscopy |
13945-1 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field |
13946-9 | Complement+Immunoglobulin [Presence] in Red Blood Cells |
13947-7 | Coccidioides immitis IgG Ab [Presence] in Serum by Immunoassay |
13948-5 | Coccidioides immitis IgM Ab [Presence] in Serum by Immunoassay |
13949-3 | Cytomegalovirus IgG Ab [Presence] in Serum by Immunoassay |
1395-3 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
13950-1 | Hepatitis A virus IgM Ab [Presence] in Serum or Plasma by Immunoassay |
13951-9 | Hepatitis A virus Ab [Presence] in Serum by Immunoassay |
13952-7 | Hepatitis B virus core Ab [Presence] in Serum or Plasma by Immunoassay |
13953-5 | Hepatitis B virus e Ab [Presence] in Serum or Plasma by Immunoassay |
13954-3 | Hepatitis B virus e Ag [Presence] in Serum or Plasma by Immunoassay |
13955-0 | Hepatitis C virus Ab [Presence] in Serum or Plasma by Immunoassay |
13956-8 | Mycobacterium tuberculosis DNA [Presence] in Unspecified specimen by Probe and target amplification method |
13957-6 | Clostridium difficile toxin A [Presence] in Stool by Immunoassay |
13958-4 | Arsenic [Presence] in 24 hour Urine |
13959-2 | Calcium.ionized [Moles/volume] in Serum or Plasma by calculation |
1396-1 | Cortisol Free [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
13960-0 | Coproporphyrin [Presence] in 24 hour Urine |
13961-8 | Mercury [Presence] in 24 hour Urine |
13962-6 | Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
13963-4 | Orotate [Moles/volume] in Urine |
13964-2 | Methylmalonate [Moles/volume] in Serum or Plasma |
13965-9 | Homocysteine [Moles/volume] in Serum or Plasma |
13966-7 | Cystine [Moles/time] in 24 hour Urine |
13967-5 | Sex hormone binding globulin [Moles/volume] in Serum or Plasma |
13968-3 | Penicillin [Susceptibility] by Disk diffusion (KB) |
13969-1 | Creatine kinase.MB [Mass/volume] in Serum or Plasma |
1397-9 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
13970-9 | Delta tocopherol [Mass/volume] in Serum or Plasma |
13971-7 | Histoplasma capsulatum Ag [Units/volume] in Urine by Immunoassay |
13972-5 | Alpha 1 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13973-3 | Prealbumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13974-1 | Albumin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13975-8 | Alpha 2 globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13976-6 | Beta globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13977-4 | Gamma globulin/Protein.total in Cerebral spinal fluid by Electrophoresis |
13978-2 | Alpha 1 globulin/Protein.total in Serum or Plasma by Electrophoresis |
13979-0 | Prealbumin/Protein.total in Serum or Plasma by Electrophoresis |
1398-7 | Cortisol [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
13980-8 | Albumin/Protein.total in Serum or Plasma by Electrophoresis |
13981-6 | Alpha 2 globulin/Protein.total in Serum or Plasma by Electrophoresis |
13982-4 | Beta globulin/Protein.total in Serum or Plasma by Electrophoresis |
13983-2 | Gamma globulin/Protein.total in Serum or Plasma by Electrophoresis |
13984-0 | Alpha 1 globulin/Protein.total in 24 hour Urine by Electrophoresis |
13985-7 | Prealbumin/Protein.total in 24 hour Urine by Electrophoresis |
13986-5 | Albumin/Protein.total in 24 hour Urine by Electrophoresis |
13987-3 | Alpha 2 globulin/Protein.total in 24 hour Urine by Electrophoresis |
13988-1 | Beta globulin/Protein.total in 24 hour Urine by Electrophoresis |
13989-9 | Gamma globulin/Protein.total in 24 hour Urine by Electrophoresis |
1399-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
13990-7 | Alpha 1 globulin/Protein.total in Urine by Electrophoresis |
13991-5 | Prealbumin/Protein.total in Urine by Electrophoresis |
13992-3 | Albumin/Protein.total in Urine by Electrophoresis |
13993-1 | Alpha 2 globulin/Protein.total in Urine by Electrophoresis |
13994-9 | Beta globulin/Protein.total in Urine by Electrophoresis |
13995-6 | Gamma globulin/Protein.total in Urine by Electrophoresis |
13996-4 | Hydroxyproline/Creatinine [Molar ratio] in 24 hour Urine |
13997-2 | Neuronal nuclear type 1 Ab [Titer] in Serum |
13998-0 | Neuronal nuclear type 2 Ab [Titer] in Serum |
13999-8 | Transferrin.carbohydrate deficient [Units/volume] in Serum or Plasma |
14-1 | Amikacin [Susceptibility] by Serum bactericidal titer |
140-4 | Ceftriaxone [Susceptibility] by Minimum lethal concentration (MLC) |
1400-1 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 1 ug/kg CRH IV |
14000-4 | Urea nitrogen [Mass/volume] in Cerebral spinal fluid |
14001-2 | IgE [Units/volume] in Cord blood |
14002-0 | IgM [Units/volume] in Cord blood |
14003-8 | Carbon dioxide [Partial pressure] in Cord blood |
14004-6 | Prostaglandin A [Mass/time] in 24 hour Urine |
14005-3 | Prostaglandin E1 [Mass/time] in 24 hour Urine |
14006-1 | Prostaglandin E2 [Mass/time] in 24 hour Urine |
14007-9 | Prostaglandin F2 alpha [Mass/time] in 24 hour Urine |
14008-7 | Phosphatidylcholine IgG Ab [Units/volume] in Serum by Immunoassay |
14009-5 | Phosphatidylcholine IgM Ab [Units/volume] in Serum by Immunoassay |
1401-9 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM rapid |
14010-3 | Phosphatidylcholine IgA Ab [Units/volume] in Serum by Immunoassay |
14011-1 | Deprecated Platelet associated IgA Ab [Units/volume] in Blood |
14012-9 | Platelet associated IgG Ab [Units/volume] in Blood by Flow cytometry (FC) |
14013-7 | Platelet associated IgM Ab [Units/volume] in Blood by Flow cytometry (FC) |
14014-5 | Thyroxine (T4).prealbumin bound [Mass/volume] in Serum or Plasma |
14015-2 | Thyroxine (T4).prealbumin bound/Prealbumin [Mass Ratio] in Serum or Plasma |
14016-0 | Thyroxine.thyroxine binding globulin bound [Mass/volume] in Serum or Plasma |
14017-8 | CD22 cells/100 cells in Blood |
14018-6 | CD23 cells/100 cells in Blood |
14019-4 | HTLV I+II gp46 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
1402-7 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IV rapid |
14020-2 | HTLV I+II p19 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
14021-0 | HTLV I+II p24 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
14022-8 | HTLV I+II p26 Ab [Presence] in Serum by Immunoblot (IB) |
14023-6 | HTLV I+II p28 Ab [Presence] in Serum by Immunoblot (IB) |
14024-4 | HTLV I+II p32 Ab [Presence] in Serum by Immunoblot (IB) |
14025-1 | HTLV I+II p36 Ab [Presence] in Serum by Immunoblot (IB) |
14026-9 | HTLV I+II p53 Ab [Presence] in Serum by Immunoblot (IB) |
14027-7 | HTLV I+II rgp21 Ab [Presence] in Serum or Plasma by Immunoblot (IB) |
14028-5 | Deprecated HTLV I+II rgp46-I Ab [Presence] in Serum by Immunoblot (IB) |
14029-3 | Deprecated HTLV I+II rgp46-II Ab [Presence] in Serum by Immunoblot (IB) |
1403-5 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
14030-1 | Smith extractable nuclear Ab+Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunoassay |
14031-9 | Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
14032-7 | Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
14033-5 | 1,4-Dioxane [Mass/volume] in Blood by Gas chromatography |
14034-3 | Rheumatoid factor [Units/volume] in Cerebral spinal fluid |
14035-0 | Japanese Cedar IgE Ab [Units/volume] in Serum |
14036-8 | Dermatophagoides microceras IgE Ab [Units/volume] in Serum |
14037-6 | Fox IgE Ab [Units/volume] in Serum |
14038-4 | Pacific Squid IgE Ab [Units/volume] in Serum |
14039-2 | Neutrophils/100 leukocytes in Cerebral spinal fluid by Microscopy |
1404-3 | Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
14040-0 | Carbon dioxide, total [Moles/volume] in Stool |
14041-8 | Choriogonadotropin.beta subunit [Units/volume] in Cerebral spinal fluid |
14042-6 | Corticosterone [Mass/time] in 24 hour Urine |
14043-4 | Cortisol Free [Mass/time] in 12 hour Urine |
14044-2 | Cortisone [Mass/time] in 24 hour Urine |
14045-9 | D-Lactate [Moles/volume] in Serum or Plasma |
14046-7 | D-Lactate [Moles/volume] in Urine |
14047-5 | Androstanolone Free [Mass/volume] in Serum or Plasma |
14048-3 | Elastase.pancreatic [Mass/volume] in Serum |
14049-1 | Epidermal growth factor [Mass/volume] in Serum or Plasma |
1405-0 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
14050-9 | Epidermal growth factor receptor [Moles/mass] in Tissue |
14051-7 | Estrogen binding protein [Mass/volume] in Serum or Plasma |
14052-5 | Formate [Mass/volume] in Urine |
14053-3 | Homocystine [Presence] in Urine |
14054-1 | Prostaglandin D2 [Mass/time] in 24 hour Urine |
14055-8 | Sodium [Moles/mass] in Stool |
14056-6 | Carbamazepine 10,11-epoxide free [Mass/volume] in Serum or Plasma |
14057-4 | Carbamazepine free [Mass/volume] in Saliva (oral fluid) |
14058-2 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --peak |
14059-0 | Deprecated Ciprofloxacin [Mass/volume] in Serum or Plasma --trough |
1406-8 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post 1 ug/kg CRH IV |
14060-8 | Cyclobenzaprine [Presence] in Urine |
14061-6 | Cyclobenzaprine [Mass/volume] in Urine |
14062-4 | Dexamethasone [Mass/volume] in Serum or Plasma |
14063-2 | Dezocine [Presence] in Urine |
14064-0 | Diethylstilbestrol [Mass/volume] in Serum or Plasma |
14065-7 | Diflunisal [Mass/volume] in Serum or Plasma |
14066-5 | Dihydrocodeine [Presence] in Urine |
14067-3 | Dihydrocodeine [Mass/volume] in Blood |
14068-1 | Triamterene+Hydrochlorothiazide [Mass/volume] in Serum or Plasma |
14069-9 | Estazolam [Mass/volume] in Serum or Plasma |
1407-6 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14070-7 | Fluphenazine [Presence] in Urine |
14071-5 | Ibuprofen [Presence] in Urine |
14072-3 | Monoacetyldapsone [Mass/volume] in Serum or Plasma |
14073-1 | Phenytoin [Mass/volume] in Saliva (oral fluid) |
14074-9 | Spironolactone [Mass/volume] in Serum or Plasma |
14075-6 | Sulfapyridine [Mass/volume] in Serum or Plasma |
14076-4 | Complement total hemolytic CH100 [Presence] in Serum or Plasma by Immune diffusion (ID) |
14077-2 | Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
14078-0 | Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
14079-8 | Brucella canis IgG Ab [Titer] in Serum by Immunofluorescence |
1408-4 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 40 ug corticotropin IM BID 3 day |
14080-6 | Brucella canis IgM Ab [Titer] in Serum by Immunofluorescence |
14081-4 | Coliform bacteria [Presence] in Water |
14082-2 | Echinococcus sp IgG Ab [Units/volume] in Serum by Immunoblot (IB) |
14083-0 | Epstein Barr virus early Ab [Titer] in Serum by Immunofluorescence |
14084-8 | Herpes simplex virus 1 [Presence] in Isolate by Immunofluorescence |
14085-5 | Herpes simplex virus 2 [Presence] in Isolate by Immunofluorescence |
14086-3 | Herpes simplex virus 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14087-1 | Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14088-9 | Deprecated Herpes simplex virus 1 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14089-7 | Herpes simplex virus 2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
1409-2 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug corticotropin IM |
14090-5 | Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14091-3 | Deprecated Herpes simplex virus 2 IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14092-1 | HIV 1 Ab [Presence] in Serum by Immunofluorescence |
14093-9 | Bacteria identified in Water by Culture |
14094-7 | Trypanosoma cruzi IgG Ab [Titer] in Serum |
14095-4 | Fibronectin aggregate IgG Ab [Units/volume] in Serum |
14096-2 | Intercalated disk Ab [Titer] in Serum by Immunofluorescence |
14097-0 | Antimony [Mass/time] in 24 hour Urine |
14098-8 | Dimethylsulfoxide [Mass/volume] in Serum or Plasma |
14099-6 | Nickel [Mass/volume] in Urine |
141-2 | Ceftriaxone [Susceptibility] by Minimum inhibitory concentration (MIC) |
1410-0 | Cortisol [Mass/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14100-2 | Strontium [Presence] in Urine |
14101-0 | Strychnine [Mass/volume] in Gastric fluid |
14102-8 | Strychnine [Mass/volume] in Blood |
14103-6 | Epithelial cells [Presence] in Stool by Light microscopy |
14104-4 | Barley smut+Wheat smut IgE Ab [Units/volume] in Serum |
14105-1 | Leukocytes [Presence] in Nose by Light microscopy |
14106-9 | Lymphocytes [#/volume] in Cerebral spinal fluid by Manual count |
14107-7 | Segmented neutrophils/100 leukocytes in Cerebral spinal fluid by Manual count |
14108-5 | CD16C+CD56+ cells [#/volume] in Blood |
14109-3 | CD16C+CD56+ cells/100 cells in Blood |
1411-8 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14110-1 | Deprecated CD22 cells/100 cells in Blood |
14111-9 | Deprecated CD23 cells/100 lymphocytes in Blood |
14112-7 | CD25+CD19+ cells/100 cells in Blood |
14113-5 | CD56 cells [#/volume] in Blood |
14114-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --1 hour post 250 ug corticotropin IM |
14115-0 | Collagen crosslinked N-telopeptide/Creatinine [Molar ratio] in Urine |
14116-8 | IgG synthesis rate [Mass/time] in Serum and CSF by calculation |
14117-6 | IgG clearance/Albumin clearance [Ratio] in Serum and CSF |
14118-4 | Lactate [Mass/volume] in Serum or Plasma |
14119-2 | Lactate dehydrogenase 1/Lactate dehydrogenase 2 [Enzymatic activity ratio] in Serum or Plasma |
1412-6 | Cortisol [Mass/volume] in Serum or Plasma --26 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14120-0 | Deprecated Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma |
14121-8 | Pyruvate [Moles/volume] in Blood |
14122-6 | Pyruvate [Moles/volume] in Cerebral spinal fluid |
14123-4 | Thyroxine (T4).albumin bound/Albumin [Mass Ratio] in Serum or Plasma |
14124-2 | Bacteria [Presence] in Semen by Light microscopy |
14125-9 | Entamoeba histolytica [Presence] in Stool by Trichrome stain |
14126-7 | HIV 1 gp120+gp160 Ab [Presence] in Serum by Immunoblot (IB) |
14127-5 | Neisseria gonorrhoeae [Presence] in Anal by Organism specific culture |
14128-3 | Rabies virus Ab [Titer] in Serum |
14129-1 | Respiratory syncytial virus [Presence] in Nose by Organism specific culture |
1413-4 | Cortisol [Mass/volume] in Serum or Plasma --2 days post 500 ug corticotropin IM |
14130-9 | Estrogen receptor [Moles/mass] in Tissue |
14131-7 | PM-1 Ab [Presence] in Serum |
14132-5 | Color of Gastric fluid |
14133-3 | Silver Maple IgE Ab [Units/volume] in Serum |
14134-1 | Deprecated Free Hemoglobin [Mass/volume] in Serum |
14135-8 | CD3+CD8+ (T8 suppressor cells) cells [#/volume] in Blood |
14136-6 | CD34 cells [#/volume] in Blood |
14137-4 | Glucose [Mass/volume] in Serum or Plasma --5.5 hours post 75 g glucose PO |
14138-2 | Ketones [Presence] in Urine --30 minutes post XXX challenge |
14139-0 | Ketones [Presence] in Urine --4 hours post XXX challenge |
1414-2 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
14140-8 | Ketones [Presence] in Urine --5 hours post XXX challenge |
14141-6 | Ketones [Presence] in Urine --6 hours post XXX challenge |
14142-4 | Somatotropin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
14143-2 | Somatotropin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
14144-0 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
14145-7 | Somatotropin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
14146-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
14147-3 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
14148-1 | 18-Hydroxycortisol [Mass/time] in 24 hour Urine |
14149-9 | Corticotropin Big Fragment [Mass/volume] in Serum or Plasma |
1415-9 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 1 ug/kg CRH IV |
14150-7 | Deprecated Beta glucuronidase [Enzymatic activity/volume] in Serum or Plasma |
14151-5 | Bicarbonate [Moles/volume] in Cord blood |
14152-3 | Bilirubin.direct [Mass/volume] in Body fluid |
14153-1 | Carnitine esters/Creatinine [Mass Ratio] in Urine |
14154-9 | Cholesterol sulfate [Mass/volume] in Serum |
14155-6 | Cholesterol in LDL [Percentile] |
14156-4 | Coproporphyrin [Mass/mass] in 24 hour Stool |
14157-2 | Coproporphyrin [Mass/volume] in Serum or Plasma |
14158-0 | Cortisol [Mass/time] in 24 hour Urine |
14159-8 | Cortisone [Mass/volume] in Serum or Plasma |
1416-7 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM rapid |
14160-6 | Estrone (E1).unconjugated/Estrone (E1).total in Serum or Plasma |
14161-4 | Deprecated Formaldehyde in Nonbiological fluid |
14162-2 | Gamma melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
14163-0 | IgA.secretory [Mass/volume] in Serum or Plasma |
14164-8 | Immunosuppressive acidic protein [Mass/volume] in Serum or Plasma |
14165-5 | Lactate [Moles/volume] in Body fluid |
14166-3 | Methane [Mass/volume] in Blood |
14167-1 | N-methylimidazoleacetate [Mass/time] in 24 hour Urine |
14168-9 | Palatinase [Enzymatic activity/mass] in Tissue |
14169-7 | Peptide histidine isoleucine [Mass/volume] in Plasma |
1417-5 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IV rapid |
14170-5 | Pituitary glucoprotein hormone.alpha subunit [Mass/volume] in Serum |
14171-3 | Porphyrins [Mass/mass] in 24 hour Stool |
14172-1 | Potassium [Moles/volume] in Synovial fluid |
14173-9 | Progesterone Free [Mass/time] in 24 hour Urine |
14174-7 | Prostaglandin F2 alpha [Mass/volume] in Serum or Plasma |
14175-4 | Protoporphyrin [Mass/mass] in 24 hour Stool |
14176-2 | Pyrroles [Mass/volume] in Urine |
14177-0 | Growth hormone-releasing hormone [Mass/volume] in Serum or Plasma |
14178-8 | Sucrase [Enzymatic activity/mass] in Tissue |
14179-6 | Tissue polypeptide Ag [Mass/volume] in Serum or Plasma |
1418-3 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post 250 ug corticotropin IM |
14180-4 | Uroporphyrin [Mass/volume] in Red Blood Cells |
14181-2 | Uroporphyrin [Mass/mass] in 24 hour Stool |
14182-0 | Thrombin antithrombin complex Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
14183-8 | Aprobarbital [Mass/volume] in Urine |
14184-6 | Atropine [Presence] in Urine |
14185-3 | Methimazole [Mass/volume] in Serum or Plasma |
14186-1 | Methylprednisolone [Mass/volume] in Serum or Plasma |
14187-9 | OKT3 [Mass/volume] in Serum or Plasma |
14188-7 | Omeprazole [Mass/volume] in Serum or Plasma |
14189-5 | Phenyltoloxamine [Mass/volume] in Urine |
1419-1 | Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
14190-3 | Phenytoin Free [Mass/volume] in Saliva (oral fluid) |
14191-1 | Prazosin [Mass/volume] in Serum or Plasma |
14192-9 | Triazolam [Presence] in Urine |
14193-7 | Tripelennamine [Presence] in Urine |
14194-5 | Spermatozoa Progressive/100 spermatozoa in Semen |
14195-2 | Complement C3b Inactive [Mass/volume] in Plasma |
14196-0 | Reticulocytes [#/volume] in Blood |
14197-8 | Blastomyces dermatitidis exoantigen [Identifier] in Isolate |
14198-6 | Chlamydophila psittaci Ab [Titer] in Serum by Immunofluorescence |
14199-4 | Chlamydia trachomatis B IgA Ab [Titer] in Serum by Immunofluorescence |
142-0 | Ceftriaxone [Susceptibility] by Disk diffusion (KB) |
1420-9 | Deprecated Cortisol [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
14200-0 | Chlamydia trachomatis B IgG Ab [Titer] in Serum by Immunofluorescence |
14201-8 | Chlamydia trachomatis B IgM Ab [Titer] in Serum by Immunofluorescence |
14202-6 | Chlamydia trachomatis C IgA Ab [Titer] in Serum by Immunofluorescence |
14203-4 | Chlamydia trachomatis C IgG Ab [Titer] in Serum by Immunofluorescence |
14204-2 | Chlamydia trachomatis C IgM Ab [Titer] in Serum by Immunofluorescence |
14205-9 | Coccidioides immitis Ag [Presence] in Isolate by Immune diffusion (ID) |
14206-7 | Coccidioides immitis exoantigen [Identifier] in Isolate |
14207-5 | Streptococcal DNAse B [Titer] in Serum |
14208-3 | Filaria IgG4 Ab [Units/volume] in Serum |
14209-1 | Francisella tularensis IgA Ab [Presence] in Serum |
1421-7 | Cortisol [Mass/volume] in Serum or Plasma --32 hours post 40 ug corticotropin IM BID 3 day |
14210-9 | Giardia lamblia Ag [Presence] in Stool by Immunofluorescence |
14211-7 | Hepatitis E virus IgG Ab [Presence] in Serum |
14212-5 | Hepatitis E virus IgM Ab [Presence] in Serum |
14213-3 | Herpes simplex virus IgM Ab [Titer] in Serum by Immunofluorescence |
14214-1 | Histoplasma capsulatum exoantigen [Identifier] in Isolate |
14215-8 | HTLV I g46 Ab [Presence] in Serum |
14216-6 | HTLV 1 gp46 Ab [Presence] in Serum |
14217-4 | HTLV I p19 Ab [Presence] in Serum |
14218-2 | HTLV I p24 Ab [Presence] in Serum |
14219-0 | HTLV I p26 Ab [Presence] in Serum |
1422-5 | Cortisol [Mass/volume] in Serum or Plasma --3 days post 500 ug corticotropin IM |
14220-8 | HTLV I p28 Ab [Presence] in Serum |
14221-6 | HTLV I p32 Ab [Presence] in Serum |
14222-4 | HTLV I p36 Ab [Presence] in Serum |
14223-2 | HTLV I p53 Ab [Presence] in Serum |
14224-0 | HTLV I rgp21 Ab [Presence] in Serum |
14225-7 | HTLV II g46 Ab [Presence] in Serum |
14226-5 | Nocardia sp identified in Isolate by Organism specific culture |
14227-3 | Salmonella typhi H D Ab [Titer] in Serum |
14228-1 | Estrogen receptor/100 cells in Tissue by Immune stain |
14229-9 | P53 protein Ag [Presence] in Tissue by Immune stain |
1423-3 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post 1 ug/kg CRH IV |
14230-7 | Progesterone receptor/100 cells in Tissue by Immune stain |
14231-5 | H2a-H2b DNA IgG Ab [Units/volume] in Serum |
14232-3 | Adrenal Ab [Presence] in Serum |
14233-1 | Beta tubulin IgG Ab [Titer] in Serum |
14234-9 | Beta tubulin IgM Ab [Titer] in Serum |
14235-6 | Jo-1 extractable nuclear Ab [Titer] in Serum |
14236-4 | Mitochondria Ab [Presence] in Serum |
14237-2 | Myelin basic protein IgA Ab [Units/volume] in Serum |
14238-0 | Myelin basic protein IgG Ab [Units/volume] in Serum |
14239-8 | Myelin basic protein IgM Ab [Units/volume] in Serum |
1424-1 | Cortisol [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
14240-6 | Neuronal nuclear Ab [Units/volume] in Cerebral spinal fluid |
14241-4 | Parietal cell Ab [Presence] in Serum |
14242-2 | Phosphatidylcholine IgA Ab [Presence] in Serum |
14243-0 | Phosphatidylcholine IgG Ab [Presence] in Serum |
14244-8 | Phosphatidylcholine IgM Ab [Presence] in Serum |
14245-5 | Phosphatidylserine IgG Ab [Units/volume] in Serum |
14246-3 | Phosphatidylserine IgM Ab [Units/volume] in Serum |
14247-1 | Purkinje cells Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
14248-9 | Purkinje cells Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
14249-7 | Purkinje cells Ab [Presence] in Serum by Immunofluorescence |
1425-8 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14250-5 | Purkinje cells IgG Ab [Units/volume] in Serum by Immunofluorescence |
14251-3 | Mitochondria M2 IgG Ab [Units/volume] in Serum |
14252-1 | Smooth muscle Ab [Presence] in Serum |
14253-9 | Somatotropin Ab [Presence] in Serum or Plasma |
14254-7 | Ganglioside GQ1b IgG Ab [Titer] in Serum |
14255-4 | Thyrotropin blocking Ab [Units/volume] in Serum |
14256-2 | Tetrachlorodiphenylethane [Mass/mass] in Tissue |
14257-0 | Tetrachlorodiphenylethane [Mass/volume] in Serum or Plasma |
14258-8 | 1,4-Dioxane [Mass/volume] in Blood |
14259-6 | 1-Pentanol [Mass/volume] in Blood |
1426-6 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 40 ug corticotropin IM BID 3 day |
14260-4 | Bromoform [Mass/volume] in Blood |
14261-2 | Codeine [Presence] in Gastric fluid |
14262-0 | Dichlorodiphenyldichloroethylene [Mass/mass] in Tissue |
14263-8 | Dichlorodiphenyltrichloroethane [Mass/mass] in Tissue |
14264-6 | Enflurane [Mass/volume] in Blood |
14265-3 | Isobutyl acetate [Mass/volume] in Blood |
14266-1 | Methoxyflurane [Mass/volume] in Blood |
14267-9 | Methylenedioxymethamphetamine [Presence] in Urine |
14268-7 | Butyl acetate [Mass/volume] in Blood |
14269-5 | Sec-butyl acetate [Mass/volume] in Blood |
1427-4 | Cortisol [Mass/volume] in Serum or Plasma --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14270-3 | Tert-butyl acetate [Mass/volume] in Blood |
14271-1 | Character of Synovial fluid |
14272-9 | Liver kidney microsomal Ab [Presence] in Serum |
14273-7 | Reticulin IgA Ab [Presence] in Serum |
14274-5 | Uroporphyrin [Mass/volume] in Serum or Plasma |
14275-2 | Immune complex [Units/volume] in Serum or Plasma by C3b binding assay |
14276-0 | Hemoglobin F distribution [Interpretation] in Blood by Kleihauer-Betke method |
14277-8 | Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence |
14278-6 | Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence |
1428-2 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14282-8 | Acylcarnitine [Moles/volume] in Serum or Plasma |
14283-6 | Acylcarnitine [Moles/volume] in Urine |
14284-4 | Beta glucuronidase [Moles/volume] in Serum or Plasma |
14285-1 | Carnitine free (C0) [Moles/volume] in Urine |
14286-9 | Carnitine free (C0) [Moles/volume] in Serum or Plasma |
14287-7 | Carnitine [Moles/volume] in Urine |
14288-5 | Carnitine [Moles/volume] in Serum or Plasma |
14289-3 | Deprecated Coproporphyrin [Presence] in 24 hour Urine |
1429-0 | Cortisol [Mass/volume] in Serum or Plasma --50 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14290-1 | Deprecated Erythrocytes [Units/volume] in Urine sediment by Manual count |
14291-9 | Follitropin [Moles/volume] in Serum or Plasma --baseline |
14292-7 | IgE [Moles/volume] in Serum |
14293-5 | Insulin [Moles/volume] in Serum or Plasma --baseline |
14294-3 | Lysosomal enzymes screen [Identifier] in Plasma and Urine |
14295-0 | Organic acids/Creatinine [Molar ratio] in Urine |
14296-8 | Thyroperoxidase Ab [Moles/volume] in Serum or Plasma |
14297-6 | Thyrotropin [Moles/volume] in Serum or Plasma |
14298-4 | Plasma units available [#] |
14299-2 | Cryoprecipitate units available [#] |
143-8 | Ceftriaxone [Susceptibility] by Serum bactericidal titer |
1430-8 | Cortisol [Mass/volume] in Serum or Plasma --56 hours post 40 ug corticotropin IM BID 3 day |
14300-8 | Plateletpheresis units available [#] |
14301-6 | Platelet concentrate units available [#] |
14302-4 | Packed erythrocytes units available [#] |
14303-2 | Transfuse plateletpheresis [Volume] |
14304-0 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
14305-7 | Measles virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
14306-5 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
14307-3 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
14308-1 | Amphetamines [Presence] in Urine by Screen method >1000 ng/mL |
14309-9 | Amphetamines [Presence] in Urine by Confirm method >200 ng/mL |
1431-6 | Cortisol [Mass/volume] in Serum or Plasma --5 minutes post 1 ug/kg CRH IV |
14310-7 | Phencyclidine [Presence] in Urine by Screen method >25 ng/mL |
14311-5 | Phencyclidine [Presence] in Urine by Confirm method >20 ng/mL |
14312-3 | Tetrahydrocannabinol [Presence] in Urine by Screen method >50 ng/mL |
14313-1 | Tetrahydrocannabinol [Mass/volume] in Urine by Confirmatory method |
14314-9 | Benzoylecgonine [Presence] in Urine by Screen method |
14315-6 | Benzoylecgonine [Presence] in Urine by Confirmatory method |
14316-4 | Benzodiazepines [Presence] in Urine by Screen method |
14317-2 | Microscopic observation [Identifier] in Genital specimen by Wet preparation |
14318-0 | Microscopic observation [Identifier] in Cervix by Wet preparation |
14319-8 | Microscopic observation [Identifier] in Vaginal fluid by Wet preparation |
1432-4 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14320-6 | Deprecated Bacteria identified in Urine by Culture @1:100 |
14321-4 | Haemophilus influenzae B Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
14322-2 | Streptococcus pneumoniae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
14323-0 | Streptococcus agalactiae Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
14324-8 | Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
14325-5 | Bacteria identified in Unspecified specimen by Environmental culture |
14326-3 | Eosinophils/100 leukocytes in Stool by Manual count |
14327-1 | Epithelial cells.squamous [Presence] in Sputum by Light microscopy |
14328-9 | Leukocytes [Presence] in Sputum by Light microscopy |
14329-7 | Mucus [Presence] in Sputum by Light microscopy |
1433-2 | Cortisol [Mass/volume] in Serum or Plasma --72 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14330-5 | Polymorphonuclear cells/100 leukocytes in Stool by Manual count |
14331-3 | Erythrocytes [Units/volume] in Stool by Manual count |
14332-1 | Para aminosalicylate [Susceptibility] by Minimum inhibitory concentration (MIC) |
14333-9 | Lead [Presence] in 24 hour Urine |
14334-7 | Lithium [Moles/volume] in Serum or Plasma |
14335-4 | Optical density of Amniotic fluid by Spectrophotometry |
14336-2 | Ethanol [Mass/volume] in Serum or Plasma by Gas chromatography |
14337-0 | Phenytoin.total/Phenytoin.free [Mass Ratio] in Serum or Plasma |
14338-8 | Prealbumin [Mass/volume] in Serum or Plasma |
14339-6 | IgG/Protein.total in Cerebral spinal fluid |
1434-0 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 1 mg dexamethasone PO overnight |
14340-4 | Gammopathy [Interpretation] in Serum or Plasma by Electrophoresis |
14341-2 | Globulin/Protein.total in 24 hour Urine by Electrophoresis |
14342-0 | Deprecated Catecholamines/Creatinine [Mass ratio] in Urine |
14343-8 | Eosinophils/100 leukocytes in Peritoneal fluid by Manual count |
14344-6 | Eosinophils/100 leukocytes in Pleural fluid by Manual count |
14345-3 | Specific gravity of Amniotic fluid by Refractometry |
14346-1 | Specific gravity of Cerebral spinal fluid by Refractometry |
14347-9 | Specific gravity of Gastric fluid by Refractometry |
14348-7 | Specific gravity of Peritoneal fluid by Refractometry |
14349-5 | Specific gravity of Pleural fluid by Refractometry |
1435-7 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14350-3 | Specific gravity of Synovial fluid by Refractometry |
14351-1 | Specific gravity of Stool by Refractometry |
14352-9 | Specific gravity of Water by Refractometry |
14353-7 | Microscopic observation [Identifier] in Pleural fluid by Acid fast stain.Kinyoun modified |
14354-5 | Microscopic observation [Identifier] in Wound by Acid fast stain.Kinyoun modified |
14355-2 | Microscopic observation [Identifier] in Cervix by KOH preparation |
14356-0 | Microscopic observation [Identifier] in Vaginal fluid by KOH preparation |
14357-8 | Microscopic observation [Identifier] in Cerebral spinal fluid by Gram stain |
14358-6 | Microscopic observation [Identifier] in Aspirate by Gram stain |
14359-4 | Microscopic observation [Identifier] in Peritoneal fluid by Gram stain |
1436-5 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 30 mg/kg metyrapone PO |
14360-2 | Microscopic observation [Identifier] in Pleural fluid by Gram stain |
14361-0 | Microscopic observation [Identifier] in Vaginal fluid by Gram stain |
14362-8 | Microscopic observation [Identifier] in Throat by Gram stain |
14363-6 | Microscopic observation [Identifier] in Synovial fluid by Gram stain |
14364-4 | Microscopic observation [Identifier] in Eye by Gram stain |
14365-1 | Microscopic observation [Identifier] in Ear by Gram stain |
14366-9 | Trichomonas vaginalis [Presence] in Cervix by Wet preparation |
14367-7 | Trichomonas vaginalis [Presence] in Vaginal fluid by Wet preparation |
14368-5 | Trichomonas vaginalis [Presence] in Urethra by Wet preparation |
14369-3 | Yeast [Presence] in Cervix by Wet preparation |
1437-3 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14370-1 | Yeast [Presence] in Vaginal fluid by Wet preparation |
14371-9 | Yeast [Presence] in Urethra by Wet preparation |
14372-7 | Erythrocytes [#/volume] in Gastric fluid by Manual count |
14373-5 | Leukocytes [#/volume] in Gastric fluid by Manual count |
14374-3 | Polymorphonuclear cells/100 leukocytes in Pleural fluid by Manual count |
14375-0 | Polymorphonuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
14376-8 | Polymorphonuclear cells/100 leukocytes in Synovial fluid by Manual count |
14377-6 | Polymorphonuclear cells/100 leukocytes in Semen by Manual count |
14378-4 | Polymorphonuclear cells/100 leukocytes in Urine by Manual count |
14379-2 | Polymorphonuclear cells/100 leukocytes in Gastric fluid by Manual count |
1438-1 | Cortisol [Mass/volume] in Serum or Plasma --8 hours post 40 ug corticotropin IM BID 3 day |
14380-0 | Mononuclear cells/100 leukocytes in Pleural fluid by Manual count |
14381-8 | Mononuclear cells/100 leukocytes in Peritoneal fluid by Manual count |
14382-6 | Mononuclear cells/100 leukocytes in Synovial fluid by Manual count |
14383-4 | Mononuclear cells/100 leukocytes in Semen by Manual count |
14384-2 | Mononuclear cells/100 leukocytes in Urine sediment by Manual count |
14385-9 | Mononuclear cells/100 leukocytes in Gastric fluid by Manual count |
14386-7 | Glucose [Mass/volume] in Gastric fluid |
14387-5 | Protein [Mass/volume] in Gastric fluid |
14388-3 | Amylase [Enzymatic activity/volume] in Synovial fluid |
14389-1 | Amylase [Enzymatic activity/volume] in Cerebral spinal fluid |
1439-9 | Cortisol [Mass/volume] in Serum or Plasma --9.5 hours post 8 mg dexamethasone PO overnight high dose |
14390-9 | Amylase [Enzymatic activity/volume] in Dialysis fluid |
14391-7 | Amylase [Enzymatic activity/volume] in Gastric fluid |
14392-5 | Amylase [Enzymatic activity/volume] in Amniotic fluid |
14393-3 | Urea nitrogen [Mass/volume] in Amniotic fluid |
14394-1 | Urea nitrogen [Mass/volume] in Pleural fluid |
14395-8 | Deprecated Urea nitrogen [Mass/volume] in Peritoneal fluid |
14396-6 | Urea nitrogen [Mass/volume] in Synovial fluid |
14397-4 | Urea nitrogen [Mass/volume] in Gastric fluid |
14398-2 | Creatinine [Mass/volume] in Cerebral spinal fluid |
14399-0 | Creatinine [Mass/volume] in Pleural fluid |
144-6 | Cefuroxime Parenteral [Susceptibility] by Minimum lethal concentration (MLC) |
1440-7 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 1 mg dexamethasone PO overnight |
14400-6 | Deprecated Creatinine [Mass/volume] in Peritoneal fluid |
14401-4 | Creatinine [Mass/volume] in Synovial fluid |
14402-2 | Creatinine [Mass/volume] in Gastric fluid |
14403-0 | Lactate dehydrogenase [Enzymatic activity/volume] in Gastric fluid |
14404-8 | Phosphate [Mass/volume] in Pleural fluid |
14405-5 | Phosphate [Mass/volume] in Peritoneal fluid |
14406-3 | Phosphate [Mass/volume] in Synovial fluid |
14407-1 | Phosphate [Mass/volume] in Gastric fluid |
14408-9 | Phosphate [Mass/volume] in Amniotic fluid |
14409-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Pleural fluid |
1441-5 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 3 g metyrapone PO overnight |
14410-5 | Aspartate aminotransferase [Enzymatic activity/volume] in Peritoneal fluid |
14411-3 | Aspartate aminotransferase [Enzymatic activity/volume] in Synovial fluid |
14412-1 | Aspartate aminotransferase [Enzymatic activity/volume] in Gastric fluid |
14413-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Urine |
14414-7 | Aspartate aminotransferase [Enzymatic activity/volume] in Dialysis fluid |
14415-4 | Calcium [Moles/volume] in Amniotic fluid |
14416-2 | Calcium [Moles/volume] in Pleural fluid |
14417-0 | Calcium [Moles/volume] in Peritoneal fluid |
14418-8 | Calcium [Moles/volume] in Synovial fluid |
14419-6 | Calcium [Moles/volume] in Gastric fluid |
1442-3 | Cortisol [Mass/volume] in Serum or Plasma --9 hours post 8 mg dexamethasone PO overnight high dose |
14420-4 | Bilirubin.total [Mass/volume] in Dialysis fluid |
14421-2 | Bilirubin.total [Mass/volume] in Pleural fluid |
14422-0 | Bilirubin.total [Mass/volume] in Peritoneal fluid |
14423-8 | Bilirubin.total [Mass/volume] in Synovial fluid |
14424-6 | Bilirubin.total [Mass/volume] in Gastric fluid |
14425-3 | Globulin [Mass/volume] in Amniotic fluid |
14426-1 | Globulin [Mass/volume] in Cerebral spinal fluid |
14427-9 | Globulin [Mass/volume] in Pleural fluid |
14428-7 | Globulin [Mass/volume] in Peritoneal fluid |
14429-5 | Globulin [Mass/volume] in Semen |
1443-1 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 ug/kg CRH IV |
14430-3 | Globulin [Mass/volume] in Synovial fluid |
14431-1 | Globulin [Mass/volume] in Urine |
14432-9 | Albumin/Globulin [Mass Ratio] in Amniotic fluid |
14433-7 | Albumin/Globulin [Mass Ratio] in Cerebral spinal fluid |
14434-5 | Albumin/Globulin [Mass Ratio] in Pleural fluid |
14435-2 | Albumin/Globulin [Mass Ratio] in Peritoneal fluid |
14436-0 | Albumin/Globulin [Mass Ratio] in Semen |
14437-8 | Albumin/Globulin [Mass Ratio] in Synovial fluid |
14438-6 | Cholesterol [Mass/volume] in Amniotic fluid |
14439-4 | Cholesterol [Mass/volume] in Cerebral spinal fluid |
1444-9 | Cortisol [Mass/volume] in Serum or Plasma --pre 12 hour fast |
14440-2 | Deprecated Cholesterol [Mass/volume] in Pleural fluid |
14441-0 | Cholesterol [Mass/volume] in Peritoneal fluid |
14442-8 | Cholesterol [Mass/volume] in Semen |
14443-6 | Cholesterol [Mass/volume] in Synovial fluid |
14444-4 | Cholesterol [Mass/volume] in Urine |
14445-1 | Triglyceride [Mass/volume] in Amniotic fluid |
14446-9 | Triglyceride [Mass/volume] in Cerebral spinal fluid |
14447-7 | Triglyceride [Mass/volume] in Peritoneal fluid |
14448-5 | Triglyceride [Mass/volume] in Semen |
14449-3 | Triglyceride [Mass/volume] in Synovial fluid |
1445-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 1 mg dexamethasone PO overnight |
14450-1 | Triglyceride [Mass/volume] in Urine |
14451-9 | Virus identified in Eye by Culture |
14452-7 | Virus identified in Cervix by Culture |
14453-5 | Virus identified in Vaginal fluid by Culture |
14454-3 | Virus identified in Nose by Culture |
14455-0 | Virus identified in Pleural fluid by Culture |
14456-8 | Virus identified in Peritoneal fluid by Culture |
14457-6 | Virus identified in Urine by Culture |
14458-4 | Virus identified in Sputum by Culture |
14459-2 | Virus identified in Penis by Culture |
1446-4 | Cortisol [Mass/volume] in Serum or Plasma --pre 3 g metyrapone PO overnight |
14460-0 | Virus identified in Urethra by Culture |
14461-8 | Chlamydia trachomatis [Presence] in Blood by Organism specific culture |
14462-6 | Chlamydia trachomatis [Presence] in Cerebral spinal fluid by Organism specific culture |
14463-4 | Chlamydia trachomatis [Presence] in Cervix by Organism specific culture |
14464-2 | Chlamydia trachomatis [Presence] in Vaginal fluid by Organism specific culture |
14465-9 | Chlamydia trachomatis [Presence] in Urethra by Organism specific culture |
14466-7 | Deprecated Chlamydia trachomatis [Presence] in Penis by Organism specific culture |
14467-5 | Chlamydia trachomatis [Presence] in Urine sediment by Organism specific culture |
14468-3 | Chlamydia trachomatis Ag [Presence] in Blood by Immunoassay |
14469-1 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunoassay |
1447-2 | Cortisol [Mass/volume] in Serum or Plasma --pre 40 ug corticotropin IM 3 day |
14470-9 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunoassay |
14471-7 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunoassay |
14472-5 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunoassay |
14473-3 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunoassay |
14474-1 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunoassay |
14475-8 | Bacteria identified in Cervix by Aerobe culture |
14476-6 | Deprecated Bacteria identified in Vaginal fluid by Aerobe culture |
14477-4 | Bacteria identified in Urethra by Aerobe culture |
14478-2 | Bacteria identified in Penis by Aerobe culture |
14479-0 | Diphtheria identified in Throat by Organism specific culture |
1448-0 | Cortisol [Mass/volume] in Serum or Plasma --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
14480-8 | Diphtheria identified in Sputum by Organism specific culture |
14481-6 | Diphtheria identified in Nose by Organism specific culture |
14482-4 | Diphtheria identified in Skin by Organism specific culture |
14483-2 | Diphtheria identified in Bronchial specimen by Organism specific culture |
14484-0 | Mycoplasma sp and Ureaplasma sp [Identifier] in Cervix by Organism specific culture |
14485-7 | Mycoplasma sp and Ureaplasma sp [Identifier] in Vaginal fluid by Organism specific culture |
14486-5 | Mycoplasma sp and Ureaplasma sp [Identifier] in Penis by Organism specific culture |
14487-3 | Mycoplasma sp and Ureaplasma sp [Identifier] in Urethra by Organism specific culture |
14488-1 | Virus identified in Cerebral spinal fluid by Immunofluorescence |
14489-9 | Virus identified in Blood by Immunofluorescence |
1449-8 | Cortisol [Mass/volume] in Serum or Plasma --pre 8 mg dexamethasone PO overnight high dose |
14490-7 | Virus identified in Semen by Immunofluorescence |
14491-5 | Virus identified in Throat by Immunofluorescence |
14492-3 | Virus identified in Eye by Immunofluorescence |
14493-1 | Virus identified in Cervix by Immunofluorescence |
14494-9 | Virus identified in Vaginal fluid by Immunofluorescence |
14495-6 | Virus identified in Urine sediment by Immunofluorescence |
14496-4 | Virus identified in Sputum by Immunofluorescence |
14497-2 | Virus identified in Penis by Immunofluorescence |
14498-0 | Virus identified in Urethra by Immunofluorescence |
14499-8 | Human papilloma virus Ag [Presence] in Cervix |
145-3 | Cefuroxime Parenteral [Susceptibility] by Minimum inhibitory concentration (MIC) |
1450-6 | Cortisol [Mass/volume] in Serum or Plasma --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
14500-3 | Human papilloma virus Ag [Presence] in Vaginal fluid |
14501-1 | Human papilloma virus Ag [Presence] in Penis |
14502-9 | Human papilloma virus Ag [Presence] in Urethra |
14503-7 | Human papilloma virus 16+18 Ag [Presence] in Cervix |
14504-5 | Human papilloma virus 16+18 Ag [Presence] in Vaginal fluid |
14505-2 | Human papilloma virus 16+18 Ag [Presence] in Penis |
14506-0 | Human papilloma virus 16+18 Ag [Presence] in Urethra |
14507-8 | Chlamydia trachomatis Ag [Presence] in Blood by Immunofluorescence |
14508-6 | Chlamydia trachomatis Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
14509-4 | Chlamydia trachomatis Ag [Presence] in Cervix by Immunofluorescence |
1451-4 | Cortisol [Mass/volume] in Serum or Plasma --pre dose insulin IV |
14510-2 | Chlamydia trachomatis Ag [Presence] in Vaginal fluid by Immunofluorescence |
14511-0 | Chlamydia trachomatis Ag [Presence] in Urethra by Immunofluorescence |
14512-8 | Deprecated Chlamydia trachomatis Ag [Presence] in Penis by Immunofluorescence |
14513-6 | Chlamydia trachomatis Ag [Presence] in Urine sediment by Immunofluorescence |
14514-4 | Pneumocystis jiroveci Ag [Presence] in Blood by Immunofluorescence |
14515-1 | Pneumocystis jiroveci Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
14516-9 | Pneumocystis jiroveci Ag [Presence] in Semen by Immunofluorescence |
14517-7 | Pneumocystis jiroveci Ag [Presence] in Stool by Immunofluorescence |
14518-5 | Pneumocystis jiroveci Ag [Presence] in Throat by Immunofluorescence |
14519-3 | Pneumocystis jiroveci Ag [Presence] in Eye by Immunofluorescence |
1452-2 | Creatinine [Mass/volume] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
14520-1 | Pneumocystis jiroveci Ag [Presence] in Nose by Immunofluorescence |
14521-9 | Pneumocystis jiroveci Ag [Presence] in Urine by Immunofluorescence |
14522-7 | Pneumocystis jiroveci Ag [Presence] in Bronchial specimen by Immunofluorescence |
14523-5 | Rubella virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
14524-3 | Rubella virus Ag [Presence] in Throat by Immunofluorescence |
14525-0 | Rubella virus Ag [Presence] in Skin by Immunofluorescence |
14526-8 | Rubella virus Ag [Presence] in Eye by Immunofluorescence |
14527-6 | Rubella virus Ag [Presence] in Nose by Immunofluorescence |
14528-4 | Rubella virus Ag [Presence] in Sputum by Immunofluorescence |
14529-2 | Rubella virus Ag [Presence] in Cervix by Immunofluorescence |
1453-0 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
14530-0 | Rubella virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
14531-8 | Rubella virus Ag [Presence] in Urine sediment by Immunofluorescence |
14532-6 | Rubella virus Ag [Presence] in Penis by Immunofluorescence |
14533-4 | Rubella virus Ag [Presence] in Urethra by Immunofluorescence |
14534-2 | Measles virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
14535-9 | Measles virus Ag [Presence] in Throat by Immunofluorescence |
14536-7 | Measles virus Ag [Presence] in Skin by Immunofluorescence |
14537-5 | Measles virus Ag [Presence] in Eye by Immunofluorescence |
14538-3 | Measles virus Ag [Presence] in Nose by Immunofluorescence |
14539-1 | Measles virus Ag [Presence] in Sputum by Immunofluorescence |
1454-8 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14540-9 | Measles virus Ag [Presence] in Cervix by Immunofluorescence |
14541-7 | Measles virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
14542-5 | Measles virus Ag [Presence] in Urine sediment by Immunofluorescence |
14543-3 | Measles virus Ag [Presence] in Penis by Immunofluorescence |
14544-1 | Measles virus Ag [Presence] in Urethra by Immunofluorescence |
14545-8 | Mumps virus Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
14546-6 | Mumps virus Ag [Presence] in Throat by Immunofluorescence |
14547-4 | Mumps virus Ag [Presence] in Skin by Immunofluorescence |
14548-2 | Mumps virus Ag [Presence] in Eye by Immunofluorescence |
14549-0 | Mumps virus Ag [Presence] in Nose by Immunofluorescence |
1455-5 | Creatinine [Mass/volume] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
14550-8 | Mumps virus Ag [Presence] in Sputum by Immunofluorescence |
14551-6 | Mumps virus Ag [Presence] in Cervix by Immunofluorescence |
14552-4 | Mumps virus Ag [Presence] in Vaginal fluid by Immunofluorescence |
14553-2 | Mumps virus Ag [Presence] in Urine sediment by Immunofluorescence |
14554-0 | Mumps virus Ag [Presence] in Penis by Immunofluorescence |
14555-7 | Mumps virus Ag [Presence] in Urethra by Immunofluorescence |
14556-5 | Mycobacterium tuberculosis DNA [Presence] in Sputum by Probe and target amplification method |
14557-3 | Mycobacterium tuberculosis DNA [Presence] in Bronchial specimen by Probe and target amplification method |
14558-1 | Mycobacterium tuberculosis DNA [Presence] in Gastric fluid by Probe and target amplification method |
14559-9 | Mycobacterium tuberculosis DNA [Presence] in Pleural fluid by Probe and target amplification method |
1456-3 | Creatinine [Mass/volume] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
14560-7 | Mycobacterium tuberculosis DNA [Presence] in Urine by Probe and target amplification method |
14561-5 | Mycobacterium tuberculosis DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
14562-3 | Mycobacterium tuberculosis DNA [Presence] in Semen by Probe and target amplification method |
14563-1 | Hemoglobin.gastrointestinal [Presence] in Stool --1st specimen |
14564-9 | Hemoglobin.gastrointestinal [Presence] in Stool --2nd specimen |
14565-6 | Hemoglobin.gastrointestinal [Presence] in Stool --3rd specimen |
14566-4 | Calcitriol [Moles/volume] in Serum or Plasma |
14567-2 | 11-Deoxycortisol [Moles/volume] in Serum or Plasma |
14568-0 | 17-Hydroxycorticosteroids [Moles/time] in 24 hour Urine |
14569-8 | 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma |
1457-1 | Creatinine [Mass/volume] in 24 hour Urine --pre 40 ug corticotropin IM 3 day |
14570-6 | 17-Hydroxyprogesterone [Moles/volume] in Urine |
14571-4 | 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine |
14572-2 | 17-Ketosteroids [Moles/time] in 24 hour Urine |
14573-0 | 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine |
14574-8 | 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
14575-5 | Blood group antibody investigation [Interpretation] in Plasma or RBC |
14576-3 | Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review |
14577-1 | ABO and Rh group [Type] in Blood from donor |
14578-9 | ABO group [Type] in Blood from Blood product unit |
14579-7 | ABO group [Type] in Blood from donor |
1458-9 | Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
14580-5 | ABO group [Type] in Blood from newborn |
14581-3 | Acetaminophen [Moles/volume] in Serum or Plasma |
14582-1 | Acetone [Moles/volume] in Serum or Plasma |
14583-9 | Acidity.titratable [Mass/volume] in Gastric fluid |
14584-7 | Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine |
14585-4 | Albumin/Creatinine [Molar ratio] in Urine |
14586-2 | Aldosterone [Moles/volume] in Serum or Plasma |
14587-0 | Aldosterone [Moles/time] in 24 hour Urine |
14588-8 | Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma |
14589-6 | Amylase isoenzymes [Interpretation] in Serum or Plasma |
1459-7 | Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
14590-4 | Alpha tocopherol [Moles/volume] in Serum or Plasma |
14591-2 | Alprazolam [Moles/volume] in Serum or Plasma |
14592-0 | Aluminum [Moles/volume] in 24 hour Urine |
14593-8 | Aluminum [Moles/volume] in Serum or Plasma |
14594-6 | Amitriptyline+Nortriptyline [Presence] in Gastric fluid |
14595-3 | Amitriptyline+Nortriptyline [Presence] in Serum or Plasma |
14596-1 | Amitriptyline+Nortriptyline [Presence] in Urine |
14597-9 | Amitriptyline [Moles/volume] in Serum or Plasma |
14598-7 | Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma |
14599-5 | Ammonium [Presence] in Stone |
146-1 | Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB) |
1460-5 | Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin |
14600-1 | Amoxapine [Moles/volume] in Serum or Plasma |
14601-9 | Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma |
14602-7 | Deprecated Amoxapine+8-Hydroxyamoxapine [Molecules/volume] in Serum or Plasma |
14603-5 | Androstenedione [Moles/volume] in Serum or Plasma |
14604-3 | Blood group antibodies identified in Serum or Plasma from Blood product unit |
14605-0 | Blood group antibodies identified in Serum or Plasma from donor |
14606-8 | Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed |
14607-6 | Nuclear Ab [Presence] in Body fluid |
14608-4 | Nuclear Ab [Presence] in Pleural fluid |
14609-2 | Nuclear Ab [Presence] in Peritoneal fluid |
1461-3 | Epinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
14610-0 | Nuclear Ab [Presence] in Synovial fluid |
14611-8 | Nuclear Ab pattern [Interpretation] in Serum |
14612-6 | Nuclear Ab [Titer] in Pericardial fluid |
14613-4 | Nuclear Ab [Titer] in Body fluid |
14614-2 | Nuclear Ab [Titer] in Pleural fluid |
14615-9 | Nuclear Ab [Titer] in Peritoneal fluid |
14616-7 | Nuclear Ab [Titer] in Synovial fluid |
14617-5 | Appearance of Pericardial fluid |
14618-3 | Appearance of Stone |
14619-1 | Appearance of Plasma |
1462-1 | Epinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
14620-9 | Appearance of Pleural fluid |
14621-7 | Appearance of Peritoneal fluid |
14622-5 | Ascorbate [Moles/volume] in Serum or Plasma |
14623-3 | Barbital [Presence] in Serum or Plasma |
14624-1 | Barbiturates [Presence] in Gastric fluid |
14625-8 | Basophils/100 leukocytes in Bronchial specimen by Manual count |
14626-6 | Beta-2-Microglobulin [Moles/volume] in Serum |
14627-4 | Bicarbonate [Moles/volume] in Venous blood |
14628-2 | Bile acid [Moles/volume] in Serum |
14629-0 | Bilirubin.direct [Moles/volume] in Serum or Plasma |
1463-9 | Epinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
14630-8 | Bilirubin.indirect [Moles/volume] in Serum or Plasma |
14631-6 | Bilirubin.total [Moles/volume] in Serum or Plasma |
14632-4 | Deprecated Buffy coat |
14633-2 | C peptide [Moles/volume] in Serum or Plasma |
14634-0 | C reactive protein [Titer] in Serum or Plasma |
14635-7 | Calcidiol [Moles/volume] in Serum or Plasma |
14636-5 | Calcium [Presence] in Stone |
14637-3 | Calcium [Moles/time] in 24 hour Urine |
14638-1 | Calculus analysis [Interpretation] in Stone |
14639-9 | Carbamazepine [Moles/volume] in Serum or Plasma |
1464-7 | Epinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO |
14640-7 | Carbon dioxide, total [Moles/volume] in Dialysis fluid |
14641-5 | Carbonate [Presence] in Stone |
14642-3 | Carotene [Moles/volume] in Serum |
14643-1 | Catecholamines Free [Moles/time] in 24 hour Urine |
14644-9 | Chlorpromazine [Presence] in Gastric fluid |
14645-6 | Chlorpromazine [Moles/volume] in Serum or Plasma |
14646-4 | Cholesterol in HDL [Moles/volume] in Serum or Plasma |
14647-2 | Cholesterol [Moles/volume] in Serum or Plasma |
14648-0 | Chylomicrons [Moles/volume] in Serum or Plasma |
14649-8 | Cimetidine [Presence] in Gastric fluid |
1465-4 | Epinephrine [Mass/volume] in Plasma --supine |
14650-6 | Citrate [Moles/time] in 24 hour Urine |
14651-4 | Clobazam [Moles/volume] in Serum or Plasma |
14652-2 | Clomipramine [Moles/volume] in Serum or Plasma |
14653-0 | Clomipramine [Moles/volume] in Urine |
14654-8 | Clomipramine+Norclomipramine [Moles/volume] in Serum or Plasma |
14655-5 | Clonazepam [Moles/volume] in Serum or Plasma |
14656-3 | Clozapine [Moles/volume] in Serum or Plasma |
14657-1 | Clozapine+Norclozapine [Moles/volume] in Serum or Plasma |
14658-9 | Cold agglutinin [Titer] in Serum or Plasma |
14659-7 | Deprecated Collection duration of Urine |
1466-2 | Deprecated Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV |
14660-5 | Color of Peritoneal fluid |
14661-3 | Color of Pericardial fluid |
14662-1 | Color of Pleural fluid |
14663-9 | Deprecated Color of Semen by Visual |
14664-7 | Color of Synovial fluid |
14665-4 | Copper [Moles/volume] in Serum or Plasma |
14666-2 | Copper [Moles/time] in 24 hour Urine |
14667-0 | Coproporphyrin 1 [Moles/volume] in Serum or Plasma |
14668-8 | Coproporphyrin 1 [Moles/volume] in Stool |
14669-6 | Coproporphyrin 1 [Moles/volume] in Urine |
1467-0 | Follitropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
14670-4 | Coproporphyrin 1/Porphyrins.total in Urine |
14671-2 | Coproporphyrin 3 [Moles/volume] in Serum or Plasma |
14672-0 | Coproporphyrin 3 [Moles/volume] in Stool |
14673-8 | Coproporphyrin 3 [Moles/volume] in Urine |
14674-6 | Corticotropin [Moles/volume] in Plasma |
14675-3 | Cortisol [Moles/volume] in Serum or Plasma |
14676-1 | Cortisol Free [Moles/time] in 24 hour Urine |
14677-9 | Cortisol [Moles/volume] in Serum or Plasma --24 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
14678-7 | Cortisol [Moles/volume] in Serum or Plasma --PM trough specimen |
14679-5 | Cortisol [Moles/volume] in Serum or Plasma --AM peak specimen |
1468-8 | Follitropin [Mass/volume] in Serum or Plasma --105 minutes post 100 ug lutenizing releasing hormone IV |
14680-3 | Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis |
14681-1 | Creatinine [Moles/volume] in Peritoneal dialysis fluid |
14682-9 | Creatinine [Moles/volume] in Serum or Plasma |
14683-7 | Creatinine [Moles/volume] in Urine |
14684-5 | Creatinine [Moles/time] in 24 hour Urine |
14685-2 | Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma |
14686-0 | Cystine [Presence] in Stone |
14687-8 | Transfusion date |
14688-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma |
14689-4 | Delta aminolevulinate [Moles/time] in 24 hour Urine |
1469-6 | Follitropin [Mass/volume] in Serum or Plasma --15 minutes post 100 ug lutenizing releasing hormone IV |
14690-2 | N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
14691-0 | Desipramine [Moles/volume] in Serum or Plasma |
14692-8 | Desipramine [Moles/volume] in Urine |
14693-6 | Norclobazam [Moles/volume] in Serum or Plasma |
14694-4 | Norclomipramine [Moles/volume] in Serum or Plasma |
14695-1 | Nordoxepin [Moles/volume] in Serum or Plasma |
14696-9 | Deuteroporphyrin [Moles/volume] in Stool |
14697-7 | Diazepam [Moles/volume] in Serum or Plasma |
14698-5 | Digoxin [Moles/volume] in Serum or Plasma |
14699-3 | Diphenhydramine+Dimenhydrinate [Presence] in Gastric fluid |
147-9 | Cefuroxime Parenteral [Susceptibility] by Serum bactericidal titer |
1470-4 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post 100 ug lutenizing releasing hormone IV |
14700-9 | Diphenhydramine+Dimenhydrinate [Presence] in Serum or Plasma |
14701-7 | Diphenhydramine+Dimenhydrinate [Presence] in Urine |
14702-5 | Disopyramide [Moles/volume] in Serum or Plasma |
14703-3 | Dopamine [Moles/volume] in Serum or Plasma |
14704-1 | Doxepin [Presence] in Gastric fluid |
14705-8 | Doxepin [Moles/volume] in Serum or Plasma |
14706-6 | Doxepin [Moles/volume] in Urine |
14707-4 | Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
14708-2 | Endomysium Ab [Titer] in Serum |
14709-0 | Eosinophils/100 leukocytes in Bronchial specimen by Manual count |
1471-2 | Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
14710-8 | Ephedrine+Pseudoephedrine [Presence] in Gastric fluid |
14711-6 | Epinephrine [Moles/volume] in Plasma |
14712-4 | Epinephrine [Moles/time] in 24 hour Urine |
14713-2 | Erythrocytes [#/volume] in Pericardial fluid by Manual count |
14714-0 | Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
14715-7 | Estradiol (E2) [Moles/volume] in Serum or Plasma |
14716-5 | Estriol (E3) [Moles/volume] in Serum or Plasma |
14717-3 | Estriol (E3) [Moles/volume] in Urine |
14718-1 | Estriol (E3) [Moles/time] in 24 hour Urine |
14719-9 | Ethanol [Moles/volume] in Serum or Plasma |
1472-0 | Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug lutenizing releasing hormone IV |
14720-7 | Ethosuximide [Moles/volume] in Serum or Plasma |
14721-5 | Ethylene glycol [Moles/volume] in Serum or Plasma |
14722-3 | Extractable nuclear Ab [Presence] in Serum |
14723-1 | Ferritin [Moles/volume] in Serum or Plasma |
14724-9 | Ferritin [Interpretation] in Blood |
14725-6 | [Type] of Body fluid |
14726-4 | Fluoride [Moles/volume] in Serum or Plasma |
14727-2 | Fluoxetine [Presence] in Gastric fluid |
14728-0 | Fluoxetine [Moles/volume] in Serum or Plasma |
14729-8 | Flurazepam [Moles/volume] in Serum or Plasma |
1473-8 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post 100 ug lutenizing releasing hormone IV |
14730-6 | Flurazepam+N-desalkylflurazepam [Moles/volume] in Serum or Plasma |
14731-4 | Folate [Moles/volume] in Red Blood Cells |
14732-2 | Folate [Moles/volume] in Serum or Plasma |
14733-0 | Folate+Cyanocobalamin [Interpretation] in Serum or Blood |
14734-8 | Follitropin [Moles/time] in 24 hour Urine |
14735-5 | Gastrin [Moles/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
14736-3 | Gastrin [Moles/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
14737-1 | Gastrin [Moles/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
14738-9 | Gastrin [Moles/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
14739-7 | Gastrin [Moles/volume] in Serum or Plasma --2 minutes post 0.2 U/kg secretin |
1474-6 | Follitropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
14740-5 | Gastrin [Moles/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
14741-3 | Gastrin [Moles/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
14742-1 | Gastrin [Moles/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
14743-9 | Glucose [Moles/volume] in Capillary blood by Glucometer |
14744-7 | Glucose [Moles/volume] in Cerebral spinal fluid |
14745-4 | Glucose [Moles/volume] in Body fluid |
14746-2 | Glucose [Moles/volume] in Peritoneal dialysis fluid |
14747-0 | Glucose [Moles/volume] in Pleural fluid |
14748-8 | Glucose [Moles/volume] in Peritoneal fluid |
14749-6 | Glucose [Moles/volume] in Serum or Plasma |
1475-3 | Follitropin [Mass/volume] in Serum or Plasma --45 minutes post 100 ug lutenizing releasing hormone IV |
14750-4 | Glucose [Moles/volume] in Synovial fluid |
14751-2 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post 50 g lactose PO |
14752-0 | Glucose [Moles/volume] in Serum or Plasma --1.5 hours post dose glucose |
14753-8 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
14754-6 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
14755-3 | Glucose [Moles/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
14756-1 | Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose |
14757-9 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
14758-7 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
14759-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose |
1476-1 | Follitropin [Mass/volume] in Serum or Plasma --75 minutes post 100 ug lutenizing releasing hormone IV |
14760-3 | Glucose [Moles/volume] in Capillary blood --2 hours post meal |
14761-1 | Glucose [Moles/volume] in Serum or Plasma --2 hours post meal |
14762-9 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
14763-7 | Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose |
14764-5 | Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
14765-2 | Glucose [Moles/volume] in Serum or Plasma --3 hours post dose glucose |
14766-0 | Glucose [Moles/volume] in Serum or Plasma --4 hours post dose glucose |
14767-8 | Glucose [Moles/volume] in Serum or Plasma --5 hours post dose glucose |
14768-6 | Glucose [Moles/volume] in Serum or Plasma --baseline |
14769-4 | Glucose [Moles/volume] in Serum or Plasma --pre 12 hour fast |
1477-9 | Follitropin [Mass/volume] in Serum or Plasma --baseline |
14770-2 | Fasting glucose [Moles/volume] in Capillary blood by Glucometer |
14771-0 | Fasting glucose [Moles/volume] in Serum or Plasma |
14772-8 | Gold [Moles/volume] in Serum or Plasma |
14773-6 | Granulocytes/100 leukocytes in Bronchial specimen by Manual count |
14774-4 | Haloperidol [Moles/volume] in Serum or Plasma |
14775-1 | Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
14776-9 | Heptacarboxylate [Moles/volume] in Plasma |
14777-7 | Heptacarboxylate [Moles/volume] in Stool |
14778-5 | Heptacarboxylate [Moles/volume] in Urine |
14779-3 | Hexacarboxylate [Moles/volume] in Plasma |
1478-7 | Follitropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
14780-1 | Hexacarboxylate [Moles/volume] in Stool |
14781-9 | Hexacarboxylate [Moles/volume] in Urine |
14782-7 | Homovanillate [Moles/volume] in Urine |
14783-5 | Homovanillate [Moles/time] in 24 hour Urine |
14784-3 | Hydroxyproline Free [Moles/time] in 24 hour Urine |
14785-0 | Hydroxyproline [Moles/time] in 24 hour Urine |
14786-8 | Deprecated Arthropod identified in Unspecified specimen |
14787-6 | Arthropod identified in Unspecified specimen by Permanent mount |
14788-4 | Helminth+Arthropod identified in Unspecified specimen by Rearing/Culture |
14789-2 | Helminth identified in Unspecified specimen by Macro/micro identification |
1479-5 | Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO |
14790-0 | Helminth identified in Unspecified specimen by Permanent mount |
14791-8 | Imipramine+Desipramine [Presence] in Gastric fluid |
14792-6 | Imipramine+Desipramine [Presence] in Serum or Plasma |
14793-4 | Imipramine+Desipramine [Presence] in Urine |
14794-2 | Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
14795-9 | Immunoglobulin light chains [Interpretation] in Urine |
14796-7 | Insulin [Moles/volume] in Serum or Plasma |
14797-5 | Iron [Interpretation] in Serum or Plasma |
14798-3 | Iron [Moles/volume] in Serum or Plasma |
14799-1 | Iron [Moles/time] in 24 hour Urine |
148-7 | Cephalexin [Susceptibility] by Minimum lethal concentration (MLC) |
1480-3 | Galactose [Mass/volume] in Blood --1 hour post 40 g galactose PO |
14800-7 | Iron binding capacity [Moles/volume] in Serum or Plasma |
14801-5 | Iron saturation [Molar fraction] in Serum or Plasma |
14802-3 | Isopropanol [Moles/volume] in Serum or Plasma |
14803-1 | Lactate dehydrogenase [Enzymatic activity/volume] in Body fluid by Lactate to pyruvate reaction |
14804-9 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction |
14805-6 | Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Pyruvate to lactate reaction |
14806-4 | Lactose.PO [Mass] of Dose |
14807-2 | Lead [Moles/volume] in Blood |
14808-0 | Lead [Moles/volume] in Urine |
14809-8 | Lead [Moles/time] in 24 hour Urine |
1481-1 | Galactose [Mass/volume] in Blood --2 hours post 40 g galactose PO |
14810-6 | Leukocytes [#/volume] in Bronchial specimen by Manual count |
14811-4 | Leukocytes [#/volume] in Pericardial fluid by Manual count |
14812-2 | Lidocaine [Moles/volume] in Serum or Plasma |
14813-0 | Lipoprotein.alpha [Moles/volume] in Serum or Plasma by Electrophoresis |
14814-8 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by Electrophoresis |
14815-5 | Lipoprotein.beta [Moles/volume] in Serum or Plasma by calculation |
14816-3 | Lipoprotein.pre-beta [Moles/volume] in Serum or Plasma by Electrophoresis |
14817-1 | Lorazepam [Moles/volume] in Serum or Plasma |
14818-9 | Lymphocytes/100 leukocytes in Pericardial fluid by Manual count |
14819-7 | Lymphocytes/100 leukocytes in Bronchial specimen by Manual count |
1482-9 | Galactose [Mass/volume] in Blood --30 minutes post 40 g galactose PO |
14820-5 | Lymphocytes/100 leukocytes in Pleural fluid by Manual count |
14821-3 | Lymphocytes/100 leukocytes in Peritoneal fluid by Manual count |
14822-1 | Lymphocytes/100 leukocytes in Synovial fluid by Manual count |
14823-9 | Macrophages/100 leukocytes in Bronchial specimen by Manual count |
14824-7 | Magnesium [Presence] in Stone |
14825-4 | Maprotiline [Moles/volume] in Serum or Plasma |
14826-2 | Meperidine [Presence] in Gastric fluid |
14827-0 | Mesoporphyrin [Moles/volume] in Stool |
14828-8 | Mesothelial cells/100 leukocytes in Pericardial fluid by Manual count |
14829-6 | Mesothelial cells/100 leukocytes in Pleural fluid by Manual count |
1483-7 | Galactose [Mass/time] in 5 hour Urine --post 40 g dose PO |
14830-4 | Mesothelial cells/100 leukocytes in Peritoneal fluid by Manual count |
14831-2 | Metanephrine/Creatinine [Molar ratio] in Urine |
14832-0 | Metanephrines [Moles/volume] in Urine |
14833-8 | Metanephrines [Moles/time] in 24 hour Urine |
14834-6 | Methamphetamine [Presence] in Gastric fluid |
14835-3 | Methanol [Moles/volume] in Serum or Plasma |
14836-1 | Methotrexate [Moles/volume] in Serum or Plasma |
14837-9 | Methsuximide [Moles/volume] in Serum or Plasma |
14838-7 | Toxoplasma gondii [Presence] in Tissue by Organism specific culture |
14839-5 | Trypanosoma sp identified in Buffy Coat by Light microscopy |
1484-5 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post 0.2 U/kg secretin |
14840-3 | Trypanosoma sp identified in Cerebral spinal fluid by Wet preparation |
14841-1 | Microscopic observation [Identifier] in Unspecified specimen by Iron hematoxylin stain |
14842-9 | Microscopic observation [Identifier] in Unspecified specimen by Kinyoun iron hematoxylin stain |
14843-7 | 6-Monoacetylmorphine (6-MAM) [Presence] in Gastric fluid |
14844-5 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma |
14845-2 | Deprecated Monoacetylmorphine [Presence] in Urine |
14846-0 | N-acetylprocainamide [Moles/volume] in Serum or Plasma |
14847-8 | Neutrophils/100 leukocytes in Pericardial fluid by Manual count |
14848-6 | Neutrophils/100 leukocytes in Pleural fluid by Manual count |
14849-4 | Nitrazepam [Moles/volume] in Serum or Plasma |
1485-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post 0.2 U/kg secretin |
14850-2 | Nitrazepam [Moles/volume] in Urine |
14851-0 | Norclozapine [Moles/volume] in Serum or Plasma |
14852-8 | Norepinephrine [Moles/volume] in Plasma |
14853-6 | Norepinephrine [Moles/volume] in Urine |
14854-4 | Norepinephrine [Moles/time] in 24 hour Urine |
14855-1 | Norfluoxetine [Moles/volume] in Serum or Plasma |
14856-9 | Nortriptyline [Moles/volume] in Serum or Plasma |
14857-7 | Leukocytes other/100 leukocytes in Pericardial fluid by Manual count |
14858-5 | Leukocytes other/100 leukocytes in Pleural fluid by Manual count |
14859-3 | Leukocytes other/100 leukocytes in Peritoneal fluid by Manual count |
1486-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post 0.2 U/kg secretin |
14860-1 | Leukocytes other/100 leukocytes in Synovial fluid by Manual count |
14861-9 | Oxalate [Presence] in Stone |
14862-7 | Oxalate [Moles/time] in 24 hour Urine |
14863-5 | Oxycodone [Presence] in Gastric fluid |
14864-3 | Oxygen [Partial pressure] in Cord blood |
14865-0 | Parathyrin [Interpretation] in Serum or Plasma |
14866-8 | Parathyrin.intact [Moles/volume] in Serum or Plasma |
14867-6 | Paroxetine [Moles/volume] in Serum or Plasma |
14868-4 | Pathologist report of Plasma or RBC tests |
14869-2 | Pathologist review of Blood tests |
1487-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post 0.2 U/kg secretin |
14870-0 | Pentacarboxylate [Moles/volume] in Plasma |
14871-8 | Pentacarboxylate [Moles/volume] in Stool |
14872-6 | Pentacarboxylate [Moles/volume] in Urine |
14873-4 | pH of Cord blood |
14874-2 | Phenobarbital [Moles/volume] in Serum or Plasma |
14875-9 | Phenylalanine [Moles/volume] in Serum or Plasma |
14876-7 | Phenylpropanolamine [Presence] in Gastric fluid |
14877-5 | Phenytoin [Moles/volume] in Serum or Plasma |
14878-3 | Phosphate [Presence] in Stone |
14879-1 | Phosphate [Moles/volume] in Serum or Plasma |
1488-6 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post 0.2 U/kg secretin |
14880-9 | Deprecated Phosphate [Molecules/volume] in Urine |
14881-7 | Phosphate [Moles/time] in 24 hour Urine |
14882-5 | Porphobilinogen [Moles/time] in 24 hour Urine |
14883-3 | Porphyrins [Interpretation] in Serum or Plasma |
14884-1 | Porphyrins [Interpretation] in Stool |
14885-8 | Pregnanediol [Moles/time] in 24 hour Urine |
14886-6 | Pregnanetriol [Moles/time] in 24 hour Urine |
14887-4 | Primidone [Moles/volume] in Serum or Plasma |
14888-2 | Procainamide [Moles/volume] in Serum or Plasma |
14889-0 | Procainamide+N-acetylprocainamide [Moles/volume] in Serum or Plasma |
1489-4 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post 0.2 U/kg secretin |
14890-8 | Progesterone [Moles/volume] in Serum or Plasma |
14891-6 | Propranolol [Moles/volume] in Serum or Plasma |
14892-4 | Propranolol [Moles/volume] in Urine |
14893-2 | Propranolol [Moles/time] in 24 hour Urine |
14894-0 | Propylene glycol [Presence] in Serum or Plasma |
14895-7 | Protein Fractions [Interpretation] in Serum or Plasma by Immunofixation |
14896-5 | Protein Fractions [Interpretation] in Urine by Immunofixation |
14897-3 | Deprecated Protein [Mass/volume] in Plasma |
14898-1 | Protriptyline [Moles/volume] in Serum or Plasma |
14899-9 | Quinidine [Moles/volume] in Serum or Plasma |
149-5 | Cephalexin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1490-2 | Gastrin [Mass/volume] in Serum or Plasma --pre 0.2 U/kg secretin |
14900-5 | Ranitidine [Presence] in Gastric fluid |
14901-3 | Ranitidine [Presence] in Serum or Plasma |
14902-1 | Ranitidine [Presence] in Urine |
14903-9 | Folate [Interpretation] in Blood |
14904-7 | Reagin Ab [Presence] in Unspecified specimen by VDRL |
14905-4 | Retinol [Moles/volume] in Serum or Plasma |
14906-2 | Rh [Type] in Cord blood |
14907-0 | Rh [Type] in Blood from Blood product unit |
14908-8 | Rh [Type] in Blood from newborn |
14909-6 | Salicylates [Moles/volume] in Serum or Plasma |
1491-0 | Glucose [Mass/volume] in Urine --30 minutes post 100 g glucose PO |
14910-4 | Serotonin [Moles/volume] in Serum |
14911-2 | Sertraline [Moles/volume] in Serum or Plasma |
14912-0 | Smudge cells/100 leukocytes in Blood by Manual count |
14913-8 | Testosterone [Moles/volume] in Serum or Plasma |
14914-6 | Testosterone Free [Moles/volume] in Serum or Plasma |
14915-3 | Theophylline [Moles/volume] in Serum or Plasma |
14916-1 | Thiocyanate [Moles/volume] in Serum or Plasma |
14917-9 | Thioridazine [Moles/volume] in Serum or Plasma |
14918-7 | Thyroglobulin [Moles/volume] in Serum or Plasma |
14919-5 | Thyrotropin binding inhibitory immunoglobulins [Presence] in Serum |
1492-8 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.5 g/kg glucose IV |
14920-3 | Thyroxine (T4) free [Moles/volume] in Serum or Plasma |
14921-1 | Thyroxine (T4) [Moles/volume] in Serum or Plasma |
14922-9 | Toxoplasma gondii IgA+IgE Ab [Units/volume] in Serum by Immunoassay |
14923-7 | Toxoplasma gondii Ab [Units/volume] in Unspecified specimen |
14924-5 | Transfusion reaction [Interpretation] in Plasma or RBC Narrative |
14925-2 | Trazodone [Moles/volume] in Serum or Plasma |
14926-0 | Triazolam [Moles/volume] in Serum or Plasma |
14927-8 | Triglyceride [Moles/volume] in Serum or Plasma |
14928-6 | Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma |
14929-4 | Triiodothyronine (T3).reverse [Moles/volume] in Serum or Plasma |
1493-6 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 0.05-0.15 U insulin/kg IV 12 hours fasting |
14930-2 | Triiodothyronine (T3) [Moles/volume] in Serum or Plasma |
14931-0 | Trimipramine [Moles/volume] in Serum or Plasma |
14932-8 | Urate [Presence] in Stone |
14933-6 | Urate [Moles/volume] in Serum or Plasma |
14934-4 | Urate [Moles/volume] in Urine |
14935-1 | Urate [Moles/time] in 24 hour Urine |
14936-9 | Urea nitrogen [Moles/volume] in Peritoneal dialysis fluid |
14937-7 | Urea nitrogen [Moles/volume] in Serum or Plasma |
14938-5 | Urea nitrogen [Moles/volume] in Urine |
14939-3 | Urea nitrogen [Moles/time] in 24 hour Urine |
1494-4 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 100 g glucose PO |
14940-1 | Uroporphyrin 1 isomer [Moles/volume] in Serum or Plasma |
14941-9 | Uroporphyrin 1 isomer [Moles/volume] in Stool |
14942-7 | Uroporphyrin 1 isomer [Moles/volume] in Urine |
14943-5 | Uroporphyrin 3 isomer [Moles/volume] in Serum or Plasma |
14944-3 | Uroporphyrin 3 isomer [Moles/volume] in Stool |
14945-0 | Uroporphyrin 3 isomer [Moles/volume] in Urine |
14946-8 | Valproate [Moles/volume] in Serum or Plasma |
14947-6 | Vanillylmandelate [Moles/time] in 24 hour Urine |
14948-4 | Vanillylmandelate/Creatinine [Molar ratio] in Urine |
14949-2 | Vasopressin [Moles/volume] in Plasma |
1495-1 | Glucose [Mass/volume] in Urine --1.5 hours post 100 g glucose PO |
14950-0 | Viscosity of Synovial fluid Qualitative |
14951-8 | Volatile drugs positive [Identifier] in Serum or Plasma by Screen method |
14952-6 | Xylose [Moles/volume] in Blood --1 hour post 25 g xylose PO |
14953-4 | Xylose [Moles/volume] in Blood --2 hours post 25 g xylose PO |
14954-2 | Xylose [Moles/time] in 5 hour Urine --post dose PO |
14955-9 | Zinc [Moles/volume] in Serum or Plasma |
14956-7 | Microalbumin [Mass/time] in 24 hour Urine |
14957-5 | Microalbumin [Mass/volume] in Urine |
14958-3 | Microalbumin/Creatinine [Mass Ratio] in 24 hour Urine |
14959-1 | Microalbumin/Creatinine [Mass Ratio] in Urine |
1496-9 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post 75 g glucose PO |
14960-9 | Estradiol (E2) Free/Estradiol (E2).total in Serum or Plasma |
14961-7 | CD10 Abnormal blood cells/Abnormal blood cells.total in Blood |
14962-5 | CD13 Abnormal blood cells/Abnormal blood cells.total in Blood |
14963-3 | CD14 Abnormal blood cells/Abnormal blood cells.total in Blood |
14964-1 | CD19 Abnormal blood cells/Abnormal blood cells.total in Blood |
14965-8 | CD2 Abnormal blood cells/Abnormal blood cells.total in Blood |
14966-6 | CD20 Abnormal blood cells/Abnormal blood cells.total in Blood |
14967-4 | CD33 Abnormal blood cells/Abnormal blood cells.total in Blood |
14968-2 | CD5 Abnormal blood cells/Abnormal blood cells.total in Blood |
14969-0 | CD7 Abnormal blood cells/Abnormal blood cells.total in Blood |
1497-7 | Glucose [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
14970-8 | Estrone (E1).bioavailable [Mass/volume] in Serum or Plasma |
14971-6 | Estrone (E1).bioavailable/Estrone (E1).total in Serum or Plasma |
14972-4 | Mycobacterium sp DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
14973-2 | Mycobacterium sp DNA [Presence] in Sputum by Probe and target amplification method |
14974-0 | Mycobacterium sp DNA [Presence] in Unspecified specimen by Probe and target amplification method |
14975-7 | Human antimouse Ab [Mass/volume] in Serum |
14976-5 | Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
14977-3 | Immunoglobulin light chains.free [Type] in Urine |
14978-1 | Cyclosporine [Mass/volume] in Blood by Immunoassay |
14979-9 | aPTT in Platelet poor plasma by Coagulation assay |
1498-5 | Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV |
14980-7 | A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
14981-5 | A variant subtype Ab [Presence] in Serum or Plasma from donor |
14982-3 | A variant subtype Ab [Presence] in Serum or Plasma |
14983-1 | I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
14984-9 | I (intermediate) subtype [Presence] on Red Blood Cells from donor |
14985-6 | I (intermediate) subtype [Presence] on Red Blood Cells |
14986-4 | little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
14987-2 | little i-1 subtype [Presence] on Red Blood Cells from donor |
14988-0 | little i-1 subtype [Presence] on Red Blood Cells |
14989-8 | little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
1499-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
14990-6 | little i-2 subtype [Presence] on Red Blood Cells from donor |
14991-4 | little i-2 subtype [Presence] on Red Blood Cells |
14992-2 | O group [Presence] on Red Blood Cells from Blood product unit |
14993-0 | O group [Presence] on Red Blood Cells from donor |
14994-8 | O group [Presence] on Red Blood Cells |
14995-5 | Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
14996-3 | Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO |
14997-1 | Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
14998-9 | Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
14999-7 | Thyrotropin [Units/volume] in Serum or Plasma --baseline |
15-8 | Amoxicillin [Susceptibility] by Minimum lethal concentration (MLC) |
150-3 | Cephalexin [Susceptibility] by Disk diffusion (KB) |
1500-8 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.05-0.15 U insulin/kg IV post 12H CFst |
15000-3 | Thyrotropin [Units/volume] in Serum or Plasma --pre dose TRH IV |
15001-1 | Xylose [Moles/volume] in Serum or Plasma --1 hour post 25 g xylose PO |
15002-9 | Xylose [Moles/volume] in Serum or Plasma --2 hours post 25 g xylose PO |
15003-7 | 11-Hydroxyandrosterone [Moles/time] in 24 hour Urine |
15004-5 | 11-Hydroxyetiocholanolone [Moles/time] in 24 hour Urine |
15005-2 | 11-Ketoandrosterone [Moles/time] in 24 hour Urine |
15006-0 | 11-Ketoetiocholanolone [Moles/time] in 24 hour Urine |
15007-8 | 2,3-Diphosphoglycerate [Moles/volume] in Red Blood Cells |
15008-6 | 3-Alpha-Androstanediol glucuronide [Moles/volume] in Serum |
15009-4 | 5-Hydroxyindoleacetate [Moles/volume] in Urine |
1501-6 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
15010-2 | Aldosterone [Moles/volume] in Urine |
15011-0 | Aldosterone [Moles/volume] in Serum or Plasma --supine |
15012-8 | Aldosterone [Moles/volume] in Serum or Plasma --upright |
15013-6 | Alkaline phosphatase.bone/Alkaline phosphatase.total in Serum or Plasma |
15014-4 | Alkaline phosphatase.intestinal/Alkaline phosphatase.total in Serum or Plasma |
15015-1 | Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma |
15016-9 | Alkaline phosphatase.placental/Alkaline phosphatase.total in Serum or Plasma |
15017-7 | Alkaline phosphatase.regan/Alkaline phosphatase.total in Serum or Plasma |
15018-5 | Alkaline phosphatase.renal/Alkaline phosphatase.total in Serum or Plasma |
15019-3 | Alpha-1-Fetoprotein [Moles/volume] in Amniotic fluid |
1502-4 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 100 g glucose PO |
15020-1 | Amylase.P1/Amylase.total in Serum or Plasma |
15021-9 | Amylase.P2/Amylase.total in Serum or Plasma |
15022-7 | Amylase.P3/Amylase.total in Serum or Plasma |
15023-5 | Amylase S1/Amylase.total in Serum or Plasma |
15024-3 | Amylase S2/Amylase.total in Serum or Plasma |
15025-0 | Amylase S3/Amylase.total in Serum or Plasma |
15026-8 | Androstanediol [Moles/volume] in Serum or Plasma |
15027-6 | Androstenedione [Moles/volume] in Urine |
15028-4 | Androstenedione [Moles/time] in 24 hour Urine |
15029-2 | Androsterone [Moles/volume] in Serum or Plasma |
1503-2 | Glucose [Mass/volume] in Urine --1 hour post 100 g glucose PO |
15030-0 | Androsterone [Moles/time] in 24 hour Urine |
15031-8 | Angiotensin I [Moles/volume] in Plasma |
15032-6 | Angiotensin II [Moles/volume] in Plasma |
15033-4 | Ascorbate [Moles/time] in 24 hour Urine |
15034-2 | Bromide [Moles/volume] in Serum or Plasma |
15035-9 | Calcitonin [Moles/volume] in Serum or Plasma |
15036-7 | Catecholamines [Moles/time] in 24 hour Urine |
15037-5 | Chymotrypsin [Moles/mass] in Stool |
15038-3 | Citrate [Moles/volume] in Serum or Plasma |
15039-1 | Deprecated Cobalamin [Molecules/volume] in Serum |
1504-0 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g glucose PO |
15040-9 | Coproporphyrin [Moles/time] in 24 hour Stool |
15041-7 | Coproporphyrin [Moles/time] in 24 hour Urine |
15042-5 | Corticotropin [Units/volume] in Serum |
15043-3 | Cortisol [Moles/volume] in Urine |
15044-1 | Cortisol Free [Moles/volume] in Serum or Plasma |
15045-8 | Creatine [Moles/volume] in Serum or Plasma |
15046-6 | Creatine [Moles/volume] in Urine |
15047-4 | Creatine [Moles/time] in 24 hour Urine |
15048-2 | Creatine kinase.BB/Creatine kinase.total in Serum or Plasma by Electrophoresis |
15049-0 | Creatine kinase.MM/Creatine kinase.total in Serum or Plasma by Electrophoresis |
1505-7 | Glucose [Mass/volume] in Urine --1 hour post 50 g glucose PO |
15050-8 | Creatinine [Moles/volume] in Amniotic fluid |
15051-6 | Creatinine [Moles/volume] in Dialysis fluid |
15052-4 | Cobalamin (Vitamin B12).unsaturated Binding Capacity [Moles/volume] in Serum or Plasma |
15053-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Moles/time] in 24 hour Urine |
15054-0 | Dehydroepiandrosterone (DHEA) [Moles/volume] in Serum or Plasma |
15055-7 | Deoxypyridinoline [Moles/time] in 24 hour Urine |
15056-5 | Deprecated Deoxypyridinoline [Molecules/time] in 24 hour Urine |
15057-3 | Androstanolone [Moles/volume] in Serum or Plasma |
15058-1 | Dopamine [Moles/volume] in Urine |
15059-9 | Dopamine [Moles/time] in 24 hour Urine |
1506-5 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
15060-7 | Enolase.neuron specific [Mass/volume] in Serum or Plasma |
15061-5 | Erythropoietin (EPO) [Units/volume] in Serum or Plasma |
15062-3 | Estradiol (E2).unconjugated [Moles/time] in 24 hour Urine |
15063-1 | Estriol (E3).conjugated [Moles/volume] in Serum or Plasma |
15064-9 | Estriol (E3).unconjugated [Moles/volume] in Serum or Plasma |
15065-6 | Etiocholanolone [Moles/time] in 24 hour Urine |
15066-4 | Fatty acids.nonesterified [Moles/volume] in Serum or Plasma |
15067-2 | Follitropin [Units/volume] in Serum or Plasma |
15068-0 | Follitropin [Units] in 24 hour Urine |
15069-8 | Fructosamine [Moles/volume] in Serum or Plasma |
1507-3 | Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
15070-6 | Fructose [Moles/time] in 24 hour Urine |
15071-4 | Galactose [Moles/time] in 24 hour Urine |
15072-2 | Gastrin [Moles/volume] in Serum or Plasma |
15073-0 | Glucagon [Moles/volume] in Serum or Plasma |
15074-8 | Glucose [Moles/volume] in Blood |
15075-5 | Glucose [Moles/volume] in Dialysis fluid |
15076-3 | Glucose [Moles/volume] in Urine |
15077-1 | Glucose [Moles/time] in 24 hour Urine |
15078-9 | Lactate [Moles/time] in 24 hour Urine |
15079-7 | Lutropin [Units/volume] in Urine |
1508-1 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
15080-5 | Lutropin [Units] in 24 hour Urine |
15081-3 | Prolactin [Units/volume] in Serum or Plasma |
15082-1 | Methemoglobin [Mass/volume] in Blood |
15083-9 | Normetanephrine [Moles/time] in 24 hour Urine |
15084-7 | Osteocalcin [Moles/volume] in Serum or Plasma |
15085-4 | Oxalate [Moles/volume] in Serum or Plasma |
15086-2 | Oxalate [Moles/volume] in Urine |
15087-0 | Parathyrin related protein [Moles/volume] in Serum or Plasma |
15088-8 | Parathyrin.C-terminal [Moles/volume] in Serum or Plasma |
15089-6 | Phospholipid [Moles/volume] in Serum or Plasma |
1509-9 | Glucose [Mass/volume] in Urine --1 hour post 75 g glucose PO |
15090-4 | Porphyrins [Moles/time] in 24 hour Stool |
15091-2 | Pregnanediol [Moles/volume] in Urine |
15092-0 | Pregnanetriol [Moles/volume] in Urine |
15093-8 | Protoporphyrin Free [Moles/volume] in Blood |
15094-6 | Testosterone [Moles/volume] in Urine |
15095-3 | Testosterone [Moles/time] in 24 hour Urine |
15096-1 | Uroporphyrin [Moles/time] in 24 hour Urine |
15097-9 | Vanillylmandelate [Moles/volume] in Urine |
15098-7 | Amikacin [Moles/volume] in Serum or Plasma --random |
15099-5 | Amiodarone [Moles/volume] in Serum or Plasma |
151-1 | Cephalexin [Susceptibility] by Serum bactericidal titer |
1510-7 | Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
15100-1 | Barbiturates [Moles/volume] in Serum or Plasma |
15101-9 | Chloramphenicol [Moles/volume] in Serum or Plasma |
15102-7 | Codeine [Moles/volume] in Serum or Plasma |
15103-5 | Cyclosporine [Moles/volume] in Serum |
15104-3 | Digitoxin [Moles/volume] in Serum or Plasma |
15105-0 | Flecainide [Moles/volume] in Serum or Plasma |
15106-8 | Gentamicin [Moles/volume] in Serum or Plasma --random |
15107-6 | Imipramine [Moles/volume] in Serum or Plasma |
15108-4 | Methadone [Moles/volume] in Serum or Plasma |
15109-2 | Midazolam [Moles/volume] in Serum or Plasma |
1511-5 | Deprecated Glucose [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
15110-0 | Morphine [Moles/volume] in Serum or Plasma |
15111-8 | Tricyclic antidepressants [Moles/volume] in Serum or Plasma |
15112-6 | Leukocyte phosphatase [Units/volume] in Leukocytes |
15113-4 | Aluminum [Moles/volume] in Dialysis fluid |
15114-2 | Arsenic [Moles/volume] in Blood |
15115-9 | Arsenic [Moles/volume] in Urine |
15116-7 | Deprecated Arsenic [Molecules/volume] in Urine |
15117-5 | Cadmium [Moles/volume] in Blood |
15118-3 | Chromium [Moles/volume] in Blood |
15119-1 | Cobalt [Moles/volume] in Blood |
1512-3 | Glucose [Mass/volume] in Serum or Plasma --1 minute post 0.5 g/kg glucose IV |
15120-9 | Ethanol [Moles/volume] in Blood |
15121-7 | Lipoprotein.alpha/total Lipoprotein in Serum or Plasma |
15122-5 | Lipoprotein.beta/total Lipoprotein in Serum or Plasma |
15123-3 | Lipoprotein.pre-beta/total Lipoprotein in Serum or Plasma |
15124-1 | Albumin/Protein.total in Synovial fluid by Electrophoresis |
15125-8 | Alpha 1 globulin/Protein.total in Synovial fluid by Electrophoresis |
15126-6 | Alpha 2 globulin/Protein.total in Synovial fluid by Electrophoresis |
15127-4 | Beta globulin/Protein.total in Synovial fluid by Electrophoresis |
15128-2 | Gamma globulin/Protein.total in Synovial fluid by Electrophoresis |
15129-0 | Deprecated Fibrin D-dimer EIA |
1513-1 | Glucose [Mass/volume] in Serum or Plasma --20 minutes post 0.5 g/kg glucose IV |
15130-8 | Methionine+Tryptophan [Presence] in Serum or Plasma |
15131-6 | Isoleucine+Leucine [Presence] in Serum or Plasma |
15132-4 | Beta aminoisobutyrate+Proline [Presence] in Serum or Plasma |
15133-2 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Serum or Plasma |
15134-0 | Glutamate+Glutamine+Threonine [Presence] in Serum or Plasma |
15135-7 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Serum or Plasma |
15136-5 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Serum or Plasma |
15137-3 | Alanine+Ethanolamine [Presence] in Serum or Plasma |
15138-1 | Isoleucine+Leucine [Presence] in Urine |
15139-9 | Anserine+Carnosine+Cysteine+Histidine+Ornithine [Presence] in Urine |
1514-9 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
15140-7 | Arginine+Argininosuccinate+Lysine+Serine+Taurine [Presence] in Urine |
15141-5 | Beta aminoisobutyrate+Proline [Presence] in Urine |
15142-3 | Alanine+Ethanolamine [Presence] in Urine |
15143-1 | Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline [Presence] in Urine |
15144-9 | Glutamate+Glutamine+Threonine [Presence] in Urine |
15145-6 | Methionine+Tryptophan [Presence] in Urine |
15146-4 | Acetone [Units/volume] in Body fluid |
15147-2 | Deprecated Acetone [Units] in 24 hour Urine Qualitative |
15148-0 | Alkaline phosphatase [Enzymatic activity/volume] in Body fluid |
15149-8 | Ammonia [Moles/volume] in Body fluid |
1515-6 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 100 g glucose PO |
15150-6 | Anisocytosis [Presence] in Blood by Automated count |
15151-4 | Aspergillus fumigatus 3 Ab [Presence] in Serum by Immune diffusion (ID) |
15152-2 | Bilirubin.conjugated [Mass/volume] in Serum or Plasma |
15153-0 | Deprecated Indirect bilirubin [Mass/volume] in Serum or Plasma |
15154-8 | Blasts [Presence] in Blood by Automated count |
15155-5 | Calcium [Mass/volume] in Body fluid |
15156-3 | Cancer Ag 125 [Units/volume] in Body fluid by Dilution |
15157-1 | Cancer Ag 125 [Units/volume] in Serum or Plasma by Dilution |
15158-9 | Chloride [Moles/volume] in Stool |
15159-7 | Coagulation factor extrinsic pathway [Interpretation] in Platelet poor plasma Narrative |
1516-4 | Glucose [Mass/volume] in Urine --2 hours post 100 g glucose PO |
15160-5 | Coagulation factor Intrinsic Factor [Interpretation] in Platelet poor plasma Narrative |
15161-3 | Complement C1 esterase inhibitor.functional [Presence] in Serum or Plasma |
15162-1 | Complement C1q [Mass/volume] in Body fluid |
15163-9 | Complement C2 [Mass/volume] in Body fluid |
15164-7 | Complement C3 [Mass/volume] in Synovial fluid |
15165-4 | Complement C4 [Mass/volume] in Synovial fluid |
15166-2 | Complement C5 [Mass/volume] in Body fluid |
15167-0 | Complement C6 [Mass/volume] in Body fluid |
15168-8 | Complement total hemolytic C50 [Units/volume] in Body fluid by Immunoassay |
15169-6 | Complement total hemolytic C50 [Units/volume] in Serum or Plasma by Immunoassay |
1517-2 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
15170-4 | Complement total hemolytic C50 [Units/volume] in Synovial fluid by Immunoassay |
15171-2 | Cryoglobulin.IgA [Units/volume] in Serum |
15172-0 | Cryoglobulin.IgG [Units/volume] in Serum |
15173-8 | Cryoglobulin.IgM [Units/volume] in Serum |
15174-6 | Cryocrit of Serum by Spun Westergren |
15175-3 | Cryoproteins [Interpretation] in Serum or Plasma by Electrophoresis agarose gel |
15176-1 | Cryoproteins identified in Serum or Plasma |
15177-9 | DNA double strand Ab [Units/volume] in Body fluid |
15178-7 | Complement factor B [Mass/volume] in Body fluid |
15179-5 | Fibrin D-dimer [Presence] in Platelet poor plasma |
1518-0 | Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
15180-3 | Hypochromia [Presence] in Blood by Automated count |
15181-1 | IgA [Mass/volume] in Body fluid |
15182-9 | IgA [Presence] in Serum by Immunoelectrophoresis |
15183-7 | IgG [Mass/volume] in Body fluid |
15184-5 | IgG [Presence] in Serum by Immunoelectrophoresis |
15185-2 | IgM [Mass/volume] in Body fluid |
15186-0 | IgM [Presence] in Serum by Immunoelectrophoresis |
15187-8 | Immunoglobulin light chains.lambda [Mass/volume] in 24 hour Urine |
15188-6 | Immunoglobulin light chains.kappa [Mass/volume] in 24 hour Urine |
15189-4 | Immunoglobulin light chains.kappa/Immunoglobulin light chains.lambda [Mass Ratio] in Serum |
1519-8 | Deprecated Glucose [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
15190-2 | Leukocytes other [Identifier] in Blood by Automated count |
15191-0 | Lupus anticoagulant neutralization dilute phospholipid [Presence] in Platelet poor plasma |
15192-8 | Variant lymphocytes [Presence] in Blood by Automated count |
15193-6 | CD3-CD16+ cells [#/volume] in Blood |
15194-4 | CD3-CD16+ cells/100 cells in Blood |
15195-1 | CD3-CD19+ cells [#/volume] in Blood |
15196-9 | CD3-CD19+ cells/100 cells in Blood |
15197-7 | Lymphocytes clefted/100 leukocytes in Blood by Manual count |
15198-5 | Macrocytes [Presence] in Blood by Automated count |
15199-3 | Microcytes [Presence] in Blood by Automated count |
152-9 | Cephaloglycin [Susceptibility] by Minimum lethal concentration (MLC) |
1520-6 | Glucose [Mass/volume] in Urine --2 hours post 75 g glucose PO |
15200-9 | Osmolality of Body fluid |
15201-7 | Platelets Large Fragments [#/volume] in Blood by Manual count |
15202-5 | Potassium [Moles/volume] in Stool |
15203-3 | Rheumatoid factor [Units/volume] in Body fluid by Nephlometry |
15204-1 | Rheumatoid factor [Titer] in Serum by Nephlometry |
15205-8 | Rheumatoid factor [Units/volume] in Serum by Nephlometry |
15206-6 | Rheumatoid factor [Units/volume] in Synovial fluid by Nephlometry |
15207-4 | Sodium [Moles/volume] in Stool |
15208-2 | Taurine [Presence] in Nose |
15209-0 | Saccharomonospora viridis Ab [Presence] in Serum by Immune diffusion (ID) |
1521-4 | Glucose [Mass/volume] in Serum or Plasma --2 hours post meal |
15210-8 | Thyroglobulin Ab [Presence] in Serum |
15211-6 | Biopsy [Interpretation] in Thyroid Narrative |
15212-4 | Lipase [Enzymatic activity/volume] in Body fluid |
15213-2 | Epidermal Allergen Mix 2 (Cat dander+Dog dander+Guinea pig epithelium+Mouse+Rat) IgE Ab [Presence] in Serum by Multidisk |
15214-0 | Epidermal Allergen Mix 70 (Guinea pig epithelium+Hamster epithelium+Mouse+Rabbit epithelium+Rat) IgE Ab [Presence] in Serum by Multidisk |
15215-7 | Epidermal Allergen Mix 71 (Chicken feather+Duck feather+Goose feather+Turkey feather) IgE Ab [Presence] in Serum by Multidisk |
15216-5 | Epidermal Allergen Mix 72 (Budgerigar feather+Canary feather+Finch feather+Parakeet feather+Parrot feather) IgE Ab [Presence] in Serum by Multidisk |
15217-3 | Food Allergen Mix 1 (Peanut+Brazil nut+Coconut+Hazelnut+Almond) IgE Ab [Presence] in Serum by Multidisk |
15218-1 | Food Allergen Mix 2 (Cod+Blue Mussel+Shrimp+Salmon+Tuna) IgE Ab [Presence] in Serum by Multidisk |
15219-9 | Food Allergen Mix 3 (Oat+Buckwheat+Sesame seed+Wheat+Corn) IgE Ab [Presence] in Serum by Multidisk |
1522-2 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.5 g/kg glucose IV |
15220-7 | Food Allergen Mix A (Peanut+Cow milk+Egg white+Soybean+Wheat) IgE Ab [Presence] in Serum by Multidisk |
15221-5 | Food Allergen Mix F (Buckwheat+Soybean+Rice+Sesame seed+Wheat) IgE Ab [Presence] in Serum by Multidisk |
15222-3 | Food Allergen Mix E (Crab+Buckwheat+Shrimp+Sesame seed+Corn) IgE Ab [Presence] in Serum by Multidisk |
15223-1 | Food Allergen Mix B (Tarragon+Lovage+Marjoram) IgE Ab [Presence] in Serum by Multidisk |
15224-9 | Food Allergen Mix 71 (Caraway+Cardamon+Mace+Clove) IgE Ab [Presence] in Serum by Multidisk |
15225-6 | Food Allergen Mix 72 (Fennel seed+Basil+Anise+Ginger) IgE Ab [Presence] in Serum by Multidisk |
15226-4 | Food Allergen Mix G (Beef+Chicken meat+Pork+Plaice) IgE Ab [Presence] in Serum by Multidisk |
15227-2 | Food Allergen Mix 74 (Herring+Cod+Plaice+Mackerel) IgE Ab [Presence] in Serum by Multidisk |
15228-0 | Grass Allergen Mix 4 (Sweet vernal grass+Velvet grass+Perennial rye grass+Common reed+Rye) IgE Ab [Presence] in Serum by Multidisk |
15229-8 | Grass Allergen Mix 3 (Sweet vernal grass+Perennial rye grass+Timothy+Rye+Velvet grass) IgE Ab [Presence] in Serum by Multidisk |
1523-0 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.05-0.15 U insulin/kg IV post 12H CFst |
15230-6 | Grass Allergen Mix C (Brome+Bermuda grass+Velvet grass+Bahia grass+Timothy+Johnson grass) IgE Ab [Presence] in Serum by Multidisk |
15231-4 | Dust Allergen Mix A (Cockroach+American house dust mite+European house dust mite+House dust Greer) IgE Ab [Presence] in Serum by Multidisk |
15232-2 | Regional Allergen Mix A (Common ragweed+Mugwort+Japenese cedar+Orchard grass+Timothy) IgE Ab [Presence] in Serum by Multidisk |
15233-0 | Mold Allergen Mix A (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
15234-8 | Mold Allergen Mix 2 (Alternaria alternata+Aspergillus fumigatus+Candida albicans+Cladosporium herbarum+Setomelanomma rostrata+Penicillium notatum) IgE Ab [Presence] in Serum by Multidisk |
15235-5 | Occupational Allergen Mix 1 (Chicken feather+Cow dander+Goose feather+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
15236-3 | Occupational Allergen Mix 2 (Acarus siro+Lepidoglyphus destructor+Horse bot fly+Grain weevel) IgE Ab [Presence] in Serum by Multidisk |
15237-1 | Occupational Allergen Mix 3 (Alternaria alternata+Aspergillus fumigatus+rye pollen+wheat pollen) IgE Ab [Presence] in Serum by Multidisk |
15238-9 | Occupational Allergen Mix 4 (Amylase+Soybean+Grain weevel+Wheat) IgE Ab [Presence] in Serum by Multidisk |
15239-7 | Occupational Allergen Mix 5 (Isocyanate HDI+MDI+TDI+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
1524-8 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 0.1 U/kg insulin |
15240-5 | Occupational Allergen Mix 6 (Chloramin T+Ethylene oxide+Formaldehyde+Phthalic anhydride) IgE Ab [Presence] in Serum by Multidisk |
15241-3 | Food Allergen Mix 10 (Beef+Chicken meat+Egg yolk+Pork+Turkey meat) IgE Ab [Presence] in Serum by Multidisk |
15242-1 | Food Allergen Mix 11 (Broccoli+Carrot+White bean+Peas+Corn) IgE Ab [Presence] in Serum by Multidisk |
15243-9 | Food Allergen Mix 12 (Mushroom+Pumpkin+Rice+Rye+Potato) IgE Ab [Presence] in Serum by Multidisk |
15244-7 | Food Allergen Mix 13 (Carrot+White bean+Peas+Potato) IgE Ab [Presence] in Serum by Multidisk |
15245-4 | Food Allergen Mix 14 (Cabbage+Paprika+Tomato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
15246-2 | Food Allergen Mix 15 (Orange+Apple+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
15247-0 | Food Allergen Mix H (Pineapple+Lemon+Strawberry+Avocado) IgE Ab [Presence] in Serum by Multidisk |
15248-8 | Food Allergen Mix 18 (Peanut+Soybean+Peas) IgE Ab [Presence] in Serum by Multidisk |
15249-6 | Food Allergen Mix 19 (Cucumber+Carrot+Potato+Spinach) IgE Ab [Presence] in Serum by Multidisk |
1525-5 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 100 g glucose PO |
15250-4 | Food Allergen Mix 20 (Barley+Rice+Rye+Wheat) IgE Ab [Presence] in Serum by Multidisk |
15251-2 | Food Allergen Mix 21 (Kiwi+Pineapple+Melon+Banana+Peach) IgE Ab [Presence] in Serum by Multidisk |
15252-0 | Food Allergen Mix 22 (Cashew+Pecan or Hickory nut+Walnut+Pistachio) IgE Ab [Presence] in Serum by Multidisk |
15253-8 | Food Allergen Mix 7 (Onion+Garlic+Celery+Tomato+Yeast) IgE Ab [Presence] in Serum by Multidisk |
15254-6 | Food Allergen Mix 8 (Brazil nut+Orange+Hazelnut+Apple+Cocoa) IgE Ab [Presence] in Serum by Multidisk |
15255-3 | Food Allergen Mix 9 (Kiwi+Melon+Banana+Almond+Grape) IgE Ab [Presence] in Serum by Multidisk |
15256-1 | Regional Allergen Mix 1 (Mugwort+Silver birch+Pellitory+Timothy+English plantain) IgE Ab [Presence] in Serum by Multidisk |
15257-9 | Regional Allergen Mix 2 (Alternaria alternata+Cat dander+American house dust mite+Dog dander+Horse dander) IgE Ab [Presence] in Serum by Multidisk |
15258-7 | Regional Allergen Mix B (Common ragweed+Goosefoot or Lambs quarters+Bermuda grass+Perennial rye grass+Bahia grass) IgE Ab [Presence] in Serum by Multidisk |
15259-5 | Regional Allergen Mix 4 (Bermuda grass+Perennial rye grass+Brome+Common ragweed+Mugwort+English plantain) IgE Ab [Presence] in Serum by Multidisk |
1526-3 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
15260-3 | Tree Allergen Mix 10 (Grey alder+Silver birch+Hazelnut+White ash) IgE Ab [Presence] in Serum by Multidisk |
15261-1 | Weed Allergen Mix 209 (Common ragweed+Western ragweed+Giant ragweed) IgE Ab [Presence] in Serum by Multidisk |
15262-9 | Tree Allergen Mix 1 (Boxelder+Silver birch+White oak+White elm+California walnut) IgE Ab [Presence] in Serum by Multidisk |
15263-7 | Tree Allergen Mix D (Cottonwood+Elm+Maple+Oak+Pecan tree) IgE Ab [Presence] in Serum by Multidisk |
15264-5 | Tree Allergen Mix 3 (Mountain juniper+White oak+White elm+Cottonwood+Mesquite) IgE Ab [Presence] in Serum by Multidisk |
15265-2 | Tree Allergen Mix E (American sycamore+Cottonwood+White oak+Willow+White elm) IgE Ab [Presence] in Serum by Multidisk |
15266-0 | Tree Allergen Mix 5 (Grey alder+Hazelnut+White elm+Willow+Cottonwood) IgE Ab [Presence] in Serum by Multidisk |
15267-8 | Tree Allergen Mix 6 (Boxelder+Silver birch+American beech+White oak+California walnut) IgE Ab [Presence] in Serum by Multidisk |
15268-6 | Tree Allergen Mix 7 (Olive+Willow+Eastern white pine+Eucalyptus spp+Wattle+Cajeput) IgE Ab [Presence] in Serum by Multidisk |
15269-4 | Tree Allergen Mix 9 (Grey alder+Silver birch+Hazelnut+White oak+Willow) IgE Ab [Presence] in Serum by Multidisk |
1527-1 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post 75 g glucose PO |
15270-2 | Tree Allergen Mix 8 (Boxelder+Silver birch+Hazelnut+White oak+London plane or Maple leaf sycamore) IgE Ab [Presence] in Serum by Multidisk |
15271-0 | Weed Allergen Mix 1 (Common ragweed+Mugwort+Goosefoot or Lambs quarters+English plantain+Saltwort) IgE Ab [Presence] in Serum by Multidisk |
15272-8 | Weed Allergen Mix 2 (Western ragweed+Mugwort+Lenscale+Goosefoot or Lambs quarters+English plantain) IgE Ab [Presence] in Serum by Multidisk |
15273-6 | Weed Allergen Mix 3 (Mugwort+Goosefoot or Lambs quarters+English plantain+Goldenrod+Nettle) IgE Ab [Presence] in Serum by Multidisk |
15274-4 | Weed Allergen Mix 5 (Common ragweed+Mugwort+Ox-eye daisy+Dandelion+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
15275-1 | Weed Allergen Mix 6 (English plantain+Goosefoot or Lambs quarters+Saltwort+Sheep sorrel) IgE Ab [Presence] in Serum by Multidisk |
15276-9 | Weed Allergen Mix 7 (Ox-eye daisy+Dandelion+English plantain+Goosefoot or Lambs quarters+Goldenrod) IgE Ab [Presence] in Serum by Multidisk |
15277-7 | Deprecated Turkey feather IgE Ab [Units/volume] in Serum |
15278-5 | Lovage IgE Ab [Units/volume] in Serum |
15279-3 | Cardamon IgE Ab [Units/volume] in Serum |
1528-9 | Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
15280-1 | Mace IgE Ab [Units/volume] in Serum |
15281-9 | Horse Bot Fly IgE Ab [Units/volume] in Serum |
15282-7 | Deprecated Cultivated Rye IgE Ab [Units/volume] in Serum |
15283-5 | Silver Birch IgE Ab [Units/volume] in Serum |
15284-3 | Grey Alder IgE Ab [Units/volume] in Serum |
15285-0 | London Plane IgE Ab [Units/volume] in Serum |
15286-8 | Kidney - left Height by US |
15287-6 | Kidney - left Width by US |
15288-4 | Kidney - left Length by US |
15289-2 | Kidney - right Height by US |
1529-7 | Deprecated Glucose [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
15290-0 | Kidney - right Width by US |
15291-8 | Kidney - right Length by US |
15292-6 | Testis - left Height by US |
15293-4 | Testis - left Width by US |
15294-2 | Testis - left Length by US |
15295-9 | Testis - right Height by US |
15296-7 | Testis - right Width by US |
15297-5 | Testis - right Length by US |
15298-3 | Urinary bladder Height by US |
15299-1 | Urinary bladder Width by US |
153-7 | Cephaloglycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1530-5 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
15300-7 | Urinary bladder Length by US |
15301-5 | Prostate Height by US |
15302-3 | Prostate Width by US |
15303-1 | Prostate Length by US |
15304-9 | Kidney - left Volume by derived from height, width and length (US) |
15305-6 | Kidney - right Volume by derived from height, width and length (US) |
15306-4 | Testis - left Volume by derived from height, width and length (US) |
15307-2 | Testis - right Volume by derived from height, width and length (US) |
15308-0 | Prostate Volume by derived from height, width and length (US) |
15309-8 | Urinary bladder Volume by derived from height, width and length (US) |
1531-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --3 hours post 100 g glucose PO |
15310-6 | Kidney - left Volume by derived.from ROT (US) |
15311-4 | Kidney - right Volume by derived.from ROT (US) |
15312-2 | Testis - left Volume by derived.from ROT (US) |
15313-0 | Testis - right Volume by derived.from ROT (US) |
15314-8 | Prostate Volume by derived.from ROT (US) |
15315-5 | Prostate Volume by derived by planimetry (US) |
15316-3 | Volume planimetry Stepsize by - Reported |
15317-1 | Kidney - left Volume by derived by automated ultrasound testing (US) |
15318-9 | Kidney - right Volume by derived by automated ultrasound testing (US) |
15319-7 | Testis - left Volume by derived by automated ultrasound testing (US) |
1532-1 | Glucose [Mass/volume] in Urine --3 hours post 100 g glucose PO |
15320-5 | Testis - right Volume by derived by automated ultrasound testing (US) |
15321-3 | Urinary bladder Volume by derived by EMP (US) |
15323-9 | Prostate specific Ag/Prostate volume calculated from height, width and length |
15324-7 | Prostate specific Ag/Prostate volume calculated from planimetry |
15325-4 | Prostate specific Ag/Prostate volume calculated |
15326-2 | Prostate Adenoma Volume by derived from height, width and length (US) |
15327-0 | Prostate Adenoma Volume by derived by planimetry (US) |
15328-8 | Penile cavernosal artery Peak systolic flow-baseline- by US.doppler |
15329-6 | Penile cavernosal artery Peak systolic flow-post XXX challenge- by US.doppler |
1533-9 | Glucose [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
15330-4 | Penile cavernosal artery End diastolic blood flow-baseline- by US.doppler |
15331-2 | Penile cavernosal artery End diastolic blood flow-post XXX challenge- by US.doppler |
15332-0 | Penile cavernosal artery Resistance index-baseline- by US.calculated |
15333-8 | Penile cavernosal artery Resistance index-post XXX challenge- by US.calculated |
15334-6 | Challenge |
15335-3 | Penile cavernosal artery Pulsativity index by US.calculated |
15336-1 | Other Antibiotic [Susceptibility] by Serum bactericidal titer |
15337-9 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --peak |
15338-7 | Other Antibiotic [Susceptibility] by Serum bactericidal titer --trough |
15339-5 | Berlin Beetle IgE Ab [Units/volume] in Serum |
1534-7 | Glucose [Mass/volume] in Serum or Plasma --3 minutes post 0.5 g/kg glucose IV |
15340-3 | Italian Cedar IgE Ab [Units/volume] in Serum |
15341-1 | Black Fly IgE Ab [Units/volume] in Serum |
15342-9 | European Hornet IgE Ab [Units/volume] in Serum |
15343-7 | Blood group antibody screen [Titer] in Serum or Plasma |
15344-5 | little i Ab [Titer] in Serum or Plasma |
15345-2 | Aldosterone [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
15346-0 | Aldosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
15347-8 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
15348-6 | Alkaline phosphatase.liver 1/Alkaline phosphatase.total in Serum or Plasma |
15349-4 | Alkaline phosphatase.liver 2/Alkaline phosphatase.total in Serum or Plasma |
1535-4 | Glucose [Mass/volume] in Serum or Plasma --40 minutes post 0.5 g/kg glucose IV |
15350-2 | Amylase [Enzymatic activity/time] in 2 hour Urine |
15351-0 | Apolipoprotein E2 [Presence] in Blood |
15352-8 | Apolipoprotein E3 [Presence] in Blood |
15353-6 | Apolipoprotein E4 [Presence] in Blood |
15354-4 | Bombesin Ag [Presence] in Tissue by Immune stain |
15355-1 | Estrone sulfate [Mass/volume] in Serum or Plasma |
15356-9 | Globulin [Mass/time] in 24 hour Urine |
15357-7 | Iron [Mass/mass] in Tissue |
15358-5 | Macroamylase [Presence] in Serum or Plasma |
15359-3 | dRVVT actual/normal (normalized LA screen) |
1536-2 | Glucose [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
15360-1 | dRVVT actual/normal [Presence] in Platelet poor plasma by Coagulation assay |
15361-9 | aPTT.factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:4 addition of normal plasma |
15362-7 | aPTT.inhibitor sensitive in Platelet poor plasma by Coagulation assay |
15363-5 | Busulfan [Mass/volume] in Serum or Plasma |
15364-3 | Codeine [Mass/volume] in Meconium |
15365-0 | Deprecated Codeine |
15366-8 | Dextroamphetamine [Mass/volume] in Urine |
15367-6 | Ganciclovir [Mass/volume] in Serum or Plasma |
15368-4 | Hypoglycemics.sulfonyluric [Identifier] in Serum or Plasma |
15369-2 | Lithium.saliva/Lithium.serum |
1537-0 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 100 g glucose PO |
15370-0 | Morphine [Mass/volume] in Meconium |
15371-8 | Deprecated Morphine |
15372-6 | Nordiazepam [Mass/volume] in Urine |
15373-4 | Phenyltoloxamine [Mass/volume] in Blood |
15374-2 | Sulfonylurea [Presence] in Serum or Plasma |
15375-9 | Valproate Free [Mass/volume] in Saliva (oral fluid) |
15376-7 | Spermatozoa Abnormal/100 spermatozoa in Semen |
15377-5 | Cytomegalovirus Ab [Presence] in Serum by Latex agglutination |
15378-3 | Fungus identified in Isolate by Culture |
15379-1 | Haemophilus influenzae B Ag [Presence] in Urine |
1538-8 | Glucose [Mass/volume] in Urine --4 hours post 100 g glucose PO |
15380-9 | Leishmania brasilensis IgG Ab [Titer] in Serum |
15381-7 | Leishmania brasilensis IgM Ab [Titer] in Serum |
15382-5 | Leishmania donovani IgG Ab [Titer] in Serum |
15383-3 | Leishmania donovani IgM Ab [Titer] in Serum |
15384-1 | Leishmania mexicana IgG Ab [Titer] in Serum |
15385-8 | Leishmania mexicana IgM Ab [Titer] in Serum |
15386-6 | Leishmania tropica IgG Ab [Titer] in Serum |
15387-4 | Leishmania tropica IgM Ab [Titer] in Serum |
15388-2 | Mycoplasma hominis [Presence] in Unspecified specimen by Organism specific culture |
15389-0 | Parainfluenza virus 1 IgG Ab [Presence] in Serum |
1539-6 | Glucose [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
15390-8 | Parainfluenza virus 1 IgM Ab [Presence] in Serum |
15391-6 | Parainfluenza virus 1 IgM Ab [Titer] in Serum |
15392-4 | Parainfluenza virus 2 IgG Ab [Presence] in Serum |
15393-2 | Parainfluenza virus 2 IgM Ab [Titer] in Serum |
15394-0 | Parainfluenza virus 3 IgG Ab [Presence] in Serum |
15395-7 | Parainfluenza virus 3 IgM Ab [Presence] in Serum |
15396-5 | Deprecated Toxoplasma gondii IgG Ab [Units/volume] in Serum |
15397-3 | Trypanosoma cruzi IgM Ab [Titer] in Serum |
15398-1 | Neuronal nuclear Ab [Titer] in Serum |
15399-9 | Neuronal nuclear IgG Ab [Units/volume] in Serum by Immunofluorescence |
154-5 | Cephaloglycin [Susceptibility] by Disk diffusion (KB) |
1540-4 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 100 g glucose PO |
15400-5 | Platelet IgG Ab [Presence] in Serum |
15401-3 | Drugs identified in Blood by Screen method |
15402-1 | Ethanol [Presence] in Meconium |
15403-9 | Isopropanol [Presence] in Meconium |
15404-7 | Levomethamphetamine/Amphetamines.total in Urine |
15405-4 | Methamphetamine [Mass/volume] in Meconium |
15406-2 | Deprecated Methamphetamine |
15407-0 | Methanol [Presence] in Meconium |
15408-8 | Thallium [Mass/mass] in Hair |
15409-6 | Thallium [Mass/mass] in Nail |
1541-2 | Glucose [Mass/volume] in Urine --5 hours post 100 g glucose PO |
15410-4 | Varicella zoster virus IgG Ab [Presence] in Serum by Immunoassay |
15411-2 | Ergosterol [Mass/volume] in Serum or Plasma |
15412-0 | Service comment 21 |
15413-8 | Service comment 22 |
15414-6 | Service comment 23 |
15415-3 | Service comment 24 |
15416-1 | Service comment 25 |
15417-9 | Service comment 26 |
15418-7 | Service comment 27 |
15419-5 | Service comment 28 |
1542-0 | Glucose [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
15420-3 | Service comment 29 |
15421-1 | Service comment 30 |
15422-9 | Service comment 31 |
15423-7 | Service comment 32 |
15424-5 | Service comment 33 |
15425-2 | Service comment 34 |
15426-0 | Service comment 35 |
15427-8 | Service comment 36 |
15428-6 | Service comment 37 |
15429-4 | Service comment 38 |
1543-8 | Glucose [Mass/volume] in Serum or Plasma --5 minutes post 0.5 g/kg glucose IV |
15430-2 | Service comment 39 |
15431-0 | Service comment 40 |
15432-8 | Testosterone Free/Testosterone.total in Serum or Plasma |
15433-6 | Anaplasma marginale Ab [Presence] in Serum by Agglutination |
15434-4 | Avian adenovirus Ab [Presence] in Serum by Immune diffusion (ID) |
15435-1 | Avian adenovirus 2 Ab [Presence] in Serum by Immune diffusion (ID) |
15436-9 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immunoassay |
15437-7 | Avian encephalomyelitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
15438-5 | Avian hemorrhagic enteritis virus Ab [Presence] in Serum by Immunoassay |
15439-3 | Infectious bronchitis virus Ark-99 Ab [Titer] in Serum by Hemagglutination inhibition |
1544-6 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
15440-1 | Infectious bronchitis virus Mass-41 Ab [Titer] in Serum by Hemagglutination inhibition |
15441-9 | Infectious bronchitis virus Conn-42 Ab [Titer] in Serum by Hemagglutination inhibition |
15442-7 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immunoassay |
15443-5 | Avian infectious laryngotracheitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
15444-3 | Influenza virus A Ab [Presence] in Serum by Immune diffusion (ID) |
15445-0 | Avian leukosis virus Ag [Titer] in Serum by Immunoassay |
15446-8 | Avian leukosis virus Ag [Titer] in Egg yolk by Immunoassay |
15447-6 | Avian paramyxovirus 1 Ab [Presence] in Serum by Immunoassay |
15448-4 | Avian paramyxovirus 1 Ab [Titer] in Serum by Hemagglutination inhibition |
15449-2 | Avian paramyxovirus 2 Ab [Titer] in Serum by Hemagglutination inhibition |
1545-3 | Deprecated Glucose [Mass/volume] in Serum or Plasma --6 hours post 100 g glucose PO |
15450-0 | Avian paramyxovirus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
15451-8 | Avian pox virus Ab [Presence] in Serum by Immune diffusion (ID) |
15452-6 | Avian reovirus Ab [Presence] in Serum by Immune diffusion (ID) |
15453-4 | Avian reovirus Ab [Presence] in Serum by Immunoassay |
15454-2 | Reticuloendotheliosis virus Ab [Presence] in Serum by Immunoassay |
15455-9 | Bluetongue virus Ab [Presence] in Serum by Immune diffusion (ID) |
15456-7 | Bluetongue virus Ab [Presence] in Serum by Immunoassay |
15457-5 | Bordetella avium Ab [Titer] in Serum by Agglutination |
15458-3 | Bordetella avium Ab [Presence] in Serum by Immunoassay |
15459-1 | Bovine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
1546-1 | Glucose [Mass/volume] in Urine --6 hours post 100 g glucose PO |
15460-9 | Bovine leukemia virus Ab [Presence] in Serum by Immunoassay |
15461-7 | Bovine leukemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
15462-5 | Bovine diarrhea virus 1 Ab [Titer] in Serum by Neutralization test |
15463-3 | Bovine diarrhea virus 2 Ab [Titer] in Serum by Neutralization test |
15464-1 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immunoassay |
15465-8 | Caprine arthritis encephalitis virus Ab [Presence] in Serum by Immune diffusion (ID) |
15466-6 | Epizootic hemorrhagic disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
15467-4 | Equine herpesvirus 1 Ab [Titer] in Serum by Neutralization test |
15468-2 | Equine infectious anemia virus Ab [Presence] in Serum by Immune diffusion (ID) |
15469-0 | Equine influenza virus A1 Ab [Titer] in Serum by Hemagglutination inhibition |
1547-9 | Glucose [Mass/volume] in Serum or Plasma --baseline |
15470-8 | Equine influenza virus A2 Ab [Presence] in Serum |
15471-6 | Equine influenza virus A2 Ab [Titer] in Serum by Hemagglutination inhibition |
15472-4 | Equine influenza virus Ag [Presence] in Nose by Immunoassay |
15473-2 | Equine arteritis virus Ab [Titer] in Serum by Neutralization test |
15474-0 | Infectious bursal disease virus Ab [Presence] in Serum by Immune diffusion (ID) |
15475-7 | Infectious bursal disease virus Ab [Presence] in Serum by Immunoassay |
15476-5 | Leptospira interrogans sv Bratislava Ab [Titer] in Serum by Agglutination |
15477-3 | Leptospira interrogans sv Canicola Ab [Titer] in Serum by Agglutination |
15478-1 | Leptospira interrogans sv Grippotyphosa Ab [Titer] in Serum by Agglutination |
15479-9 | Leptospira interrogans sv Hardjo Ab [Titer] in Serum by Agglutination |
1548-7 | Glucose [Mass/volume] in Serum or Plasma --pre 0.5 g/kg glucose IV |
15480-7 | Leptospira interrogans sv Icterohaemorrhagiae Ab [Titer] in Serum by Agglutination |
15481-5 | Leptospira interrogans sv Pomona Ab [Titer] in Serum by Agglutination |
15482-3 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immune diffusion (ID) |
15483-1 | Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum by Immunoassay |
15484-9 | Mycoplasma gallisepticum Ab [Presence] in Serum by Agglutination |
15485-6 | Mycoplasma gallisepticum Ab [Presence] in Serum by Immunoassay |
15486-4 | Mycoplasma gallisepticum rRNA [Presence] in Nose or Trachea by DNA probe |
15487-2 | Mycoplasma meleagridis Ab [Presence] in Serum by Immunoassay |
15488-0 | Mycoplasma meleagridis Ab [Presence] in Serum by Agglutination |
15489-8 | Mycoplasma synoviae Ab [Presence] in Serum by Immunoassay |
1549-5 | Glucose [Mass/volume] in Serum or Plasma --pre 100 g glucose PO |
15490-6 | Mycoplasma synoviae Ab [Presence] in Serum by Agglutination |
15491-4 | Mycoplasma synoviae rRNA [Presence] in Serum by DNA probe |
15492-2 | Neospora caninum Ab [Presence] in Serum by Immunoassay |
15493-0 | Parainfluenza virus 3 Ab [Titer] in Serum by Hemagglutination inhibition |
15494-8 | Pasteurella multocida Ab [Presence] in Serum by Immunoassay |
15495-5 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunoassay |
15496-3 | Porcine reproductive and respiratory syndrome virus Ab [Presence] in Serum by Immunofluorescence |
15497-1 | Pseudorabies virus Ab [Presence] in Serum by Immunoassay |
15498-9 | Pseudorabies virus Ab [Presence] in Serum by Latex agglutination |
15499-7 | Pseudorabies virus Ab [Titer] in Serum by Neutralization test |
155-2 | Cephaloglycin [Susceptibility] by Serum bactericidal titer |
1550-3 | Glucose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
15500-2 | Pseudorabies virus Clinease gene deletion Ab [Presence] in Serum by Immunoassay |
15501-0 | Pseudorabies virus Herdcheck gene deletion Ab [Presence] in Serum by Immunoassay |
15502-8 | Pseudorabies virus Omnimark gene deletion Ab [Presence] in Serum by Immunoassay |
15503-6 | Pseudorabies virus Tolvid gene deletion Ab [Presence] in Serum by Immunoassay |
15504-4 | Salmonella arizonae Ab [Presence] in Serum by Agglutination |
15505-1 | Salmonella pullorum Ab [Presence] in Serum by Agglutination |
15506-9 | Salmonella typhimurium Ab [Presence] in Serum by Agglutination |
15507-7 | Provider-unspecified ED Progress note |
15508-5 | Labor and delivery records |
15509-3 | Ambulance transport, Rationale for scheduled transport |
1551-1 | Glucose [Mass/volume] in Serum or Plasma --pre 50 g lactose PO |
15510-1 | Ambulance transport, Distance transported Length |
15511-9 | Ambulance transport, Origination site information Set |
15512-7 | Ambulance transport, Destination site information Set |
15513-5 | Ambulance transport, Reason for scheduled trip Set |
15514-3 | Ambulance transport, Ordering practitioner identifier type |
15515-0 | Ambulance transport, Medical reason for transport |
15516-8 | Ambulance transport, Justification for extra attendants |
15517-6 | Ambulance transport, Transport direction |
15518-4 | Abalone IgE Ab RAST class [Presence] in Serum |
15519-2 | Wattle IgE Ab RAST class [Presence] in Serum |
1552-9 | Glucose [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
15520-0 | Corticotropin IgE Ab RAST class [Presence] in Serum |
15521-8 | White Alder IgE Ab RAST class [Presence] in Serum |
15522-6 | Deprecated Alder Ab.IgE.RAST class |
15523-4 | Smooth Alder IgE Ab RAST class [Presence] in Serum |
15524-2 | Alfalfa IgE Ab RAST class [Presence] in Serum |
15525-9 | Alkalase IgE Ab RAST class [Presence] in Serum |
15526-7 | Allspice IgE Ab RAST class [Presence] in Serum |
15527-5 | Almond IgE Ab RAST class [Presence] in Serum |
15528-3 | Almond Tree IgE Ab RAST class [Presence] in Serum |
15529-1 | Lactalbumin alpha IgE Ab RAST class [Presence] in Serum |
1553-7 | Glucose [Mass/volume] in Serum or Plasma --pre dose insulin IV |
15530-9 | Alternaria alternata IgE Ab RAST class [Presence] in Serum |
15531-7 | Deprecated Alternaria alternata IgE Ab RAST class in Serum |
15532-5 | Amoxicillin IgE Ab RAST class [Presence] in Serum |
15533-3 | Ampicillin IgE Ab RAST class [Presence] in Serum |
15534-1 | Anchovy IgE Ab RAST class [Presence] in Serum |
15535-8 | Anisakis IgE Ab RAST class [Presence] in Serum |
15536-6 | Anise IgE Ab RAST class [Presence] in Serum |
15537-4 | Red Imported Fire Ant IgE Ab RAST class [Presence] in Serum |
15538-2 | Deprecated Red Imported Fire Ant IgE Ab RAST class in Serum |
15539-0 | Apple IgE Ab RAST class [Presence] in Serum |
1554-5 | Glucose [Mass/volume] in Serum or Plasma --12 hours fasting |
15540-8 | Apple Tree IgE Ab RAST class [Presence] in Serum |
15541-6 | Apricot IgE Ab RAST class [Presence] in Serum |
15542-4 | Arrowroot IgE Ab RAST class [Presence] in Serum |
15543-2 | Artichoke IgE Ab RAST class [Presence] in Serum |
15544-0 | Ascaris sp IgE Ab RAST class [Presence] in Serum |
15545-7 | Arizona Ash IgE Ab RAST class [Presence] in Serum |
15546-5 | White Ash IgE Ab RAST class [Presence] in Serum |
15547-3 | Asparagus IgE Ab RAST class [Presence] in Serum |
15548-1 | Aspen IgE Ab RAST class [Presence] in Serum |
15549-9 | Aspergillus fumigatus IgE Ab RAST class [Presence] in Serum |
1555-2 | Glucose [Mass/volume] in Urine --12 hours fasting |
15550-7 | Aspergillus niger IgE Ab RAST class [Presence] in Serum |
15551-5 | Avocado IgE Ab RAST class [Presence] in Serum |
15552-3 | Groundsel Tree IgE Ab RAST class [Presence] in Serum |
15553-1 | Bamboo shoot IgE Ab RAST class [Presence] in Serum |
15554-9 | Banana IgE Ab RAST class [Presence] in Serum |
15555-6 | Barley IgE Ab RAST class [Presence] in Serum |
15556-4 | Barley Pollen IgE Ab RAST class [Presence] in Serum |
15557-2 | Basil IgE Ab RAST class [Presence] in Serum |
15558-0 | Bass, Black IgE Ab RAST class [Presence] in Serum |
15559-8 | Fivehook Bassia IgE Ab RAST class [Presence] in Serum |
1556-0 | Fasting glucose [Mass/volume] in Capillary blood |
15560-6 | Bayberry IgE Ab RAST class [Presence] in Serum |
15561-4 | Bayleaf IgE Ab RAST class [Presence] in Serum |
15562-2 | Castor Bean IgE Ab RAST class [Presence] in Serum |
15563-0 | Green Coffee Bean IgE Ab RAST class [Presence] in Serum |
15564-8 | Green Bean IgE Ab RAST class [Presence] in Serum |
15565-5 | Red Kidney Bean IgE Ab RAST class [Presence] in Serum |
15566-3 | Lima Bean IgE Ab RAST class [Presence] in Serum |
15567-1 | Pinto Bean IgE Ab RAST class [Presence] in Serum |
15568-9 | Soybean IgE Ab RAST class [Presence] in Serum |
15569-7 | White Bean IgE Ab RAST class [Presence] in Serum |
1557-8 | Fasting glucose [Mass/volume] in Venous blood |
15570-5 | Honey bee IgE Ab RAST class [Presence] in Serum |
15571-3 | American Beech IgE Ab RAST class [Presence] in Serum |
15572-1 | Beef IgE Ab RAST class [Presence] in Serum |
15573-9 | Beet IgE Ab RAST class [Presence] in Serum |
15574-7 | Sugar Beet Seed (Beta vulgaris seed) IgE Ab RAST class [Presence] in Serum |
15575-4 | Berlin Beetle IgE Ab RAST class [Presence] in Serum |
15576-2 | Lactalbumin beta IgE Ab RAST class [Presence] in Serum |
15577-0 | Beta lactoglobulin IgE Ab RAST class [Presence] in Serum |
15578-8 | Deprecated Birch Ab.IgE.RAST class |
15579-6 | Silver Birch IgE Ab RAST class [Presence] in Serum |
1558-6 | Fasting glucose [Mass/volume] in Serum or Plasma |
15580-4 | Blackberry IgE Ab RAST class [Presence] in Serum |
15581-2 | Blomia tropicalis IgE Ab RAST class [Presence] in Serum |
15582-0 | Bloodworm IgE Ab RAST class [Presence] in Serum |
15583-8 | Blueberry IgE Ab RAST class [Presence] in Serum |
15584-6 | Botrytis cinerea IgE Ab RAST class [Presence] in Serum |
15585-3 | Boxelder IgE Ab RAST class [Presence] in Serum |
15586-1 | Brazil Nut IgE Ab RAST class [Presence] in Serum |
15587-9 | Broccoli IgE Ab RAST class [Presence] in Serum |
15588-7 | Bromelin IgE Ab RAST class [Presence] in Serum |
15589-5 | Brussel Sprouts IgE Ab RAST class [Presence] in Serum |
1559-4 | Insulin [Mass/volume] in Serum or Plasma --1.5 hours post dose tolbutamide IV |
15590-3 | Bovine serum albumin (BSA) IgE Ab RAST class [Presence] in Serum |
15591-1 | Buckwheat IgE Ab RAST class [Presence] in Serum |
15592-9 | Budgerigar feather IgE Ab RAST class [Presence] in Serum |
15593-7 | Bumble Bee IgE Ab RAST class [Presence] in Serum |
15594-5 | Burrobrush IgE Ab RAST class [Presence] in Serum |
15595-2 | Burweed marshelder IgE Ab RAST class [Presence] in Serum |
15596-0 | Cabbage IgE Ab RAST class [Presence] in Serum |
15597-8 | Cocoa IgE Ab RAST class [Presence] in Serum |
15598-6 | Canary feather IgE Ab RAST class [Presence] in Serum |
15599-4 | Candida albicans IgE Ab RAST class [Presence] in Serum |
156-0 | Cephaloridine [Susceptibility] by Minimum lethal concentration (MLC) |
1560-2 | Insulin [Mass/volume] in Serum or Plasma --1 hour post dose tolbutamide IV |
15600-0 | Deprecated Melon IgE Ab RAST class in Serum |
15601-8 | Starfruit IgE Ab RAST class [Presence] in Serum |
15602-6 | Caraway IgE Ab RAST class [Presence] in Serum |
15603-4 | Careless Weed IgE Ab RAST class [Presence] in Serum |
15604-2 | Carob IgE Ab RAST class [Presence] in Serum |
15605-9 | Carrot IgE Ab RAST class [Presence] in Serum |
15606-7 | Casein IgE Ab RAST class [Presence] in Serum |
15607-5 | Cashew Nut IgE Ab RAST class [Presence] in Serum |
15608-3 | Deprecated Cat IgE Ab RAST class in Serum |
15609-1 | Cat dander IgE Ab RAST class [Presence] in Serum |
1561-0 | Insulin [Mass/volume] in Serum or Plasma --1 hour post 75 g glucose PO |
15610-9 | Deprecated Cat epithelium IgE Ab RAST class in Serum |
15611-7 | Catfish IgE Ab RAST class [Presence] in Serum |
15612-5 | Cauliflower IgE Ab RAST class [Presence] in Serum |
15613-3 | Italian Cedar IgE Ab RAST class [Presence] in Serum |
15614-1 | Japanese Cedar IgE Ab RAST class [Presence] in Serum |
15615-8 | Mountain Juniper IgE Ab RAST class [Presence] in Serum |
15616-6 | Red Cedar IgE Ab RAST class [Presence] in Serum |
15617-4 | Saltcedar IgE Ab RAST class [Presence] in Serum |
15618-2 | Celery IgE Ab RAST class [Presence] in Serum |
15619-0 | Acremonium sp IgE Ab RAST class [Presence] in Serum |
1562-8 | Insulin [Mass/volume] in Serum or Plasma --2.5 hours post dose tolbutamide IV |
15620-8 | Chaetomium globosum IgE Ab RAST class [Presence] in Serum |
15621-6 | Chamomile IgE Ab RAST class [Presence] in Serum |
15622-4 | American Cheese IgE Ab RAST class [Presence] in Serum |
15623-2 | Cheese cheddar type IgE Ab RAST class [Presence] in Serum |
15624-0 | Cottage Cheese IgE Ab RAST class [Presence] in Serum |
15625-7 | Mozzarella Cheese IgE Ab RAST class [Presence] in Serum |
15626-5 | Parmesan Cheese IgE Ab RAST class [Presence] in Serum |
15627-3 | Swiss Cheese IgE Ab RAST class [Presence] in Serum |
15628-1 | Cherry IgE Ab RAST class [Presence] in Serum |
15629-9 | Chestnut IgE Ab RAST class [Presence] in Serum |
1563-6 | Insulin [Mass/volume] in Serum or Plasma --2 hours post dose tolbutamide IV |
15630-7 | Horse Chestnut IgE Ab RAST class [Presence] in Serum |
15631-5 | Deprecated Chestnut IgE Ab RAST class in Serum |
15632-3 | Chestnut Pollen IgE Ab RAST class [Presence] in Serum |
15633-1 | Chicken feather IgE Ab RAST class [Presence] in Serum |
15634-9 | Chicken meat IgE Ab RAST class [Presence] in Serum |
15635-6 | Chicory IgE Ab RAST class [Presence] in Serum |
15636-4 | Chinchilla IgE Ab RAST class [Presence] in Serum |
15637-2 | Chloramin T IgE Ab RAST class [Presence] in Serum |
15638-0 | Chortoglyphus arcuatus IgE Ab RAST class [Presence] in Serum |
15639-8 | Deprecated Chymofast IgE Ab RAST class in Serum |
1564-4 | Insulin [Mass/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
15640-6 | Chymopapain IgE Ab RAST class [Presence] in Serum |
15641-4 | Cinnamon IgE Ab RAST class [Presence] in Serum |
15642-2 | Cladosporium herbarum IgE Ab RAST class [Presence] in Serum |
15643-0 | Clam IgE Ab RAST class [Presence] in Serum |
15644-8 | Clove IgE Ab RAST class [Presence] in Serum |
15645-5 | Clover IgE Ab RAST class [Presence] in Serum |
15646-3 | Cocklebur IgE Ab RAST class [Presence] in Serum |
15647-1 | Cockroach IgE Ab RAST class [Presence] in Serum |
15648-9 | Deprecated Cocoa IgE Ab RAST class in Serum |
15649-7 | Coconut IgE Ab RAST class [Presence] in Serum |
1565-1 | Insulin [Mass/volume] in Serum or Plasma --30 minutes post dose tolbutamide IV |
15650-5 | Codfish IgE Ab RAST class [Presence] in Serum |
15651-3 | Coffee IgE Ab RAST class [Presence] in Serum |
15652-1 | Cola IgE Ab RAST class [Presence] in Serum |
15653-9 | Corn IgE Ab RAST class [Presence] in Serum |
15654-7 | Cultivated Corn IgE Ab RAST class [Presence] in Serum |
15655-4 | Cultivated Cotton IgE Ab RAST class [Presence] in Serum |
15656-2 | Cotton fibers IgE Ab RAST class [Presence] in Serum |
15657-0 | Cotton western IgE Ab RAST class [Presence] in Serum |
15658-8 | Cottonseed IgE Ab RAST class [Presence] in Serum |
15659-6 | Cottonwood IgE Ab RAST class [Presence] in Serum |
1566-9 | Insulin [Mass/volume] in Serum or Plasma --3 hours post dose tolbutamide IV |
15660-4 | Western Cottonwood IgE Ab RAST class [Presence] in Serum |
15661-2 | Cow dander IgE Ab RAST class [Presence] in Serum |
15662-0 | Cow epithelium IgE Ab RAST class [Presence] in Serum |
15663-8 | Crab IgE Ab RAST class [Presence] in Serum |
15664-6 | Cranberry IgE Ab RAST class [Presence] in Serum |
15665-3 | Crawfish IgE Ab RAST class [Presence] in Serum |
15666-1 | Cryptococcus terreus IgE Ab RAST class [Presence] in Serum |
15667-9 | Cucumber IgE Ab RAST class [Presence] in Serum |
15668-7 | Curry IgE Ab RAST class [Presence] in Serum |
15669-5 | Curvularia lunata IgE Ab RAST class [Presence] in Serum |
1567-7 | Insulin [Mass/volume] in Serum or Plasma --3 hours post 75 g glucose PO |
15670-3 | Curvularia specifera IgE Ab RAST class [Presence] in Serum |
15671-1 | Arizona Cypress IgE Ab RAST class [Presence] in Serum |
15672-9 | Bald Cypress IgE Ab RAST class [Presence] in Serum |
15673-7 | Italian Cypress IgE Ab RAST class [Presence] in Serum |
15674-5 | Daisy IgE Ab RAST class [Presence] in Serum |
15675-2 | Ox-eye daisy IgE Ab RAST class [Presence] in Serum |
15676-0 | Dandelion IgE Ab RAST class [Presence] in Serum |
15677-8 | Daphnia (fish feed) IgE Ab RAST class [Presence] in Serum |
15678-6 | Date Palm Pollen IgE Ab RAST class [Presence] in Serum |
15679-4 | Deer epithelium IgE Ab RAST class [Presence] in Serum |
1568-5 | Insulin [Mass/volume] in Serum or Plasma --4 hours post 75 g glucose PO |
15680-2 | American house dust mite IgE Ab RAST class [Presence] in Serum |
15681-0 | Dermatophagoides microceras IgE Ab RAST class [Presence] in Serum |
15682-8 | European house dust mite IgE Ab RAST class [Presence] in Serum |
15683-6 | Dill IgE Ab RAST class [Presence] in Serum |
15684-4 | Yellow Dock IgE Ab RAST class [Presence] in Serum |
15685-1 | Dog dander IgE Ab RAST class [Presence] in Serum |
15686-9 | Dog epithelium IgE Ab RAST class [Presence] in Serum |
15687-7 | Duck feather IgE Ab RAST class [Presence] in Serum |
15688-5 | Echinococcus sp IgE Ab RAST class [Presence] in Serum |
15689-3 | Egg white IgE Ab RAST class [Presence] in Serum |
1569-3 | Insulin [Mass/volume] in Serum or Plasma --5 hours post 75 g glucose PO |
15690-1 | Whole Egg IgE Ab RAST class [Presence] in Serum |
15691-9 | Egg yolk IgE Ab RAST class [Presence] in Serum |
15692-7 | Eggplant IgE Ab RAST class [Presence] in Serum |
15693-5 | Marsh Elder IgE Ab RAST class [Presence] in Serum |
15694-3 | Elder IgE Ab RAST class [Presence] in Serum |
15695-0 | Deprecated Elderberry IgE Ab RAST class in Serum |
15696-8 | Elk or Moose Meat IgE Ab RAST class [Presence] in Serum |
15697-6 | White Elm IgE Ab RAST class [Presence] in Serum |
15698-4 | Chinese Elm IgE Ab RAST class [Presence] in Serum |
15699-2 | Endive IgE Ab RAST class [Presence] in Serum |
157-8 | Cephaloridine [Susceptibility] by Minimum inhibitory concentration (MIC) |
1570-1 | Insulin [Mass/volume] in Serum or Plasma --baseline |
15700-8 | Epicoccum purpurascens IgE Ab RAST class [Presence] in Serum |
15701-6 | Epidermophyton floccosum IgE Ab RAST class [Presence] in Serum |
15702-4 | Ethylene oxide IgE Ab RAST class [Presence] in Serum |
15703-2 | Gum-Tree IgE Ab RAST class [Presence] in Serum |
15704-0 | Euroglyphus maynei IgE Ab RAST class [Presence] in Serum |
15705-7 | Dog Fennel IgE Ab RAST class [Presence] in Serum |
15706-5 | Fennel Fresh IgE Ab RAST class [Presence] in Serum |
15707-3 | Fennel Seed IgE Ab RAST class [Presence] in Serum |
15708-1 | Ferret epithelium IgE Ab RAST class [Presence] in Serum |
15709-9 | Meadow Fescue IgE Ab RAST class [Presence] in Serum |
1571-9 | Insulin [Mass/volume] in Serum or Plasma --pre dose tolbutamide IV |
15710-7 | Finch feather IgE Ab RAST class [Presence] in Serum |
15711-5 | Douglas Fir IgE Ab RAST class [Presence] in Serum |
15712-3 | Firebush IgE Ab RAST class [Presence] in Serum |
15713-1 | Fiscus sp IgE Ab RAST class [Presence] in Serum |
15714-9 | Flea IgE Ab RAST class [Presence] in Serum |
15715-6 | Flounder IgE Ab RAST class [Presence] in Serum |
15716-4 | Black Fly IgE Ab RAST class [Presence] in Serum |
15717-2 | Horse Fly IgE Ab RAST class [Presence] in Serum |
15718-0 | Formaldehyde IgE Ab RAST class [Presence] in Serum |
15719-8 | Fox IgE Ab RAST class [Presence] in Serum |
1572-7 | Insulin [Mass/volume] in Serum or Plasma --pre 75 g glucose PO |
15720-6 | Meadow Foxtail IgE Ab RAST class [Presence] in Serum |
15721-4 | Fusarium culmorum IgE Ab RAST class [Presence] in Serum |
15722-2 | Fusarium moniliforme IgE Ab RAST class [Presence] in Serum |
15723-0 | Fusarium solani IgE Ab RAST class [Presence] in Serum |
15724-8 | Garlic IgE Ab RAST class [Presence] in Serum |
15725-5 | Gelatin IgE Ab RAST class [Presence] in Serum |
15726-3 | Geotrichum candidum IgE Ab RAST class [Presence] in Serum |
15727-1 | Gerbil IgE Ab RAST class [Presence] in Serum |
15728-9 | Ginger IgE Ab RAST class [Presence] in Serum |
15729-7 | Gluten IgE Ab RAST class [Presence] in Serum |
1573-5 | Insulin [Mass/volume] in Serum or Plasma --12 hours fasting |
15730-5 | Glycyphagus domesticus IgE Ab RAST class [Presence] in Serum |
15731-3 | Goat epithelium IgE Ab RAST class [Presence] in Serum |
15732-1 | Goat milk IgE Ab RAST class [Presence] in Serum |
15733-9 | Goldenrod IgE Ab RAST class [Presence] in Serum |
15734-7 | Goose feather IgE Ab RAST class [Presence] in Serum |
15735-4 | Grape IgE Ab RAST class [Presence] in Serum |
15736-2 | Grapefruit IgE Ab RAST class [Presence] in Serum |
15737-0 | Bahia grass IgE Ab RAST class [Presence] in Serum |
15738-8 | Bermuda grass IgE Ab RAST class [Presence] in Serum |
15739-6 | Canadian blue grass IgE Ab RAST class [Presence] in Serum |
1574-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --24 hours post 40 ug corticotropin IM BID 3 day |
15740-4 | Brome IgE Ab RAST class [Presence] in Serum |
15741-2 | False oat grass IgE Ab RAST class [Presence] in Serum |
15742-0 | Gramma grass (Bouteloua gracilis) IgE Ab RAST class [Presence] in Serum |
15743-8 | Johnson grass IgE Ab RAST class [Presence] in Serum |
15744-6 | Kentucky blue grass IgE Ab RAST class [Presence] in Serum |
15745-3 | Koehlers grass IgE Ab RAST class [Presence] in Serum |
15746-1 | Cocksfoot IgE Ab RAST class [Presence] in Serum |
15747-9 | Quack grass IgE Ab RAST class [Presence] in Serum |
15748-7 | Red top grass IgE Ab RAST class [Presence] in Serum |
15749-5 | Perennial rye grass IgE Ab RAST class [Presence] in Serum |
1575-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 40 ug corticotropin IM BID 3 day |
15750-3 | Deprecated Grass rye Italian IgE Ab RAST class in Serum |
15751-1 | Wild rye grass IgE Ab RAST class [Presence] in Serum |
15752-9 | Salt grass IgE Ab RAST class [Presence] in Serum |
15753-7 | Sorghum grass IgE Ab RAST class [Presence] in Serum |
15754-5 | Sudan grass IgE Ab RAST class [Presence] in Serum |
15755-2 | Sweet Vernal grass IgE Ab RAST class [Presence] in Serum |
15756-0 | Velvet grass IgE Ab RAST class [Presence] in Serum |
15757-8 | Guar gum IgE Ab RAST class [Presence] in Serum |
15758-6 | Guava IgE Ab RAST class [Presence] in Serum |
15759-4 | Guinea pig epithelium IgE Ab RAST class [Presence] in Serum |
1576-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 500 ug dexamethasone PO 2.5 day low dose q6h |
15760-2 | Gum arabic IgE Ab RAST class [Presence] in Serum |
15761-0 | Sweet gum IgE Ab RAST class [Presence] in Serum |
15762-8 | Hackberry tree IgE Ab RAST class [Presence] in Serum |
15763-6 | Haddock IgE Ab RAST class [Presence] in Serum |
15764-4 | Halibut IgE Ab RAST class [Presence] in Serum |
15765-1 | Hamster epithelium IgE Ab RAST class [Presence] in Serum |
15766-9 | Hazelnut IgE Ab RAST class [Presence] in Serum |
15767-7 | Hazelnut Pollen IgE Ab RAST class [Presence] in Serum |
15768-5 | Helminthosporium sp IgE Ab RAST class [Presence] in Serum |
15769-3 | Setomelanomma rostrata IgE Ab RAST class [Presence] in Serum |
1577-6 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --48 hours post 2 mg dexamethasone PO 2.5 day high dose q6h |
15770-1 | Eastern Hemlock IgE Ab RAST class [Presence] in Serum |
15771-9 | Water Hemp IgE Ab RAST class [Presence] in Serum |
15772-7 | Herring IgE Ab RAST class [Presence] in Serum |
15773-5 | Pecan or Hickory Nut IgE Ab RAST class [Presence] in Serum |
15774-3 | Pecan or Hickory Tree IgE Ab RAST class [Presence] in Serum |
15775-0 | Shellbark Hickory IgE Ab RAST class [Presence] in Serum |
15776-8 | White Hickory IgE Ab RAST class [Presence] in Serum |
15777-6 | Honey IgE Ab RAST class [Presence] in Serum |
15778-4 | Honeysuckle IgE Ab RAST class [Presence] in Serum |
15779-2 | Hop IgE Ab RAST class [Presence] in Serum |
1578-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --72 hours post 40 ug corticotropin IM BID 3 day |
15780-0 | Horn beam IgE Ab RAST class [Presence] in Serum |
15781-8 | Hornet IgE Ab RAST class [Presence] in Serum |
15782-6 | Whitefaced Hornet IgE Ab RAST class [Presence] in Serum |
15783-4 | Yellow Hornet IgE Ab RAST class [Presence] in Serum |
15784-2 | Horse dander IgE Ab RAST class [Presence] in Serum |
15785-9 | Horse epithelium IgE Ab RAST class [Presence] in Serum |
15786-7 | Horse serum proteins IgE Ab RAST class [Presence] in Serum |
15787-5 | Horseradish IgE Ab RAST class [Presence] in Serum |
15788-3 | House dust IgE Ab RAST class [Presence] in Serum |
15789-1 | House dust Greer IgE Ab RAST class [Presence] in Serum |
1579-2 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 50 ug corticotropin IM 3 day |
15790-9 | House dust Hausstaub IgE Ab RAST class [Presence] in Serum |
15791-7 | House dust Hollister Stier IgE Ab RAST class [Presence] in Serum |
15792-5 | Insulin bovine IgE Ab RAST class [Presence] in Serum |
15793-3 | Insulin human IgE Ab RAST class [Presence] in Serum |
15794-1 | Insulin porcine IgE Ab RAST class [Presence] in Serum |
15795-8 | Iodinebush IgE Ab RAST class [Presence] in Serum |
15796-6 | Isocyanate HDI IgE Ab RAST class [Presence] in Serum |
15797-4 | Isocyanate MDI IgE Ab RAST class [Presence] in Serum |
15798-2 | Isocyanate TDI IgE Ab RAST class [Presence] in Serum |
15799-0 | Ispaghula laxative IgE Ab RAST class [Presence] in Serum |
158-6 | Cephaloridine [Susceptibility] by Disk diffusion (KB) |
1580-0 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h |
15800-6 | Juniper IgE Ab RAST class [Presence] in Serum |
15801-4 | Kapok IgE Ab RAST class [Presence] in Serum |
15802-2 | Kiwifruit IgE Ab RAST class [Presence] in Serum |
15803-0 | Lamb IgE Ab RAST class [Presence] in Serum |
15804-8 | Deprecated Mutton IgE Ab RAST class in Serum |
15805-5 | Goosefoot IgE Ab RAST class [Presence] in Serum |
15806-3 | Latex IgE Ab RAST class [Presence] in Serum |
15807-1 | Latex glove extract IgE Ab RAST class [Presence] in Serum |
15808-9 | Latex glove extract ammoniated IgE Ab RAST class [Presence] in Serum |
15809-7 | Latex glove extract buffered IgE Ab RAST class [Presence] in Serum |
1581-8 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h |
15810-5 | Legume IgE Ab RAST class [Presence] in Serum |
15811-3 | Lemon IgE Ab RAST class [Presence] in Serum |
15812-1 | Lenscale IgE Ab RAST class [Presence] in Serum |
15813-9 | Lentils IgE Ab RAST class [Presence] in Serum |
15814-7 | Lepidoglyphus destructor IgE Ab RAST class [Presence] in Serum |
15815-4 | Lettuce IgE Ab RAST class [Presence] in Serum |
15816-2 | Lilac IgE Ab RAST class [Presence] in Serum |
15817-0 | Easter lily IgE Ab RAST class [Presence] in Serum |
15818-8 | Lime IgE Ab RAST class [Presence] in Serum |
15819-6 | Linden IgE Ab RAST class [Presence] in Serum |
1582-6 | Lactose [Mass/volume] in Serum or Plasma --1 hour post 50 g lactose PO |
15820-4 | Liver beef IgE Ab RAST class [Presence] in Serum |
15821-2 | Lobster IgE Ab RAST class [Presence] in Serum |
15822-0 | Spiny lobster IgE Ab RAST class [Presence] in Serum |
15823-8 | Black Locust IgE Ab RAST class [Presence] in Serum |
15824-6 | Lupin IgE Ab RAST class [Presence] in Serum |
15825-3 | Lycopodium spp IgE Ab RAST class [Presence] in Serum |
15826-1 | Lysozyme IgE Ab RAST class [Presence] in Serum |
15827-9 | Mackerel IgE Ab RAST class [Presence] in Serum |
15828-7 | Chub Mackerel IgE Ab RAST class [Presence] in Serum |
15829-5 | Scad IgE Ab RAST class [Presence] in Serum |
1583-4 | Lactose [Mass/volume] in Serum or Plasma --2 hours post 50 g lactose PO |
15830-3 | Deprecated Corn IgE Ab RAST class in Serum |
15831-1 | Malt IgE Ab RAST class [Presence] in Serum |
15832-9 | Mango IgE Ab RAST class [Presence] in Serum |
15833-7 | Coastal Maple IgE Ab RAST class [Presence] in Serum |
15834-5 | Red Maple IgE Ab RAST class [Presence] in Serum |
15835-2 | Silver Maple IgE Ab RAST class [Presence] in Serum |
15836-0 | Maple sugar IgE Ab RAST class [Presence] in Serum |
15837-8 | Mare milk IgE Ab RAST class [Presence] in Serum |
15838-6 | Marjoram IgE Ab RAST class [Presence] in Serum |
15839-4 | Maxatase IgE Ab RAST class [Presence] in Serum |
1584-2 | Lactose [Mass/volume] in Serum or Plasma --30 minutes post 50 g lactose PO |
15840-2 | Whiff IgE Ab RAST class [Presence] in Serum |
15841-0 | Cajeput tree IgE Ab RAST class [Presence] in Serum |
15842-8 | Deprecated Melon IgE Ab RAST class in Serum. |
15843-6 | Mesquite IgE Ab RAST class [Presence] in Serum |
15844-4 | Mexican tea IgE Ab RAST class [Presence] in Serum |
15845-1 | Green Nimitti IgE Ab RAST class [Presence] in Serum |
15846-9 | Milk IgE Ab RAST class [Presence] in Serum |
15847-7 | Cow milk boiled IgE Ab RAST class [Presence] in Serum |
15848-5 | Milk powder IgE Ab RAST class [Presence] in Serum |
15849-3 | Common Millet IgE Ab RAST class [Presence] in Serum |
1585-9 | Lactose [Mass/volume] in Serum or Plasma --pre 12 hour fast |
15850-1 | Foxtail Millet IgE Ab RAST class [Presence] in Serum |
15851-9 | Cockspur IgE Ab RAST class [Presence] in Serum |
15852-7 | Mink epithelium IgE Ab RAST class [Presence] in Serum |
15853-5 | Mint IgE Ab RAST class [Presence] in Serum |
15854-3 | Cheese mold type IgE Ab RAST class [Presence] in Serum |
15855-0 | Chrysonilia sitophila IgE Ab RAST class [Presence] in Serum |
15856-8 | Aedes mosquito IgE Ab RAST class [Presence] in Serum |
15857-6 | Moth IgE Ab RAST class [Presence] in Serum |
15858-4 | Mediterranean flour moth IgE Ab RAST class [Presence] in Serum |
15859-2 | Mouse epithelium IgE Ab RAST class [Presence] in Serum |
1586-7 | Lead [Mass/volume] in Urine --post EDTA therapy |
15860-0 | Mouse serum proteins IgE Ab RAST class [Presence] in Serum |
15861-8 | Mouse urine proteins IgE Ab RAST class [Presence] in Serum |
15862-6 | Mucor racemosus IgE Ab RAST class [Presence] in Serum |
15863-4 | Mugwort IgE Ab RAST class [Presence] in Serum |
15864-2 | White mulberry IgE Ab RAST class [Presence] in Serum |
15865-9 | Deprecated White mulberry IgE Ab RAST class in Serum |
15866-7 | Mushroom IgE Ab RAST class [Presence] in Serum |
15867-5 | Deprecated Melon IgE Ab Ab RAST class in Serum |
15868-3 | Deprecated Blue mussel IgE Ab RAST class in Serum |
15869-1 | Blue mussel IgE Ab RAST class [Presence] in Serum |
1587-5 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post 100 g lutropin IV |
15870-9 | Mustard IgE Ab RAST class [Presence] in Serum |
15871-7 | Nectarine IgE Ab RAST class [Presence] in Serum |
15872-5 | Nettle IgE Ab RAST class [Presence] in Serum |
15873-3 | Nigrospora sphaerica IgE Ab RAST class [Presence] in Serum |
15874-1 | Nutmeg IgE Ab RAST class [Presence] in Serum |
15875-8 | White Oak IgE Ab RAST class [Presence] in Serum |
15876-6 | California Black Oak IgE Ab RAST class [Presence] in Serum |
15877-4 | Coastal Oak IgE Ab RAST class [Presence] in Serum |
15878-2 | Gamble Oak IgE Ab RAST class [Presence] in Serum |
15879-0 | Jerusalem oak IgE Ab RAST class [Presence] in Serum |
1588-3 | Lutropin [Mass/volume] in Serum or Plasma --1.5 hours post dose gonadotropin releasing hormone |
15880-8 | Virginia Live Oak IgE Ab RAST class [Presence] in Serum |
15881-6 | Red Oak IgE Ab RAST class [Presence] in Serum |
15882-4 | Valley Oak IgE Ab RAST class [Presence] in Serum |
15883-2 | Deprecated Virginia Live Oak IgE Ab RAST class in Serum |
15884-0 | Deprecated White Oak IgE Ab RAST class in Serum |
15885-7 | Oat IgE Ab RAST class [Presence] in Serum |
15886-5 | Oat pollen IgE Ab RAST class [Presence] in Serum |
15887-3 | Deprecated Oat pollen IgE Ab RAST class in Serum |
15888-1 | Octopus IgE Ab RAST class [Presence] in Serum |
15889-9 | Oidiodendrum spp IgE Ab RAST class [Presence] in Serum |
1589-1 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --105 minutes post 100 g lutropin IV |
15890-7 | Okra IgE Ab RAST class [Presence] in Serum |
15891-5 | Deprecated Olive IgE Ab RAST class [Presence] in Serum |
15892-3 | Olive Pollen IgE Ab RAST class [Presence] in Serum |
15893-1 | Onion IgE Ab RAST class [Presence] in Serum |
15894-9 | Orange IgE Ab RAST class [Presence] in Serum |
15895-6 | Oregano IgE Ab RAST class [Presence] in Serum |
15896-4 | Orris root IgE Ab RAST class [Presence] in Serum |
15897-2 | Ovalbumin IgE Ab RAST class [Presence] in Serum |
15898-0 | Ovomucoid IgE Ab RAST class [Presence] in Serum |
15899-8 | Oyster IgE Ab RAST class [Presence] in Serum |
159-4 | Cephaloridine [Susceptibility] by Serum bactericidal titer |
1590-9 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --15 minutes post 100 g lutropin IV |
15900-4 | Queen Palm IgE Ab RAST class [Presence] in Serum |
15901-2 | Papaya (Carica papaya) IgE Ab RAST class [Presence] in Serum |
15902-0 | Paprika IgE Ab RAST class [Presence] in Serum |
15903-8 | Parakeet feather IgE Ab RAST class [Presence] in Serum |
15904-6 | Budgerigar droppings IgE Ab RAST class [Presence] in Serum |
15905-3 | Deprecated Budgerigar feather IgE Ab RAST class in Serum |
15906-1 | Budgerigar serum proteins IgE Ab RAST class [Presence] in Serum |
15907-9 | Parrot droppings IgE Ab RAST class [Presence] in Serum |
15908-7 | Parrot feather IgE Ab RAST class [Presence] in Serum |
15909-5 | Parrot serum proteins IgE Ab RAST class [Presence] in Serum |
1591-7 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --1 hour post 100 g lutropin IV |
15910-3 | Parsley IgE Ab RAST class [Presence] in Serum |
15911-1 | Parsnip IgE Ab RAST class [Presence] in Serum |
15912-9 | Passion fruit IgE Ab RAST class [Presence] in Serum |
15913-7 | Pea IgE Ab RAST class [Presence] in Serum |
15914-5 | Black-eye pea IgE Ab RAST class [Presence] in Serum |
15915-2 | Chick Pea IgE Ab RAST class [Presence] in Serum |
15916-0 | Peach IgE Ab RAST class [Presence] in Serum |
15917-8 | Peanut IgE Ab RAST class [Presence] in Serum |
15918-6 | Pear IgE Ab RAST class [Presence] in Serum |
15919-4 | Deprecated Pecan or Hickory Nut IgE Ab RAST class in Serum |
1592-5 | Lutropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
15920-2 | Deprecated Pecan or Hickory Tree IgE Ab RAST class in Serum |
15921-0 | Penicillin G IgE Ab RAST class [Presence] in Serum |
15922-8 | Penicillin V IgE Ab RAST class [Presence] in Serum |
15923-6 | Penicillium frequentans IgE Ab RAST class [Presence] in Serum |
15924-4 | Penicillium notatum IgE Ab RAST class [Presence] in Serum |
15925-1 | Black Pepper IgE Ab RAST class [Presence] in Serum |
15926-9 | Cayenne IgE Ab RAST class [Presence] in Serum |
15927-7 | Chili Pepper IgE Ab RAST class [Presence] in Serum |
15928-5 | Green Pepper IgE Ab RAST class [Presence] in Serum |
15929-3 | Pepper tree IgE Ab RAST class [Presence] in Serum |
1593-3 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --2 hours post 100 g lutropin IV |
15930-1 | Perch IgE Ab RAST class [Presence] in Serum |
15931-9 | Phoma betae IgE Ab RAST class [Presence] in Serum |
15932-7 | Phospholipase IgE Ab RAST class [Presence] in Serum |
15933-5 | Phthalic anhydride IgE Ab RAST class [Presence] in Serum |
15934-3 | Pigeon droppings IgE Ab RAST class [Presence] in Serum |
15935-0 | Pigeon feather IgE Ab RAST class [Presence] in Serum |
15936-8 | Common Pigweed IgE Ab RAST class [Presence] in Serum |
15937-6 | Rough Pigweed IgE Ab RAST class [Presence] in Serum |
15938-4 | Spiny Pigweed IgE Ab RAST class [Presence] in Serum |
15939-2 | Austrian Pine IgE Ab RAST class [Presence] in Serum |
1594-1 | Lutropin [Mass/volume] in Serum or Plasma --2 hours post dose gonadotropin releasing hormone |
15940-0 | Loblolly Pine IgE Ab RAST class [Presence] in Serum |
15941-8 | Long Leaf Pine IgE Ab RAST class [Presence] in Serum |
15942-6 | Pine IgE Ab RAST class [Presence] in Serum |
15943-4 | Pine Nut IgE Ab RAST class [Presence] in Serum |
15944-2 | Short Leaf Pine IgE Ab RAST class [Presence] in Serum |
15945-9 | Slash Pine IgE Ab RAST class [Presence] in Serum |
15946-7 | Virginia Scrub Pine IgE Ab RAST class [Presence] in Serum |
15947-5 | Eastern White Pine IgE Ab RAST class [Presence] in Serum |
15948-3 | Pineapple IgE Ab RAST class [Presence] in Serum |
15949-1 | Pistachio IgE Ab RAST class [Presence] in Serum |
1595-8 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --30 minutes post 100 g lutropin IV |
15950-9 | Malassezia furfur IgE Ab RAST class [Presence] in Serum |
15951-7 | Plaice IgE Ab RAST class [Presence] in Serum |
15952-5 | English Plantain IgE Ab RAST class [Presence] in Serum |
15953-3 | Plum IgE Ab RAST class [Presence] in Serum |
15954-1 | Black Cottonwood IgE Ab RAST class [Presence] in Serum |
15955-8 | Poppy Seed IgE Ab RAST class [Presence] in Serum |
15956-6 | Pork IgE Ab RAST class [Presence] in Serum |
15957-4 | Potato IgE Ab RAST class [Presence] in Serum |
15958-2 | Sweet potato IgE Ab RAST class [Presence] in Serum |
15959-0 | Povertyweed IgE Ab RAST class [Presence] in Serum |
1596-6 | Lutropin [Mass/volume] in Serum or Plasma --30 minutes post dose gonadotropin releasing hormone |
15960-8 | Privet IgE Ab RAST class [Presence] in Serum |
15961-6 | Protamine IgE Ab RAST class [Presence] in Serum |
15962-4 | Prune IgE Ab RAST class [Presence] in Serum |
15963-2 | Psyllium seed IgE Ab RAST class [Presence] in Serum |
15964-0 | Aureobasidium pullulans IgE Ab RAST class [Presence] in Serum |
15965-7 | Deprecated Pullularia pullulans IgE Ab RAST class in Serum |
15966-5 | Pumpkin IgE Ab RAST class [Presence] in Serum |
15967-3 | Pumpkin Seed IgE Ab RAST class [Presence] in Serum |
15968-1 | Pyrethrum IgE Ab RAST class [Presence] in Serum |
15969-9 | Rabbit meat IgE Ab RAST class [Presence] in Serum |
1597-4 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --45 minutes post 100 g lutropin IV |
15970-7 | Rabbit Bush IgE Ab RAST class [Presence] in Serum |
15971-5 | Rabbit epithelium IgE Ab RAST class [Presence] in Serum |
15972-3 | Rabbit serum proteins IgE Ab RAST class [Presence] in Serum |
15973-1 | Rabbit urine proteins IgE Ab RAST class [Presence] in Serum |
15974-9 | Radish IgE Ab RAST class [Presence] in Serum |
15975-6 | Common Ragweed IgE Ab RAST class [Presence] in Serum |
15976-4 | Desert Ragweed IgE Ab RAST class [Presence] in Serum |
15977-2 | False ragweed IgE Ab RAST class [Presence] in Serum |
15978-0 | Giant Ragweed IgE Ab RAST class [Presence] in Serum |
15979-8 | Deprecated Common Ragweed IgE Ab RAST class in Serum |
1598-2 | Deprecated Lutropin [Mass/volume] in Serum or Plasma --75 minutes post 100 g lutropin IV |
15980-6 | Southern Ragweed IgE Ab RAST class [Presence] in Serum |
15981-4 | Western Ragweed IgE Ab RAST class [Presence] in Serum |
15982-2 | Rapeseed IgE Ab RAST class [Presence] in Serum |
15983-0 | Raspberry IgE Ab RAST class [Presence] in Serum |
15984-8 | Rat epithelium IgE Ab RAST class [Presence] in Serum |
15985-5 | Rat serum proteins IgE Ab RAST class [Presence] in Serum |
15986-3 | Rat urine proteins IgE Ab RAST class [Presence] in Serum |
15987-1 | Redwood IgE Ab RAST class [Presence] in Serum |
15988-9 | Canary grass IgE Ab RAST class [Presence] in Serum |
15989-7 | Common Reed IgE Ab RAST class [Presence] in Serum |
1599-0 | Lutropin [Mass/volume] in Serum or Plasma --baseline |
15990-5 | Reindeer epithelium IgE Ab RAST class [Presence] in Serum |
15991-3 | Rhizopus nigricans IgE Ab RAST class [Presence] in Serum |
15992-1 | Rhodotorula spp IgE Ab RAST class [Presence] in Serum |
15993-9 | Rhubarb IgE Ab RAST class [Presence] in Serum |
15994-7 | Rice IgE Ab RAST class [Presence] in Serum |
15995-4 | Wild Rice IgE Ab RAST class [Presence] in Serum |
15996-2 | Rose Hip IgE Ab RAST class [Presence] in Serum |
15997-0 | Cultivated Rye IgE Ab RAST class [Presence] in Serum |
15998-8 | Rye IgE Ab RAST class [Presence] in Serum |
15999-6 | Deprecated Cultivated Rye IgE Ab RAST class in Serum |
16-6 | Amoxicillin [Susceptibility] by Minimum inhibitory concentration (MIC) |
160-2 | Cephalothin [Susceptibility] by Minimum lethal concentration (MLC) |
1600-6 | Lutropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
16000-2 | Deprecated rye Perennial IgE Ab RAST class in Serum |
16001-0 | Safflower IgE Ab RAST class [Presence] in Serum |
16002-8 | Sage IgE Ab RAST class [Presence] in Serum |
16003-6 | Common Sagebrush IgE Ab RAST class [Presence] in Serum |
16004-4 | Deprecated Sagebrush IgE Ab RAST class in Serum |
16005-1 | Saline fish feed IgE Ab RAST class [Presence] in Serum |
16006-9 | Salmon IgE Ab RAST class [Presence] in Serum |
16007-7 | Saltbush IgE Ab RAST class [Presence] in Serum |
16008-5 | Sardine (pilchard) IgE Ab RAST class [Presence] in Serum |
16009-3 | Savinase IgE Ab RAST class [Presence] in Serum |
1601-4 | Norepinephrine [Mass/volume] in Plasma --supine |
16010-1 | Deprecated Lenscale IgE Ab RAST class in Serum |
16011-9 | Scallop IgE Ab RAST class [Presence] in Serum |
16012-7 | Scotch broom IgE Ab RAST class [Presence] in Serum |
16013-5 | Sericin IgE Ab RAST class [Presence] in Serum |
16014-3 | Sesame Seed IgE Ab RAST class [Presence] in Serum |
16015-0 | Sheep epithelium IgE Ab RAST class [Presence] in Serum |
16016-8 | Sheep Sorrel IgE Ab RAST class [Presence] in Serum |
16017-6 | Sheep wool IgE Ab RAST class [Presence] in Serum |
16018-4 | Shrimp IgE Ab RAST class [Presence] in Serum |
16019-2 | Silk IgE Ab RAST class [Presence] in Serum |
1602-2 | Norepinephrine [Mass/volume] in Plasma --10 minutes post standing |
16020-0 | Silk waste IgE Ab RAST class [Presence] in Serum |
16021-8 | Silver IgE Ab RAST class [Presence] in Serum |
16022-6 | Bermuda grass smut IgE Ab RAST class [Presence] in Serum |
16023-4 | Johnson grass smut IgE Ab RAST class [Presence] in Serum |
16024-2 | Escargot IgE Ab RAST class [Presence] in Serum |
16025-9 | Red Snapper IgE Ab RAST class [Presence] in Serum |
16026-7 | Sole IgE Ab RAST class [Presence] in Serum |
16027-5 | Spinach IgE Ab RAST class [Presence] in Serum |
16028-3 | Spondylocladium citrovirens IgE Ab RAST class [Presence] in Serum |
16029-1 | Spruce IgE Ab RAST class [Presence] in Serum |
1603-0 | Norepinephrine [Mass/volume] in Plasma --1 hour post 300 ug clonidine PO |
16030-9 | Squash IgE Ab RAST class [Presence] in Serum |
16031-7 | Squid IgE Ab RAST class [Presence] in Serum |
16032-5 | Pacific Squid IgE Ab RAST class [Presence] in Serum |
16033-3 | Stemphylium botryosum IgE Ab RAST class [Presence] in Serum |
16034-1 | Stemphylium solani IgE Ab RAST class [Presence] in Serum |
16035-8 | Acarus siro IgE Ab RAST class [Presence] in Serum |
16037-4 | Tyrophagus putrescentiae IgE Ab RAST class [Presence] in Serum |
16038-2 | Strawberry IgE Ab RAST class [Presence] in Serum |
16039-0 | Succinylcholine IgE Ab RAST class [Presence] in Serum |
1604-8 | Norepinephrine [Mass/volume] in Plasma --2 hours post 300 ug clonidine PO |
16040-8 | Sugar Cane IgE Ab RAST class [Presence] in Serum |
16041-6 | Sunflower Pollen IgE Ab RAST class [Presence] in Serum |
16042-4 | Sunflower Seed IgE Ab RAST class [Presence] in Serum |
16043-2 | Swine epithelium IgE Ab RAST class [Presence] in Serum |
16044-0 | Swine urine proteins IgE Ab RAST class [Presence] in Serum |
16045-7 | Swordfish IgE Ab RAST class [Presence] in Serum |
16046-5 | American Sycamore IgE Ab RAST class [Presence] in Serum |
16047-3 | Mandarin IgE Ab RAST class [Presence] in Serum |
16048-1 | Tapioca IgE Ab RAST class [Presence] in Serum |
16049-9 | Tarragon IgE Ab RAST class [Presence] in Serum |
1605-5 | Norepinephrine [Mass/volume] in Plasma --3 hours post 300 ug clonidine PO |
16050-7 | Tea IgE Ab RAST class [Presence] in Serum |
16051-5 | Tetramin IgE Ab RAST class [Presence] in Serum |
16052-3 | Saltwort IgE Ab RAST class [Presence] in Serum |
16053-1 | Thyme IgE Ab RAST class [Presence] in Serum |
16054-9 | Timothy IgE Ab RAST class [Presence] in Serum |
16055-6 | Deprecated Tobacco IgE Ab RAST class in Serum |
16056-4 | Tobacco IgE Ab RAST class [Presence] in Serum |
16057-2 | Tomato IgE Ab RAST class [Presence] in Serum |
16058-0 | Tragacanth IgE Ab RAST class [Presence] in Serum |
16059-8 | Trichoderma viride IgE Ab RAST class [Presence] in Serum |
1606-3 | Norepinephrine [Mass/volume] in Plasma --pre 300 ug clonidine PO |
16060-6 | Trichophyton sp IgE Ab RAST class [Presence] in Serum |
16061-4 | Trichophyton rubrum IgE Ab RAST class [Presence] in Serum |
16062-2 | Trichosporon spp IgE Ab RAST class [Presence] in Serum |
16063-0 | Trimellitic anhydride (TMA) IgE Ab RAST class [Presence] in Serum |
16064-8 | Trout IgE Ab RAST class [Presence] in Serum |
16065-5 | Tuna IgE Ab RAST class [Presence] in Serum |
16066-3 | Turkey meat IgE Ab RAST class [Presence] in Serum |
16067-1 | Turnip IgE Ab RAST class [Presence] in Serum |
16069-7 | Ulocladium chartarum IgE Ab RAST class [Presence] in Serum |
1607-1 | Osmolality of Urine--12 hours post fluid fast |
16070-5 | Barley smut IgE Ab RAST class [Presence] in Serum |
16071-3 | Vanilla IgE Ab RAST class [Presence] in Serum |
16072-1 | Veal IgE Ab RAST class [Presence] in Serum |
16073-9 | Wall pellitory IgE Ab RAST class [Presence] in Serum |
16074-7 | Walnut IgE Ab RAST class [Presence] in Serum |
16075-4 | Black Walnut IgE Ab RAST class [Presence] in Serum |
16076-2 | Black Walnut Pollen IgE Ab RAST class [Presence] in Serum |
16077-0 | English Walnut Pollen IgE Ab RAST class [Presence] in Serum |
16078-8 | California Walnut Pollen IgE Ab RAST class [Presence] in Serum |
16079-6 | Deprecated California Walnut Pollen IgE Ab RAST class in Serum |
1608-9 | Osmolality of Urine--8 hours post fluid fast |
16080-4 | Paper Wasp IgE Ab RAST class [Presence] in Serum |
16081-2 | Deprecated Paper Wasp IgE Ab RAST class in Serum |
16082-0 | Yellow Jacket IgE Ab RAST class [Presence] in Serum |
16083-8 | Watermelon IgE Ab RAST class [Presence] in Serum |
16084-6 | Grain weevel IgE Ab RAST class [Presence] in Serum |
16085-3 | Wheat IgE Ab RAST class [Presence] in Serum |
16086-1 | Cultivated Wheat IgE Ab RAST class [Presence] in Serum |
16087-9 | Deprecated Cultivated Wheat IgE Ab RAST class in Serum |
16088-7 | Wheat Stem Rust IgE Ab RAST class [Presence] in Serum |
16089-5 | Cow whey IgE Ab RAST class [Presence] in Serum |
1609-7 | Prolactin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
16090-3 | Whitefish IgE Ab RAST class [Presence] in Serum |
16091-1 | Willow IgE Ab RAST class [Presence] in Serum |
16092-9 | Black Willow IgE Ab RAST class [Presence] in Serum |
16093-7 | Pussy Willow IgE Ab RAST class [Presence] in Serum |
16094-5 | Wingscale IgE Ab RAST class [Presence] in Serum |
16095-2 | Wormwood IgE Ab RAST class [Presence] in Serum |
16096-0 | Baker's yeast IgE Ab RAST class [Presence] in Serum |
16097-8 | Deprecated Bakers Yeast IgE Ab RAST class in Serum |
16098-6 | Brewer's yeast IgE Ab RAST class [Presence] in Serum |
16099-4 | Ethionamide [Susceptibility] by Minimum inhibitory concentration (MIC) |
161-0 | Cephalothin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1610-5 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose L-dopa PO |
16100-0 | Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
16101-8 | Cumin IgE Ab [Units/volume] in Serum |
16102-6 | Bovine Gelatin IgE Ab [Units/volume] in Serum |
16103-4 | Porcine Gelatin IgE Ab [Units/volume] in Serum |
16104-2 | Paper Mulberry IgE Ab [Units/volume] in Serum |
16105-9 | Pheasant IgE Ab [Units/volume] in Serum |
16106-7 | CD8+CD28+ cells [#/volume] in Blood |
16107-5 | CD8+HLA-DR+ cells [#/volume] in Blood |
16108-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma --45 minutes post 250 ug corticotropin IM |
16109-1 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
1611-3 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
16110-9 | 11-Deoxycorticosterone [Mass/time] in 24 hour Urine |
16111-7 | Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine |
16112-5 | Estrogen receptor [Interpretation] in Tissue |
16113-3 | Progesterone receptor [Interpretation] in Tissue |
16114-1 | Amitriptyline [Mass/volume] in Urine |
16115-8 | Doxepin [Mass/mass] in Tissue |
16116-6 | Tetrahydrocortisone [Mass/time] in 24 hour Urine |
16117-4 | Babesia microti IgG Ab [Titer] in Serum |
16118-2 | Babesia microti IgM Ab [Titer] in Serum |
16119-0 | Brucella abortus IgG Ab [Titer] in Serum |
1612-1 | Prolactin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
16120-8 | Brucella abortus IgM Ab [Titer] in Serum |
16121-6 | Colorado tick fever virus IgG Ab [Titer] in Serum |
16122-4 | Colorado tick fever virus IgM Ab [Titer] in Serum |
16123-2 | Cryptococcus sp Ab [Titer] in Cerebral spinal fluid |
16124-0 | Cryptococcus sp Ab [Titer] in Serum |
16125-7 | Helicobacter pylori IgA Ab [Presence] in Serum |
16126-5 | Helicobacter pylori IgG Ab [Presence] in Serum |
16127-3 | Helicobacter pylori IgM Ab [Presence] in Serum |
16128-1 | Hepatitis C virus Ab [Presence] in Serum |
16129-9 | Hepatitis C virus IgG Ab [Presence] in Serum |
1613-9 | Prolactin [Mass/volume] in Serum or Plasma --2 hours post dose L-dopa PO |
16130-7 | Herpes simplex virus 1 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
16131-5 | Herpes simplex virus 2 DNA [Presence] in Unspecified specimen by Probe and target amplification method |
16132-3 | HIV 1 p15+p18 Ab [Presence] in Serum by Immunoblot (IB) |
16133-1 | Legionella pneumophila IgM Ab [Titer] in Serum by Immunofluorescence |
16134-9 | Neisseria meningitidis [Presence] in Unspecified specimen by Organism specific culture |
16135-6 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum |
16136-4 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum |
16137-2 | Centromere Ab [Presence] in Serum |
16138-0 | Ganglioside GM1 IgA Ab [Titer] in Serum |
16139-8 | Neuronal nuclear Ab [Titer] in Cerebral spinal fluid |
1614-7 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
16140-6 | Tellurium [Mass/volume] in Blood |
16141-4 | Nitrogen [Mass/time] in 24 hour Stool |
16142-2 | Fat [Mass/time] in 24 hour Stool |
16143-0 | Deprecated Butane [Mass/volume] in Blood |
16144-8 | Droperidol [Presence] in Serum or Plasma |
16145-5 | Mescaline [Mass/volume] in Serum or Plasma |
16146-3 | Psilocin [Mass/volume] in Serum or Plasma |
16147-1 | Aldosterone [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
16148-9 | Aldosterone [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
16149-7 | Aldosterone [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
1615-4 | Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
16150-5 | Carboxy tetrahydrocannabinol [Mass/volume] in Serum or Plasma |
16151-3 | Dechlorane [Presence] in Serum or Plasma |
16152-1 | Gastrin [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
16153-9 | Gastrin [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
16154-7 | Gastrin [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
16155-4 | Gastrin [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
16156-2 | Gastrin [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
16157-0 | Gastrin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16158-8 | Gastrin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
16159-6 | Gastrin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
1616-2 | Deprecated Prolactin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
16160-4 | Gastrin [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
16161-2 | Gastrin [Mass/volume] in Serum or Plasma --post XXX challenge |
16162-0 | Parathyrin.intact [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
16163-8 | Parathyrin.intact [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
16164-6 | Parathyrin.intact [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
16165-3 | Glucose [Mass/volume] in Serum or Plasma --10 AM specimen |
16166-1 | Glucose [Mass/volume] in Serum or Plasma --11 AM specimen |
16167-9 | Glucose [Mass/volume] in Serum or Plasma --2 PM specimen |
16168-7 | Glucose [Mass/volume] in Serum or Plasma --3 PM specimen |
16169-5 | Glucose [Mass/volume] in Serum or Plasma --4 PM specimen |
1617-0 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post dose L-dopa PO |
16170-3 | Glucose [Mass/volume] in Serum or Plasma --5 PM specimen |
16171-1 | Cocaethylene [Mass/mass] in Hair |
16172-9 | Magnesium [Mass/mass] in Hair |
16173-7 | Amyl ether [Mass/volume] in Blood |
16174-5 | Bartonella henselae IgG Ab [Presence] in Cerebral spinal fluid |
16175-2 | Bartonella henselae IgM Ab [Presence] in Cerebral spinal fluid |
16176-0 | Bartonella quintana IgG Ab [Units/volume] in Cerebral spinal fluid |
16177-8 | Bartonella quintana IgM Ab [Units/volume] in Cerebral spinal fluid |
16178-6 | Beryllium [Mass/mass] in Tissue |
16179-4 | Polychlorinated biphenyl (PCB) [Mass/mass] in Tissue |
1618-8 | Prolactin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
16180-2 | Zinc [Mass/mass] in Tissue |
16181-0 | Tricyclic antidepressants [Mass/volume] in Urine by Confirmatory method |
16182-8 | Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability |
16183-6 | Phenolphthalein [Mass/volume] in Stool |
16184-4 | Temazepam [Mass/volume] in Stool |
16185-1 | Chlordiazepoxide [Mass/volume] in Stool |
16186-9 | Hydroxyalprazolam [Mass/volume] in Stool |
16187-7 | Alprazolam [Mass/volume] in Stool |
16188-5 | Creatinine [Mass/volume] in Serum or Plasma --2 hour specimen |
16189-3 | Creatinine [Mass/volume] in Serum or Plasma --4 hour specimen |
1619-6 | Prolactin [Mass/volume] in Serum or Plasma --pre dose L-dopa PO |
16190-1 | Amobarbital [Presence] in Urine by Confirmatory method |
16191-9 | Butabarbital [Presence] in Urine by Confirmatory method |
16192-7 | Phenobarbital [Presence] in Urine by Confirmatory method |
16193-5 | Pentobarbital [Presence] in Urine by Confirmatory method |
16194-3 | Secobarbital [Presence] in Urine by Confirmatory method |
16195-0 | Benzodiazepines [Presence] in Urine by Confirmatory method |
16196-8 | Morphine [Presence] in Urine by Confirmatory method |
16197-6 | Codeine [Presence] in Urine by Confirmatory method |
16198-4 | Diamorphine [Presence] in Urine by Confirmatory method |
16199-2 | Methadone [Presence] in Urine by Confirmatory method |
162-8 | Cephalothin [Susceptibility] by Disk diffusion (KB) |
1620-4 | Prolactin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
16200-8 | Propoxyphene [Presence] in Urine by Confirmatory method |
16201-6 | Oxazepam [Mass/volume] in Urine by Confirmatory method |
16202-4 | Nordiazepam [Presence] in Urine by Confirmatory method |
16203-2 | Alprazolam [Presence] in Urine by Confirmatory method |
16204-0 | Clonazepam [Presence] in Urine by Confirmatory method |
16205-7 | Lorazepam [Presence] in Urine by Confirmatory method |
16206-5 | Temazepam [Presence] in Urine by Confirmatory method |
16207-3 | Meperidine [Presence] in Urine by Confirmatory method |
16208-1 | Buprenorphine [Presence] in Urine by Confirmatory method |
16209-9 | Chlorpheniramine [Presence] in Urine by Confirmatory method |
1621-2 | Prolactin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
16210-7 | Diethylpropion [Presence] in Urine by Confirmatory method |
16211-5 | Dihydrocodeine [Presence] in Urine by Confirmatory method |
16212-3 | Ethylamphetamine [Presence] in Urine by Confirmatory method |
16213-1 | Levorphanol [Presence] in Urine by Confirmatory method |
16214-9 | Lysergate diethylamide [Presence] in Urine by Confirmatory method |
16215-6 | Mephobarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
16216-4 | Methylephedrine [Presence] in Urine by Confirmatory method |
16217-2 | Methyprylon [Presence] in Urine by Confirmatory method |
16218-0 | Nalbuphine [Presence] in Urine by Confirmatory method |
16219-8 | Pentazocine [Presence] in Urine by Confirmatory method |
1622-0 | Renin [Enzymatic activity/volume] in Plasma --5 hours post 600 ug furosemide PO |
16220-6 | Phenmetrazine [Presence] in Urine by Confirmatory method |
16221-4 | Phenothiazines [Presence] in Urine by Confirmatory method |
16222-2 | Phentermine [Presence] in Urine by Confirmatory method |
16223-0 | Thiopental [Presence] in Urine by Confirmatory method |
16224-8 | Triazolam [Presence] in Urine by Confirmatory method |
16225-5 | Amitriptyline [Presence] in Urine by Confirmatory method |
16226-3 | Benzoylecgonine [Mass/volume] in Urine by Confirmatory method |
16227-1 | Diazepam [Mass/volume] in Urine by Confirmatory method |
16228-9 | Nordiazepam [Mass/volume] in Urine by Confirmatory method |
16229-7 | Clonazepam [Mass/volume] in Urine by Confirmatory method |
1623-8 | Renin [Enzymatic activity/volume] in Plasma --pre 600 ug furosemide PO |
16230-5 | N-desalkylflurazepam [Mass/volume] in Urine by Confirmatory method |
16231-3 | Flurazepam [Mass/volume] in Urine by Confirmatory method |
16232-1 | Triazolam [Mass/volume] in Urine by Confirmatory method |
16233-9 | Midazolam [Mass/volume] in Urine by Confirmatory method |
16234-7 | Amphetamine [Mass/volume] in Urine by Confirmatory method |
16235-4 | Methamphetamine [Mass/volume] in Urine by Confirmatory method |
16236-2 | Butabarbital [Mass/volume] in Urine by Confirmatory method |
16237-0 | Butalbital [Mass/volume] in Urine by Confirmatory method |
16238-8 | Secobarbital [Mass/volume] in Urine by Confirmatory method |
16239-6 | Amobarbital [Mass/volume] in Urine by Confirmatory method |
1624-6 | Retinol [Mass/volume] in Serum or Plasma --3 hours post 5000 units |
16240-4 | Pentobarbital [Mass/volume] in Urine by Confirmatory method |
16241-2 | Phenobarbital [Mass/volume] in Urine by Confirmatory method |
16242-0 | Propoxyphene [Mass/volume] in Urine by Confirmatory method |
16243-8 | Cannabinoids [Mass/volume] in Blood by Confirmatory method |
16244-6 | Methaqualone [Mass/volume] in Urine by Confirmatory method |
16245-3 | Hydroxyethylflurazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
16246-1 | Methadone [Mass/volume] in Urine by Confirmatory method |
16247-9 | Dextromethorphan [Mass/volume] in Serum or Plasma by Confirmatory method |
16248-7 | 6-monoacetylmorphine free [Mass/volume] in Serum or Plasma by Confirmatory method |
16249-5 | Oxycodone [Mass/volume] in Urine by Confirmatory method |
1625-3 | Retinol [Mass/volume] in Serum or Plasma --6 hours post 5000 units |
16250-3 | Codeine [Mass/volume] in Urine by Confirmatory method |
16251-1 | Morphine [Mass/volume] in Urine by Confirmatory method |
16252-9 | Hydrocodone [Mass/volume] in Urine by Confirmatory method |
16253-7 | Meperidine [Mass/volume] in Urine by Confirmatory method |
16254-5 | Phencyclidine [Mass/volume] in Urine by Confirmatory method |
16255-2 | Troponin I.cardiac [Units/volume] in Serum or Plasma |
16257-8 | Sodium urate crystals [Presence] in Stone by Infrared spectroscopy |
16258-6 | Ammonium urate crystals [Presence] in Stone by Infrared spectroscopy |
16259-4 | Urate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
1626-1 | Retinol [Mass/volume] in Serum or Plasma --pre 5000 units |
16260-2 | Triamterene crystals [Presence] in Stone by Infrared spectroscopy |
16261-0 | Calcium bilirubinate crystals [Presence] in Stone by Infrared spectroscopy |
16262-8 | Newberyite crystals [Presence] in Stone by Infrared spectroscopy |
16263-6 | Calcium oxalate dihydrate crystals [Presence] in Stone by Infrared spectroscopy |
16264-4 | Calcium oxalate monohydrate crystals [Presence] in Stone by Infrared spectroscopy |
16265-1 | Triple phosphate crystals [Presence] in Stone by Infrared spectroscopy |
16266-9 | Calcium hydrogen phosphate crystals [Presence] in Stone by Infrared spectroscopy |
16267-7 | Calcium carbonate crystals [Presence] in Stone by Infrared spectroscopy |
16268-5 | Calcium phosphate crystals [Presence] in Stone by Infrared spectroscopy |
16269-3 | Urate crystals [Presence] in Stone by Infrared spectroscopy |
1627-9 | Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post dose insulin IV |
16270-1 | Calcium [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
16271-9 | Calcium [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
16272-7 | Calcium [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
16273-5 | Calcium [Mass/mass] in Red Blood Cells |
16274-3 | Deprecated Cells.CD4/Cells.C4 |
16275-0 | Bartonella sp DNA [Presence] in Blood by Probe and target amplification method |
16276-8 | Bartonella henselae DNA [Presence] in Blood by Probe and target amplification method |
16277-6 | Bartonella quintana DNA [Presence] in Blood by Probe and target amplification method |
16278-4 | Mycobacterium tuberculosis DNA [Presence] in Blood by Probe and target amplification method |
16279-2 | Toxoplasma gondii DNA [Presence] in Blood by Probe and target amplification method |
1628-7 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post 1 g/kg glucose PO |
16280-0 | Human papilloma virus DNA [Presence] in Unspecified specimen by Probe with amplification |
16281-8 | Trazodone [Units/volume] in Urine |
16282-6 | Acetaminophen [Units/volume] in Urine |
16283-4 | Escherichia coli verotoxin [Presence] in Unspecified specimen |
16284-2 | Polio virus Ab [Units/volume] in Serum |
16285-9 | Creatinine/Protein [Mass Ratio] in Urine |
16286-7 | Deprecated Testosterone Free/Testosterone.total in Serum or Plasma |
16287-5 | Deprecated Sulfatide Ab |
16288-3 | Deprecated Monosialoganglioside GM1 Ab.IgG+IgM |
16289-1 | Deprecated Monosialoganglioside GM1 Ab |
1629-5 | Somatotropin [Mass/volume] in Serum or Plasma --1 hour post dose insulin IV |
16290-9 | Neutrophils [Presence] in Stool |
16291-7 | Herpes simplex virus 1 [Presence] in Unspecified specimen by Organism specific culture |
16292-5 | 1,4-Dioxane [Mass/volume] in Urine |
16293-3 | 11-Deoxycorticosteroids [Mass/volume] in Plasma |
16294-1 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
16295-8 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --post XXX challenge |
16296-6 | 11-Hydroxyandrosterone [Mass/volume] in Serum or Plasma |
16297-4 | 17-Hydroxypregnenolone [Mass/volume] in Urine |
16298-2 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
16299-0 | 17-Hydroxypregnenolone [Mass/volume] in Serum or Plasma --6 hours post XXX challenge |
163-6 | Cephalothin [Susceptibility] by Serum bactericidal titer |
1630-3 | Somatotropin [Mass/volume] in Serum or Plasma --2 hours post 1 g/kg glucose PO |
16300-6 | 17-Ketogenic steroids [Mass/time] in 72 hour Urine |
16301-4 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine --baseline |
16302-2 | 1-Methylhistidine [Presence] in Urine |
16303-0 | 2-Hexanol [Mass/volume] in Urine |
16304-8 | 2-Hexanol/Creatinine [Mass Ratio] in Urine |
16305-5 | 2-Methoxyethanol [Mass/volume] in Blood |
16306-3 | 3-Methylhistidine [Presence] in Urine |
16307-1 | Acetate [Mass/volume] in Dialysis fluid |
16308-9 | Acetazolamide [Units/volume] in Serum or Plasma |
16309-7 | Acetazolamide [Units/volume] in Urine |
1631-1 | Somatotropin [Mass/volume] in Serum or Plasma --30 minutes post dose insulin IV |
16310-5 | Acetone [Presence] in Body fluid |
16311-3 | Acetone [Mass/volume] in Body fluid |
16312-1 | Acetonitrile [Mass/volume] in Serum or Plasma |
16313-9 | Acetylene [Mass/volume] in Blood |
16314-7 | Acetylsalicylate [Presence] in Urine |
16315-4 | Acid phosphatase [Enzymatic activity/volume] in Blood by Tartrate inhibited |
16316-2 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Blood |
16317-0 | Prostatic acid phosphatase [Presence] in Vaginal fluid |
16318-8 | Acrylamide [Mass/volume] in Urine |
16319-6 | Acrylamide [Mass/volume] in Serum or Plasma |
1632-9 | Somatotropin [Mass/volume] in Serum or Plasma --3 hours post 1 g/kg glucose PO |
16320-4 | Acyclovir [Susceptibility] by Serum bactericidal titer |
16321-2 | Deprecated Acyl carnitine [Mass/volume] in Serum or Plasma |
16322-0 | Biperiden [Mass/volume] in Serum or Plasma |
16323-8 | Alanine [Presence] in Urine |
16324-6 | Alanine aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
16325-3 | Alanine aminotransferase/Aspartate aminotransferase [Enzymatic activity ratio] in Serum or Plasma |
16327-9 | Allyl alcohol [Mass/volume] in Blood |
16328-7 | Benzyl alcohol [Presence] in Blood |
16329-5 | Aldosterone [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
1633-7 | Somatotropin [Mass/volume] in Serum or Plasma --45 minutes post dose insulin IV |
16330-3 | Aldosterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16331-1 | Aldosterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
16332-9 | Aldosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
16333-7 | Aldrin [Mass/volume] in Blood |
16334-5 | Alfentanil [Mass/volume] in Urine |
16335-2 | Hydrocarbons Aliphatic [Identifier] in Blood |
16336-0 | Deprecated Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
16337-8 | Alkaline phosphatase [Enzymatic activity/volume] in Urine |
16338-6 | Alpha aminoadipate [Presence] in Urine |
16339-4 | Alpha aminoisobutyrate [Presence] in Urine |
1634-5 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post 250 ug L-dopa TID 2day PO |
16340-2 | Alpha aminoisobutyrate [Mass/volume] in Urine |
16341-0 | Alpha aminoisobutyrate [Presence] in Plasma |
16342-8 | Alpha aminoisobutyrate [Mass/volume] in Plasma |
16343-6 | Alpha aminoisobutyrate [Mass/volume] in Cerebral spinal fluid |
16344-4 | Alpha aminoisobutyrate [Mass/volume] in Amniotic fluid |
16345-1 | Alpha aminobutyrate [Presence] in Urine |
16346-9 | Alpha chlordane [Mass/volume] in Urine |
16347-7 | Alpha chlordane [Mass/volume] in Blood |
16348-5 | Alpha hydroxyalprazolam [Mass/volume] in Urine by Confirmatory method |
16349-3 | Aluminum [Mass/volume] in Body fluid |
1635-2 | Somatotropin [Mass/volume] in Serum or Plasma --pre 1 g/kg glucose PO |
16350-1 | Amantadine [Susceptibility] by Serum bactericidal titer |
16351-9 | Amiloride [Units/volume] in Serum or Plasma |
16352-7 | Amiloride [Units/volume] in Urine |
16353-5 | Amino beta guanidinopropionate [Presence] in Urine |
16354-3 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Urine |
16355-0 | Amino beta guanidinopropionate [Presence] in Plasma |
16356-8 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Plasma |
16357-6 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Cerebral spinal fluid |
16358-4 | Deprecated Amino beta guanidinopropionate [Mass/volume] in Amniotic fluid |
16359-2 | Deprecated Amiodarone+Desethylamiodarone [Mass/volume] in Serum or Plasma |
1636-0 | Somatotropin [Mass/volume] in Serum or Plasma --pre 250 ug L-dopa TID 2day PO |
16360-0 | Amitriptyline [Mass/volume] in Serum or Plasma --peak |
16361-8 | Amitriptyline [Mass/volume] in Serum or Plasma --trough |
16362-6 | Ammonia [Moles/volume] in Plasma |
16363-4 | Ammonia [Moles/mass] in Tissue |
16364-2 | Amobarbital [Mass/volume] in Gastric fluid |
16365-9 | Amoxicillin+Clavulanate [Mass/volume] in Serum or Plasma |
16366-7 | Diethylpropion [Mass/volume] in Serum or Plasma |
16367-5 | Deprecated Amphetamine/Methamphetamine [Mass ratio] in Urine Qualitative |
16369-1 | Amphetamines [Presence] in Urine by Confirmatory method |
1637-8 | Somatotropin [Mass/volume] in Serum or Plasma --pre dose insulin IV |
16370-9 | Amphotericin B [Mass/volume] in Urine |
16373-3 | Amyl ether [Presence] in Blood |
16374-1 | Amyl nitrite [Mass/volume] in Serum or Plasma |
16378-2 | Androstenedione [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
16379-0 | Androstenedione [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
1638-6 | Testosterone [Mass/volume] in Serum or Plasma --96 hours post 5000 U HCG IM |
16380-8 | Androstenedione [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
16381-6 | Androstenedione [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
16382-4 | Androstenedione [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
16383-2 | Androstenedione [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16384-0 | Androstenedione [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
16385-7 | Androstenedione [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
16386-5 | Deprecated Rifabutin [Susceptibility] by Minimum inhibitory concentration (MIC) |
16387-3 | Rifabutin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
16388-1 | Anticonvulsants [Identifier] in Urine |
16389-9 | Antidepressants [Identifier] in Serum or Plasma |
1639-4 | Testosterone [Mass/volume] in Serum or Plasma --pre 5000 U HCG IM |
16390-7 | Antidiuretics [Identifier] in Urine |
16391-5 | Antimony [Presence] in Urine |
16392-3 | Nuclear Ab [Presence] in Serum by Rodent substrate |
16393-1 | Nuclear Ab [Units/volume] in Serum by Rodent substrate |
16394-9 | Nuclear Ab [Presence] in Body fluid by Immunofluorescence |
16395-6 | Antipsychotics [Identifier] in Urine |
164-4 | Cephapirin [Susceptibility] by Minimum lethal concentration (MLC) |
1640-2 | Thyrotropin [Mass/volume] in Serum or Plasma --30 minutes post dose TRH IV |
16400-4 | Appearance of Seminal plasma |
16401-2 | Arginine [Presence] in Urine |
16402-0 | Aromatic solvents [Identifier] in Blood |
16403-8 | Arsenic [Presence] in Serum or Plasma |
16404-6 | Arsenic [Presence] in Urine |
16405-3 | Arylamidase [Presence] in Urine |
16406-1 | Arylamidase [Enzymatic activity/volume] in Urine |
16407-9 | Asbestos identified in Sputum by Light microscopy |
16408-7 | Ascorbate [Mass/volume] in Urine |
16409-5 | Ascorbate [Mass/volume] in Serum or Plasma --post dose |
1641-0 | Thyrotropin [Mass/volume] in Serum or Plasma --1 hour post dose TRH IV |
16410-3 | Asparagine [Presence] in Urine |
16411-1 | Aspartate [Presence] in Urine |
16412-9 | Aspartate aminotransferase [Enzymatic activity/volume] in Red Blood Cells |
16414-5 | Aspergillus amstelodami Ab [Units/volume] in Serum |
16415-2 | Aspergillus flavus Ab [Presence] in Cerebral spinal fluid |
16416-0 | Aspergillus terreus Ab [Units/volume] in Serum |
16417-8 | Aspergillus versicolor Ab [Units/volume] in Serum |
16418-6 | Azatadine [Presence] in Urine |
16419-4 | Azathioprine [Mass/volume] in Serum or Plasma |
1642-8 | Thyrotropin [Mass/volume] in Serum or Plasma --baseline |
16420-2 | Azithromycin [Mass/volume] in Serum or Plasma |
16421-0 | Azithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
16422-8 | Azlocillin [Mass/volume] in Urine |
16423-6 | Aztreonam [Mass/volume] in Urine |
16424-4 | Deprecated Sulfasalazine [Mass/volume] in Serum or Plasma |
16425-1 | Babesia sp IgM Ab [Units/volume] in Serum by Immunofluorescence |
16426-9 | Babesia sp IgM Ab [Titer] in Serum |
16427-7 | Babesia microti Ab [Titer] in Serum |
16428-5 | Bacitracin [Mass/volume] in Serum or Plasma |
16429-3 | Barbiturates [Presence] in Urine by Confirmatory method |
1643-6 | Thyrotropin [Mass/volume] in Serum or Plasma --pre dose TRH IV |
16430-1 | Barbiturates [Units/volume] in Urine |
16431-9 | Barium [Presence] in Urine |
16432-7 | Barium [Mass/volume] in Blood |
16433-5 | Basement membrane Ab [Presence] in Serum |
16434-3 | Basement membrane Ab [Units/volume] in Serum by Immunofluorescence |
16435-0 | Deprecated White Bean IgE Ab [Units/volume] in Serum |
16436-8 | Deprecated Bean string IgE Ab [Units/volume] in Serum |
16437-6 | Bendroflumethiazide [Units/volume] in Urine |
16438-4 | Benzaldehyde [Presence] in Urine |
16439-2 | Benzene [Presence] in Blood |
1644-4 | Triglyceride [Mass/volume] in Serum or Plasma --12 hours fasting |
16440-0 | Benzene ring IgE Ab [Units/volume] in Serum |
16441-8 | Benzene ring IgG Ab [Units/volume] in Serum |
16442-6 | Benzene ring IgM Ab [Units/volume] in Serum |
16443-4 | Benzonatate [Mass/volume] in Serum |
16444-2 | Benzophenone [Mass/volume] in Serum or Plasma |
16446-7 | Benzoylecgonine [Presence] in Serum or Plasma by Confirmatory method |
16447-5 | Cocaine [Units/volume] in Serum or Plasma |
16448-3 | Cocaine [Units/volume] in Urine |
16449-1 | Benzthiazide [Mass/volume] in Serum or Plasma |
1645-1 | Xylose [Mass/volume] in Blood --2 hours post 25 g xylose PO |
16450-9 | Benzylhydrazine [Mass/volume] in Serum or Plasma |
16451-7 | Beryllium [Presence] in Urine |
16452-5 | Beta alanine [Presence] in Urine |
16453-3 | Beta aminoisobutyrate [Presence] in Urine |
16454-1 | Beta galactosidase [Enzymatic activity/volume] in Blood |
16455-8 | Beta hydroxybutyrate [Moles/volume] in Cerebral spinal fluid |
16456-6 | Beta hydroxybutyrate [Moles/volume] in Urine |
16457-4 | Beta-N-acetylhexosaminidase.A [Enzymatic activity/volume] in Leukocytes |
16458-2 | Bethanechol [Mass/volume] in Serum or Plasma |
16459-0 | Bicarbonate [Moles/volume] in Body fluid |
1646-9 | Xylose [Mass/time] in 5 hour Urine --post dose PO |
16460-8 | Bicarbonate [Moles/volume] in Cerebral spinal fluid |
16461-6 | Bicarbonate [Moles/volume] in Red Blood Cells |
16462-4 | Bicarbonate [Moles/volume] in Amniotic fluid |
16463-2 | Bile acid.dihydroxy [Mass/volume] in Serum |
16464-0 | Bile acid [Units/volume] in Exhaled gas |
16465-7 | Bile acid [Mass/volume] in Urine |
16466-5 | Bile acid.trihydroxy [Mass/volume] in Serum |
16467-3 | Bismuth [Presence] in Blood |
16468-1 | Bismuth [Presence] in Urine |
16469-9 | Bismuth/Creatinine [Mass Ratio] in Urine |
1647-7 | Tuberculosis reaction wheal [Diameter] --3 days post 25 TU intradermal |
16470-7 | Blastomyces dermatitidis Ab [Presence] in Serum by Complement fixation |
16471-5 | Blastomyces dermatitidis Ab [Units/volume] in Serum |
16472-3 | Blastomyces dermatitidis rRNA [Presence] in Serum by DNA probe |
16473-1 | Bordetella parapertussis Ab [Units/volume] in Serum |
16474-9 | Bordetella pertussis Ab [Units/volume] in Serum by Complement fixation |
16475-6 | Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid by Immunoassay |
16476-4 | Borrelia burgdorferi Ab [Presence] in Body fluid by Immunoassay |
16477-2 | Borrelia burgdorferi Ab [Presence] in Body fluid |
16478-0 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoassay |
16479-8 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoassay |
1648-5 | Tuberculosis reaction wheal [Diameter] --3 days post 5 TU intradermal |
16480-6 | Borrelia burgdorferi IgG Ab [Presence] in Serum by Immunoassay |
16481-4 | Borrelia burgdorferi IgG Ab [Units/volume] in Body fluid by Immunoassay |
16482-2 | Borrelia burgdorferi IgM Ab [Units/volume] in Body fluid by Immunoassay |
16483-0 | Borrelia hermsii [Presence] in Unspecified specimen by Organism specific culture |
16484-8 | Boysenberry IgE Ab [Units/volume] in Serum |
16485-5 | Bromodiphenhydramine [Mass/volume] in Urine |
16486-3 | Brucella abortus IgA+IgG+IgM Ab [Units/volume] in Serum |
16487-1 | Brucella abortus IgG Ab [Units/volume] in Serum by Agglutination |
16488-9 | Brucella abortus IgG Ab [Units/volume] in Serum by Complement fixation |
16489-7 | Brucella melitensis Ab [Units/volume] in Serum by Latex agglutination |
1649-3 | Calcitriol [Mass/volume] in Serum or Plasma |
16490-5 | Brucella suis Ab [Units/volume] in Serum by Latex agglutination |
16491-3 | Brush border Ab [Presence] in Serum by Immunofluorescence |
16492-1 | Bufotenine [Units/volume] in Urine |
16493-9 | Bufotenine [Units/volume] in Serum or Plasma |
16494-7 | Bumetanide [Units/volume] in Urine |
16495-4 | Buprenorphine [Units/volume] in Serum or Plasma |
16496-2 | Buprenorphine [Units/volume] in Urine |
16497-0 | Butabarbital [Mass/volume] in Gastric fluid |
16498-8 | Butalbital [Units/volume] in Gastric fluid |
16499-6 | Butorphanol [Mass/volume] in Urine by Confirmatory method |
165-1 | Cephapirin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1650-1 | 1,4-Alpha glucan branching enzyme [Enzymatic activity/volume] in Leukocytes |
16500-1 | Butyrate (C4) [Mass/volume] in Stool |
16501-9 | C peptide [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16502-7 | C peptide [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
16503-5 | C reactive protein [Mass/volume] in Body fluid |
16504-3 | Calcitonin [Mass/volume] in Serum or Plasma --1.5 minutes post XXX challenge |
16505-0 | Calcitonin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
16506-8 | Calcitonin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
16507-6 | Calcitonin [Mass/volume] in Serum or Plasma --4 hours post XXX challenge |
16508-4 | Calcitonin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
16509-2 | Calcitonin [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
1651-9 | 1-Methylhistidine [Presence] in Serum or Plasma |
16510-0 | Calcitonin [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
16511-8 | Calcitonin [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
16512-6 | Calcium.ionized [Moles/volume] in Serum or Plasma --2nd specimen post XXX challenge |
16513-4 | Calcium.ionized [Moles/volume] in Serum or Plasma --3rd specimen post XXX challenge |
16514-2 | Calcium.ionized [Moles/volume] in Serum or Plasma --4th specimen post XXX challenge |
16515-9 | Calcium.ionized [Moles/volume] in Serum or Plasma --5th specimen post XXX challenge |
16516-7 | Calcium.ionized [Moles/volume] in Serum or Plasma --6th specimen post XXX challenge |
16517-5 | Calcium.ionized [Moles/volume] in Serum or Plasma --7th specimen post XXX challenge |
16518-3 | Calcium [Mass/time] in 2 hour Urine |
16519-1 | Calcium [Moles/volume] in Serum or Plasma --10 minutes post XXX challenge |
1652-7 | 1-Methylhistidine [Mass/volume] in Serum or Plasma |
16520-9 | Calcium [Moles/volume] in Urine --2nd specimen post XXX challenge |
16521-7 | Calcium [Moles/volume] in Urine --3rd specimen post XXX challenge |
16522-5 | Calcium [Moles/volume] in Urine --4th specimen post XXX challenge |
16523-3 | Calcium [Moles/volume] in Serum or Plasma --5 minutes post XXX challenge |
16524-1 | Calcium [Moles/volume] in Serum or Plasma --6 hours post XXX challenge |
16525-8 | Calcium/Phosphate [Mass Ratio] in Serum or Plasma |
16526-6 | Calcium/Protein [Mass Ratio] in Serum or Plasma |
16527-4 | Calcium/Sodium [Mass Ratio] in Serum or Plasma |
16528-2 | Campylobacter coli rRNA [Units/volume] in Serum by DNA probe |
16529-0 | Campylobacter jejuni rRNA [Units/volume] in Serum by DNA probe |
1653-5 | 1-Methylhistidine [Mass/volume] in Urine |
16530-8 | Campylobacter jejuni rRNA [Presence] in Serum by DNA probe |
16531-6 | Campylobacter lari rRNA [Units/volume] in Serum by DNA probe |
16532-4 | Campylobacter lari rRNA [Presence] in Serum by DNA probe |
16533-2 | Helicobacter pylori Ab [Titer] in Serum |
16534-0 | Campylobacter sp rRNA [Presence] in Serum by DNA probe |
16535-7 | Canary droppings IgE Ab [Units/volume] in Serum |
16536-5 | Canary serum proteins Ab [Units/volume] in Serum |
16537-3 | Candida albicans Ab [Units/volume] in Serum by Immune diffusion (ID) |
16538-1 | Candida sp IgA Ab [Units/volume] in Saliva (oral fluid) |
16539-9 | Candida sp Ag [Presence] in Serum |
1654-3 | 1-Naphthalene [Mass/volume] in Urine |
16540-7 | Deprecated Cannabinoids [Presence] in Serum or Plasma by Confirm method |
16542-3 | Cannabinoids [Mass/volume] in Serum or Plasma by Confirmatory method |
16543-1 | Cannabinoids [Mass/volume] in Unknown substance by Confirmatory method |
16544-9 | Canrenone [Units/volume] in Urine |
16545-6 | Capreomycin [Mass/volume] in Serum or Plasma |
16546-4 | Captopril [Mass/volume] in Serum or Plasma |
16547-2 | Carbamate pesticides [Type] in Urine |
16548-0 | Carbamazepine [Mass/volume] in Urine |
16549-8 | Carbinoxamine [Presence] in Urine |
1655-0 | Deprecated 11-Deoxy/11-Oxy steroids in Urine |
16550-6 | Carbohydrates [Identifier] in Urine |
16551-4 | Carbon dioxide, total [Moles/volume] in Capillary blood |
16553-0 | Carnitine [Mass/mass] in Tissue |
16555-5 | Carnitine [Mass/volume] in Cerebral spinal fluid |
16556-3 | Carnitine [Mass/volume] in Amniotic fluid |
16557-1 | Carnosine [Presence] in Urine |
16558-9 | Catecholamines [Mass/volume] in Plasma --2 hours post XXX challenge |
16559-7 | Catecholamines [Mass/volume] in Plasma --3 hours post XXX challenge |
1656-8 | 11-Deoxycorticosterone [Mass/volume] in Serum or Plasma |
16560-5 | Catecholamines [Mass/volume] in Plasma --5th specimen post XXX challenge |
16561-3 | Catecholamines [Mass/volume] in Plasma --6th specimen post XXX challenge |
16562-1 | Cathartic laxatives [Identifier] in Urine |
16563-9 | Cathepsin D in Serum or Plasma |
16564-7 | Cefaclor [Mass/volume] in Serum or Plasma |
16565-4 | Cefadroxil [Mass/volume] in Serum or Plasma |
16566-2 | Cefazolin [Mass/volume] in Urine |
16567-0 | Cefixime [Mass/volume] in Serum or Plasma |
16568-8 | Cefuroxime IgE Ab [Units/volume] in Serum |
16569-6 | Ceftriaxone IgE Ab [Mass/volume] in Serum |
1657-6 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma |
16570-4 | Centromere Ab [Presence] in Serum by Immunofluorescence |
16571-2 | Cephadrine [Mass/volume] in Serum or Plasma |
16572-0 | Cephaloridine [Mass/volume] in Serum or Plasma |
16573-8 | Deprecated Cerebroside sulfatase [Presence] in Serum or Plasma |
16574-6 | Deprecated Cerebroside sulfatase [Enzymatic activity/mass] in Tissue |
16575-3 | Deprecated Cerebroside sulfatase B in urine |
16576-1 | Deprecated Cerebroside sulfatase B in amniotic fluid |
16577-9 | Deprecated Cerebroside sulfatase B in serum or plasma |
16578-7 | Deprecated Cerebroside sulfatase B in tissue |
16579-5 | Deprecated Cerebroside sulfatase B in blood |
1658-4 | 11-Hydroxyandrostenedione [Mass/volume] in Serum or Plasma |
16580-3 | Deprecated Cerebroside sulfatase B in leukocytes |
16581-1 | Chlamydophila pneumoniae IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16582-9 | Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16583-7 | Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16584-5 | Chlamydophila pneumoniae rRNA [Presence] in Sputum by DNA probe |
16585-2 | Chlamydophila pneumoniae rRNA [Presence] in Serum or Plasma by DNA probe |
16586-0 | Chlamydophila psittaci IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16587-8 | Chlamydophila psittaci IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16588-6 | Chlamydophila psittaci IgM Ab [Units/volume] in Cerebral spinal fluid |
16589-4 | Chlamydia sp Ab [Units/volume] in Serum by Immunofluorescence |
1659-2 | 11-Hydroxyandrosterone [Mass/volume] in Urine |
16590-2 | Chlamydia sp Ab [Units/volume] in Serum by Complement fixation |
16591-0 | Chlamydia sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
16592-8 | Chlamydia sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
16593-6 | Chlamydia sp Ag [Presence] in Urine |
16594-4 | Chlamydia trachomatis IgA Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
16595-1 | Chlamydia trachomatis IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
16596-9 | Chlamydia trachomatis IgM Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
16597-7 | Chlamydia trachomatis B IgG Ab [Units/volume] in Serum |
16598-5 | Chlamydia trachomatis C IgG Ab [Units/volume] in Serum |
16599-3 | Chlamydia trachomatis DNA [Presence] in Blood by Probe and target amplification method |
166-9 | Cephapirin [Susceptibility] by Disk diffusion (KB) |
1660-0 | 11-Hydroxyetiocholanolone [Mass/volume] in Serum |
16600-9 | Chlamydia trachomatis rRNA [Presence] in Genital specimen by DNA probe |
16601-7 | Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
16602-5 | Deprecated Chlamydia trachomatis rRNA [Presence] in Urine by DNA probe |
16603-3 | Chloramphenicol [Mass/volume] in Serum or Plasma --peak |
16604-1 | Chloramphenicol [Mass/volume] in Serum or Plasma --trough |
16605-8 | Chlorocycline [Mass/volume] in Urine |
16606-6 | Chlorine [Mass/volume] in Dialysis fluid |
16607-4 | Chlorine [Mass/volume] in Water |
16608-2 | Chlorpheniramine [Units/volume] in Urine |
16609-0 | Chlorphentermine [Units/volume] in Blood |
1661-8 | 11-Ketoandrosterone [Mass/volume] in Serum |
16610-8 | Chlorphentermine [Units/volume] in Urine |
16611-6 | Chlorpyrifos [Mass/volume] in Urine |
16612-4 | Chlorthalidone [Mass/volume] in Serum or Plasma |
16613-2 | Cholesterol crystals [Presence] in Stone by Infrared spectroscopy |
16614-0 | Cholesterol crystals [Presence] in Body fluid by Light microscopy |
16615-7 | Cholesterol.total/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
16616-5 | Cholesterol in HDL/Cholesterol in LDL [Mass Ratio] in Serum or Plasma |
16617-3 | Choriogonadotropin.intact [Moles/volume] in Semen |
16618-1 | Cladosporium herbarum Ab [Units/volume] in Serum |
16619-9 | Clarithromycin [Mass/volume] in Serum or Plasma |
1662-6 | 11-Ketoetiocholanolone [Mass/volume] in Serum |
16620-7 | Clarithromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
16621-5 | Clindamycin [Mass/volume] in Serum or Plasma --peak |
16622-3 | Clindamycin [Mass/volume] in Serum or Plasma --trough |
16623-1 | Clofazimine [Susceptibility] by Minimum inhibitory concentration (MIC) |
16624-9 | Clomipramine [Units/volume] in Milk |
16625-6 | Clomipramine [Mass/volume] in Milk |
16626-4 | Clostridium tetani Ab [Units/volume] in Serum --1st specimen |
16627-2 | Clostridium tetani Ab [Units/volume] in Serum --2nd specimen |
16628-0 | Cloxacillin [Mass/volume] in Serum or Plasma |
16629-8 | Deprecated Activated partial thrombplastin time (aPTT) in Blood from control by Coagulation assay |
1663-4 | 11-Oxycorticosterone [Mass/volume] in Serum |
16630-6 | aPTT in control Blood by Coagulation 1:1 saline |
16631-4 | aPTT in Blood by Coagulation 1:1 saline |
16632-2 | Cocaethylene [Mass/volume] in Urine by Confirmatory method |
16633-0 | Cocaine [Presence] in Blood |
16634-8 | Coccidioides immitis Ab [Units/volume] in Cerebral spinal fluid |
16635-5 | Coccidioides immitis IgA Ab [Units/volume] in Serum by Immunoassay |
16636-3 | Coccidioides immitis IgA Ab [Units/volume] in Cerebral spinal fluid |
16637-1 | Coccidioides immitis IgE Ab [Units/volume] in Serum |
16638-9 | Coccidioides immitis IgG Ab [Units/volume] in Cerebral spinal fluid |
16639-7 | Coccidioides immitis IgM Ab [Units/volume] in Cerebral spinal fluid |
1664-2 | 17-Hydroxycorticosteroids [Mass/volume] in Amniotic fluid |
16640-5 | Coccidioides reaction wheal [Diameter] |
16641-3 | Cockatiel droppings Ab [Units/volume] in Serum |
16642-1 | Cockatiel droppings IgG Ab [Units/volume] in Serum |
16643-9 | Cockatoo droppings Ab [Units/volume] in Serum |
16644-7 | Codeine Free [Presence] in Serum or Plasma by Confirmatory method |
16645-4 | Colistin [Mass/volume] in Serum or Plasma |
16647-0 | Collagen Ab [Units/volume] in Serum |
16648-8 | Copper [Mass/volume] in Body fluid |
16649-6 | Coproporphyrinogen oxidase [Enzymatic activity/volume] in Red Blood Cells |
1665-9 | 17-Hydroxycorticosteroids [Mass/volume] in Plasma |
16650-4 | Cilantro IgE Ab [Units/volume] in Serum |
16651-2 | Corticosterone [Mass/volume] in Serum or Plasma --post XXX challenge |
16652-0 | Corticotropin [Mass/volume] in Amniotic fluid by Radioimmunoassay (RIA) |
16653-8 | Corticotropin Canine [Mass/volume] in Plasma |
16654-6 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1.5 hours post XXX challenge |
16655-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --10 minutes post XXX challenge |
16656-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --15 minutes post XXX challenge |
16657-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 hour post XXX challenge |
16658-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --1 minute post XXX challenge |
16659-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2.5 hours post XXX challenge |
1666-7 | 17-Hydroxycorticosteroids [Mass/volume] in Urine |
16660-3 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --20 minutes post XXX challenge |
16661-1 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --2 hours post XXX challenge |
16662-9 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --30 minutes post XXX challenge |
16663-7 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --3 hours post XXX challenge |
16664-5 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --45 minutes post XXX challenge |
16665-2 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --5 minutes post XXX challenge |
16666-0 | Corticotropin [Mass/volume] in Plasma by Radioimmunoassay (RIA) --9th specimen post XXX challenge |
16667-8 | Cortisol Free [Mass/time] in 48 hour Urine |
16668-6 | Cortisol Free [Mass/time] in 72 hour Urine |
16669-4 | Cortisol [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
1667-5 | 17-Hydroxyketosteroids [Mass/volume] in Urine |
16670-2 | Cortisol [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
16671-0 | Cortisol [Mass/volume] in Serum or Plasma --1 minute post XXX challenge |
16672-8 | Cortisol [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
16673-6 | Cortisol [Mass/volume] in Serum or Plasma --50 minutes post XXX challenge |
16674-4 | Cortisol [Mass/volume] in Serum or Plasma --70 minutes post XXX challenge |
16675-1 | Cortisol [Mass/volume] in Serum or Plasma --80 minutes post XXX challenge |
16676-9 | Corynebacterium diphtheriae [Presence] in Unspecified specimen by Organism specific culture |
16677-7 | Coxiella burnetii IgG Ab [Units/volume] in Serum |
16678-5 | Coxiella burnetii IgM Ab [Units/volume] in Serum |
16679-3 | Coxsackievirus A Ab [Units/volume] in Serum |
1668-3 | 17-Hydroxyprogesterone [Mass/volume] in Serum or Plasma |
16680-1 | Coxsackievirus A IgG Ab [Units/volume] in Serum |
16681-9 | Coxsackievirus A IgM Ab [Units/volume] in Serum |
16682-7 | Coxsackievirus A2 Ab [Titer] in Cerebral spinal fluid |
16683-5 | Coxsackievirus A4 Ab [Titer] in Cerebral spinal fluid |
16684-3 | Coxsackievirus B Ab [Units/volume] in Serum |
16685-0 | Coxsackievirus B IgG Ab [Units/volume] in Serum by Neutralization test |
16686-8 | Coxsackievirus B IgM Ab [Units/volume] in Serum by Neutralization test |
16687-6 | Creatine [Mass/volume] in Vitreous fluid |
16688-4 | Creatine kinase [Enzymatic activity/volume] in Body fluid |
16689-2 | Creatinine [Mass/time] in 48 hour Urine |
1669-1 | Deprecated 17-Hydroxyprogesterone [Mass/volume] in Serum |
16690-0 | Creatinine [Mass/time] in 72 hour Urine |
16691-8 | Cresols [Identifier] in Unspecified specimen |
16692-6 | Cryptococcus sp Ag [Presence] in Body fluid |
16693-4 | Cryptococcus sp Ag [Presence] in Urine |
16694-2 | Cumene [Presence] in Blood |
16695-9 | Cobalamin (Vitamin B12) [Mass/volume] in Blood |
16696-7 | Cobalamin (Vitamin B12) [Mass/volume] in Urine --post XXX challenge |
16697-5 | Cyclohexane [Presence] in Blood |
16698-3 | Cyclohexanol [Mass/volume] in Blood |
16699-1 | Cyclohexanol [Mass/volume] in Urine |
167-7 | Cephapirin [Susceptibility] by Serum bactericidal titer |
1670-9 | 17-Hydroxyprogesterone [Mass/volume] in Urine |
16700-7 | Cyclohexanol/Creatinine [Mass Ratio] in Urine |
16701-5 | Cyclopropane [Presence] in Blood |
16702-3 | Cycloserine [Mass/volume] in Urine |
16703-1 | Cyclosporine [Mass/volume] in Plasma |
16704-9 | Cyproheptadine [Mass/volume] in Serum or Plasma |
16705-6 | Cystathionine [Presence] in Urine |
16706-4 | Taenia solium larva IgM Ab [Units/volume] in Cerebral spinal fluid |
16707-2 | Taenia solium larva IgM Ab [Units/volume] in Serum |
16708-0 | Taenia solium larva Ab [Units/volume] in Cerebral spinal fluid |
16709-8 | Cystine [Units/volume] in Urine |
1671-7 | 17-Ketogenic steroids [Mass/volume] in Blood |
16710-6 | Cystine crystals [Presence] in Stone by Infrared spectroscopy |
16711-4 | Cystine+Homocystine [Presence] in Urine |
16712-2 | Cytomegalovirus Ab [Units/volume] in Body fluid |
16713-0 | Cytomegalovirus Ab [Units/volume] in Cerebral spinal fluid |
16714-8 | Cytomegalovirus Ab [Units/volume] in Serum by Latex agglutination |
16715-5 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunofluorescence |
16716-3 | Cytomegalovirus IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
16717-1 | Cytomegalovirus Ag [Presence] in Urine by Immunoassay |
16718-9 | Cytomegalovirus Ag [Presence] in Blood |
16719-7 | Cytomegalovirus inclusion bodies [Presence] in Urine by Microscopic observation |
1672-5 | Deprecated 17-Ketogenic steroids [Mass/volume] in Blood |
16720-5 | Dechlorane [Presence] in Blood |
16721-3 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Saliva (oral fluid) |
16722-1 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --10th specimen post XXX challenge |
16723-9 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
16724-7 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --3rd specimen post XXX challenge |
16725-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --4th specimen post XXX challenge |
16726-2 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --5th specimen post XXX challenge |
16727-0 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge |
16728-8 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16729-6 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
1673-3 | 17-Ketogenic steroids [Mass/time] in 24 hour Urine |
16730-4 | Dehydroepiandrosterone sulfate (DHEA-S) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
16731-2 | Deprecated Dehydroepiandrosterone.unconjugated [Mass/volume] in Serum or Plasma |
16732-0 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
16733-8 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
16734-6 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --baseline |
16735-3 | Dehydroepiandrosterone (DHEA) [Mass/volume] in Serum or Plasma --post XXX challenge |
16736-1 | Dengue virus 1 Ab [Titer] in Serum |
16737-9 | Dengue virus 2 Ab [Titer] in Serum |
16738-7 | Dengue virus 3 Ab [Titer] in Serum |
16739-5 | Dengue virus 4 Ab [Titer] in Serum |
1674-1 | 18-Hydroxycorticosterone [Mass/volume] in Serum or Plasma |
16740-3 | Dengue virus Ab [Presence] in Serum |
16741-1 | American house dust mite IgG Ab [Presence] in Blood |
16742-9 | European house dust mite IgG Ab [Presence] in Blood |
16743-7 | Deprecated Nordiazepam [Presence] in Serum or Plasma |
16744-5 | Deprecated Nordiazepam [Presence] in Urine |
16745-2 | Deprecated Desmethylmethsuximide [Mass/volume] in Serum or Plasma |
16746-0 | Nortrimipramine [Mass/volume] in Serum or Plasma |
16747-8 | Dextromoramide [Presence] in Serum or Plasma |
16748-6 | Propoxyphene [Presence] in Serum or Plasma by Confirmatory method |
16749-4 | Propoxyphene + Norpropoxyphene [Units/volume] in Urine |
1675-8 | 2,3-Diphosphoglycerate [Mass/volume] in Red Blood Cells |
16750-2 | Dezocine [Mass/volume] in Serum or Plasma |
16751-0 | Dezocine [Mass/volume] in Blood |
16752-8 | Deprecated Diacetate [Presence] in Urine |
16753-6 | Deprecated Dialtrazene |
16754-4 | Diamorphine [Mass/volume] in Unknown substance |
16755-1 | Diamorphine [Mass/volume] in Urine by Confirmatory method |
16756-9 | Diamorphine [Mass/volume] in Serum or Plasma by Confirmatory method |
16757-7 | Diazepam+Nordiazepam [Mass/volume] in Serum or Plasma |
16758-5 | Dicamba [Mass/volume] in Serum or Plasma |
16759-3 | Dicamba [Mass/volume] in Urine |
1676-6 | 2,3-Diphosphoglycerate [Mass/volume] in Serum |
16760-1 | Deprecated Dicarboxylporphyrin [Mass/volume] in Blood |
16761-9 | Protoporphyrin [Mass/volume] in Stool |
16762-7 | Dichlorobenzene [Mass/volume] in Blood |
16763-5 | Dichlorodiphenyldichloroethylene [Mass/volume] in Urine |
16764-3 | Dichlorodiphenyldichloroethylene [Mass/volume] in Blood |
16765-0 | Dichlorodiphenyltrichloroethane [Mass/volume] in Milk |
16766-8 | Dichloroethane [Presence] in Blood |
16767-6 | Deprecated 2,4-Dichlorophenoxyacetate [Mass/volume] in Urine |
16768-4 | Dichlorvos [Mass/volume] in Urine |
16769-2 | Dicloxacillin [Mass/volume] in Urine |
1677-4 | Alpha hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
16770-0 | Dicoumarol [Mass/volume] in Urine |
16771-8 | Dicyclomine [Mass/volume] in Serum or Plasma |
16772-6 | Dieldrin [Mass/volume] in Urine |
16773-4 | Dieldrin [Mass/volume] in Blood |
16774-2 | Diethylcarbamazepine [Mass/volume] in Serum or Plasma |
16775-9 | Dihydrocodeine Free [Presence] in Serum or Plasma by Confirmatory method |
16776-7 | Diltiazem [Mass/volume] in Urine |
16777-5 | Dimethylacetamide [Presence] in Urine |
16778-3 | Dinitrophenol [Presence] in Serum or Plasma |
16779-1 | Dinitrophenol [Mass/volume] in Urine |
1678-2 | 20-Hydroxyprogesterone [Mass/volume] in Serum |
16780-9 | Disopyramide [Mass/volume] in Urine |
16781-7 | Disulfiram [Presence] in Urine |
16782-5 | Deprecated DNA double strand Ab [Presence] in Serum by Farr method |
16784-1 | Dopamine [Mass/volume] in Urine --2nd specimen post XXX challenge |
16785-8 | Dopamine [Mass/volume] in Urine --3rd specimen post XXX challenge |
16786-6 | Dopamine [Mass/volume] in Urine --4th specimen post XXX challenge |
16787-4 | Dopamine [Mass/volume] in Urine --5th specimen post XXX challenge |
16788-2 | Dopamine [Mass/volume] in Urine --6th specimen post XXX challenge |
16789-0 | Dopamine [Mass/volume] in Urine --7th specimen post XXX challenge |
1679-0 | 24r-Hydroxycalcidiol [Mass/volume] in Serum or Plasma |
16790-8 | Deprecated Doxepin+Desmethyldoxepin [Mass/volume] in Serum or Plasma |
16791-6 | Doxylamine [Mass/volume] in Serum or Plasma |
16792-4 | Doxylamine [Mass/volume] in Urine |
16793-2 | Drugs identified in Unknown substance by Screen method |
16794-0 | Echinococcus sp IgM Ab [Units/volume] in Serum |
16795-7 | Echovirus Ab [Units/volume] in Serum |
16796-5 | Echovirus Ab [Units/volume] in Serum by Complement fixation |
16797-3 | Echovirus 1 Ab [Units/volume] in Serum by Complement fixation |
16798-1 | Echovirus 14 Ab [Units/volume] in Serum |
16799-9 | Deprecated Echovirus 140 Ab by complement fixation |
168-5 | Cephradine [Susceptibility] by Minimum lethal concentration (MLC) |
1680-8 | 3-Alpha-Androstanediol glucuronide [Mass/volume] in Serum |
16800-5 | Echovirus 19 Ab [Units/volume] in Serum by Complement fixation |
16801-3 | Echovirus 3 Ab [Units/volume] in Serum by Complement fixation |
16802-1 | Echovirus 30 Ab [Units/volume] in Serum |
16803-9 | Echovirus 4 Ab [Units/volume] in Serum by Complement fixation |
16804-7 | Echovirus 40 Ab [Units/volume] in Serum |
16805-4 | Echovirus 6 Ab [Units/volume] in Serum by Complement fixation |
16806-2 | Echovirus 6+18+30 Ab [Units/volume] in Serum |
16807-0 | Echovirus 9 Ab [Units/volume] in Serum by Complement fixation |
16808-8 | Anaplasma phagocytophilum IgG Ab [Units/volume] in Serum |
16809-6 | Anaplasma phagocytophilum IgM Ab [Units/volume] in Serum |
1681-6 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Blood |
16811-2 | Arachidate (C20:0) [Mass/volume] in Serum or Plasma |
16812-0 | Emetine [Presence] in Serum or Plasma |
16813-8 | Emetine [Units/volume] in Serum or Plasma |
16814-6 | Endomysium Ab [Presence] in Serum by Immunofluorescence |
16815-3 | Endomysium Ab [Units/volume] in Serum by Immunofluorescence |
16816-1 | Enoxacin [Mass/volume] in Urine |
16817-9 | Entamoeba histolytica Ab [Presence] in Serum by Immune diffusion (ID) |
16818-7 | Entamoeba histolytica Ab [Units/volume] in Cerebral spinal fluid |
16819-5 | Entamoeba histolytica Ab [Units/volume] in Serum by Immunofluorescence |
1682-4 | Beta hydroxybutyrate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma |
16820-3 | Entamoeba histolytica Ab [Units/volume] in Serum by Complement fixation |
16821-1 | Epinephrine [Mass/volume] in Plasma --4 hours post XXX challenge |
16822-9 | Epithelial cells [Presence] in Nose by Light microscopy |
16823-7 | Epstein Barr virus early Ab [Units/volume] in Serum by Immunoassay |
16824-5 | Epstein Barr virus nuclear Ab [Presence] in Cerebral spinal fluid |
16825-2 | Epstein Barr virus nuclear IgG Ab [Presence] in Body fluid |
16826-0 | Epstein Barr virus capsid IgG Ab [Units/volume] in Cerebral spinal fluid |
16827-8 | Epstein Barr virus capsid IgG Ab [Presence] in Cerebral spinal fluid |
16828-6 | Erythrocytes [#/volume] in Seminal plasma by Manual count |
16829-4 | Erythromycin [Mass/volume] in Urine |
1683-2 | 3-Hydroxyisovalerate [Mass/volume] in Urine |
16830-2 | Erythromycin+Ethambutol [Susceptibility] by Minimum inhibitory concentration (MIC) |
16832-8 | Escherichia coli enterotoxic identified in Stool by Organism specific culture |
16833-6 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Immunoassay |
16834-4 | Escherichia coli K1 Ag [Presence] in Unspecified specimen by Latex agglutination |
16835-1 | Escherichia coli shiga-like identified in Stool by Organism specific culture |
16836-9 | Escherichia coli verotoxic identified in Stool by Organism specific culture |
16838-5 | Estriol (E3) [Mass/volume] in Body fluid |
1684-0 | 3-Methoxy-4-Hydroxyphenylglycol [Mass/volume] in Urine |
16840-1 | Ethacrynate [Mass/volume] in Serum or Plasma |
16841-9 | Ethambutol+Rifampin [Susceptibility] by Minimum inhibitory concentration (MIC) |
16842-7 | Ethanol [Mass/volume] in Unknown substance |
16843-5 | Ethanol [Mass/volume] in Body fluid |
16844-3 | Ethinamate [Presence] in Serum or Plasma by Confirmatory method |
16845-0 | Ethionamide [Mass/volume] in Serum or Plasma |
16847-6 | Ethoheptazine [Presence] in Serum or Plasma |
16848-4 | Ethoheptazine [Mass/volume] in Serum or Plasma |
16849-2 | Ethyl benzene [Mass/volume] in Urine |
1685-7 | 3-Methylhistidine [Presence] in Serum or Plasma |
16850-0 | Ethylene oxide [Mass/volume] in Blood |
16851-8 | Ethylmorphine [Units/volume] in Urine |
16852-6 | Etodolac [Mass/volume] in Serum or Plasma |
16853-4 | Fat [Mass] in Stool |
16855-9 | Fat [Mass/time] in 48 hour Stool |
16856-7 | Fat.microscopic observation [Identifier] in Synovial fluid by Sudan IV stain |
16857-5 | Fenclorvos [Presence] in Blood |
16858-3 | Fentanyl [Mass/volume] in Body fluid |
16859-1 | Fibrinogen [Presence] in Platelet poor plasma |
1686-5 | 3-Methylhistidine [Mass/volume] in Serum or Plasma |
16860-9 | Fibrinopeptide A Ag [Units/volume] in Peritoneal fluid by Immunologic method |
16861-7 | Fibrinopeptide A Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16862-5 | Fibrinopeptide B Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16863-3 | Fibrinopeptide B beta (1-14) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16864-1 | Fibrinopeptide B beta (1-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16865-8 | Fibrinopeptide B beta (15-42) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16866-6 | Fibrinopeptide B beta (43-47) Ag [Units/volume] in Platelet poor plasma by Immunologic method |
16867-4 | Fibronectin aggregate IgG Ab [Mass/volume] in Serum |
16868-2 | Finch droppings IgE Ab [Presence] in Serum |
16869-0 | Deprecated Flurbiprofen [Mass/volume] in Serum or Plasma |
1687-3 | 3-Methylhistidine [Mass/volume] in Urine |
16870-8 | Fluconazole [Mass/volume] in Urine |
16871-6 | Fluoride [Units/volume] in Bone |
16872-4 | Fluorocarbons [Identifier] in Serum or Plasma |
16873-2 | Follitropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
16874-0 | Formate+Formaldehyde [Mass/volume] in Blood |
16875-7 | Francisella tularensis Ab [Titer] in Serum |
16876-5 | Francisella tularensis IgA Ab [Presence] in Serum by Latex agglutination |
16877-3 | Francisella tularensis IgG Ab [Presence] in Serum by Latex agglutination |
16878-1 | Francisella tularensis IgM Ab [Units/volume] in Serum |
16879-9 | Francisella tularensis Ag [Presence] in Serum by Immunofluorescence |
1688-1 | 4-Pyridoxate [Mass/volume] in Serum or Plasma |
16881-5 | Gallium [Mass/volume] in Blood |
16882-3 | Gamma aminobutyrate [Presence] in Urine |
16883-1 | Deprecated Gamma aminobutyrate [Mass/volume] in Urine |
16884-9 | Deprecated Gamma aminobutyrate [Presence] in Serum or Plasma |
16885-6 | Deprecated Gamma aminobutyrate [Mass/volume] in Serum or Plasma |
16886-4 | Deprecated Gamma aminobutyrate [Mass/volume] in Cerebral spinal fluid |
16887-2 | Gamma aminobutyrate [Mass/volume] in Amniotic fluid |
16888-0 | Gamma chlordane [Mass/volume] in Urine |
1689-9 | 5'-Nucleotidase [Enzymatic activity/volume] in Amniotic fluid |
16890-6 | Gastrin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
16891-4 | Gastrin [Mass/volume] in Serum or Plasma --11th specimen post XXX challenge |
16892-2 | Gastrin [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
16893-0 | Gastrin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
16894-8 | Gastrin [Mass/volume] in Serum or Plasma --25 minutes post XXX challenge |
16895-5 | Gastrin [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
16896-3 | Gastrin [Mass/volume] in Serum or Plasma --5 minutes post XXX challenge |
16898-9 | Giardia lamblia 65 Ag [Presence] in Stool |
16899-7 | Giardia lamblia Ag [Presence] in Unspecified specimen |
169-3 | Cephradine [Susceptibility] by Minimum inhibitory concentration (MIC) |
1690-7 | 5'-Nucleotidase [Enzymatic activity/volume] in Serum or Plasma |
16900-3 | Gliadin Ab [Units/volume] in Saliva (oral fluid) |
16901-1 | Gliadin IgA Ab [Presence] in Serum |
16902-9 | Gliadin IgG Ab [Presence] in Serum |
16903-7 | Glucose [Mass/volume] in Vitreous fluid |
16904-5 | Glucose [Presence] in Urine --1st specimen post XXX challenge |
16905-2 | Glucose [Presence] in Urine --2nd specimen post XXX challenge |
16906-0 | Glucose [Presence] in Urine --3rd specimen post XXX challenge |
16907-8 | Glucose [Presence] in Urine --4th specimen post XXX challenge |
16908-6 | Glucose [Presence] in Urine --5th specimen post XXX challenge |
16909-4 | Glucose [Presence] in Urine --6th specimen post XXX challenge |
1691-5 | 5,10-Methylenetetrahydrofolate reductase [Enzymatic activity/volume] in Serum |
16910-2 | Glucose [Presence] in Urine --7th specimen post XXX challenge |
16911-0 | Glucose [Presence] in Urine --8th specimen post XXX challenge |
16912-8 | Glucose [Presence] in Urine --9th specimen post XXX challenge |
16913-6 | Fasting glucose [Presence] in Urine |
16914-4 | Glucose [Mass/volume] in Serum or Plasma --post XXX challenge |
16915-1 | Glucose [Mass/volume] in Serum or Plasma --post meal |
16916-9 | Glutamate [Presence] in Urine |
16917-7 | Glutamine [Presence] in Urine |
16918-5 | Glutathione [Mass/volume] in Serum or Plasma |
16919-3 | Glycine [Presence] in Urine |
1692-3 | 5-Hydroxyindoleacetate [Mass/volume] in Cerebral spinal fluid |
16920-1 | Glycoproteins [Presence] in Serum or Plasma |
16921-9 | St. Augustine grass IgE Ab [Units/volume] in Serum |
16922-7 | Wild rye grass IgE Ab [Units/volume] in Serum |
16923-5 | Guaifenesin [Mass/volume] in Serum or Plasma |
16924-3 | Haemophilus influenzae IgG Ab [Units/volume] in Serum |
16925-0 | Haemophilus influenzae A Ag [Presence] in Urine |
16926-8 | Haemophilus influenzae A Ag [Presence] in Cerebral spinal fluid |
16927-6 | Haemophilus influenzae B IgG Ab [Units/volume] in Serum |
16928-4 | Hantavirus puumala IgG+IgM Ab [Units/volume] in Serum |
16929-2 | Helicobacter pylori Ab [Units/volume] in Serum by Immunofluorescence |
1693-1 | 5-Hydroxyindoleacetate [Mass/volume] in Serum |
16930-0 | Helminth IgE Ab [Units/volume] in Serum |
16931-8 | Hematocrit/Hemoglobin [Ratio] of Blood by Automated count |
16932-6 | Hemoglobin A3/Hemoglobin.total in Blood by Electrophoresis |
16933-4 | Hepatitis B virus core Ab [Presence] in Serum |
16934-2 | Hepatitis B virus polymerase DNA [Presence] in Blood by Probe and target amplification method |
16935-9 | Hepatitis B virus surface Ab [Units/volume] in Serum |
16936-7 | Hepatitis C virus IgG Ab [Units/volume] in Serum |
16937-5 | Hepatitis G virus RNA [Presence] in Serum by Probe and target amplification method |
16938-3 | Heptacarboxylporphyrin [Mass/volume] in Stool |
16939-1 | Heptachlor [Mass/volume] in Urine |
1694-9 | 5-Hydroxyindoleacetate [Mass/volume] in Urine |
16940-9 | Heptachlorepoxide [Mass/volume] in Urine |
16941-7 | Herbicide [Identifier] in Unspecified specimen |
16942-5 | Herpes simplex virus Ab [Presence] in Serum by Immunoblot (IB) |
16943-3 | Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid |
16944-1 | Herpes simplex virus IgM Ab [Units/volume] in Serum |
16945-8 | Herpes simplex virus Ag [Presence] in Unspecified specimen |
16947-4 | Herpes simplex virus 1 Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
16948-2 | Herpes simplex virus 1 IgG Ab [Units/volume] in Cerebral spinal fluid |
16949-0 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --1st specimen |
1695-6 | 5-Hydroxyindoleacetate [Mass/time] in 24 hour Urine |
16950-8 | Herpes simplex virus 1 IgG Ab [Units/volume] in Serum --2nd specimen |
16952-4 | Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
16953-2 | Herpes simplex virus 1 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
16954-0 | Herpes simplex virus 2 Ab [Presence] in Serum |
16955-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum by Immunoblot (IB) |
16956-5 | Herpes simplex virus 2 IgG Ab [Units/volume] in Cerebral spinal fluid |
16957-3 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --1st specimen |
16958-1 | Herpes simplex virus 2 IgG Ab [Units/volume] in Serum --2nd specimen |
16959-9 | Herpes simplex virus 2 DNA [Presence] in Serum or Plasma by Probe and target amplification method |
1696-4 | 5-Methyltetrahydrofolate homocysteine methyltransferase [Enzymatic activity/volume] in Serum |
16960-7 | Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by Probe and target amplification method |
16962-3 | Heterophile Ab [Presence] in Synovial fluid by Latex agglutination |
16963-1 | Hexacarboxylporphyrin [Mass/volume] in Blood |
16964-9 | Hexacarboxylporphyrin [Mass/volume] in Stool |
16965-6 | Lindane [Mass/volume] in Blood |
16966-4 | Hexachloroethane [Mass/volume] in Blood |
16967-2 | Hexokinase 1 [Enzymatic activity/volume] in Red Blood Cells |
16968-0 | Hexokinase 3 [Enzymatic activity/volume] in Red Blood Cells |
16969-8 | Histone H2a+H2b Ab [Units/volume] in Serum by Immunofluorescence |
1697-2 | 6-Phosphogluconate dehydrogenase [Enzymatic activity/volume] in Red Blood Cells |
16970-6 | Histoplasma capsulatum Ab [Presence] in Serum by Complement fixation |
16971-4 | Histoplasma capsulatum IgA Ab [Presence] in Serum by Immune diffusion (ID) |
16972-2 | Histoplasma capsulatum IgE Ab [Presence] in Serum by Immune diffusion (ID) |
16973-0 | Histoplasma capsulatum IgM Ab [Presence] in Serum by Immune diffusion (ID) |
16974-8 | HIV 1 Ab [Presence] in Cerebral spinal fluid |
16975-5 | HIV 1 IgG Ab [Presence] in Serum |
16976-3 | HIV 1 Ag [Units/volume] in Serum |
16977-1 | HIV 1 Ag [Presence] in Cerebral spinal fluid |
16978-9 | HIV 1 p24 Ab [Units/volume] in Serum |
16979-7 | HIV 1 p24 Ag [Units/volume] in Cerebral spinal fluid |
1698-0 | 8-Hydroxyamoxapine [Mass/volume] in Serum or Plasma |
16980-5 | HTLV II DNA [Presence] in Unspecified specimen by Probe and target amplification method |
16981-3 | HTLV I DNA [Presence] in Unspecified specimen by Probe and target amplification method |
16982-1 | HTLV I+II Ab [Presence] in Serum by Immunoblot (IB) |
16983-9 | Hydralazine [Presence] in Urine |
16984-7 | Hydrastine [Presence] in Urine |
16985-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose glucose |
16986-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose glucose |
16987-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2.5 hours post dose glucose |
16988-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose glucose |
16989-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3.5 hours post dose glucose |
1699-8 | Alpha-L-iduronidase [Enzymatic activity/mass] in Tissue |
16990-4 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --3 hours post dose glucose |
16991-2 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4.5 hours post dose glucose |
16992-0 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --4 hours post dose glucose |
16993-8 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5.5 hours post dose glucose |
16994-6 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --5 hours post dose glucose |
16995-3 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --6 hours post dose glucose |
16996-1 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose glucose |
16997-9 | Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose glucose |
16998-7 | Hydromorphone [Mass/volume] in Urine by Confirmatory method |
16999-5 | Hydroquinone [Mass/volume] in Urine |
17-4 | Amoxicillin [Susceptibility] by Disk diffusion (KB) |
170-1 | Cephradine [Susceptibility] by Disk diffusion (KB) |
1700-4 | Acetaldehyde [Mass/volume] in Blood |
17000-1 | Hydroxylysine [Presence] in Urine |
17001-9 | Hydroxyproline [Presence] in Urine |
17002-7 | Hydroxytriazolam [Mass/volume] in Serum or Plasma by Confirmatory method |
17003-5 | Serotonin [Mass/volume] in Urine |
17004-3 | Hypoxanthine [Mass/volume] in Urine |
17005-0 | IgA subclass 1 [Mass/volume] in Cerebral spinal fluid |
17006-8 | IgA subclass 2 [Mass/volume] in Cerebral spinal fluid |
17007-6 | IgG [Presence] in Serum |
17008-4 | IgG/Beta tubulin [Mass Ratio] in Serum |
17009-2 | IgM [Presence] in Serum |
1701-2 | Acetaldehyde [Mass/volume] in Serum or Plasma |
17010-0 | Imipenem [Mass/volume] in Serum or Plasma |
17012-6 | Influenza virus A Ab [Units/volume] in Cerebral spinal fluid |
17013-4 | Influenza virus A+B Ab [Units/volume] in Serum by Immunofluorescence |
17014-2 | Influenza virus B Ab [Units/volume] in Cerebral spinal fluid |
17015-9 | Influenza virus B IgG Ab [Units/volume] in Serum |
17016-7 | Influenza virus B IgM Ab [Units/volume] in Serum |
17017-5 | Insulin [Mass/volume] in Serum or Plasma --10 minutes post XXX challenge |
17018-3 | Insulin [Mass/volume] in Serum or Plasma --20 minutes post XXX challenge |
17019-1 | Insulin-like growth factor-I [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
1702-0 | Acetoacetate [Mass/volume] in Urine |
17020-9 | Intercellular substance Ab [Presence] in Serum by Immunofluorescence |
17021-7 | Intercellular substance Ab [Units/volume] in Serum by Immunofluorescence |
17022-5 | Interleukin 1+2 [Units/volume] in Serum or Plasma |
17023-3 | Deprecated Interleukin 7 [Units/volume] in Serum or Plasma |
17024-1 | Iodine.inorganic [Mass/volume] in Serum or Plasma |
17025-8 | Iron [Mass/volume] in Water |
17026-6 | Isocyanate IgE Ab [Units/volume] in Serum |
17027-4 | Isocyanate IgG Ab [Units/volume] in Serum |
17028-2 | Isocyanate IgM Ab [Units/volume] in Serum |
17029-0 | Isoleucine [Presence] in Urine |
1703-8 | Acetoacetate [Mass/volume] in Cerebral spinal fluid |
17030-8 | Isopropyl ether [Presence] in Blood |
17031-6 | Jo-1 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
17032-4 | Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
17033-2 | Ketamine [Presence] in Urine by Confirmatory method |
17034-0 | Ketoprofen [Mass/volume] in Serum or Plasma |
17035-7 | Ketorolac [Mass/volume] in Serum or Plasma |
17036-5 | La Crosse virus Ab [Titer] in Serum |
17037-3 | La Crosse virus Ab [Titer] in Cerebral spinal fluid |
17038-1 | La Crosse virus IgG Ab [Titer] in Serum |
17039-9 | La Crosse virus IgM Ab [Titer] in Serum |
1704-6 | Acetoacetate [Presence] in Serum or Plasma |
17040-7 | Labetalol [Presence] in Serum or Plasma |
17041-5 | Lactate dehydrogenase [Presence] in Urine |
17042-3 | Lactoglobulin IgE Ab [Units/volume] in Serum |
17043-1 | Lactose [Mass/volume] in Urine |
17044-9 | Lamellar bodies [Presence] in Amniotic fluid |
17045-6 | Latex IgE Ab [Units/volume] in Blood |
17046-4 | Latex IgG Ab [Units/volume] in Serum |
17047-2 | Latex Bencard IgE Ab [Units/volume] in Serum |
17048-0 | Latex glove extract IgE Ab [Units/volume] in Blood |
17049-8 | Latex glove extract ammoniated IgE Ab [Units/volume] in Blood |
1705-3 | Acetoacetate [Mass/volume] in Serum or Plasma |
17050-6 | Latex glove extract buffered IgE Ab [Units/volume] in Blood |
17051-4 | Laxatives [Identifier] in Urine |
17052-2 | Lead [Presence] in Blood |
17053-0 | Legionella longbeachae 1 IgG Ab [Presence] in Serum |
17054-8 | Legionella longbeachae 1 IgM Ab [Presence] in Serum |
17055-5 | Legionella longbeachae 2 IgG Ab [Presence] in Serum |
17056-3 | Legionella longbeachae 2 IgM Ab [Presence] in Serum |
17057-1 | Legionella pneumophila Ag [Presence] in Unspecified specimen |
17058-9 | Legionella pneumophila Ag [Presence] in Urine by Latex agglutination |
17059-7 | Legionella pneumophila Ag [Presence] in Urine by Immunofluorescence |
1706-1 | Acetonitrile [Mass/volume] in Blood |
17060-5 | Legionella pneumophila 1 Ab [Titer] in Serum |
17061-3 | Legionella pneumophila 1 IgM Ab [Units/volume] in Serum |
17062-1 | Legionella pneumophila 2 Ab [Titer] in Serum |
17063-9 | Legionella pneumophila 2 IgM Ab [Units/volume] in Serum |
17064-7 | Legionella pneumophila 3 Ab [Titer] in Serum |
17065-4 | Legionella pneumophila 3 IgM Ab [Units/volume] in Serum |
17066-2 | Legionella pneumophila 4 Ab [Titer] in Serum |
17067-0 | Legionella pneumophila 4 IgM Ab [Units/volume] in Serum |
17068-8 | Legionella pneumophila 5 Ab [Titer] in Serum |
17069-6 | Legionella pneumophila 5 IgM Ab [Units/volume] in Serum |
1707-9 | Acetylcholine [Mass/volume] in Serum |
17070-4 | Legionella pneumophila 6 Ab [Titer] in Serum |
17071-2 | Legionella pneumophila 7 Ab [Presence] in Serum |
17072-0 | Legionella pneumophila 8 Ab [Presence] in Serum |
17073-8 | Legionella pneumophila 9 Ab [Presence] in Serum |
17074-6 | Leucine [Units/volume] in Amniotic fluid |
17075-3 | Lidocaine [Mass/volume] in Urine |
17076-1 | Lidocaine [Mass/volume] in Body fluid |
17077-9 | Deprecated Lindane [Mass/volume] in Blood |
17078-7 | Fatty acids.esterified [Mass/volume] in Serum or Plasma |
17079-5 | Fatty acids.long chain [Identifier] in Serum or Plasma |
1708-7 | Acetylcholinesterase [Enzymatic activity/volume] in Amniotic fluid |
17080-3 | Fatty acids.very long chain [Identifier] in Serum or Plasma |
17081-1 | Deprecated Triglyceride [Mass/volume] in Serum or Plasma --post CFst |
17082-9 | Lipoprotein.alpha [Mass/volume] in Body fluid |
17083-7 | Lipoprotein.beta [Mass/volume] in Body fluid |
17084-5 | Lipoprotein.pre-beta [Mass/volume] in Body fluid |
17085-2 | Lipoproteins [Presence] in Serum or Plasma |
17086-0 | Lithium [Mass/volume] in Body fluid |
17087-8 | Loperamide [Mass/volume] in Serum or Plasma |
17088-6 | Lorazepam [Mass/volume] in Urine by Confirmatory method |
17089-4 | Lorcainide [Mass/volume] in Serum or Plasma |
1709-5 | Acetylcholinesterase [Enzymatic activity/volume] in Red Blood Cells |
17090-2 | Loxapine+8-Hydroxyloxapine [Mass/volume] in Serum or Plasma |
17091-0 | Lumpfish roe IgE Ab [Units/volume] in Serum |
17092-8 | Lupus erythematosus factor [Presence] in Serum by Latex agglutination |
17094-4 | Lutropin [Moles/volume] in Serum or Plasma --105 minutes post XXX challenge |
17095-1 | Lutropin [Moles/volume] in Serum or Plasma --75 minutes post XXX challenge |
17096-9 | Kappa lymphocytes/100 lymphocytes in Blood |
17097-7 | CD10+CD20+ cells/100 cells in Blood |
17098-5 | CD100 cells/100 cells in Blood |
17099-3 | CD102 cells/100 cells in Blood |
171-9 | Cephradine [Susceptibility] by Serum bactericidal titer |
1710-3 | Acetylcholinesterase [Enzymatic activity/volume] in Serum or Plasma |
17100-9 | CD103 cells/100 cells in Blood |
17101-7 | CD104 cells/100 cells in Blood |
17102-5 | CD105 cells/100 cells in Blood |
17103-3 | CD106 cells/100 cells in Blood |
17104-1 | CD107a cells/100 cells in Blood |
17105-8 | CD107b cells/100 cells in Blood |
17106-6 | CD115 cells/100 cells in Blood |
17107-4 | CD117 cells/100 cells in Blood |
17108-2 | CD118 cells/100 cells in Blood |
17109-0 | CD11a cells/100 cells in Blood |
1711-1 | Acid phosphatase [Enzymatic activity/volume] in Blood |
17110-8 | CD11b cells/100 cells in Blood |
17111-6 | CD12 cells/100 cells in Blood |
17112-4 | CD120A cells/100 cells in Blood |
17113-2 | CD120B cells/100 cells in Blood |
17114-0 | CD122 cells/100 cells in Blood |
17115-7 | CD126 cells/100 cells in Blood |
17116-5 | CD128 cells/100 cells in Blood |
17117-3 | CD15 cells/100 cells in Blood |
17118-1 | CD16B cells/100 cells in Blood |
17119-9 | CD16-CD34+ cells/100 cells in Blood |
1712-9 | Prostatic acid phosphatase [Enzymatic activity/volume] in Vaginal fluid |
17120-7 | CD17 cells/100 cells in Blood |
17121-5 | CD18 cells/100 cells in Blood |
17122-3 | CD19+Kappa+ cells/100 cells in Blood |
17123-1 | CD19+Lambda+ cells/100 cells in Blood |
17124-9 | CD2+CD20+ cells/100 cells in Blood |
17125-6 | CD22+CD19+ cells/100 cells in Blood |
17126-4 | CD24 cells/100 cells in Blood |
17127-2 | CD26 cells/100 cells in Blood |
17128-0 | CD27 cells/100 cells in Blood |
17129-8 | CD28 cells/100 cells in Blood |
1713-7 | Prostatic acid phosphatase [Enzymatic activity/volume] in Semen |
17130-6 | CD29 cells/100 cells in Blood |
17131-4 | CD3+CD69+ cells/100 cells in Blood |
17132-2 | CD3+IL2R1+ cells/100 cells in Blood |
17133-0 | CD3+CD16+ cells/100 cells in Blood |
17135-5 | CD3+CD56+ cells/100 cells in Blood |
17136-3 | CD3+DR+ cells/100 cells in Blood |
17137-1 | CD30 cells/100 cells in Blood |
17138-9 | CD31 cells/100 cells in Blood |
17139-7 | CD32 cells/100 cells in Blood |
1714-5 | Prostatic acid phosphatase [Enzymatic activity/volume] in Serum |
17140-5 | CD34+DR+ cells/100 cells in Blood |
17141-3 | CD36 cells/100 cells in Blood |
17142-1 | CD37 cells/100 cells in Blood |
17143-9 | CD39 cells/100 cells in Blood |
17144-7 | CD4+CD69+ cells/100 cells in Blood |
17145-4 | Deprecated CD4+2H4 cells/100 cells in Blood |
17146-2 | CD4+CD8+ cells/100 cells in Blood |
17147-0 | CD40 cells/100 cells in Blood |
17148-8 | CD41 cells/100 cells in Blood |
17149-6 | CD42a cells/100 cells in Blood |
1715-2 | Acid phosphatase [Enzymatic activity/volume] in Serum or Plasma |
17150-4 | CD42b cells/100 cells in Blood |
17151-2 | CD42c cells/100 cells in Blood |
17152-0 | CD42d cells/100 cells in Blood |
17153-8 | CD4+CD45RA+ cells/CD8 Cells [# Ratio] in Blood |
17154-6 | CD43 cells/100 cells in Blood |
17155-3 | CD44 cells/100 cells in Blood |
17156-1 | CD44R cells/100 cells in Blood |
17157-9 | CD45RA cells/100 cells in Blood |
17158-7 | CD45RB cells/100 cells in Blood |
17159-5 | CD45RO cells/100 cells in Blood |
1716-0 | Acidity.titratable [Mass/volume] in Urine |
17160-3 | CD46 cells/100 cells in Blood |
17161-1 | CD47 cells/100 cells in Blood |
17162-9 | CD48 cells/100 cells in Blood |
17163-7 | CD49a cells/100 cells in Blood |
17164-5 | CD49b cells/100 cells in Blood |
17165-2 | CD49c cells/100 cells in Blood |
17166-0 | CD49d cells/100 cells in Blood |
17167-8 | CD49e cells/100 cells in Blood |
17168-6 | CD49f cells/100 cells in Blood |
17169-4 | CD5+CD2- cells/100 cells in Blood |
1717-8 | Acylcarnitine [Mass/volume] in Serum or Plasma |
17170-2 | CD50 cells/100 cells in Blood |
17171-0 | CD51 cells/100 cells in Blood |
17172-8 | CD52 cells/100 cells in Blood |
17173-6 | CD53 cells/100 cells in Blood |
17174-4 | CD54 cells/100 cells in Blood |
17175-1 | CD55 cells/100 cells in Blood |
17176-9 | CD58 cells/100 cells in Blood |
17177-7 | CD59 cells/100 cells in Blood |
17178-5 | CD6 cells/100 cells in Blood |
17179-3 | CD62E cells/100 cells in Blood |
1718-6 | Acyl CoA dehydrogenase [Enzymatic activity/volume] in Serum |
17180-1 | CD62L cells/100 cells in Blood |
17181-9 | CD62P cells/100 cells in Blood |
17182-7 | CD63 cells/100 cells in Blood |
17183-5 | CD64 cells/100 cells in Blood |
17184-3 | CD66a cells/100 cells in Blood |
17185-0 | CD66b cells/100 cells in Blood |
17186-8 | CD66c cells/100 cells in Blood |
17187-6 | CD66d cells/100 cells in Blood |
17188-4 | CD66e cells/100 cells in Blood |
17189-2 | CD68 cells/100 cells in Blood |
1719-4 | Adenine [Mass/volume] in Serum |
17190-0 | CD69 cells/100 cells in Blood |
17191-8 | CD3-CD7+cells/100 cells in Blood |
17192-6 | CD72 cells/100 cells in Blood |
17193-4 | CD73 cells/100 cells in Blood |
17194-2 | CD74 cells/100 cells in Blood |
17195-9 | CD77 cells/100 cells in Blood |
17196-7 | CD79a cells/100 cells in Blood |
17197-5 | CD79b cells/100 cells in Blood |
17198-3 | CD8+CD28+ cells/100 cells in Blood |
17199-1 | CD80 cells/100 cells in Blood |
172-7 | Chloramphenicol [Susceptibility] by Minimum lethal concentration (MLC) |
1720-2 | Adenine phosphoribosyltransferase [Enzymatic activity/volume] in Red Blood Cells |
17200-7 | CD82 cells/100 cells in Blood |
17201-5 | CD83 cells/100 cells in Blood |
17202-3 | CD85 cells/100 cells in Blood |
17203-1 | CD86 cells/100 cells in Blood |
17204-9 | CD87 cells/100 cells in Blood |
17205-6 | CD88 cells/100 cells in Blood |
17206-4 | CD9 cells/100 cells in Blood |
17207-2 | CD91 cells/100 cells in Blood |
17208-0 | CD93 cells/100 cells in Blood |
17209-8 | CD94 cells/100 cells in Blood |
1721-0 | Adenosine triphosphate [Mass/volume] in Blood |
17210-6 | CD95 cells/100 cells in Blood |
17211-4 | CD96 cells/100 cells in Blood |
17212-2 | CD97 cells/100 cells in Blood |
17213-0 | CD98 cells/100 cells in Blood |
17214-8 | CD99 cells/100 cells in Blood |
17215-5 | CV lymphocytes/100 lymphocytes in Blood |
17216-3 | Cytoplasmic CD3 cells/100 cells in Blood |
17217-1 | Cytoplasmic CD79 cells/100 cells in Blood |
17218-9 | Cytoplasmic Ig mu cells/100 cells in Blood |
17219-7 | Cytoplasmic Ig cells/100 cells in Blood |
1722-8 | Adenosine deaminase [Enzymatic activity/volume] in Blood |
17220-5 | FMC7 cells/100 cells in Blood |
17221-3 | CD235a cells/100 cells in Blood |
17222-1 | HLE lymphocytes/100 lymphocytes in Blood |
17223-9 | Deprecated CD14 cells/100 cells in Blood |
17224-7 | Lambda lymphocytes/100 lymphocytes in Blood |
17225-4 | SMIg lymphocytes/100 lymphocytes in Blood |
17226-2 | SmIg-Cd79 cells/100 cells in Blood |
17227-0 | Lymphocytes/100 leukocytes in Synovial fluid by Automated count |
17228-8 | Lymphocytic choriomeningitis virus Ab [Titer] in Cerebral spinal fluid |
17229-6 | Lymphocytic choriomeningitis virus IgM Ab [Titer] in Cerebral spinal fluid |
1723-6 | Adenosine deaminase binding protein [Mass/volume] in Urine |
17230-4 | Lysine [Presence] in Urine |
17231-2 | Lysosomal enzymes [Identifier] in Plasma |
17232-0 | Lysozyme [Enzymatic activity/volume] in Tear |
17234-6 | Magnesium.plasma/Magnesium.RBC [Molar ratio] in Blood |
17235-3 | Magnesium [Moles/volume] in Leukocytes |
17236-1 | Magnesium [Moles/volume] in Stool |
17237-9 | Magnesium [Moles/mass] in Hair |
17238-7 | Malignin Ab [Units/volume] in Serum |
1724-4 | Adenosine diphosphate [Mass/volume] in Serum |
17241-1 | Prolactin [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
17242-9 | Prolactin [Mass/volume] in Serum or Plasma --40 minutes post XXX challenge |
17243-7 | Prolactin [Mass/volume] in Serum or Plasma --pre XXX challenge |
17244-5 | Manganese [Mass/mass] in Hair |
17245-2 | Deprecated Meclizine [Mass/volume] in Serum or Plasma |
17246-0 | Mefenamate [Mass/volume] in Serum or Plasma |
17247-8 | Melanin [Units/volume] in Urine |
17248-6 | Melanin [Units/volume] in Serum or Plasma |
17249-4 | Menthol [Mass/volume] in Blood |
1725-1 | Adenosine monophosphate deaminase [Enzymatic activity/volume] in Serum |
17250-2 | Mephobarbital [Mass/volume] in Urine by Confirmatory method |
17251-0 | Mepivacaine [Presence] in Serum or Plasma |
17252-8 | Mercaptopurine [Presence] in Serum or Plasma |
17253-6 | Mercury [Mass/volume] in Milk |
17254-4 | Mercury [Mass/volume] in Food |
17255-1 | Mercury [Mass/volume] in Dialysis fluid |
17256-9 | Mesoridazine [Mass/volume] in Urine |
17257-7 | Mesothelial cells [Presence] in Body fluid by Light microscopy |
17258-5 | Metandienone [Mass/volume] in Serum or Plasma |
17259-3 | Methadone.long acting metabolite [Mass/volume] in Serum or Plasma |
1726-9 | Adenosine monophosphate.cyclic [Mass/volume] in Serum or Plasma |
17260-1 | Methamphetamine [Mass/volume] in Serum or Plasma by Confirmatory method |
17261-9 | Methapyrilene [Mass/volume] in Urine |
17263-5 | Methemalbumin [Presence] in Serum or Plasma |
17264-3 | Methionine [Presence] in Urine |
17265-0 | Methocarbamol [Units/volume] in Serum or Plasma |
17266-8 | Methotrexate [Mass/volume] in Urine |
17267-6 | Methoxychlor [Mass/volume] in Urine |
17268-4 | Deprecated Methsuximide+Normethsuximide [Mass/volume] in Serum or Plasma |
17269-2 | Methyl isobutyl ketone [Mass/volume] in Urine |
1727-7 | Adenosine monophosphate.cyclic [Mass/time] in 24 hour Urine |
17270-0 | Methylacrylate [Mass/volume] in Serum or Plasma |
17271-8 | Deprecated 1,1,1-Trichloroethane [Mass/volume] in Serum or Plasma |
17272-6 | Methylenedianiline [Mass/volume] in Blood |
17273-4 | Methylephedrine [Units/volume] in Urine |
17274-2 | Methylergonovine [Mass/volume] in Serum or Plasma |
17275-9 | Methylfentanyl [Mass/volume] in Serum or Plasma |
17276-7 | 2-Methylpentane [Mass/volume] in Blood |
17277-5 | Metolazone [Mass/volume] in Serum or Plasma |
17278-3 | Miconazole [Mass/volume] in Serum or Plasma |
17279-1 | Bacteria identified in Pleural fluid by Aerobe culture |
1728-5 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Serum or Plasma |
17280-9 | Microscopic observation [Identifier] in Tissue by Malaria thick smear |
17281-7 | Microscopic observation [Identifier] in Sputum by KOH preparation |
17282-5 | Minoxidil [Mass/volume] in Serum or Plasma |
17283-3 | Mirtazapine [Mass/volume] in Serum or Plasma |
17284-1 | Mitochondria Ab [Presence] in Serum by Immunofluorescence |
17285-8 | Mitochondria Ab [Units/volume] in Serum by Immunofluorescence |
17286-6 | Monocytes/100 leukocytes in Synovial fluid by Manual count |
17287-4 | Monocytes/100 leukocytes in Urine by Manual count |
17288-2 | Ganglioside GM1 Ab [Presence] in Serum by Immunofluorescence |
17289-0 | Monosodium glutamate (MSG) IgE Ab [Units/volume] in Serum |
1729-3 | Adenosine triphosphatase [Enzymatic activity/volume] in Red Blood Cells |
17290-8 | Morphine [Presence] in Serum or Plasma by Confirmatory method |
17291-6 | Deprecated Mulberry tree IgE Ab [Units/volume] in Serum |
17292-4 | Mumps virus Ab [Units/volume] in Cerebral spinal fluid |
17293-2 | Mumps virus IgG+IgM Ab [Units/volume] in Serum |
17294-0 | Mushroom toxins [Identifier] in Urine |
17296-5 | Mycobacterium tuberculosis complex rRNA [Presence] in Unspecified specimen by DNA probe |
17297-3 | Deprecated Mycobacterium tuberculosum rRNA [Presence] in Unspecified specimen by DNA probe |
17298-1 | Deprecated Mycobacterium tuberculosis rRNA [Presence] in Unspecified specimen by DNA probe |
17299-9 | Mycoplasma fermentans Ab [Presence] in Serum |
173-5 | Chloramphenicol [Susceptibility] by Minimum inhibitory concentration (MIC) |
1730-1 | Adenosine triphosphatase [Enzymatic activity/volume] in Semen |
17300-5 | Mycoplasma hominis Ab [Titer] in Serum by Complement fixation |
17301-3 | Mycoplasma hominis Ab [Presence] in Serum |
17302-1 | Mycoplasma pneumoniae Ab [Presence] in Serum |
17303-9 | Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid |
17304-7 | Mycoplasma pneumoniae IgG+IgM Ab [Units/volume] in Serum |
17305-4 | Myelin IgA Ab [Presence] in Serum |
17306-2 | Myelin IgG Ab [Presence] in Serum |
17307-0 | Myelin IgM Ab [Presence] in Serum |
17308-8 | Myelin associated glycoprotein Ab [Units/volume] in Serum by Immunoblot (IB) |
1731-9 | Adenylate kinase [Enzymatic activity/volume] in Serum |
17310-4 | Myelin associated glycoprotein Ab [Presence] in Serum by Immunofluorescence |
17311-2 | Myelin associated glycoprotein IgA Ab [Units/volume] in Serum |
17312-0 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum |
17313-8 | Myelin associated glycoprotein IgG Ab [Units/volume] in Serum by Immunofluorescence |
17314-6 | Myelin associated glycoprotein IgM Ab [Units/volume] in Serum by Immunoassay |
17315-3 | Myelin basic protein Ab [Mass/volume] in Serum |
17316-1 | Myeloperoxidase Ab [Presence] in Serum |
17317-9 | N-acetylprocainamide [Mass/volume] in Urine |
17318-7 | Nalbuphine [Mass/volume] in Serum or Plasma |
17319-5 | Nalidixate [Mass/volume] in Serum or Plasma |
1732-7 | Adenylosuccinate lyase [Enzymatic activity/volume] in Serum |
17320-3 | Nefazodone [Mass/volume] in Urine |
17321-1 | Neisseria meningitidis A+Y Ag [Presence] in Urine |
17322-9 | Neisseria meningitidis Ab [Presence] in Serum |
17323-7 | Neisseria meningitidis Ag [Presence] in Urine |
17324-5 | Neisseria meningitidis Ag [Units/volume] in Cerebral spinal fluid by Latex agglutination |
17325-2 | Neisseria meningitidis C+w135 Ag [Presence] in Urine |
17326-0 | Neisseria meningitidis A Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
17327-8 | Neisseria meningitidis B Ab [Units/volume] in Serum |
17328-6 | Neisseria meningitidis B Ag [Presence] in Urine by Latex agglutination |
17329-4 | Neisseria meningitidis C Ag [Presence] in Cerebral spinal fluid by Immunofluorescence |
1733-5 | Adipate [Mass/volume] in Urine |
17330-2 | Neisseria meningitidis Y Ag [Presence] in Cerebral spinal fluid |
17331-0 | Neisseria meningitidis polyvalent Ab [Units/volume] in Serum |
17332-8 | Neisseria meningitidis polyvalent Ag [Presence] in Cerebral spinal fluid |
17333-6 | Neisseria meningitidis w135 Ag [Presence] in Serum or Plasma by Latex agglutination |
17334-4 | Neopterin/Creatinine [Mass Ratio] in Urine |
17335-1 | Neostigmine [Mass/volume] in Serum or Plasma |
17336-9 | Neuronal Ab [Presence] in Serum by Immunofluorescence |
17337-7 | Neuronal Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
17338-5 | Neuronal Ab [Units/volume] in Serum by Immunofluorescence |
17339-3 | Neuronal Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
1734-3 | Aldosterone renal clearance in 24 hour |
17340-1 | Neuronal IgG Ab [Presence] in Body fluid by Immunoassay |
17341-9 | Neuronal nuclear Ab [Presence] in Cerebral spinal fluid by Immunofluorescence |
17342-7 | Neuronal nuclear type 2 Ab [Units/volume] in Serum |
17343-5 | Neuronal nuclear type 2 Ab [Presence] in Cerebral spinal fluid |
17344-3 | Neuronal nuclear type 2 Ab [Units/volume] in Serum by Immunofluorescence |
17345-0 | Deprecated Neutrophil Ab [Units/volume] in Serum |
17346-8 | Neutrophil Ab [Presence] in Serum by Immunofluorescence |
17347-6 | Neutrophil Ab [Units/volume] in Serum by Immunofluorescence |
17348-4 | Neutrophil IgA Ab [Units/volume] in Serum |
17349-2 | Neutrophil IgG Ab [Units/volume] in Serum |
1735-0 | Alanine [Mass/volume] in Cerebral spinal fluid |
17350-0 | Neutrophil IgM Ab [Units/volume] in Serum |
17351-8 | Neutrophil cytoplasmic Ab [Presence] in Serum |
17352-6 | Neutrophil cytoplasmic Ab [Interpretation] in Serum |
17353-4 | Neutrophil cytoplasmic Ab.classic [Presence] in Serum by Immunofluorescence |
17354-2 | Neutrophil cytoplasmic IgA Ab [Presence] in Serum |
17355-9 | Neutrophil cytoplasmic IgG Ab [Presence] in Serum |
17356-7 | Neutrophil cytoplasmic IgM Ab [Presence] in Serum |
17357-5 | Neutrophil cytoplasmic Ab.perinuclear [Presence] in Serum by Immunofluorescence |
17358-3 | Neutrophil Cytoplasmic Ab atypical [Units/volume] in Serum |
17359-1 | Neutrophils [#/volume] in Semen by Manual count |
1736-8 | Alanine [Presence] in Serum or Plasma |
17360-9 | Heptane [Mass/volume] in Blood |
17361-7 | Deprecated Hexane [Mass/volume] in Blood |
17362-5 | Nicotinamide [Presence] in Urine |
17363-3 | Nitrazepam [Mass/volume] in Serum or Plasma by Confirmatory method |
17364-1 | Nitrophenol [Presence] in Urine |
17365-8 | Nitroprusside [Mass/volume] in Serum or Plasma |
17366-6 | Nizatidine [Mass/volume] in Serum or Plasma |
17367-4 | Nomifensine [Mass/volume] in Serum or Plasma |
17368-2 | Norepinephrine [Mass/volume] in Plasma --standing |
17369-0 | Norepinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
1737-6 | Alanine [Mass/volume] in Serum or Plasma |
17370-8 | Norepinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
17371-6 | Norepinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
17372-4 | Norepinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
17373-2 | Norepinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
17374-0 | Norepinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
17375-7 | Norflunitrazepam [Mass/volume] in Blood |
17376-5 | Norpropoxyphene [Presence] in Urine by Confirmatory method |
17377-3 | Norpropoxyphene [Mass/volume] in Urine by Confirmatory method |
17378-1 | Novobiocin [Mass/volume] in Serum or Plasma |
17379-9 | Propanol [Mass/volume] in Blood |
1738-4 | Alanine [Mass/volume] in Urine |
17380-7 | Nuclear Ab.histone reactive [Presence] in Serum |
17381-5 | Uroporphyrin [Mass/time] in 24 hour Stool |
17382-3 | Octadecanoate (C18:0) [Mass/volume] in Serum or Plasma |
17384-9 | Opiates [Mass/volume] in Urine by Confirmatory method |
17385-6 | Organic acids [Units/volume] in Urine |
17386-4 | Organic acids [Units/volume] in Blood |
17387-2 | Organic acids [Units/volume] in Serum or Plasma |
17388-0 | Organochlorine pesticides [Type] in Urine |
17389-8 | Ornithine [Presence] in Urine |
1739-2 | Alanine [Mass/time] in 24 hour Urine |
17390-6 | Orphenadrine [Mass/volume] in Urine |
17391-4 | Orthocresol [Mass/volume] in Blood |
17392-2 | Osmium [Mass/volume] in Urine |
17393-0 | Ovary Ab [Presence] in Serum |
17394-8 | Oxychlordane [Mass/volume] in Urine |
17395-5 | Oxymorphone [Mass/volume] in Urine by Confirmatory method |
17396-3 | Oxytetracycline [Mass/volume] in Serum or Plasma |
17397-1 | Oxytriphylline [Mass/volume] in Serum or Plasma |
17398-9 | Human papilloma virus 11 Ag [Presence] in Unspecified specimen |
17399-7 | Human papilloma virus 16 Ag [Presence] in Unspecified specimen |
174-3 | Chloramphenicol [Susceptibility] by Disk diffusion (KB) |
1740-0 | Alanine aminopeptidase [Mass/volume] in Serum |
17400-3 | Human papilloma virus 16+18 Ag [Presence] in Unspecified specimen |
17401-1 | Human papilloma virus 18 Ag [Presence] in Unspecified specimen |
17402-9 | Human papilloma virus 31 Ag [Presence] in Unspecified specimen |
17403-7 | Human papilloma virus 31+33+35 Ag [Presence] in Unspecified specimen |
17404-5 | Human papilloma virus 33 Ag [Presence] in Unspecified specimen |
17405-2 | Human papilloma virus 42 Ag [Presence] in Unspecified specimen |
17406-0 | Human papilloma virus 43 Ag [Presence] in Unspecified specimen |
17407-8 | Human papilloma virus 44 Ag [Presence] in Unspecified specimen |
17408-6 | Human papilloma virus 45 Ag [Presence] in Unspecified specimen |
17409-4 | Human papilloma virus 5 Ag [Presence] in Unspecified specimen |
1741-8 | Alanine aminotransferase [Enzymatic activity/volume] in Amniotic fluid |
17410-2 | Human papilloma virus 51 Ag [Presence] in Unspecified specimen |
17411-0 | Human papilloma virus 6 Ag [Presence] in Unspecified specimen |
17412-8 | Human papilloma virus 6+11 Ag [Presence] in Unspecified specimen |
17413-6 | Papova virus SV 40 Ab [Units/volume] in Serum |
17414-4 | Parainfluenza virus 1+2+3 Ag [Presence] in Unspecified specimen |
17415-1 | Parainfluenza virus A Ab [Units/volume] in Serum |
17416-9 | Parakeet droppings Ab [Units/volume] in Serum |
17417-7 | Parakeet droppings IgG Ab [Units/volume] in Serum |
17418-5 | Parakeet serum Ab [Units/volume] in Serum |
17419-3 | Parathion [Mass/volume] in Urine |
1742-6 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma |
17420-1 | Parrot droppings Ab [Units/volume] in Serum |
17421-9 | Parrot serum Ab [Units/volume] in Serum |
17422-7 | Parvovirus B19 IgG+IgM Ab [Units/volume] in Serum |
17423-5 | Deprecated Parvovirus B19 IgM Ab [Presence] in Serum |
17424-3 | 1,4-Dichlorobenzene [Mass/volume] in Blood |
17426-8 | Penicillium roqueforti IgE Ab [Units/volume] in Serum |
17427-6 | Penicillium sp Ab [Units/volume] in Serum |
17428-4 | Pentacarboxylporphyrins [Mass/time] in 24 hour Stool |
17429-2 | Pentachlorophenol [Mass/volume] in Blood |
1743-4 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by With P-5'-P |
17430-0 | Pentane [Mass/volume] in Blood |
17431-8 | Pentobarbital [Mass/volume] in Gastric fluid |
17432-6 | Tetrachloroethylene [Mass/volume] in Serum or Plasma |
17433-4 | pH of Unspecified specimen |
17434-2 | Phenazopyridine [Mass/volume] in Serum or Plasma |
17435-9 | Pheniramine [Mass/volume] in Urine |
17436-7 | Phenobarbital [Mass/volume] in Gastric fluid |
17437-5 | Phenolphthalein [Mass/volume] in Urine |
17438-3 | Phenolphthalein [Mass/volume] in Blood |
17439-1 | Phenols [Mass/volume] in Blood |
1744-2 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma by Without P-5'-P |
17440-9 | Phenothiazines [Units/volume] in Serum or Plasma |
17441-7 | Phenothiazines [Units/volume] in Urine |
17442-5 | Phenylephrine [Mass/volume] in Serum or Plasma |
17443-3 | Phenylpropanolamine [Mass/volume] in Urine |
17444-1 | Phenytoin [Mass/volume] in Urine |
17445-8 | Phoma herbarum IgG Ab [Units/volume] in Serum |
17446-6 | Phoma sp IgE Ab [Units/volume] in Serum |
17447-4 | Phosphate [Presence] in Stool |
17448-2 | Phosphatidylethanolamine IgA Ab [Presence] in Serum |
17449-0 | Phosphatidylethanolamine IgG Ab [Presence] in Serum |
1745-9 | Albumin [Mass/volume] in Amniotic fluid |
17450-8 | Phosphatidylethanolamine IgM Ab [Presence] in Serum |
17451-6 | Phosphatidylglycerol IgA Ab [Presence] in Serum |
17452-4 | Phosphatidylglycerol IgG Ab [Presence] in Serum |
17453-2 | Phosphatidylglycerol IgM Ab [Presence] in Serum |
17454-0 | Phosphatidylinositol IgA Ab [Presence] in Serum |
17455-7 | Phosphatidylinositol IgG Ab [Presence] in Serum |
17456-5 | Phosphatidylinositol IgM Ab [Presence] in Serum |
17457-3 | Phosphoethanolamine [Presence] in Urine |
17458-1 | Phosphoethanolamine [Presence] in Serum or Plasma |
17459-9 | Phospholipid IgA Ab [Units/volume] in Serum by Immunoassay |
1746-7 | Albumin [Mass/volume] in Cerebral spinal fluid |
17460-7 | Phosphoserine [Presence] in Urine |
17461-5 | Phosphoserine [Presence] in Serum or Plasma |
17462-3 | Picloram [Mass/volume] in Urine |
17463-1 | Pigeon droppings Ab [Units/volume] in Serum |
17464-9 | Pigeon feather IgE Ab [Presence] in Serum |
17465-6 | Pigeon serum IgE Ab [Presence] in Serum |
17466-4 | Deprecated Plasminogen activator inhibitor 1 Ag [Units/volume] in Platelet poor plasma by Immunologic method |
17467-2 | Plasminogen activator inhibitor 2 Ag [Units/volume] in Platelet poor plasma by Immunoassay |
17468-0 | Plutonium [Mass/volume] in Urine |
17469-8 | PM-1 Ab [Units/volume] in Serum |
1747-5 | Albumin [Mass/volume] in Body fluid |
17470-6 | PM-1 Ab [Presence] in Serum by Immunofluorescence |
17471-4 | PM-1 Ab [Units/volume] in Serum by Immunofluorescence |
17472-2 | Polybrominated biphenyl [Mass/volume] in Serum or Plasma |
17473-0 | Polymyxin B [Mass/volume] in Serum or Plasma |
17474-8 | Porphobilinogen [Moles/volume] in Serum or Plasma |
17475-5 | Porphyrins [Units/volume] in Urine |
17476-3 | Porphyrins [Units/volume] in Red Blood Cells |
17477-1 | Porphyrins [Units/volume] in Stool |
17478-9 | Porphyrins [Presence] in Body fluid |
17479-7 | Prazepam [Mass/volume] in Urine by Confirmatory method |
1748-3 | Albumin [Mass/volume] in Pleural fluid |
17480-5 | Pregnenolone [Mass/volume] in Urine |
17481-3 | Probenecid [Units/volume] in Urine |
17482-1 | Procainamide [Mass/volume] in Urine |
17483-9 | Progesterone [Mass/volume] in Urine |
17484-7 | Progesterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
17485-4 | Progesterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
17486-2 | Progesterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
17487-0 | Progesterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
17488-8 | Progesterone [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge |
17489-6 | Progesterone [Mass/volume] in Serum or Plasma --8th specimen post XXX challenge |
1749-1 | Albumin [Mass/volume] in Peritoneal fluid |
17490-4 | Progesterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge |
17491-2 | Proinsulin [Mass/volume] in Serum or Plasma --baseline |
17492-0 | Proline [Presence] in Urine |
17493-8 | Prostaglandin E [Mass/volume] in Serum or Plasma |
17494-6 | Prostaglandin F2 alpha [Mass/volume] in Urine |
17495-3 | Prostaglandins [Mass/volume] in Urine |
17496-1 | Alpha 1 globulin [Mass/volume] in Body fluid by Electrophoresis |
17497-9 | Alpha 2 globulin [Mass/volume] in Body fluid by Electrophoresis |
17498-7 | Beta globulin [Mass/volume] in Body fluid by Electrophoresis |
17499-5 | Gamma globulin [Mass/volume] in Body fluid by Electrophoresis |
175-0 | Chloramphenicol [Susceptibility] by Serum bactericidal titer |
1750-9 | Albumin [Mass/volume] in Semen |
17501-8 | Protoporphyrin [Mass/volume] in Serum or Plasma |
17502-6 | Pseudomonas aeruginosa Ab [Units/volume] in Serum |
17504-2 | Psilocybin [Presence] in Urine |
17505-9 | Psilocybin/Psilocin [Mass Ratio] in Serum or Plasma |
17506-7 | Quinacrine [Mass/volume] in Serum or Plasma |
17507-5 | Quinidine [Mass/volume] in Urine |
17508-3 | Quinine [Units/volume] in Urine |
17509-1 | Marsh Ragweed IgE Ab [Units/volume] in Serum |
1751-7 | Albumin [Mass/volume] in Serum or Plasma |
17510-9 | Raisin IgE Ab [Units/volume] in Serum |
17511-7 | Red dye IgE Ab [Units/volume] in Serum |
17512-5 | Redfish IgE Ab [Units/volume] in Serum |
17513-3 | Renin [Enzymatic activity/volume] in Plasma --5 hours post XXX challenge |
17514-1 | Renin [Enzymatic activity/volume] in Plasma --9th specimen post XXX challenge |
17515-8 | Renin [Enzymatic activity/volume] in Plasma --baseline |
17516-6 | Renin [Enzymatic activity/volume] in Plasma --supine |
17517-4 | Respiratory syncytial virus IgG Ab [Titer] in Cerebral spinal fluid |
17518-2 | Respiratory syncytial virus IgG Ab [Titer] in Serum |
17519-0 | Respiratory syncytial virus IgM Ab [Titer] in Cerebral spinal fluid |
1752-5 | Albumin [Mass/volume] in Synovial fluid |
17520-8 | Respiratory syncytial virus identified in Unspecified specimen by Organism specific culture |
17521-6 | Reticulin Ab [Presence] in Serum |
17522-4 | Reticulin IgA Ab [Titer] in Serum by Immunofluorescence |
17523-2 | Reticulin IgG Ab [Titer] in Serum |
17524-0 | Reticulin IgG Ab [Titer] in Serum by Immunofluorescence |
17525-7 | Retinoate esters [Mass/volume] in Serum or Plasma |
17526-5 | Retinyl esters [Mass/volume] in Serum or Plasma |
17527-3 | Retinol Free [Mass/volume] in Serum or Plasma |
17528-1 | Retinol [Mass/volume] in Serum or Plasma --3 hours post dose |
17529-9 | Retinol [Mass/volume] in Serum or Plasma --6 hours post dose |
1753-3 | Albumin [Presence] in Urine |
17530-7 | Retrovirus identified in Unspecified specimen by Organism specific culture |
17531-5 | Rh [Type] in Amniotic fluid |
17532-3 | Rheumatoid arthritis nuclear Ab [Presence] in Serum |
17533-1 | Rheumatoid arthritis nuclear Ab [Presence] in Serum by Immunofluorescence |
17534-9 | Rheumatoid factor [Units/volume] in Body fluid by Immunoassay |
17535-6 | Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
17536-4 | Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
17537-2 | Rickettsia spotted fever group RNA [Presence] in Serum by Probe and target amplification method |
17538-0 | Rickettsia spotted fever group RNA [Presence] in Serum by DNA probe |
17539-8 | Rickettsia typhi Ab [Units/volume] in Serum by Latex agglutination |
1754-1 | Albumin [Mass/volume] in Urine |
17540-6 | Rickettsia typhi IgA Ab [Units/volume] in Serum by Immunofluorescence |
17541-4 | Rickettsia typhi IgG Ab [Presence] in Serum by Immunoassay |
17544-8 | Bartonella quintana IgG Ab [Presence] in Cerebral spinal fluid |
17545-5 | Bartonella quintana IgM Ab [Presence] in Cerebral spinal fluid |
17546-3 | Bartonella quintana rRNA [Presence] in Unspecified specimen by DNA probe |
17547-1 | Rotavirus Ag [Presence] in Stool |
17548-9 | Rotavirus RNA [Presence] in Unspecified specimen by DNA probe |
17549-7 | Rubella virus Ab [Units/volume] in Cerebral spinal fluid |
1755-8 | Albumin [Mass/time] in 24 hour Urine |
17550-5 | Rubella virus Ab [Units/volume] in Serum by Latex agglutination |
17551-3 | Rubella virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
17552-1 | Rubella virus IgM Ab [Presence] in Cerebral spinal fluid |
17553-9 | Measles virus Ab [Units/volume] in Cerebral spinal fluid |
17554-7 | Measles virus IgA Ab [Units/volume] in Serum |
17555-4 | Measles virus Ab [Units/volume] in Serum --1st specimen |
17556-2 | Measles virus Ab [Units/volume] in Serum --2nd specimen |
17557-0 | Saccharomonospora viridis IgG Ab [Units/volume] in Serum |
17558-8 | Saint Louis encephalitis virus Ab [Units/volume] in Cerebral spinal fluid |
17559-6 | Salicylates [Presence] in Blood |
1756-6 | Albumin in CSF/Albumin in Serum or Plasma |
17560-4 | Salicylates [Presence] in Gastric fluid |
17561-2 | Salmon roe IgE Ab [Units/volume] in Serum |
17562-0 | Salmonella sp Ab [Presence] in Serum |
17563-8 | Salmonella sp identified in Unspecified specimen by Organism specific culture |
17564-6 | Salmonella typhi O D Ab [Presence] in Serum by Latex agglutination |
17565-3 | Salmonella typhi H D Ab [Presence] in Serum by Latex agglutination |
17566-1 | Salmonella typhi O Ab [Presence] in Serum |
17567-9 | Sasapyrine [Mass/volume] in Serum or Plasma |
17568-7 | Sarcosine [Presence] in Urine |
17569-5 | SCL-70 extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
1757-4 | Albumin renal clearance in 24 hour |
17570-3 | SCL-70 extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
17571-1 | Scopolamine [Mass/volume] in Urine |
17572-9 | 2-Butanol [Mass/volume] in Blood |
17573-7 | Secobarbital [Mass/volume] in Gastric fluid |
17574-5 | Selenium [Mass/volume] in Body fluid |
17575-2 | Serine [Presence] in Urine |
17576-0 | Shigella sp identified in Unspecified specimen by Organism specific culture |
17577-8 | Ganglioside GQ1a IgM Ab [Presence] in Serum |
17578-6 | Ganglioside GQ1b Ab [Presence] in Serum |
17579-4 | Ganglioside GQ1b IgG Ab [Presence] in Serum |
1758-2 | Albumin.glycated [Mass/volume] in Serum or Plasma |
17580-2 | Ganglioside GQ1b IgG Ab [Presence] in Cerebral spinal fluid |
17581-0 | Ganglioside GQ1b IgM Ab [Presence] in Serum |
17582-8 | Silver [Mass/volume] in Dialysis fluid |
17583-6 | Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
17584-4 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
17585-1 | Sjogrens syndrome-A extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
17586-9 | Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
17587-7 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
17588-5 | Sjogrens syndrome-B extractable nuclear IgG Ab [Presence] in Serum by Immunoassay |
17589-3 | Smith extractable nuclear Ab [Titer] in Serum by Immune diffusion (ID) |
1759-0 | Albumin/Globulin [Mass Ratio] in Serum or Plasma |
17590-1 | Smith extractable nuclear Ab [Titer] in Serum by Immunoassay |
17591-9 | Smith extractable nuclear Ab [Presence] in Serum by Immunofluorescence |
17592-7 | Smith extractable nuclear Ab [Units/volume] in Serum by Immunofluorescence |
17593-5 | Smooth muscle Ab [Presence] in Sweat |
17594-3 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
17595-0 | Deprecated Somatotropin [Mass/volume] in Serum or Plasma --1 hour post XXX challenge |
17597-6 | Somatotropin [Mass/volume] in Serum or Plasma --52 hours post XXX challenge |
17598-4 | Specific gravity of Synovial fluid |
17599-2 | Volume of 24 hour Peritoneal dialysis fluid |
176-8 | Chlortetracycline [Susceptibility] by Minimum lethal concentration (MLC) |
1760-8 | Alcohol dehydrogenase [Enzymatic activity/volume] in Serum |
17600-8 | Volume of 6 hour Urine |
17601-6 | Volume of 24 hour Sputum |
17602-4 | Volume of Seminal plasma |
17603-2 | Volume of 24 hour Stool |
17604-0 | Volume of 24 hour Sweat |
17605-7 | Volume of 24 hour Unspecified specimen |
17606-5 | Volume of Stool |
17607-3 | Volume of Cerebral spinal fluid |
17608-1 | Weight [Mass/time] of 48 hour Stool |
17609-9 | Weight [Mass/time] of 72 hour Stool |
1761-6 | Aldolase [Enzymatic activity/volume] in Serum or Plasma |
17610-7 | Spermatozoa Motile [Presence] in Semen --30 minutes post collection |
17611-5 | Stimulants [Identifier] in Serum or Plasma |
17612-3 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --1st specimen |
17613-1 | Deprecated Streptococcus pneumoniae 1 Ab [Units/volume] in Serum --2nd specimen |
17614-9 | Streptococcus pneumoniae 12 Ab [Presence] in Serum |
17615-6 | Deprecated Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --1st specimen |
17616-4 | Deprecated Streptococcus pneumoniae 12 Ab [Ratio] in Serum --2nd specimen/1st specimen |
17617-2 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
17618-0 | Streptococcus pneumoniae 14 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
17619-8 | Streptococcus pneumoniae 14 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
1762-4 | Aldosterone [Mass/volume] in Blood |
17620-6 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --1st specimen |
17621-4 | Deprecated Streptococcus pneumoniae 56 Ab [Units/volume] in Serum --2nd specimen |
17622-2 | Streptocuccus pneumoniae 18 Ab [Units/volume] in Serum --1st specimen |
17623-0 | Deprecated Streptococcus pneumoniae 19 Ab [Units/volume] in Serum --2nd specimen |
17624-8 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --1st specimen |
17625-5 | Deprecated Streptococcus pneumoniae 23 Ab [Units/volume] in Serum --2nd specimen |
17626-3 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --1st specimen |
17627-1 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
17628-9 | Deprecated Streptococcus pneumoniae 3 Ab [Units/volume] in Serum --2nd specimen |
17629-7 | Streptococcus pneumoniae 3 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
1763-2 | Aldosterone [Mass/volume] in Serum or Plasma |
17630-5 | Streptococcus pneumoniae 3 Ab [Ratio] in Serum --2nd specimen/1st specimen |
17631-3 | Deprecated Streptococcus pneumoniae 36a+6b IgG Ab [Units/volume] in Serum |
17632-1 | Streptococcus pneumoniae 4 IgG Ab [Units/volume] in Serum |
17633-9 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --1st specimen |
17634-7 | Deprecated Streptococcus pneumoniae 4 Ab [Units/volume] in Serum --2nd specimen |
17635-4 | Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum |
17636-2 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --1st specimen |
17637-0 | Deprecated Streptococcus pneumoniae 26 Ab [Units/volume] in Serum --2nd specimen |
17638-8 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
17639-6 | Streptococcus pneumoniae 51 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
1764-0 | Aldosterone [Mass/volume] in Urine |
17640-4 | Streptococcus pneumoniae 51 Ab [Ratio] in Serum by Immunoassay --2nd specimen/1st specimen |
17641-2 | Streptococcus pneumoniae 8 Ab [Presence] in Serum |
17642-0 | Streptococcus pneumoniae 8 Ab [Presence] in Serum by Immunoassay |
17643-8 | Streptococcus pneumoniae 9 Ab [Presence] in Serum by Immunoassay |
17644-6 | Streptococcus pneumoniae 9 Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
17645-3 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --1st specimen |
17646-1 | Streptococcus pneumoniae 9 Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
17647-9 | Streptococcus pneumoniae Ab [Units/volume] in Serum |
17648-7 | Streptococcus pneumoniae Ab [Units/volume] in Serum by Immunoassay |
17649-5 | Streptococcus pneumoniae IgG Ab [Ratio] in Serum by Immunoassay --1st specimen/2nd specimen |
1765-7 | Aldosterone [Mass/time] in 24 hour Urine |
17650-3 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --1st specimen |
17651-1 | Streptococcus pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay --2nd specimen |
17652-9 | Streptococcus pneumoniae Ag [Presence] in Unspecified specimen by Latex agglutination |
17653-7 | Deprecated Streptococcus pneumoniae group A Ag |
17654-5 | Deprecated Streptococcus pneumoniae group B Ab by Immunoassay |
17655-2 | Deprecated Streptococcus pneumoniae group B Ag in urine by immunofluorescence |
17656-0 | Streptococcus pyogenes [Presence] in Unspecified specimen by Organism specific culture |
17657-8 | Streptolysin O Ab [Units/volume] in Synovial fluid |
17658-6 | Strontium/Creatinine [Mass Ratio] in Urine |
17659-4 | Strychnine [Units/volume] in Serum or Plasma |
1766-5 | Aldosterone receptors [#] in Leukocytes |
17660-2 | Strychnine [Units/volume] in Urine |
17661-0 | Succinylcholine [Mass/volume] in Serum or Plasma |
17662-8 | Succinylpurines [Presence] in Urine |
17663-6 | Sulfadiazine IgE Ab [Units/volume] in Serum |
17664-4 | Sulfalazine IgE Ab [Units/volume] in Serum |
17665-1 | Sulfamedraxozole IgE Ab [Units/volume] in Serum |
17666-9 | Sulfate [Mass/volume] in Dialysis fluid |
17667-7 | Sulfate.organic/Sulfate.total in Urine |
17668-5 | Sulfatide IgG Ab [Units/volume] in Serum by Immunofluorescence |
17669-3 | Sulfatide IgG Ab [Units/volume] in Serum by Immunoassay |
1767-3 | Aldosterone [Mass/volume] in Serum or Plasma --supine |
17670-1 | Sulfatide IgM Ab [Units/volume] in Serum by Immunofluorescence |
17671-9 | Sulfatide IgM Ab [Units/volume] in Serum by Immunoassay |
17672-7 | Sulfide [Mass/volume] in Urine |
17673-5 | Sulfisoxazole IgE Ab [Units/volume] in Serum |
17674-3 | Sulfonamide [Units/volume] in Serum or Plasma |
17675-0 | Sulfonamide [Units/volume] in Urine |
17676-8 | Sulindac sulfide metabolite [Mass/volume] in Serum or Plasma |
17677-6 | Deprecated Helianthus annuus Ab.IgE |
17678-4 | Taurine [Presence] in Urine |
17679-2 | Taurine [Presence] in Cerebral spinal fluid |
1768-1 | Aldosterone [Mass/volume] in Serum or Plasma --upright |
17681-8 | Tellurium [Presence] in Urine |
17682-6 | Terpineol [Presence] in Blood |
17683-4 | 2-Methyl-2-Propanol [Mass/volume] in Blood |
17685-9 | Testosterone Free [Mass/volume] in Dialysis fluid |
17686-7 | Testosterone.weakly bound [Mass/volume] in Serum or Plasma |
17687-5 | Testosterone/Epitestosterone [Mass Ratio] in Serum or Plasma |
17688-3 | Testosterone [Mass/volume] in Serum or Plasma --1.5 hours post XXX challenge |
17689-1 | Testosterone [Mass/volume] in Serum or Plasma --15 minutes post XXX challenge |
1769-9 | Fatty acids.nonesterified [Mass/volume] in Serum or Plasma |
17690-9 | Testosterone [Mass/volume] in Serum or Plasma --2 hours post XXX challenge |
17691-7 | Testosterone [Mass/volume] in Serum or Plasma --30 minutes post XXX challenge |
17692-5 | Testosterone [Mass/volume] in Serum or Plasma --45 minutes post XXX challenge |
17693-3 | Testosterone [Mass/volume] in Serum or Plasma --4 days post XXX challenge |
17694-1 | Deprecated Coproporphyrin [Mass/time] in 24 hour Stool |
17695-8 | Tetrachlorodiphenylethane [Mass/volume] in Blood |
17696-6 | Tetrachlorodiphenylethane [Mass/volume] in Urine |
17697-4 | Tetrachloroethane [Mass/volume] in Blood |
17698-2 | Tetraethyl lead [Mass/volume] in Blood |
17699-0 | Thebaine [Mass/volume] in Serum or Plasma |
177-6 | Chlortetracycline [Susceptibility] by Minimum inhibitory concentration (MIC) |
1770-7 | Aliphatic carboxylate, C14-C26.absorption [Mass/volume] in Serum or Plasma |
17700-6 | Theophylline [Mass/volume] in Urine |
17701-4 | Thiazides [Mass/volume] in Urine |
17703-0 | Thorium [Mass/volume] in Urine |
17704-8 | Threonine [Presence] in Urine |
17705-5 | Thyroglobulin IgM Ab [Units/volume] in Serum |
17706-3 | Thyroperoxidase Ab [Titer] in Cerebral spinal fluid by Latex agglutination |
17707-1 | Thyroperoxidase IgM Ab [Units/volume] in Serum or Plasma |
17708-9 | Thyroid stimulating immunoglobulins [Presence] in Serum |
17709-7 | Ticlopidine [Presence] in Urine |
1771-5 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Serum or Plasma |
17710-5 | Tin/Creatinine [Mass Ratio] in Urine |
17712-1 | Toluene diisocyanate [Mass/volume] in Blood |
17713-9 | Topiramate [Mass/volume] in Serum or Plasma |
17714-7 | Toxaphene [Mass/volume] in Serum or Plasma |
17715-4 | Toxocara canis Ab [Units/volume] in Cerebral spinal fluid by Immunoassay |
17716-2 | Toxoplasma gondii IgE Ab [Units/volume] in Serum |
17717-0 | Toxoplasma gondii IgG+IgM Ab [Presence] in Serum |
17718-8 | Tramadol [Presence] in Urine by Confirmatory method |
17719-6 | Tramadol [Mass/volume] in Urine |
1772-3 | Aliphatic carboxylate, C14-C26.esters [Mass/volume] in Stool |
17720-4 | Trans nonachlor [Mass/volume] in Urine |
17721-2 | Trans nonachlor [Mass/volume] in Blood |
17723-8 | Treponema pallidum Ab [Presence] in Serum by Immobilization |
17724-6 | Treponema pallidum Ab [Units/volume] in Serum by Immunofluorescence |
17725-3 | Treponema pallidum Ab [Units/volume] in Serum by Latex agglutination |
17726-1 | Treponema pallidum IgG Ab [Presence] in Serum by Immunofluorescence |
17727-9 | Treponema pallidum IgG Ab [Units/volume] in Serum by Immunofluorescence |
17728-7 | Treponema pallidum IgM Ab [Units/volume] in Serum by Immunofluorescence |
17729-5 | Treponema pallidum IgM Ab [Presence] in Serum by Immunofluorescence |
1773-1 | Fatty acids.very long chain C24:0 (Tetracosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
17730-3 | Triamterene [Units/volume] in Urine |
17732-9 | Trichinella spiralis Ab [Presence] in Serum by Latex agglutination |
17733-7 | Trichinella spiralis IgA Ab [Presence] in Serum |
17734-5 | Trichinella spiralis IgG Ab [Units/volume] in Serum |
17735-2 | Trichinella spiralis IgM Ab [Presence] in Serum |
17736-0 | Trichloroacetate [Mass/volume] in Blood |
17737-8 | Trichloroethane [Mass/volume] in Urine |
17738-6 | Chloral hydrate [Presence] in Urine |
17739-4 | Chloral hydrate [Presence] in Urine by Confirmatory method |
1774-9 | Fatty acids.very long chain C26:0 (Hexacosanoate)/C22:0 (Docosanoate) [Mass Ratio] in Serum or Plasma |
17740-2 | Trichlorophenoxyacetate [Presence] in Blood |
17741-0 | Trichlorophenoxyacetate [Mass/volume] in Serum or Plasma |
17742-8 | Trichlorothiazide [Presence] in Urine |
17743-6 | Triiodothyronine resin uptake (T3RU) in Serum or Plasma --1 hour post XXX challenge |
17744-4 | Trimellitic anhydride (TMA) IgG Ab [Units/volume] in Serum |
17745-1 | Trimellitic anhydride (TMA) IgM Ab [Units/volume] in Serum |
17746-9 | Trimeprazine [Presence] in Serum or Plasma |
17747-7 | Trimethoprim [Mass/volume] in Urine |
17748-5 | Trimethylamine [Presence] in Urine |
17749-3 | Tromethamine [Mass/volume] in Serum or Plasma |
1775-6 | Alkaline phosphatase [Mass/volume] in Body fluid |
17750-1 | Trypsinogen [Enzymatic activity/volume] in Serum or Plasma |
17751-9 | Tryptamine [Mass/volume] in Serum or Plasma |
17752-7 | Tryptophan [Presence] in Urine |
17753-5 | Tungsten [Mass/volume] in Serum or Plasma |
17754-3 | Tyrosine [Presence] in Blood |
17755-0 | Urate [Mass/time] in 2 hour Urine |
17756-8 | Urate [Mass/time] in 4 hour Urine |
17757-6 | Urea nitrogen [Mass/volume] in Peritoneal dialysis fluid |
17758-4 | Urea nitrogen [Mass/volume] in Vitreous fluid |
17759-2 | Urea nitrogen [Mass/volume] in Arterial blood --post dialysis |
1776-4 | Alkaline phosphatase [Mass/volume] in Urine |
17760-0 | Urea nitrogen [Mass/volume] in Venous blood --pre dialysis |
17761-8 | Urobilinogen [Mass/time] in 48 hour Stool |
17762-6 | Valproate [Mass/volume] in Urine |
17763-4 | Varicella zoster virus IgG Ab [Units/volume] in Serum by Immunofluorescence |
17764-2 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid |
17765-9 | Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunofluorescence |
17766-7 | Varicella zoster virus IgM Ab [Units/volume] in Serum by Immunofluorescence |
17767-5 | Verapamil [Mass/volume] in Urine |
17768-3 | Vinyl chloride [Mass/volume] in Blood |
17769-1 | Western equine encephalitis virus Ab [Titer] in Cerebral spinal fluid |
1777-2 | Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma |
17770-9 | Western equine encephalitis virus Ab [Titer] in Serum |
17771-7 | Whitefish roe IgE Ab [Units/volume] in Serum |
17772-5 | Dimethylbenzene [Mass/volume] in Urine |
17773-3 | Yeast [Presence] in Stool by Light microscopy |
17774-1 | Yellow dye IgE Ab [Units/volume] in Serum |
17775-8 | Yersinia sp IgA Ab [Units/volume] in Serum |
17776-6 | Yersinia sp IgG Ab [Units/volume] in Serum |
17777-4 | Yersinia sp IgM Ab [Units/volume] in Serum |
17778-2 | Zinc [Mass/volume] in Leukocytes |
1778-0 | Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma |
17780-8 | Helicobacter pylori Ag [Presence] in Stool by Immunoassay |
17781-6 | 21-Hydroxylase Ab [Units/volume] in Serum |
17782-4 | Lipoprotein.beta.subparticle [Entitic length] in Serum or Plasma |
17783-2 | Hemosiderin [Presence] in Urine by Light microscopy |
17784-0 | Parasites in Blood by Light microscopy |
17785-7 | Radioactive iodine.thyroid/Radioactive iodine dose [Ratio] |
17786-5 | Thyrotropin [Interpretation] in Unspecified specimen--post dose TRH |
17787-3 | Thyroid Scan Study report |
17788-1 | Large unstained cells/100 leukocytes in Blood by Automated count |
17789-9 | Large unstained cells [#/volume] in Blood by Automated count |
1779-8 | Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma |
17790-7 | Leukocytes Left Shift [Presence] in Blood by Automated count |
17791-5 | Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum |
17792-3 | Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum |
17793-1 | Immunoglobulin light chains [Mass/volume] in 24 hour Urine |
17794-9 | Osmolality of Hyperal solution |
17795-6 | Potassium [Moles/volume] in Hyperal solution |
17796-4 | Sodium [Moles/volume] in Hyperal solution |
17797-2 | Thyroid colloidal Ab [Units/volume] in Serum |
17798-0 | Amikacin [Mass/volume] in Cerebral spinal fluid |
17799-8 | Promyelocytes/100 leukocytes in Body fluid |
178-4 | Chlortetracycline [Susceptibility] by Disk diffusion (KB) |
1780-6 | Alkaline phosphatase.placental [Enzymatic activity/volume] in Serum or Plasma |
17800-4 | Myelocytes/100 leukocytes in Body fluid |
17801-2 | Metamyelocytes/100 leukocytes in Body fluid |
17802-0 | Prolymphocytes/100 leukocytes in Body fluid |
17803-8 | Plasma cells/100 leukocytes in Body fluid |
17804-6 | Promonocytes/100 leukocytes in Body fluid |
17805-3 | Procainamide [Mass/volume] in Body fluid |
17806-1 | N-acetylprocainamide [Mass/volume] in Body fluid |
17807-9 | Cyclosporine [Mass/volume] in Body fluid |
17808-7 | Tobramycin [Mass/volume] in Urine |
17809-5 | Hematocrit [Volume Fraction] of Urine |
1781-4 | Alkaline phosphatase.regan [Enzymatic activity/volume] in Serum or Plasma |
17810-3 | Prealbumin/Protein.total in Body fluid by Electrophoresis |
17811-1 | Alpha 1 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
17812-9 | Alpha 1 globulin/Protein.total in Body fluid by Electrophoresis |
17813-7 | Alpha 2 globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
17814-5 | Alpha 2 globulin/Protein.total in Body fluid by Electrophoresis |
17815-2 | Beta globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
17816-0 | Beta globulin/Protein.total in Body fluid by Electrophoresis |
17817-8 | Gamma globulin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
17818-6 | Gamma globulin/Protein.total in Body fluid by Electrophoresis |
17819-4 | Albumin/Protein.total by Electrophoresis in Urine collected for unspecified duration |
1782-2 | Alkaline phosphatase.renal [Enzymatic activity/volume] in Serum or Plasma |
17820-2 | Albumin/Protein.total in Body fluid by Electrophoresis |
17821-0 | Oligoclonal bands [Interpretation] in Body fluid by Electrophoresis Narrative |
17822-8 | CD3+CD4+ (T4 helper) cells/100 cells in Body fluid |
17823-6 | CD45 (Lymphs) cells/100 cells in Body fluid |
17824-4 | CD3+CD8+ (T8 suppressor cells) cells/100 cells in Body fluid |
17825-1 | CD41a cells/100 cells in Blood |
17826-9 | CD3 cells/100 cells in Body fluid |
17827-7 | CD2 cells/100 cells in Body fluid |
17828-5 | CD16 cells/100 cells in Body fluid |
17829-3 | CD19 cells/100 cells in Body fluid |
1783-0 | Alkaline phosphatase [Enzymatic activity/volume] in Blood |
17830-1 | Centromere Ab [Units/volume] in Body fluid |
17831-9 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum inhibitory concentration (MIC) |
17832-7 | Deprecated 5-Fluorocytosine [Susceptibility] by Minimum lethal concentration (MLC) |
17833-5 | Basophils/100 leukocytes in Synovial fluid |
17834-3 | Eosinophils/100 leukocytes in Synovial fluid |
17835-0 | Monocytes/100 leukocytes in Synovial fluid |
17836-8 | Neutrophils/100 leukocytes in Synovial fluid |
17837-6 | Acid phosphatase tartrate resistant [Enzymatic activity/volume] in Serum |
17838-4 | Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma |
17839-2 | Alpha fucosidase [Enzymatic activity/volume] in Blood |
1784-8 | Alpha amino acid nitrogen [Mass/volume] in Plasma |
17840-0 | Alpha-L-iduronidase [Enzymatic activity/volume] in Blood |
17841-8 | Amylase [Enzymatic activity/time] in 12 hour Urine |
17842-6 | Cancer Ag 27-29 [Units/volume] in Serum or Plasma |
17843-4 | Cancer Ag 72-4 [Units/volume] in Serum or Plasma |
17844-2 | Estradiol (E2).albumin bound [Mass/volume] in Serum or Plasma |
17845-9 | Lipoprotein.alpha [Presence] in Serum or Plasma |
17846-7 | Lipoprotein.beta [Presence] in Serum or Plasma |
17847-5 | Lipoprotein.pre-beta [Presence] in Serum or Plasma |
17848-3 | Reticulocytes/1000 erythrocytes in Blood by Manual |
17849-1 | Reticulocytes/100 erythrocytes in Blood by Automated count |
1785-5 | Alpha amino acid nitrogen [Mass/time] in 24 hour Urine |
17850-9 | Herpes simplex virus 1 IgG Ab [Presence] in Serum |
17851-7 | Herpes simplex virus 2 IgG Ab [Presence] in Serum |
17852-5 | Ureaplasma urealyticum [Presence] in Unspecified specimen by Organism specific culture |
17853-3 | Ganglioside GM1b IgG Ab [Titer] in Serum |
17854-1 | Ganglioside GM1b IgM Ab [Titer] in Serum |
17855-8 | Hemoglobin A1c/Hemoglobin.total in Blood by calculation |
17856-6 | Hemoglobin A1c/Hemoglobin.total in Blood by HPLC |
17857-4 | Rheumatoid factor [Titer] in Serum |
17858-2 | Gamma glutamyl transferase [Enzymatic activity/volume] in Body fluid |
17859-0 | Helicobacter pylori IgG Ab [Presence] in Serum or Plasma by Immunoassay |
1786-3 | Alpha aminobutyrate [Mass/volume] in Cerebral spinal fluid |
17860-8 | 3-Methylhistidine [Mass/volume] in 24 hour Urine |
17861-6 | Calcium [Mass/volume] in Serum or Plasma |
17862-4 | Calcium [Mass/volume] in Urine |
17863-2 | Calcium.ionized [Mass/volume] in Serum or Plasma |
17864-0 | Calcium.ionized [Mass/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE) |
17865-7 | Glucose [Mass/volume] in Serum or Plasma --8 hours fasting |
17866-5 | Carnitine/Creatinine [Ratio] in Urine |
17867-3 | Carnitine free (C0)/Creatinine [Ratio] in Urine |
17868-1 | Acylcarnitine/Creatinine [Ratio] in Urine |
17869-9 | Orotate/Creatinine [Molar ratio] in Urine |
1787-1 | Alpha aminobutyrate [Presence] in Serum or Plasma |
17870-7 | Orotidine/Creatinine [Molar ratio] in Urine |
17871-5 | Hemoglobin H [Presence] in Blood by Heat denaturation |
17872-3 | Tetrahydrocannabinol [Presence] in Urine by Confirm method >25 ng/mL |
17873-1 | Bacteria # 2 identified in Bone by Aerobe culture |
17874-9 | Bacteria # 3 identified in Bone by Aerobe culture |
17875-6 | Bacteria # 4 identified in Bone by Aerobe culture |
17876-4 | Bacteria # 5 identified in Bone by Aerobe culture |
17877-2 | Bacteria # 6 identified in Bone by Aerobe culture |
17878-0 | Bacteria # 2 identified in Bronchial specimen by Aerobe culture |
17879-8 | Bacteria # 3 identified in Bronchial specimen by Aerobe culture |
1788-9 | Alpha aminobutyrate [Mass/volume] in Serum or Plasma |
17880-6 | Bacteria # 4 identified in Bronchial specimen by Aerobe culture |
17881-4 | Bacteria # 5 identified in Bronchial specimen by Aerobe culture |
17882-2 | Bacteria # 6 identified in Bronchial specimen by Aerobe culture |
17883-0 | Bacteria # 2 identified in Genital specimen by Aerobe culture |
17884-8 | Bacteria # 3 identified in Genital specimen by Aerobe culture |
17885-5 | Bacteria # 4 identified in Genital specimen by Aerobe culture |
17886-3 | Bacteria # 5 identified in Genital specimen by Aerobe culture |
17887-1 | Bacteria # 6 identified in Genital specimen by Aerobe culture |
17888-9 | Bacteria # 2 identified in Nose by Aerobe culture |
17889-7 | Bacteria # 3 identified in Nose by Aerobe culture |
1789-7 | Deprecated Alpha aminobutyrate [Mass/volume] in Serum |
17890-5 | Bacteria # 4 identified in Nose by Aerobe culture |
17891-3 | Bacteria # 5 identified in Nose by Aerobe culture |
17892-1 | Bacteria # 6 identified in Nose by Aerobe culture |
17893-9 | Bacteria # 2 identified in Sputum by Aerobe culture |
17894-7 | Bacteria # 3 identified in Sputum by Aerobe culture |
17895-4 | Bacteria # 4 identified in Sputum by Aerobe culture |
17896-2 | Bacteria # 5 identified in Sputum by Aerobe culture |
17897-0 | Bacteria # 6 identified in Sputum by Aerobe culture |
17898-8 | Bacteria identified in Throat by Aerobe culture |
17899-6 | Bacteria # 2 identified in Throat by Aerobe culture |
179-2 | Chlortetracycline [Susceptibility] by Serum bactericidal titer |
1790-5 | Alpha aminobutyrate [Mass/volume] in Urine |
17900-2 | Bacteria # 3 identified in Throat by Aerobe culture |
17901-0 | Bacteria # 4 identified in Throat by Aerobe culture |
17902-8 | Bacteria # 5 identified in Throat by Aerobe culture |
17903-6 | Bacteria # 6 identified in Throat by Aerobe culture |
17904-4 | Bacteria # 2 identified in Tissue by Aerobe culture |
17905-1 | Bacteria # 3 identified in Tissue by Aerobe culture |
17906-9 | Bacteria # 4 identified in Tissue by Aerobe culture |
17907-7 | Bacteria # 5 identified in Tissue by Aerobe culture |
17908-5 | Bacteria # 6 identified in Tissue by Aerobe culture |
17909-3 | Bacteria identified in Wound deep by Aerobe culture |
1791-3 | Alpha aminoadipate [Presence] in Plasma |
17910-1 | Bacteria # 2 identified in Wound deep by Aerobe culture |
17911-9 | Bacteria # 3 identified in Wound deep by Aerobe culture |
17912-7 | Bacteria # 4 identified in Wound deep by Aerobe culture |
17913-5 | Bacteria # 5 identified in Wound deep by Aerobe culture |
17914-3 | Bacteria # 6 identified in Wound deep by Aerobe culture |
17915-0 | Bacteria identified in Wound shallow by Aerobe culture |
17916-8 | Bacteria # 2 identified in Wound shallow by Aerobe culture |
17917-6 | Bacteria # 3 identified in Wound shallow by Aerobe culture |
17918-4 | Bacteria # 4 identified in Wound shallow by Aerobe culture |
17919-2 | Bacteria # 5 identified in Wound shallow by Aerobe culture |
1792-1 | Alpha aminoadipate [Mass/volume] in Plasma |
17920-0 | Bacteria # 6 identified in Wound shallow by Aerobe culture |
17921-8 | Bacteria # 2 identified in Nose by Anaerobe culture |
17922-6 | Bacteria # 3 identified in Nose by Anaerobe culture |
17923-4 | Bacteria # 2 identified in Tissue by Anaerobe culture |
17924-2 | Bacteria # 3 identified in Tissue by Anaerobe culture |
17925-9 | Bacteria identified in Wound deep by Anaerobe culture |
17926-7 | Bacteria # 2 identified in Wound deep by Anaerobe culture |
17927-5 | Bacteria # 3 identified in Wound deep by Anaerobe culture |
17928-3 | Bacteria identified in Blood by Aerobe culture |
17929-1 | Bacteria # 2 identified in Blood by Aerobe culture |
1793-9 | Alpha aminoadipate [Mass/volume] in Urine |
17930-9 | Bacteria # 3 identified in Blood by Aerobe culture |
17931-7 | Bacteria # 4 identified in Blood by Aerobe culture |
17932-5 | Bacteria # 5 identified in Blood by Aerobe culture |
17933-3 | Bacteria # 6 identified in Blood by Aerobe culture |
17934-1 | Bacteria identified in Blood by Anaerobe culture |
17935-8 | Bacteria # 2 identified in Blood by Anaerobe culture |
17936-6 | Bacteria # 3 identified in Blood by Anaerobe culture |
17937-4 | Bacteria # 2 identified in Burn by Culture |
17938-2 | Bacteria # 3 identified in Burn by Culture |
17939-0 | Bacteria # 4 identified in Burn by Culture |
1794-7 | Amylase [Enzymatic activity/volume] in Duodenal fluid |
17940-8 | Bacteria # 5 identified in Burn by Culture |
17941-6 | Bacteria # 6 identified in Burn by Culture |
17942-4 | Bacteria # 2 identified in Line specimen by IV Line culture |
17943-2 | Bacteria # 3 identified in Line specimen by IV Line culture |
17944-0 | Bacteria # 4 identified in Line specimen by IV Line culture |
17945-7 | Bacteria # 5 identified in Line specimen by IV Line culture |
17946-5 | Bacteria # 6 identified in Line specimen by IV Line culture |
17947-3 | Fungus # 2 identified in Unspecified specimen by Culture |
17948-1 | Fungus # 3 identified in Unspecified specimen by Culture |
17949-9 | Fungus # 4 identified in Unspecified specimen by Culture |
1795-4 | Amylase [Enzymatic activity/volume] in Body fluid |
17950-7 | Deprecated Bacteria identified in Body fluid by Aerobe culture |
17951-5 | Bacteria # 2 identified in Body fluid by Aerobe culture |
17952-3 | Bacteria # 3 identified in Body fluid by Aerobe culture |
17953-1 | Bacteria # 4 identified in Body fluid by Aerobe culture |
17954-9 | Bacteria # 5 identified in Body fluid by Aerobe culture |
17955-6 | Bacteria # 6 identified in Body fluid by Aerobe culture |
17956-4 | Bacteria identified in Body fluid by Anaerobe culture |
17957-2 | Bacteria # 2 identified in Body fluid by Anaerobe culture |
17958-0 | Bacteria # 3 identified in Body fluid by Anaerobe culture |
17959-8 | Bacteria # 2 identified in Peritoneal fluid by Culture |
1796-2 | Amylase [Enzymatic activity/volume] in Pleural fluid |
17960-6 | Bacteria # 3 identified in Peritoneal fluid by Culture |
17961-4 | Bacteria # 4 identified in Peritoneal fluid by Culture |
17962-2 | Bacteria # 5 identified in Peritoneal fluid by Culture |
17963-0 | Bacteria # 6 identified in Peritoneal fluid by Culture |
17964-8 | Bacteria # 2 identified in Stool by Culture |
17965-5 | Bacteria # 3 identified in Stool by Culture |
17966-3 | Bacteria # 4 identified in Stool by Culture |
17967-1 | Bacteria # 5 identified in Stool by Culture |
17968-9 | Bacteria # 6 identified in Stool by Culture |
17969-7 | Deprecated Bacteria identified in Urine by Aerobe culture |
1797-0 | Amylase [Enzymatic activity/volume] in Peritoneal fluid |
17970-5 | Bacteria # 2 identified in Urine by Culture |
17971-3 | Bacteria # 3 identified in Urine by Culture |
17972-1 | Bacteria # 4 identified in Urine by Culture |
17973-9 | Bacteria # 5 identified in Urine by Culture |
17974-7 | Bacteria # 6 identified in Urine by Culture |
17975-4 | Virus # 2 identified in Unspecified specimen by Culture |
17976-2 | Virus # 3 identified in Unspecified specimen by Culture |
17977-0 | Left atrial Apical 4 chamber [Area] by US 2D |
17978-8 | Mitral valve Peak A wave by US.doppler |
17979-6 | Anterior mitral valve leaflet A-C interval by US.M-mode |
1798-8 | Amylase [Enzymatic activity/volume] in Serum or Plasma |
17980-4 | Anterior mitral valve leaflet A-C slope [Velocity] by US.M-mode |
17981-2 | Aortic valve Acceleration by US.doppler |
17982-0 | Pulmonic valve Acceleration by US.doppler |
17983-8 | Tricuspid valve Acceleration by US.doppler |
17984-6 | Aortic valve area method |
17985-3 | Left atrial AP dimension.left atrium/AP dimension.aorta root by US |
17986-1 | Left ventricular Maximum Apical 2 chamber.diastole [Volume] by US 2D modified |
17987-9 | Left ventricular Apical 2 chamber.systole.minimum [Volume] by US 2D modified |
17988-7 | Right atrial Apical 4 chamber [Area] by US 2D |
17989-5 | Left ventricular Maximum Apical 4 chamber.diastole [Volume] by US 2D modified |
1799-6 | Amylase [Enzymatic activity/volume] in Urine |
17990-3 | Left ventricular Apical 4 chamber.systole.minimum [Volume] by US 2D modified |
17991-1 | Left ventricular Cardiac echo volume method |
17992-9 | Aorta root Cardiac output by US.doppler |
17993-7 | Mitral valve Cardiac output by US.doppler |
17994-5 | Pulmonary artery Cardiac output by US |
17995-2 | Aorta Maximum coarctation gradient [Pressure] by US.doppler |
17996-0 | Aortic valve Maximum cusp separation [Length] by US |
17997-8 | Anterior mitral valve leaflet D-E excursion [Length] by US.M-mode |
17998-6 | Aortic valve regurgitant jet Deceleration [Time] by US.doppler |
17999-4 | Mitral valve Deceleration [Time] by US.doppler |
18-2 | Amoxicillin [Susceptibility] by Serum bactericidal titer |
180-0 | Cinoxacin [Susceptibility] by Minimum lethal concentration (MLC) |
1800-2 | Amylase [Enzymatic activity/time] in 24 hour Urine |
18000-0 | Tricuspid valve Deceleration [Time] by US.doppler |
18001-8 | Mitral valve Deceleration.pressure.half time by US.doppler |
18002-6 | Mitral valve Deceleration slope [Acceleration] by US.doppler |
18003-4 | Aortic valve regurgitant jet Deceleration time slope by US.doppler |
18004-2 | Atrial septum Defect diameter by US |
18005-9 | Ventricular septal Defect diameter by US |
18006-7 | Inferior vena cava Diameter by US |
18007-5 | Superior vena cava Diameter by US |
18008-3 | Ventricular septal Defect.gradient.systole.maximum [Pressure] by US.doppler |
18009-1 | Ventricular septal Defect.gradient.systole.mean [Pressure] by US.doppler |
1801-0 | Amylase renal clearance in 24 hour |
18010-9 | Aorta Diameter by US |
18011-7 | Aorta arch and Neck Diameter by US |
18012-5 | Ascending thoracic aorta Diameter by US |
18013-3 | Descending thoracic aorta Diameter by US |
18014-1 | Aorta isthmus Diameter by US |
18015-8 | Aorta root annulo-aortic junction Diameter by US |
18016-6 | Aortic valve annulus Diameter by US |
18017-4 | Mitral valve annulus Diameter by US |
18018-2 | Left ventricular outflow tract Diameter by US |
18019-0 | Left pulmonary artery Diameter by US |
1802-8 | Amylase.P1 [Enzymatic activity/volume] in Serum or Plasma |
18020-8 | Main pulmonary artery Diameter by US |
18021-6 | Right pulmonary artery Diameter by US |
18022-4 | Pulmonic valve annulus Diameter by US |
18023-2 | Tricuspid valve annulus Diameter by US |
18024-0 | Left atrial Diameter anterior-posterior systole by US.M-mode |
18025-7 | Heart Diameter anterior-posterior systole/Aortic root diameter by US |
18026-5 | Left ventricular End-diastolic volume by US |
18027-3 | Left ventricular End-diastolic volume by US.2D+Calculated by single-plane ellipse method |
18028-1 | Left ventricular End-diastolic volume by US.2D+Calculated by biplane ellipse method |
18029-9 | Left ventricular End-diastolic volume by US 2D modified |
1803-6 | Amylase.P2 [Enzymatic activity/volume] in Serum or Plasma |
18030-7 | Tricuspid valve Peak A wave by US.doppler |
18031-5 | Tricuspid valve Peak E wave by US.doppler |
18032-3 | Tricuspid valve Pressure half time during diastole by US.doppler |
18033-1 | Left ventricular Diastole-systole [Volume] by US |
18034-9 | Tricuspid valve regurgitant jet dP/dT (1 M/S to 3 M/S).systole [Pressure rate] by US.doppler |
18035-6 | Mitral valve regurgitant jet dP/dT (1M/S to 3 M/S) [Pressure rate] by US.doppler continuous wave |
18036-4 | Anterior mitral valve leaflet E point to septal separation [Time] by US.M-mode |
18037-2 | Mitral valve Peak E wave by US.doppler |
18038-0 | Mitral valve Peak E wave/Peak A wave by US.doppler |
18039-8 | Tricuspid valve Peak E wave/Peak A wave by US.doppler |
1804-4 | Amylase.P3 [Enzymatic activity/volume] in Serum or Plasma |
18040-6 | Anterior mitral valve leaflet E-F slope [Velocity] by US.M-mode |
18041-4 | Aortic valve Ejection time by US.doppler |
18042-2 | Pulmonic valve Ejection time by US.doppler |
18043-0 | Left ventricular Ejection fraction by US |
18044-8 | Left ventricular Ejection fraction by US.2D+Calculated by single-plane ellipse method |
18045-5 | Left ventricular Ejection fraction by US.2D+Calculated by biplane ellipse method |
18046-3 | Left ventricular Ejection fraction by US 2D modified |
18047-1 | Left ventricular Ejection fraction by US 2D modified biplane |
18048-9 | Left ventricular Ejection fraction by US 2D modified single-plane |
18049-7 | Left ventricular Ejection fraction by US.M-mode+Calculated by Teichholz method |
1805-1 | Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma |
18050-5 | Inferior vena cava Fractional collapse by US --inspiration |
18051-3 | Left ventricular Fractional shortening minor axis by US |
18052-1 | Right ventricular anterior wall Fractional thickening freewall by US |
18053-9 | Left ventricular posterior wall Thickening.fractional change by US |
18054-7 | Interventricular septum Fractional thickness; fractional change by US 2D |
18055-4 | Tricuspid valve Maximum gradient during diastole [Pressure] by US.doppler |
18056-2 | Tricuspid valve Mean gradient during diastole [Pressure] by US.doppler |
18057-0 | Mitral valve Peak gradient [Pressure] by US.doppler |
18058-8 | Pulmonic valve Peak gradient [Pressure] by US.doppler |
18059-6 | Mitral valve Mean gradient [Pressure] by US.doppler |
1806-9 | Amylase S1 [Enzymatic activity/volume] in Serum or Plasma |
18060-4 | Pulmonic valve Mean gradient [Pressure] by US.doppler |
18061-2 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler derived full Bernoulli |
18062-0 | Aortic valve Maximum gradient during systole [Pressure] by US.doppler+Calculated by simplified Bernoulli |
18063-8 | Aortic valve Mean systole gradient [Pressure] by US.doppler+Calculated by simplified Bernoulli |
18064-6 | Left ventricular outflow tract Maximum gradient during systole [Pressure] by US.doppler |
18065-3 | Tricuspid valve regurgitant jet Maximum gradient during systole [Pressure] by US.doppler |
18066-1 | Aortic valve Mean systole gradient [Pressure] by US.doppler derived full Bernoulli |
18067-9 | Cardiac echo imaging device Image quality by US |
18068-7 | Left ventricular Pre ejection time by US |
18069-5 | Right atrial Intrachamber mean systole pressure by Estimated from jugular venous distention |
1807-7 | Amylase S2 [Enzymatic activity/volume] in Serum or Plasma |
18070-3 | Right atrial Intrachamber mean systole pressure by US |
18071-1 | Left ventricular Isovolumic relaxation time by US.doppler |
18072-9 | Left ventricular Major axis apical 2 chamber diastole [Length] by US 2D |
18073-7 | Left ventricular Major axis apical 2 chamber systole [Length] by US 2D |
18074-5 | Left ventricular Major axis apical 4 chamber diastole [Length] by US 2D |
18075-2 | Left ventricular Major axis apical 4 chamber systole [Length] by US 2D |
18076-0 | Left ventricular Major axis apical systole [Length] by US 2D |
18077-8 | Left ventricular Major axis apical diastole [Length] by US 2D |
18078-6 | Right ventricular Major axis diastole maximum [Length] by US 2D |
18079-4 | Right ventricular Minimum major axis during systole [Length] by US 2D |
1808-5 | Amylase S3 [Enzymatic activity/volume] in Serum or Plasma |
18080-2 | Right ventricular outflow tract Peak systolic flow by US.doppler |
18081-0 | Left ventricular Minor axis at end diastole.apical 4 chamber [Length] by US 2D |
18082-8 | Left ventricular Minor axis at end systole.apical 4 chamber [Length] by US.M-mode |
18083-6 | Left ventricular Internal diameter minor axis diastole by US 2D |
18084-4 | Right ventricular Minor axis at end diastole [Length] by US 2D |
18085-1 | Left ventricular Internal diameter minor axis systole by US 2D |
18086-9 | Right ventricular Minor axis at end systole [Length] by US 2D |
18087-7 | Left ventricular Myocardial mass by US |
18088-5 | Left ventricular Myocardial mass by US.M-mode |
18089-3 | Aortic valve Orifice [Area] by US |
1809-3 | Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma |
18090-1 | Aortic valve Orifice [Area] by US.continuity |
18091-9 | Aortic valve Orifice [Area] by US.continuity.VTI+Area |
18092-7 | Aortic valve Orifice [Area] by US.continuity.VTI+Diameter |
18093-5 | Aortic valve Orifice [Area] by US.continuity.Vmax+Area |
18094-3 | Aortic valve Orifice [Area] by US.continuity.Vmax+Diameter |
18095-0 | Main pulmonary artery Crossection [Area] by US |
18096-8 | Pulmonic valve Orifice [Area] by US.continuity |
18097-6 | Mitral valve Minimum orifice [Area] by US.doppler pressure half time |
18098-4 | Mitral valve Minimum orifice minor axis [Area] by US 2D |
18099-2 | Left ventricular Apical plane 2 chamber diastole [Area] by US 2D |
181-8 | Cinoxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1810-1 | Amylase/Creatinine [Mass Ratio] in Serum or Plasma |
18100-8 | Left ventricular Apical plane 2 chamber systole [Area] by US 2D |
18101-6 | Left ventricular Apical plane 4 chamber diastole [Area] by US 2D |
18102-4 | Left ventricular Apical plane 4 chamber systole [Area] by US 2D |
18103-2 | Left ventricular outflow tract Planimetry parasternal short axis [Area] by US 2D |
18104-0 | Aortic valve Pressure half time by US.doppler |
18105-7 | Aortic valve regurgitant jet Pressure half time by US.doppler |
18106-5 | Cardiac Echo Study Procedure |
18107-3 | Cardiac echo study Procedure stress method |
18108-1 | Aortic valve Prosthetic valve type by US |
18109-9 | Mitral valve Prosthetic valve type by US |
1811-9 | Amylase/Creatinine renal clearance [Ratio] in 24 hour Urine and Serum or Plasma |
18110-7 | Pulmonic valve Prosthetic valve type by US |
18111-5 | Tricuspid valve Prosthetic valve type by US |
18112-3 | Aortic valve Regurgitation degree by US.doppler |
18113-1 | Mitral valve Regurgitation degree by US.doppler |
18114-9 | Pulmonic valve Regurgitation degree by US.doppler |
18115-6 | Tricuspid valve Regurgitation degree by US.doppler |
18116-4 | Left ventricular Segmental wall appearance by US |
18117-2 | Left ventricular Segmental wall motion by US score |
18118-0 | Left ventricular Segmental wall motion Narrative by US |
18119-8 | Left ventricular apical anterior Segmental wall motion by US |
1812-7 | Alpha fucosidase [Enzymatic activity/mass] in Tissue |
18120-6 | Left ventricular apical septum Segmental wall motion by US |
18121-4 | Left ventricular basal anterior Segmental wall motion by US |
18122-2 | Left ventricular basal anterior septum Segmental wall motion by US |
18123-0 | Left ventricular basal inferior Segmental wall motion by US |
18124-8 | Left ventricular basal lateral Segmental wall motion by US |
18125-5 | Left ventricular basal posterior Segmental wall motion by US |
18126-3 | Left ventricular basal septum Segmental wall motion by US |
18127-1 | Left ventricular inferior apical Segmental wall motion by US |
18128-9 | Left ventricular lateral apical Segmental wall motion by US |
18129-7 | Left ventricular mid anterior Segmental wall motion by US |
1813-5 | Alpha galactosidase A [Enzymatic activity/volume] in Serum or Plasma |
18130-5 | Left ventricular mid anterior septum Segmental wall motion by US |
18131-3 | Left ventricular mid inferior Segmental wall motion by US |
18132-1 | Left ventricular mid lateral Segmental wall motion by US |
18133-9 | Left ventricular mid posterior Segmental wall motion by US |
18134-7 | Left ventricular mid septum Segmental wall motion by US |
18135-4 | Left ventricular Minor axis.mitral level.diastole [Area] by US 2D |
18136-2 | Left ventricular Minor axis.mitral level.systole [Area] by US 2D |
18137-0 | Left ventricular Minor axis.papillary level.diastole [Area] by US 2D |
18138-8 | Left ventricular Minor axis.papillary level.systole [Area] by US 2D |
18139-6 | Stress study Stage by US |
1814-3 | Acid alpha glucosidase [Enzymatic activity/volume] in Semen |
18140-4 | Central cardiovascular Study observation by US |
18141-2 | Central cardiovascular Study observation Narrative by US |
18142-0 | Heart chambers Study observation by US |
18143-8 | Heart chambers Study observation Narrative by US |
18144-6 | Heart valves Study observation Narrative by US |
18145-3 | Heart valves Study observation by US |
18146-1 | Central cardiovascular Overall Study observation Narrative by US |
18147-9 | Central cardiovascular Overall Study observation by US |
18148-7 | Left ventricular End-systolic volume by US |
18149-5 | Left ventricular End-systolic volume by US.2D+Calculated by single-plane ellipse method |
1815-0 | Acid alpha glucosidase [Enzymatic activity/mass] in Tissue |
18150-3 | Left ventricular End-systolic volume by US.2D+Calculated by biplane ellipse method |
18151-1 | Left ventricular End-systolic volume by US 2D modified |
18152-9 | Left ventricular posterior wall Thickness during diastole by US |
18153-7 | Right ventricular anterior wall Thickness during diastole by US |
18154-5 | Interventricular septum Thickness during diastole by US |
18155-2 | Left ventricular Thickness septal wall/Thickness posterior wall by US |
18156-0 | Left ventricular posterior wall Thickness during systole by US |
18157-8 | Right ventricular anterior wall Thickness during systole by US |
18158-6 | Interventricular septum Thickness during systole by US |
18159-4 | Cardiac Echo Study Transducer site |
1816-8 | Acid alpha glucosidase [Enzymatic activity/volume] in Leukocytes |
18160-2 | Cardiac echo imaging device Class |
18161-0 | Tricuspid valve Maximum blood flow by US.doppler |
18162-8 | Pulmonic valve Maximum blood flow by US.doppler |
18163-6 | Aorta root Peak systolic flow by US.doppler |
18164-4 | Left ventricular outflow tract Peak systolic flow by US.doppler |
18165-1 | Pulmonic valve regurgitant jet Peak diastole flow by US.doppler |
18166-9 | Tricuspid valve regurgitant jet Peak systolic flow by US.doppler |
18167-7 | Aorta root Mean systolic flow by US.doppler |
18168-5 | Aorta root Blood velocity-time integral by US.doppler |
18169-3 | Aortic valve Blood velocity-time integral by US.doppler |
1817-6 | Alpha ketoglutarate [Mass/volume] in Serum or Plasma |
18170-1 | Left ventricular outflow tract Blood velocity-time integral by US.doppler |
18171-9 | Right ventricular outflow tract Blood velocity-time integral by US.doppler |
18172-7 | Mitral valve Blood velocity-time integral by US.doppler |
18173-5 | Pulmonary artery Blood velocity-time integral by US.doppler |
18174-3 | Pulmonic valve Blood velocity-time integral by US.doppler |
18175-0 | Tricuspid valve Velocity-time integral during diastole by US.doppler |
18176-8 | Cardiac echo imaging device Vendor model number |
18177-6 | Cardiac echo imaging device Vendor serial number |
18178-4 | Left ventricular Wall motion index by US |
18179-2 | Left ventricular Wall segment [Identifier] by US |
1818-4 | Alpha mannosidase [Enzymatic activity/volume] in Serum or Plasma |
18180-0 | Deprecated Albumin |
18182-6 | Osmolality of Serum or Plasma by calculation |
18183-4 | Melatonin [Mass/time] in 24 hour Urine |
18184-2 | Erythrocyte sedimentation rate by 2H Westergren method |
18185-9 | Gestational age |
18186-7 | Calcium [Mass/time] in 12 hour Urine |
18187-5 | Lorazepam [Presence] in Urine |
18188-3 | Acebutolol [Mass/volume] in Unspecified specimen |
18189-1 | Acetone [Mass/time] in 24 hour Urine |
1819-2 | Alpha mannosidase [Enzymatic activity/mass] in Tissue |
18190-9 | Acid phosphatase tartrate resistant [Presence] in Unspecified specimen |
18191-7 | Amino acids [Identifier] in 24 hour Urine |
18192-5 | Bacteria [Presence] in Nose by Light microscopy |
18194-1 | Barium [Mass/time] in 24 hour Urine |
18195-8 | Acid beta glucosidase [Presence] in Tissue |
18196-6 | Beta-N-acetylhexosaminidase.A [Presence] in Tissue |
18197-4 | Blastomyces dermatitidis Ab [Presence] in Cerebral spinal fluid |
18198-2 | Blastomyces dermatitidis IgE Ab [Presence] in Serum |
18199-0 | Blastomyces dermatitidis IgG Ab [Presence] in Serum |
182-6 | Cinoxacin [Susceptibility] by Disk diffusion (KB) |
1820-0 | Alpha melanocyte stimulating hormone [Mass/volume] in Serum or Plasma |
18200-6 | Blastomyces dermatitidis IgM Ab [Presence] in Serum |
18201-4 | Borrelia burgdorferi IgA Ab [Presence] in Serum by Immunoblot (IB) |
18202-2 | Borrelia burgdorferi IgA Ab [Presence] in Cerebral spinal fluid by Immunoblot (IB) |
18203-0 | Borrelia burgdorferi IgG+IgM Ab [Presence] in Serum by Immunoblot (IB) |
18204-8 | Caffeine renal clearance in 24 hour |
18205-5 | Carbon disulfide [Presence] in Urine |
18206-3 | Catecholamines [Mass/volume] in Plasma --7th specimen post XXX challenge |
18208-9 | Cocaine [Mass/volume] in Unspecified specimen |
18209-7 | Ubiquinone 10 [Units/volume] in Serum or Plasma |
1821-8 | Alpha naphthylesterase [Enzymatic activity/volume] in Serum |
18210-5 | Complement C1 esterase inhibitor bound IgG Ab [Mass/volume] in Serum or Plasma |
18211-3 | Complement C1 esterase inhibitor bound IgM Ab [Mass/volume] in Serum or Plasma |
18212-1 | Complement C1 esterase inhibitor free IgG Ab [Mass/volume] in Serum or Plasma |
18213-9 | Complement C1 esterase inhibitor free IgM Ab [Mass/volume] in Serum or Plasma |
18214-7 | Delta 5-Pregnanetriol [Mass/volume] in Urine |
18215-4 | Delta alanine [Mass/volume] in Urine |
18216-2 | Dezocine [Presence] in Urine by Confirmatory method |
18217-0 | Epidermis IgA Ab [Presence] in Tissue |
18218-8 | Epidermis IgM Ab [Presence] in Tissue |
18219-6 | Epinephrine [Mass/volume] in Urine --2nd specimen post XXX challenge |
1822-6 | Alpha thymosin [Mass/volume] in Serum |
18220-4 | Epinephrine [Mass/volume] in Urine --3rd specimen post XXX challenge |
18221-2 | Epinephrine [Mass/volume] in Urine --4th specimen post XXX challenge |
18222-0 | Epinephrine [Mass/volume] in Urine --5th specimen post XXX challenge |
18223-8 | Epinephrine [Mass/volume] in Urine --6th specimen post XXX challenge |
18224-6 | Epinephrine [Mass/volume] in Urine --7th specimen post XXX challenge |
18225-3 | Erythrocyte shape [Morphology] in Blood |
18226-1 | Erythrocyte size [Morphology] in Blood |
18227-9 | Glucose [Mass/time] in 6 hour Urine |
18228-7 | Glucose-6-Phosphate dehydrogenase [Presence] in Tissue |
18229-5 | Heparan sulfate [Presence] in Serum or Plasma |
1823-4 | Alpha tocopherol [Mass/volume] in Serum or Plasma |
18230-3 | Histone H2a+H2b Ab [Units/volume] in Serum |
18231-1 | Histone H2a+H2b Ab [Presence] in Serum by Immunofluorescence |
18232-9 | Hydrocorticosterone [Presence] in Urine |
18233-7 | Influenza virus Ab [Units/volume] in Cerebral spinal fluid |
18234-5 | Insulin [Presence] in Unknown substance |
18235-2 | Ketone solvents [Identifier] in Blood |
18236-0 | Lead [Presence] in Tissue |
18237-8 | Legionella pneumophila atypical IgM Ab [Presence] in Serum |
18238-6 | Lithium [Mass/mass] in Tissue |
18239-4 | Lupus erythematosus factor [Mass/volume] in Blood by Latex agglutination |
1824-2 | Alpha-1-Antichymotrypsin [Mass/volume] in Serum |
18240-2 | 1,3-Dichlorobenzene [Mass/volume] in Blood |
18241-0 | Cefoxitin IgE Ab [Units/volume] in Serum |
18242-8 | Methyprylon [Mass/time] in 24 hour Urine |
18243-6 | Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid |
18244-4 | Niacin [Mass/volume] in Serum or Plasma |
18245-1 | Nickel [Mass/volume] in Unspecified specimen |
18246-9 | Nitrogen [Mass/volume] in Stool |
18247-7 | Nitrogen [Mass/volume] in Dialysis fluid |
18248-5 | Nordiazepam [Mass/volume] in Stool |
18249-3 | Para aminobenzoate [Mass/volume] in Serum or Plasma |
1825-9 | Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma |
18250-1 | Pentacarboxylporphyrins [Mass/volume] in Blood |
18251-9 | Polychlorinated biphenyl (PCB) [Presence] in Tissue |
18252-7 | Prednisone [Mass/time] in 24 hour Urine |
18253-5 | Serotonin [Mass/time] in 24 hour Urine |
18254-3 | Silicate [Mass/volume] in Body fluid |
18255-0 | Sulfonylurea [Mass/volume] in Serum or Plasma |
18256-8 | Sulfonylurea [Mass/volume] in Urine |
18257-6 | Coproporphyrin [Mass/volume] in Blood |
18258-4 | Trimethoprim IgE Ab [Units/volume] in Serum |
18259-2 | Vasoactive intestinal peptide [Mass/time] in 24 hour Urine |
1826-7 | Alpha 1 antitrypsin MM [Mass/volume] in Serum or Plasma |
18260-0 | Zinc [Presence] in Tissue |
18261-8 | Cholesterol in LDL [Mass/volume] in Serum or Plasma ultracentrifugate |
18262-6 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay |
18263-4 | Cholesterol in HDL [Mass/volume] in Serum or Plasma ultracentrifugate |
18264-2 | Deprecated Direct bilirubin [Mass/volume] in Serum or Plasma |
18265-9 | Acetaminophen [Presence] in Body fluid |
18266-7 | CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Body fluid |
18267-5 | CD16+CD56+ cells/100 cells in Blood |
18268-3 | CD16+CD56+ cells/100 cells in Body fluid |
18269-1 | Immune complex [Units/volume] in Body fluid |
1827-5 | Alpha 1 antitrypsin MS [Mass/volume] in Serum or Plasma |
18270-9 | Carbamazepine 10,11-Epoxide [Moles/volume] in Serum or Plasma |
18271-7 | Alpha 1 antitrypsin fecal clearance in 24 hour |
18272-5 | RNA Ab [Units/volume] in Serum |
18273-3 | Blood group antibody screen [Presence] in Serum or Plasma from Blood product unit |
18274-1 | Blood group antibody screen [Presence] in Serum or Plasma from donor |
18275-8 | Blood group antigens present [Identifier] on Red Blood Cells from donor |
18276-6 | Blood group antigens absent [Identifier] on Red Blood Cells from donor |
18277-4 | Hemoglobin F [Presence] in Gastric fluid by Apt-Downey method |
18278-2 | Hemoglobin F [Presence] in Meconium by Apt-Downey method |
18279-0 | Deprecated Hemoglobin F [Presence] in Stool by Apt-Downey method |
1828-3 | Alpha 1 antitrypsin MZ [Mass/volume] in Serum or Plasma |
18280-8 | Background stain [Presence] in Blood by Light microscopy |
18281-6 | Calcium [Moles/volume] corrected for total protein in Serum or Plasma |
18282-4 | Cannabinoids [Presence] in Urine by Screen method |
18283-2 | CD11 cells/100 cells in Blood |
18284-0 | CD198 cells/100 cells in Blood |
18285-7 | CDA cells/100 cells in Blood |
18286-5 | Donath Landsteiner Ab [Presence] in Blood |
18287-3 | Donath Landsteiner Ab [Presence] in control Serum and RBC |
18288-1 | Donath Landsteiner Ab [Titer] in control Serum and RBC |
18289-9 | Erythrocytes [Morphology] in Cerebral spinal fluid by Light microscopy |
1829-1 | Alpha 1 antitrypsin SS [Mass/volume] in Serum or Plasma |
18290-7 | Erythrocytes [Morphology] in Synovial fluid by Light microscopy |
18291-5 | Hemoglobin F/Hemoglobin.total in Blood from newborn |
18292-3 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post amniocentesis |
18293-1 | Deprecated Hemoglobin.fetal/Hemoglobin.total^post partum |
18294-9 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre amniocentesis |
18295-6 | Deprecated Hemoglobin.fetal/Hemoglobin.total^pre partum |
18296-4 | Glucose [Interpretation] in Serum or Plasma--post dose glucose |
18297-2 | Acid hemolysis [Mass/volume] of Red Blood Cells |
18298-0 | High titer low avidity Ab [Presence] in Serum or Plasma |
18299-8 | IgA [Presence] in Serum by Immunofixation |
183-4 | Cinoxacin [Susceptibility] by Serum bactericidal titer |
1830-9 | Alpha 1 antitrypsin SZ [Mass/volume] in Serum or Plasma |
18300-4 | IgA [Presence] in Urine by Immunofixation |
18301-2 | IgG [Presence] in Serum by Immunofixation |
18302-0 | IgG [Presence] in Urine by Immunofixation |
18303-8 | IgM [Presence] in Serum by Immunofixation |
18304-6 | IgM [Presence] in Urine by Immunofixation |
18305-3 | Amoeba identified in Aspirate by Iron hematoxylin stain |
18306-1 | Hydatid cyst identified in Aspirate by Iron hematoxylin stain |
18307-9 | Ova and parasites identified in Stool by Iron hematoxylin stain |
18308-7 | Pneumocystis sp identified in Lung tissue by Immunohistochemical |
18309-5 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood by Manual count |
1831-7 | Alpha 1 antitrypsin ZZ [Mass/volume] in Serum or Plasma |
18310-3 | Deprecated Hemoglobin.other/Hemoglobin.total [interpretation] in Blood |
18311-1 | Pelger Huet cells [Presence] in Blood by Light microscopy |
18312-9 | Platelet satellitism [Presence] in Blood by Light microscopy |
18313-7 | Coagulation of Semen by Visual observation |
18314-5 | Morphology [Interpretation] in Blood Narrative |
18319-4 | Neutrophils.vacuolated [Presence] in Blood by Light microscopy |
1832-5 | Alpha-1-Fetoprotein [Mass/volume] in Amniotic fluid |
18320-2 | Globulin [Mass/volume] in Urine by calculation |
18321-0 | Benzidine [Mass/volume] in Serum or Plasma |
18322-8 | Norketamine [Mass/volume] in Urine |
18323-6 | Smith extractable nuclear IgG Ab [Units/volume] in Serum |
18324-4 | Cockatiel serum IgE Ab [Units/volume] in Serum |
18325-1 | Oxymorphone [Presence] in Urine by Confirmatory method |
18326-9 | Microscopic observation [Identifier] in Cervix by Other stain |
18327-7 | Microscopic observation [Identifier] in Duodenal fluid by Other stain |
18328-5 | Microscopic observation [Identifier] in Body fluid by Other stain |
18329-3 | Neutrophil cytoplasmic IgA Ab [Units/volume] in Serum |
1833-3 | Alpha-1-Fetoprotein [Mass/volume] in Cerebral spinal fluid |
18330-1 | Neutrophil cytoplasmic IgG Ab [Units/volume] in Serum |
18331-9 | Neutrophil cytoplasmic IgM Ab [Units/volume] in Serum |
18332-7 | Thyroperoxidase IgG Ab [Units/volume] in Serum or Plasma |
18333-5 | Echovirus 7 Ab [Units/volume] in Cerebral spinal fluid |
18334-3 | Naltrexone [Presence] in Urine by Confirmatory method |
18335-0 | Antihistamines [Presence] in Urine by Confirmatory method |
18336-8 | Methyl tert-butyl ether [Mass/volume] in Blood |
18337-6 | Hydroxyitraconazole [Mass/volume] in Serum or Plasma |
18338-4 | Nortramadol [Mass/volume] in Urine |
18339-2 | Nortramadol [Presence] in Serum or Plasma by Confirmatory method |
1834-1 | Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma |
18340-0 | Nortramadol [Mass/volume] in Serum or Plasma by Confirmatory method |
18341-8 | Propylene glycol [Mass/volume] in Urine |
18342-6 | Glucose [Mass/volume] in Serum or Plasma --3 hours post XXX challenge |
18343-4 | 6-Monoacetylmorphine (6-MAM) [Presence] in Serum or Plasma by Screen method |
18344-2 | Beta-N-acetylhexosaminidase [Enzymatic activity/volume] in Platelets |
18345-9 | Protein S Ag/Coagulation factor VII Ag Ag [Mass Ratio] in Platelet poor plasma by Coagulation assay |
18346-7 | Deprecated Streptococcus pneumoniae 56 IgG Ab [Units/volume] in Serum |
18347-5 | Streptococcus pneumoniae 12 Ab [Units/volume] in Serum --2nd specimen |
18348-3 | Toxoplasma gondii IgM Ab [Units/volume] in Cerebral spinal fluid |
18349-1 | CD8+CD25+ cells [#/volume] in Blood |
1835-8 | Alpha-2-Macroglobulin [Mass/volume] in Serum or Plasma |
18350-9 | CD8+CD57+ cells [#/volume] in Blood |
18351-7 | 11-Deoxycortisol [Mass/volume] in Serum or Plasma --2nd specimen post XXX challenge |
18352-5 | Volume of 4 hour Urine |
18353-3 | Glucose [Mass/volume] in Serum or Plasma --6 hours post 50 g lactose PO |
18354-1 | Glucose [Mass/volume] in Serum or Plasma --12 hours post 50 g lactose PO |
18355-8 | Methylenedioxyamphetamine [Mass/volume] in Urine |
18356-6 | Methylenedioxymethamphetamine [Mass/volume] in Serum or Plasma |
18357-4 | Methylenedioxymethamphetamine [Mass/volume] in Blood |
18358-2 | Methylenedioxymethamphetamine [Mass/volume] in Urine by Confirmatory method |
18359-0 | Methylenedioxyamphetamine [Mass/volume] in Blood |
1836-6 | Alpha-2-Retinol binding protein [Mass/volume] in Serum or Plasma |
18360-8 | 8-Hydroxyamoxapine [Mass/volume] in Urine |
18361-6 | Adenosine monophosphate.cyclic/Creatinine [Mass Ratio] in Urine |
18362-4 | Alpha-2-Retinol binding protein [Mass/time] in 24 hour Urine |
18363-2 | Carnitine free (C0) [Units/mass] in Tissue |
18364-0 | Chondroitin sulfate [Mass/volume] in Serum |
18365-7 | Cortisol Free [Mass/volume] in Saliva (oral fluid) |
18366-5 | Cytochrome C oxidase [Enzymatic activity/mass] in Tissue |
18367-3 | Iodine Free [Mass/volume] in Serum or Plasma |
18368-1 | Magnesium [Moles/time] in 2 hour Urine |
18369-9 | Magnesium [Moles/time] in 4 hour Urine |
1837-4 | Alpha-N-acetylglucosaminidase [Enzymatic activity/volume] in Serum or Plasma |
18370-7 | Nitrite [Mass/volume] in Blood |
18371-5 | Methyl parathion [Mass/volume] in Urine |
18372-3 | Potassium [Moles/time] in 6 hour Urine |
18373-1 | Protein [Mass/time] in 6 hour Urine |
18374-9 | Riboflavin [Mass/volume] in 24 hour Urine |
18375-6 | Deprecated Serotonin [Mass/volume] in Urine |
18376-4 | Sodium [Moles/time] in 6 hour Urine |
18377-2 | Sodium [Moles/time] in 12 hour Urine |
18378-0 | Transcortin [Mass/volume] in Cerebral spinal fluid |
18379-8 | Urate [Mass/time] in 6 hour Urine |
1838-2 | Alpha-N-acetylglucosaminidase [Enzymatic activity/mass] in Tissue |
18380-6 | Uroporphyrinogen decarboxylase [Entitic Catalytic Activity] in Red Blood Cells |
18381-4 | Uroporphyrinogen decarboxylase [Enzymatic activity/volume] in Blood |
18382-2 | Dry weight [Mass/time] of 24 hour Stool |
18383-0 | Alfentanil [Presence] in Urine |
18384-8 | Butabarbital [Mass/volume] in Serum or Plasma by Confirmatory method |
18385-5 | Butalbital [Presence] in Urine by Confirmatory method |
18386-3 | Chlorothiazide [Presence] in Serum or Plasma |
18387-1 | Diamorphine [Mass/volume] in Serum or Plasma |
18388-9 | Diazepam [Presence] in Urine by Confirmatory method |
18389-7 | Methaqualone [Presence] in Urine by Confirmatory method |
1839-0 | Ammonia [Moles/volume] in Blood |
18390-5 | Opiates [Presence] in Urine by Confirmatory method |
18391-3 | Paraldehyde [Mass/volume] in Urine |
18392-1 | Phencyclidine [Presence] in Urine by Confirmatory method |
18393-9 | Quinidine+Quinine [Presence] in Urine |
18394-7 | HLA-A24(9) [Presence] |
18395-4 | Aspergillus niger Ab [Presence] in Cerebral spinal fluid |
18396-2 | HIV 1 p24 Ag [Presence] in Serum or Plasma by Immunoassay |
18397-0 | Polio virus 1 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
18398-8 | Polio virus 2 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
18399-6 | Polio virus 3 Ab [Titer] in Cerebral spinal fluid by Complement fixation |
184-2 | Ciprofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
1840-8 | Ammonia [Moles/volume] in Cerebral spinal fluid |
18400-2 | Spermatozoa IgA Ab [Units/volume] in Cervical mucus |
18401-0 | Spermatozoa IgG Ab [Units/volume] in Cervical mucus |
18402-8 | Spermatozoa IgA Ab [Units/volume] in Semen |
18403-6 | Spermatozoa IgG Ab [Units/volume] in Semen |
18404-4 | Spermatozoa IgM Ab [Units/volume] in Semen |
18405-1 | Arsenate [Mass/volume] in Urine |
18406-9 | Arsenic trioxide [Mass/volume] in Urine |
18407-7 | Leukocytes in 12 hour Urine sediment by Light microscopy |
18408-5 | CD3+HLA-DR+ cells/100 cells in Blood |
18409-3 | Curvularia lunata IgG Ab [Units/volume] in Serum |
1841-6 | Ammonia [Moles/volume] in Serum |
18410-1 | Epicoccum purpurascens IgG Ab [Units/volume] in Serum |
18411-9 | Rhizopus nigricans IgG Ab [Units/volume] in Serum |
18412-7 | Stemphylium botryosum IgG Ab [Units/volume] in Serum |
18413-5 | HLA-DR16 [Presence] |
18414-3 | Psilocin [Presence] in Urine |
18415-0 | Psilocin [Mass/volume] in Urine |
18416-8 | Aspergillus nidulans IgG Ab [Units/volume] in Serum |
18417-6 | Black Bean IgG Ab [Units/volume] in Serum |
18418-4 | Casein IgA Ab [Units/volume] in Serum |
18419-2 | Cephalosporine mold IgG Ab [Units/volume] in Serum |
1842-4 | Ammonia [Moles/volume] in Urine |
18420-0 | Chaetomium globosum IgG Ab [Units/volume] in Serum |
18421-8 | Fusarium oxysporum IgG Ab [Units/volume] in Serum |
18422-6 | Microcytes [Presence] in Urine by Light microscopy |
18423-4 | Phthalic anhydride IgG Ab [Units/volume] in Serum |
18424-2 | Phthalic anhydride IgM Ab [Units/volume] in Serum |
18425-9 | Zucchini IgG Ab [Units/volume] in Serum |
18426-7 | Aspergillus sp Ab [Presence] in Cerebral spinal fluid |
18427-5 | Epstein Barr virus early Ab [Presence] in Body fluid |
18428-3 | Epstein Barr virus nuclear IgG Ab [Presence] in Cerebral spinal fluid |
18429-1 | Rickettsia rickettsii IgG Ab [Units/volume] in Cerebral spinal fluid |
1843-2 | Ammonia nitrogen [Mass/time] in 24 hour Urine |
18430-9 | Rickettsia rickettsii IgM Ab [Units/volume] in Cerebral spinal fluid |
18431-7 | Amphetamines [Presence] in Stool by Screen method |
18432-5 | Tetrahydrocannabinol [Presence] in Stool by Screen method |
18433-3 | Deprecated 1,3-Dichlorobenzene [Mass/volume] in Blood |
18434-1 | 1,2-Dichlorobenzene [Mass/volume] in Blood |
18435-8 | Sufentanil [Presence] in Urine |
18436-6 | Acetylcarnitine (C2) [Mass/volume] in Serum or Plasma |
18437-4 | Acrylylcarnitine (C3:1) [Mass/volume] in Serum or Plasma |
18438-2 | Propionylcarnitine (C3) [Mass/volume] in Serum or Plasma |
18439-0 | Butyrylcarnitine (C4) [Mass/volume] in Serum or Plasma |
1844-0 | Ammonium ion [Moles/volume] in Arterial blood |
18440-8 | Crotonylcarnitine (C4:1) [Mass/volume] in Serum or Plasma |
18441-6 | Isovalerylcarnitine (C5) [Mass/volume] in Serum or Plasma |
18442-4 | 3-Hydroxybutyrylcarnitine (C4-OH) [Mass/volume] in Serum or Plasma |
18443-2 | Hexanoylcarnitine (C6) [Mass/volume] in Serum or Plasma |
18444-0 | 3-Hydroxyisovalerylcarnitine (C5-OH) [Mass/volume] in Serum or Plasma |
18445-7 | Benzoylcarnitine (BzCn) [Mass/volume] in Serum or Plasma |
18446-5 | Methylmalonylcarnitine (C4-DC) [Mass/volume] in Serum or Plasma |
18447-3 | Octenoylcarnitine (C8:1) [Mass/volume] in Serum or Plasma |
18448-1 | Octanoylcarnitine (C8) [Mass/volume] in Serum or Plasma |
18449-9 | Glutarylcarnitine (C5-DC) [Mass/volume] in Serum or Plasma |
1845-7 | Ammonium ion [Moles/volume] in Plasma |
18450-7 | Adipoylcarnitine (C6-DC) [Mass/volume] in Serum or Plasma |
18451-5 | cis-4-Decenoylcarnitine (Cis 4 C10:1) [Mass/volume] in Serum or Plasma |
18452-3 | Decanoylcarnitine (C10) [Mass/volume] in Serum or Plasma |
18453-1 | Suberylcarnitine (C8-DC) [Mass/volume] in Serum or Plasma |
18454-9 | Dodecenoylcarnitine (C12:1) [Mass/volume] in Serum or Plasma |
18455-6 | Dodecanoylcarnitine (C12) [Mass/volume] in Serum or Plasma |
18456-4 | Tetradecadienoylcarnitine (C14:2) [Mass/volume] in Serum or Plasma |
18457-2 | Tetradecenoylcarnitine (C14:1) [Mass/volume] in Serum or Plasma |
18458-0 | 3-Hydroxytetradecadienoylcarnitine (C14:2-OH) [Mass/volume] in Serum or Plasma |
18459-8 | 3-Hydroxytetradecenoylcarnitine (C14:1-OH) [Mass/volume] in Serum or Plasma |
1846-5 | Amylo-alpha-1,6-glucosidase [Enzymatic activity/volume] in Red Blood Cells |
18460-6 | Palmitoylcarnitine (C16) [Mass/volume] in Serum or Plasma |
18461-4 | 3-Hydroxypalmitoylcarnitine (C16-OH) [Mass/volume] in Serum or Plasma |
18462-2 | Linoleoylcarnitine (C18:2) [Mass/volume] in Serum or Plasma |
18463-0 | Oleoylcarnitine (C18:1) [Mass/volume] in Serum or Plasma |
18464-8 | 3-Hydroxylinoleoylcarnitine (C18:2-OH) [Mass/volume] in Serum or Plasma |
18465-5 | 3-Hydroxyoleoylcarnitine (C18:1-OH) [Mass/volume] in Serum or Plasma |
18466-3 | Dicarboxyoleylcarnitine (C18:1-DC) [Mass/volume] in Serum or Plasma |
18467-1 | Venlafaxine [Mass/volume] in Urine |
18468-9 | Aspergillus fumigatus Ab [Presence] in Cerebral spinal fluid |
18469-7 | Methyclothiazide [Mass/volume] in Serum or Plasma |
1847-3 | Amyloid associated protein [Mass/volume] in Serum |
18470-5 | Norclomipramine [Mass/volume] in Urine |
18471-3 | Metoclopramide [Mass/volume] in Urine |
18472-1 | Organophosphate pesticides [Identifier] in Urine |
18473-9 | Hydromorphone [Presence] in Urine by Confirmatory method |
18474-7 | HER2 Ag [Presence] in Tissue by Immune stain |
18475-4 | Phenylalanine/Creatinine [Molar ratio] in Urine |
18476-2 | Uroporphyrinogen decarboxylase [Presence] in Red Blood Cells |
18477-0 | Lithium [Moles/time] in 24 hour Urine |
18478-8 | Human papilloma virus 16+18 DNA [Presence] in Tissue by DNA probe |
18479-6 | Human papilloma virus 31+35+51 DNA [Presence] in Tissue by DNA probe |
1848-1 | Androstanolone [Mass/volume] in Serum or Plasma |
18480-4 | Human papilloma virus 6+11 DNA [Presence] in Tissue by DNA probe |
18481-2 | Streptococcus pyogenes Ag [Presence] in Throat |
18482-0 | Yeast [Presence] in Unspecified specimen by Organism specific culture |
18483-8 | Yeast [Presence] in Genital specimen by Organism specific culture |
18484-6 | Ku Ab [Presence] in Serum |
18485-3 | Mi-2 Ab [Presence] in Serum |
18486-1 | Methylenediamine [Presence] in Urine |
18487-9 | Broad casts [#/area] in Urine sediment by Microscopy low power field |
18488-7 | Calcium [Mass/volume] in 24 hour Urine |
18489-5 | Valproate.protein bound [Mass/volume] in Serum or Plasma |
1849-9 | Androstanolone [Mass/volume] in Semen |
18490-3 | Chlamydia trachomatis G+F+K IgA Ab [Titer] in Serum by Immunofluorescence |
18491-1 | Chlamydia trachomatis G+F+K IgG Ab [Titer] in Serum by Immunofluorescence |
18492-9 | Chlamydia trachomatis G+F+K IgM Ab [Titer] in Serum by Immunofluorescence |
18493-7 | Ova and parasites identified in Stool by Concentration--3rd specimen |
18494-5 | Ova and parasites identified in Stool by Concentration--2nd specimen |
18495-2 | Ova and parasites identified in Stool by Trichrome stain--3rd specimen |
18496-0 | Ova and parasites identified in Stool by Trichrome stain--2nd specimen |
18497-8 | Microscopic observation [Identifier] in Thyroid fine needle aspirate by Cyto stain |
18498-6 | Microscopic observation [Identifier] in Breast fine needle aspirate by Cyto stain |
18499-4 | Microscopic observation [Identifier] in Nipple discharge by Cyto stain |
185-9 | Ciprofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1850-7 | Androstanediol [Mass/volume] in Urine |
18500-9 | Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep |
18501-7 | Microscopic observation [Identifier] in Buccal smear by Cyto stain |
18502-5 | Microscopic observation [Identifier] in Deep tissue fine needle aspirate by Cyto stain |
18503-3 | Microscopic observation [Identifier] in Superficial tissue fine needle aspirate by Cyto stain |
18504-1 | PP interval mean |
18505-8 | R-R interval (Mean value during study) by EKG |
18506-6 | P wave axis horizontal plane Reference beat |
18507-4 | QRS axis.horizontal plane Reference beat |
18508-2 | R wave axis.horizontal plane |
18509-0 | T wave axis.horizontal plane Reference beat |
1851-5 | Androstenedione [Mass/volume] in Amniotic fluid |
18510-8 | ST segment axis.horizontal plane |
18511-6 | P wave onset [Time] Reference beat |
18512-4 | P wave offset [Time] Reference beat |
18513-2 | QRS onset [Time] Reference beat |
18514-0 | QRS offset [Time] Reference beat |
18515-7 | T wave offset [Time] Reference beat |
18516-5 | P wave axis frontal plane Reference beat |
18517-3 | QRS axis.frontal plane Reference beat |
18518-1 | T wave axis.frontal plane Reference beat |
18519-9 | Reference beat |
1852-3 | Androstenedione [Mass/volume] in Capillary blood |
18520-7 | P-R Interval Lead AVF |
18521-5 | P-R Interval Lead AVL |
18522-3 | P-R Interval Lead AVR |
18523-1 | P-R Interval Lead I |
18524-9 | P-R Interval Lead II |
18525-6 | P-R Interval Lead III |
18526-4 | P-R Interval Lead V1 |
18527-2 | P-R Interval Lead V2 |
18528-0 | P-R Interval Lead V3 |
18529-8 | P-R Interval Lead V4 |
1853-1 | Androstenedione [Mass/volume] in Semen |
18530-6 | P-R Interval Lead V5 |
18531-4 | P-R Interval Lead V6 |
18532-2 | Q-T interval Lead AVF |
18533-0 | Q-T interval Lead AVL |
18534-8 | Q-T interval Lead AVR |
18535-5 | Q-T interval Lead I |
18536-3 | Q-T interval Lead II |
18537-1 | Q-T interval Lead III |
18538-9 | Q-T interval Lead V1 |
18539-7 | Q-T interval Lead V2 |
1854-9 | Androstenedione [Mass/volume] in Serum or Plasma |
18540-5 | Q-T interval Lead V3 |
18541-3 | Q-T interval Lead V4 |
18542-1 | Q-T interval Lead V5 |
18543-9 | Q-T interval Lead V6 |
18544-7 | ST amplitude.J point+20 ms Lead AVF |
18545-4 | ST amplitude.J point+20 ms Lead AVL |
18546-2 | ST amplitude.J point+20 ms Lead AVR |
18547-0 | ST amplitude.J point+20 ms Lead I |
18548-8 | ST amplitude.J point+20 ms Lead II |
18549-6 | ST amplitude.J point+20 ms Lead III |
1855-6 | Androstenedione [Mass/volume] in Urine |
18550-4 | ST amplitude.J point+20 ms Lead V1 |
18551-2 | ST amplitude.J point+20 ms Lead V2 |
18552-0 | ST amplitude.J point+20 ms Lead V3 |
18553-8 | ST amplitude.J point+20 ms Lead V4 |
18554-6 | ST amplitude.J point+20 ms Lead V5 |
18555-3 | ST amplitude.J point+20 ms Lead V6 |
18556-1 | ST amplitude.J point+60 ms Lead AVF |
18557-9 | ST amplitude.J point+60 ms Lead AVL |
18558-7 | ST amplitude.J point+60 ms Lead AVR |
18559-5 | ST amplitude.J point+60 ms Lead I |
1856-4 | Androsterone [Mass/volume] in Serum or Plasma |
18560-3 | ST amplitude.J point+60 ms Lead II |
18561-1 | ST amplitude.J point+60 ms Lead III |
18562-9 | ST amplitude.J point+60 ms Lead V1 |
18563-7 | ST amplitude.J point+60 ms Lead V2 |
18564-5 | ST amplitude.J point+60 ms Lead V3 |
18565-2 | ST amplitude.J point+60 ms Lead V4 |
18566-0 | ST amplitude.J point+60 ms Lead V5 |
18567-8 | ST amplitude.J point+60 ms Lead V6 |
18568-6 | ST amplitude.J point+80 ms Lead AVF |
18569-4 | ST amplitude.J point+80 ms Lead AVL |
1857-2 | Angiotensin converting enzyme [Enzymatic activity/volume] in Blood |
18570-2 | ST amplitude.J point+80 ms Lead AVR |
18571-0 | ST amplitude.J point+80 ms Lead I |
18572-8 | ST amplitude.J point+80 ms Lead II |
18573-6 | ST amplitude.J point+80 ms Lead III |
18574-4 | ST amplitude.J point+80 ms Lead V1 |
18575-1 | ST amplitude.J point+80 ms Lead V2 |
18576-9 | ST amplitude.J point+80 ms Lead V3 |
18577-7 | ST amplitude.J point+80 ms Lead V4 |
18578-5 | ST amplitude.J point+80 ms Lead V5 |
18579-3 | ST amplitude.J point+80 ms Lead V6 |
1858-0 | Angiotensin I [Mass/volume] in Plasma |
18580-1 | Ambulance transport, Origination site |
18581-9 | Ambulance transport, Origination site Address |
18582-7 | Ambulance transport, Destination site Name |
18583-5 | Ambulance transport, Destination site Address |
18584-3 | Body weight at ambulance transport Set |
18588-4 | Ambulance transport, Purpose of stretcher (narrative) |
18589-2 | Ambulance transport, Admitted at destination facility |
1859-8 | Angiotensin II [Mass/volume] in Cerebral spinal fluid |
18591-8 | Confined to bed before ambulance transport |
18592-6 | Confined to bed after ambulance transport |
18593-4 | Ambulance transport, Discharged from origin institution |
18594-2 | Psychiatric service attachment |
18598-3 | Control number identification.claims attachment |
186-7 | Ciprofloxacin [Susceptibility] by Disk diffusion (KB) |
1860-6 | Angiotensin II [Mass/volume] in Plasma |
18600-7 | Primary practitioner identifier |
18601-5 | Primary practitioner profession |
18602-3 | ED practitioner identifier |
18605-6 | Medication current Set |
18606-4 | Current medication, Name and Identifier |
18607-2 | Current medication Dose |
18608-0 | Current medication, Timing + Quantity |
18609-8 | Current medication, Route |
1861-4 | Angiotensinogen [Mass/volume] in Plasma |
18610-6 | Medication administered Set |
18611-4 | Administered medication, Name and Identifier |
18612-2 | Administered medication, Route |
18614-8 | Administered medication, Timing |
18615-5 | Medication administered Dose |
18616-3 | Administered medication, Strength |
18617-1 | Medication discharge Set |
18618-9 | Discharge medication, Name and Identifier |
18619-7 | Discharge medication Dose |
1862-2 | Aniline [Mass/volume] in Serum or Plasma |
18620-5 | Discharge medication, Timing + Quantity |
18621-3 | Discharge medication, Route |
18622-1 | Discharge medication, Amount dispensed |
18623-9 | Discharge medication, Refills |
18624-7 | ED problem (narrative) |
18626-2 | Psychiatric rehabilitation treatment plan, New/revised |
18627-0 | Psychiatric rehabilitation treatment plan, Date onset or exacerbation of primary diagnosis |
18628-8 | Deprecated Psychiatric rehabilitation treatment plan, start date |
18629-6 | Deprecated Clinical discipline - Psychiatric rehabilitation treatment plan |
1863-0 | Anion gap 4 in Serum or Plasma |
18630-4 | Primary diagnosis |
18631-2 | Psychiatric rehabilitation treatment plan, Diagnosis addressed by plan Set |
18632-0 | Psychiatric rehabilitation treatment plan, Author of treatment plan Set |
18633-8 | Psychiatric rehabilitation treatment plan, Author name |
18634-6 | Psychiatric rehabilitation treatment plan, Author profession Identifier |
18635-3 | Psychiatric rehabilitation treatment plan, Signature date Date and time |
18637-9 | Psychiatric rehabilitation treatment plan, Visit frequency TQ2 |
18638-7 | Psychiatric rehabilitation treatment plan, Visit duration Time |
18639-5 | Psychiatric rehabilitation treatment plan, Date range (from/through) described by plan Set |
1864-8 | Anserine [Mass/volume] in Cerebral spinal fluid |
18640-3 | Psychiatric rehabilitation treatment plan, Start date |
18641-1 | Psychiatric rehabilitation treatment plan, End date |
18642-9 | Psychiatric rehabilitation treatment plan, Date range (from/through) Set |
18643-7 | Psychiatric rehabilitation treatment plan, Start date of hospitalization leading to treatment |
18644-5 | Psychiatric rehabilitation treatment plan, End date of hospitalization leading to treatment |
18645-2 | Psychiatric rehabilitation treatment plan, Continuation status |
18646-0 | Psychiatric rehabilitation treatment plan, Date attending MD referred patient for Date |
18647-8 | Psychiatric rehabilitation treatment plan, Date attending MD signed Date and time |
18648-6 | Psychiatric rehabilitation treatment plan, Date rehabilitation professional signed Date and time |
18649-4 | Psychiatric rehabilitation treatment plan, Signature of responsible attending physician on file |
1865-5 | Anserine [Presence] in Serum or Plasma |
18650-2 | Psychiatric rehabilitation treatment plan, Signature of responsible rehabilitation professional on file |
18651-0 | Psychiatric rehabilitation treatment plan, Medication administered Set |
18652-8 | Psychiatric rehabilitation treatment plan, Prognosis for rehabilitation |
18653-6 | Psychiatric rehabilitation treatment plan, Estimated date of completion Date |
18654-4 | Psychiatric rehabilitation treatment plan, Date of last plan of treatment certification |
18655-1 | Psychiatric rehabilitation treatment plan, Past medical history and Level of function (narrative) |
18656-9 | Psychiatric rehabilitation treatment plan Initial evaluation note (narrative) |
18657-7 | Psychiatric rehabilitation treatment plan, Plan of treatment (narrative) |
18658-5 | Psychiatric rehabilitation treatment plan Progress note and attainment of goals (narrative) |
18659-3 | Psychiatric rehabilitation treatment plan, Reason to continue (narrative) |
1866-3 | Anserine [Mass/volume] in Serum or Plasma |
18660-1 | Psychiatric rehabilitation treatment plan, Justification (narrative) |
18661-9 | Psychiatric rehabilitation treatment plan, Psychiatric symptoms (narrative) |
18662-7 | Alcohol-substance abuse rehabilitation treatment plan, Chief complaint+Reason for referral+Reason for relapse if known (narrative) |
18663-5 | Alcohol-substance abuse, rehabilitation plan, History of present alcohol/substance abuse (narrative) |
18664-3 | Rehabilitation treatment plan, Follow-up approach Set |
18665-0 | Alcohol-substance abuse rehabilitation treatment plan, Agency that will follow up Identifier |
18666-8 | Alcohol-substance abuse rehabilitation treatment plan, Person that will follow up after Identifier |
18667-6 | Alcohol-substance abuse rehabilitation treatment plan, Methodology for follow up (narrative) Text |
18668-4 | Alcohol-substance abuse rehabilitation treatment plan, Frequency of assessments for follow up # |
18669-2 | Rehabilitation treatment plan, Level of patient participation Text |
1867-1 | Anserine [Mass/volume] in Urine |
18670-0 | Rehabilitation treatment plan, Date of next planned rehabilitation treatment Set |
18671-8 | Psychiatric rehabilitation treatment plan, Next plan of treatment (narrative) Text |
18672-6 | Alcohol or substance abuse symptoms with physiological dependence indicator |
18673-4 | Alcohol-substance abuse rehabilitation treatment plan, rehabilitation problem remission status |
18674-2 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety for abused substance (composite) |
18675-9 | Alcohol-substance abuse rehabilitation treatment plan, abused substance |
18676-7 | Alcohol-substance abuse rehabilitation treatment plan, longest period of sobriety |
18677-5 | Service claims attachment |
18679-1 | ED claims attachment (composite) |
1868-9 | Antithrombin Ag [Mass/volume] in Platelet poor plasma by Immunologic method |
18682-5 | Ambulance claims attachment |
18684-1 | First Blood pressure Set |
18685-8 | First Blood pressure special circumstances |
18686-6 | First Respiration rate Set |
18687-4 | First Respiration rate special circumstances |
18688-2 | First Body temperature Set |
18689-0 | First Body temperature special circumstances |
1869-7 | Apolipoprotein A-I [Mass/volume] in Serum or Plasma |
18690-8 | First Body weight Set |
18692-4 | First Body weight special circumstances |
18693-2 | ED consultant practitioner Set |
18694-0 | ED consultant practitioner name |
18695-7 | ED clinical finding type |
18696-5 | ED clinical finding (narrative) |
18697-3 | ED clinical finding data source |
18698-1 | ED clinical finding (composite) |
18699-9 | ED practitioner Set |
187-5 | Ciprofloxacin [Susceptibility] by Serum bactericidal titer |
1870-5 | Apolipoprotein A-II [Mass/volume] in Serum or Plasma |
18700-5 | ED practitioner name |
18701-3 | ED practitioner profession |
18702-1 | ED practitioner role |
18703-9 | ED diagnostic procedure results Set |
18704-7 | ED referring practitioner Set |
18705-4 | ED referring practitioner name |
18706-2 | ED referring practitioner identifier |
18707-0 | ED referring practitioner profession |
18708-8 | First Heart rate Set |
18709-6 | First Heart rate special circumstances |
1871-3 | Apolipoprotein B-100 [Mass/volume] in Serum or Plasma |
18710-4 | Primary practitioner Set |
18711-2 | Primary practitioner name |
18716-1 | Allergy studies (set) |
18717-9 | Blood bank studies (set) |
18718-7 | Cell marker studies (set) |
18719-5 | Chemistry studies (set) |
1872-1 | Apolipoprotein B-150 [Mass/volume] in Serum or Plasma |
18720-3 | Coagulation studies (set) |
18721-1 | Therapeutic drug monitoring studies (set) |
18722-9 | Fertility studies (set) |
18723-7 | Hematology studies (set) |
18724-5 | HLA studies (set) |
18725-2 | Microbiology studies (set) |
18726-0 | Radiology studies (set) |
18727-8 | Serology studies (set) |
18728-6 | Toxicology studies (set) |
18729-4 | Urinalysis studies (set) |
1873-9 | Apolipoprotein B-48 [Mass/volume] in Serum or Plasma |
18730-2 | Psychiatric rehabilitation treatment plan, Author ID Identifier |
18733-6 | Physician attending Progress note |
18734-4 | Occupational therapy Initial evaluation note |
18735-1 | Physical therapy Initial evaluation note |
18736-9 | Physician Initial evaluation note |
18737-7 | Podiatry Initial evaluation note |
18738-5 | Psychology Initial evaluation note |
18739-3 | Social work Initial evaluation note |
1874-7 | Apolipoprotein B/Apolipoprotein A-I [Mass Ratio] in Serum or Plasma |
18740-1 | Speech-language pathology Initial evaluation note |
18741-9 | Deprecated Attending physician progress note |
18742-7 | Arthroscopy study |
18743-5 | Autopsy report |
18744-3 | Bronchoscopy study |
18745-0 | Cardiac catheterization study |
18746-8 | Colonoscopy Study |
18747-6 | Deprecated CT Unspecified system Study |
18748-4 | Diagnostic imaging study |
18749-2 | Electromyogram study |
1875-4 | Apolipoprotein C-I [Mass/volume] in Serum or Plasma |
18750-0 | Electrophysiology study |
18751-8 | Endoscopy study |
18752-6 | Exercise stress test study |
18753-4 | Flexible sigmoidoscopy study |
18754-2 | Holter monitor study |
18755-9 | Deprecated MRI Unspecified site study |
18756-7 | MRI Spine study |
18757-5 | Deprecated Nuclear medicine study |
18758-3 | Deprecated PET scan Unspecified system Study |
18759-1 | Spirometry study |
1876-2 | Apolipoprotein C-II [Mass/volume] in Serum or Plasma |
18760-9 | Deprecated US Unspecified system Study |
18761-7 | Provider-unspecified Transfer summary |
18762-5 | Deprecated Chiropractor Progress note |
18763-3 | Physician consulting Initial evaluation note |
18764-1 | Deprecated Nurse practitioner Progress note |
18765-8 | Deprecated Podiatry visit note |
18766-6 | Deprecated Psychology visit note |
18767-4 | Blood gas studies (set) |
18768-2 | Cell counts+Differential studies (set) |
18769-0 | Microbial susceptibility tests Set |
1877-0 | Apolipoprotein C-III [Mass/volume] in Serum or Plasma |
18770-8 | Dictating practitioner name |
18771-6 | Provider signing name |
18772-4 | Surgeon.resident name |
18773-2 | Surgeon.staff name |
18774-0 | Staff practitioner name |
18775-7 | Staff practitioner identifier |
18776-5 | Plan of treatment (narrative) |
18777-3 | Psychiatric rehabilitation treatment plan, Primary diagnosis (narrative) |
18779-9 | Radiology Comparison study - date and time |
1878-8 | Apolipoprotein A-III [Mass/volume] in Serum or Plasma |
18780-7 | Ordering practitioner identifier |
18781-5 | Ordering practitioner name |
18782-3 | Radiology Study observation (narrative) |
18783-1 | Radiology Study recommendation (narrative) |
18785-6 | Radiology Reason for study (narrative) |
18789-8 | Include all data of the selected type within the date window associated with the service |
1879-6 | Apolipoprotein E2 [Mass/volume] in Serum or Plasma |
18790-6 | Include all data of the selected type on or before the date of service |
18791-4 | Include all data of the selected type within or aligned to an encounter by the same service or encounter |
18792-2 | Include all data of the selected type on or after the date of service |
18793-0 | Use no fixed time limit on data (any of the selected type are relevant no matter when obtained) |
18794-8 | Send all items of the specified type within the time window |
18795-5 | Send all items of the specified type within the time window relevant to the service |
18796-3 | Send all abnormals within the time window |
18797-1 | Send the first abnormals within the time window |
18798-9 | Send the last abnormals within the time window |
18799-7 | Send the first (i.e., oldest) result for each kind of observation in the time window |
188-3 | Clarithromycin [Susceptibility] by Minimum lethal concentration (MLC) |
1880-4 | Beta 2 glycoprotein 1 [Mass/volume] in Serum or Plasma |
18800-3 | Send the worst abnormal result for each kind of observation in the time window |
18802-9 | Send the last (most recent) within the time window |
18803-7 | Include all data of the selected type that represents observations made 30 days or fewer before the starting date of service |
18804-5 | Include all data of the selected type that represents observations made 3 months or fewer before the starting date of service |
18805-2 | Include all data of the selected type that represents observations made six months or fewer before the starting date of service |
18806-0 | Include all data of the selected type that represents observations made nine months or fewer before the starting date of service |
18807-8 | Include all data of the selected type that represents observations made one year or less before the starting date of service |
1881-2 | Apolipoprotein LPA [Mass/volume] in Serum or Plasma |
18810-2 | EKG Study observation overall (narrative) |
18812-8 | Ambulance transport, Ordering practitioner Identifier |
18813-6 | Ambulance transport, Ordering practitioner name |
18814-4 | Ambulance transport, Reason for scheduled trip |
18815-1 | Ambulance transport, Reason for scheduled trip additional service information (narrative) |
18816-9 | Medication name + identifier |
18817-7 | Medication dose |
18818-5 | Medication timing + Quantity |
18819-3 | Psychiatric rehabilitation treatment plan, Medication route Identifier |
1882-0 | Apolipoprotein LPQ [Mass/volume] in Serum or Plasma |
18820-1 | Psychiatric rehabilitation treatment plan, Primary diagnosis Identifier |
18821-9 | Diagnosis addressed by plan |
18822-7 | Diagnosis addressed by plan (narrative) |
18823-5 | Alcohol and/or substance abuse service attachment |
18824-3 | Cardiac service attachment |
18825-0 | Medical social services attachment |
18826-8 | Occupational therapy service attachment |
1883-8 | Apolipoprotein A [Mass/volume] in Serum or Plasma |
18833-4 | First Body weight |
18834-2 | Radiology Comparison study (narrative) |
18835-9 | Aortic valve area method Narrative |
18836-7 | Cardiac stress study Procedure |
18837-5 | Left ventricle Segmental wall appearance by US Narrative |
18838-3 | Cardiac echo study Transducer site Narrative |
18839-1 | Cardiac echo imaging device Class Narrative |
1884-6 | Apolipoprotein B [Mass/volume] in Serum or Plasma |
18840-9 | Left ventricular Wall motion index by US Narrative |
18841-7 | Hospital consultations Document |
18842-5 | Discharge summary |
18843-3 | EKG Comparison study (narrative) |
18844-1 | EKG impression Narrative |
18845-8 | Reference beat type (narrative) by EKG |
18846-6 | Examination level ultrasound (narrative) |
18847-4 | Narrative Fetal position palpation |
18848-2 | Narrative Fetal position US |
18849-0 | Narrative Fetal presentation palpation |
1885-3 | Apolipoprotein C [Mass/volume] in Serum or Plasma |
18850-8 | Narrative Fetal presentation US |
18851-6 | Fetal Placenta Grade US (narrative) |
18852-4 | Deprecated Operative note - surgical drains (narrative) |
18855-7 | 5-Fluorocytosine [Susceptibility] |
18857-3 | Almecillin [Susceptibility] |
18859-9 | Amdinocillin [Susceptibility] |
1886-1 | Apolipoprotein E [Mass/volume] in Serum or Plasma |
18860-7 | Amikacin [Susceptibility] |
18861-5 | Amoxicillin [Susceptibility] |
18862-3 | Amoxicillin+Clavulanate [Susceptibility] |
18863-1 | Amphotericin B [Susceptibility] |
18864-9 | Ampicillin [Susceptibility] |
18865-6 | Ampicillin+Sulbactam [Susceptibility] |
18866-4 | Azithromycin [Susceptibility] |
18867-2 | Azlocillin [Susceptibility] |
18868-0 | Aztreonam [Susceptibility] |
18869-8 | Bacampicillin [Susceptibility] |
1887-9 | Appearance of Amniotic fluid |
18870-6 | Bacitracin [Susceptibility] |
18871-4 | Butirosin [Susceptibility] |
18872-2 | Capreomycin [Susceptibility] |
18873-0 | Carbenicillin [Susceptibility] |
18874-8 | Cefaclor [Susceptibility] |
18875-5 | Cefadroxil [Susceptibility] |
18876-3 | Cefamandole [Susceptibility] |
18877-1 | Cefatrizine [Susceptibility] |
18878-9 | Cefazolin [Susceptibility] |
18879-7 | Cefepime [Susceptibility] |
1888-7 | Aquacobalamin [Mass/volume] in Serum or Plasma |
18880-5 | Cefixime [Susceptibility] |
18881-3 | Cefmetazole [Susceptibility] |
18882-1 | Cefodizime [Susceptibility] |
18883-9 | Cefonicid [Susceptibility] |
18884-7 | Cefoperazone [Susceptibility] |
18885-4 | Ceforanide [Susceptibility] |
18886-2 | Cefotaxime [Susceptibility] |
18887-0 | Cefotetan [Susceptibility] |
18888-8 | Cefoxitin [Susceptibility] |
18889-6 | Cefpirome [Susceptibility] |
1889-5 | Arachidonate (C20:4w6) [Mass/volume] in Serum or Plasma |
18890-4 | Cefpodoxime [Susceptibility] |
18891-2 | Cefprozil [Susceptibility] |
18892-0 | Cefsulodin [Susceptibility] |
18893-8 | Ceftazidime [Susceptibility] |
18894-6 | Ceftizoxime [Susceptibility] |
18895-3 | Ceftriaxone [Susceptibility] |
18896-1 | Cefuroxime Parenteral [Susceptibility] |
18897-9 | Cephalexin [Susceptibility] |
18898-7 | Cephaloglycin [Susceptibility] |
18899-5 | Cephaloridine [Susceptibility] |
189-1 | Clarithromycin [Susceptibility] by Minimum inhibitory concentration (MIC) |
1890-3 | Arginase [Enzymatic activity/volume] in Red Blood Cells |
18900-1 | Cephalothin [Susceptibility] |
18901-9 | Cephapirin [Susceptibility] |
18902-7 | Cephradine [Susceptibility] |
18903-5 | Chloramphenicol [Susceptibility] |
18904-3 | Chlortetracycline [Susceptibility] |
18905-0 | Cinoxacin [Susceptibility] |
18906-8 | Ciprofloxacin [Susceptibility] |
18907-6 | Clarithromycin [Susceptibility] |
18908-4 | Clindamycin [Susceptibility] |
18909-2 | Clotrimazole [Susceptibility] |
1891-1 | Arginine [Mass/volume] in Cerebral spinal fluid |
18910-0 | Cloxacillin [Susceptibility] |
18911-8 | Colistimethate |
18912-6 | Colistin [Susceptibility] |
18913-4 | Cyclacillin [Susceptibility] |
18914-2 | Cycloserine [Susceptibility] |
18915-9 | Demeclocycline [Susceptibility] |
18916-7 | Dicloxacillin [Susceptibility] |
18917-5 | Doxycycline [Susceptibility] |
18918-3 | Enoxacin [Susceptibility] |
18919-1 | Erythromycin [Susceptibility] |
1892-9 | Arginine [Presence] in Serum or Plasma |
18920-9 | Erythromycin+Sulfisoxazole [Susceptibility] |
18921-7 | Ethambutol [Susceptibility] |
18922-5 | Ethionamide [Susceptibility] |
18923-3 | Floxacillin [Susceptibility] |
18924-1 | Fluconazole [Susceptibility] |
18925-8 | Deprecated 5-Fluorocytosine [Susceptibility] |
18926-6 | Framycetin [Susceptibility] |
18927-4 | Fusidate [Susceptibility] |
18928-2 | Gentamicin [Susceptibility] |
18929-0 | Gentamicin.high potency [Susceptibility] |
1893-7 | Arginine [Mass/volume] in Serum or Plasma |
18930-8 | Gramicidin D [Susceptibility] |
18931-6 | Hetacillin [Susceptibility] |
18932-4 | Imipenem [Susceptibility] |
18933-2 | Deprecated Imipenem+Cilastatin [Susceptibility] |
18934-0 | Isoniazid [Susceptibility] |
18935-7 | Kanamycin [Susceptibility] |
18936-5 | Kanamycin.high potency [Susceptibility] |
18937-3 | Ketoconazole [Susceptibility] |
18938-1 | Lincomycin [Susceptibility] |
18939-9 | Lomefloxacin [Susceptibility] |
1894-5 | Arginine [Mass/volume] in Urine |
18940-7 | Loracarbef [Susceptibility] |
18941-5 | Lymecycline [Susceptibility] |
18942-3 | Meclocycline [Susceptibility] |
18943-1 | Meropenem [Susceptibility] |
18944-9 | Methacycline [Susceptibility] |
18945-6 | Methicillin [Susceptibility] |
18946-4 | Metronidazole [Susceptibility] |
18947-2 | Mezlocillin [Susceptibility] |
18948-0 | Minocycline [Susceptibility] |
18949-8 | Miocamycin [Susceptibility] |
1895-2 | Arginine [Mass/time] in 24 hour Urine |
18950-6 | Moxalactam [Susceptibility] |
18951-4 | Nafcillin [Susceptibility] |
18952-2 | Nalidixate [Susceptibility] |
18953-0 | Neomycin [Susceptibility] |
18954-8 | Netilmicin [Susceptibility] |
18955-5 | Nitrofurantoin [Susceptibility] |
18956-3 | Norfloxacin [Susceptibility] |
18957-1 | Novobiocin [Susceptibility] |
18958-9 | Nystatin [Susceptibility] |
18959-7 | Ofloxacin [Susceptibility] |
1896-0 | Argininosuccinate [Mass/volume] in Serum or Plasma |
18960-5 | Oleandomycin [Susceptibility] |
18961-3 | Oxacillin [Susceptibility] |
18962-1 | Oxytetracycline [Susceptibility] |
18963-9 | Pefloxacin [Susceptibility] |
18964-7 | Penicillin [Susceptibility] |
18965-4 | Penicillin G [Susceptibility] |
18966-2 | Penicillin V [Susceptibility] |
18967-0 | Phenethicillin [Susceptibility] |
18968-8 | Pipemidate [Susceptibility] |
18969-6 | Piperacillin [Susceptibility] |
1897-8 | Argininosuccinate [Mass/volume] in Urine |
18970-4 | Piperacillin+Tazobactam [Susceptibility] |
18971-2 | Pivampicillin [Susceptibility] |
18972-0 | Polymyxin B [Susceptibility] |
18973-8 | Pyrazinamide [Susceptibility] |
18974-6 | Rifampin [Susceptibility] |
18975-3 | Ristocetin [Susceptibility] |
18976-1 | Rolitetracycline [Susceptibility] |
18977-9 | Rosoxacin [Susceptibility] |
18978-7 | Roxithromycin [Susceptibility] |
18979-5 | Sisomicin [Susceptibility] |
1898-6 | Argininosuccinate lyase [Enzymatic activity/volume] in Serum |
18980-3 | Spectinomycin [Susceptibility] |
18981-1 | Spiramycin [Susceptibility] |
18982-9 | Streptomycin [Susceptibility] |
18983-7 | Streptomycin.high potency [Susceptibility] |
18984-5 | Sulfadiazine [Susceptibility] |
18985-2 | Sulfamethoxazole [Susceptibility] |
18986-0 | Sulfisoxazole [Susceptibility] |
18987-8 | Sulfonamide [Susceptibility] |
18988-6 | Talampicillin [Susceptibility] |
18989-4 | Teicoplanin [Susceptibility] |
1899-4 | Argininosuccinate synthase [Enzymatic activity/mass] in Tissue |
18990-2 | Temafloxacin [Susceptibility] |
18991-0 | Temocillin [Susceptibility] |
18992-8 | Terbinafine [Susceptibility] |
18993-6 | Tetracycline [Susceptibility] |
18994-4 | Ticarcillin [Susceptibility] |
18995-1 | Ticarcillin+Clavulanate [Susceptibility] |
18996-9 | Tobramycin [Susceptibility] |
18997-7 | Trimethoprim [Susceptibility] |
18998-5 | Trimethoprim+Sulfamethoxazole [Susceptibility] |
18999-3 | Troleandomycin [Susceptibility] |
19-0 | Amoxicillin+Clavulanate [Susceptibility] by Minimum lethal concentration (MLC) |
190-9 | Clarithromycin [Susceptibility] by Disk diffusion (KB) |
1900-0 | Arylamidase [Enzymatic activity/volume] in Serum |
19000-9 | Vancomycin [Susceptibility] |
19001-7 | Viomycin [Susceptibility] |
19002-5 | Physical therapy service attachment |
19003-3 | Respiratory therapy service attachment |
19004-1 | Skilled nursing service attachment |
19005-8 | Radiology Imaging study [Impression] (narrative) |
19006-6 | Cardiac echo imaging device Image quality Narrative by US |
19007-4 | Psychiatric rehabilitation treatment plan, Primary diagnosis Set |
19008-2 | Transducer site Narrative |
19009-0 | Medication current (narrative) |
1901-8 | Arylsulfatase [Enzymatic activity/volume] in Serum or Plasma |
19010-8 | Medication discharge (narrative) |
19011-6 | Medication administered (narrative) |
19012-4 | Discharge medication, Substitution instruction |
19013-2 | Medications current report request |
19014-0 | Medications discharge report request |
19015-7 | Medications administered report request |
19016-5 | X12 277, all requests for information that are included in this transaction are stated for individual services |
1902-6 | Ascorbate [Mass/volume] in Blood |
19021-5 | Palpitation Cervix Study observation (narrative) |
19022-3 | Neisseria meningitidis C+w135 Ag [Presence] in Cerebral spinal fluid |
19023-1 | Granulocytes/100 leukocytes in Blood by Automated count |
1903-4 | Ascorbate [Mass/volume] in Serum or Plasma |
1904-2 | Ascorbate [Presence] in Urine |
19044-7 | Fish Feed IgE Ab RAST class [Presence] in Serum |
19045-4 | Salmon IgG Ab RAST class [Presence] in Serum |
19046-2 | Deprecated Bovine serum albumin (BSA) IgE Ab RAST class in Serum |
19047-0 | Tuna IgG Ab RAST class [Presence] in Serum |
19048-8 | Nucleated erythrocytes/100 leukocytes [Ratio] in Blood |
19049-6 | Metanephrine [Mass/time] in 24 hour Urine |
1905-9 | Ascorbate [Mass/time] in 24 hour Urine |
19050-4 | Metanephrines [Mass/volume] in 24 hour Urine |
19051-2 | Saquinavir [Mass/volume] in Serum or Plasma |
19052-0 | Borrelia burgdorferi DNA [Presence] in Urine by Probe with amplification |
19053-8 | Brucella sp Ab [Titer] in Serum by Agglutination |
19054-6 | Mycoplasma pneumoniae [Presence] in Unspecified specimen by Organism specific culture |
19055-3 | Carboxy tetrahydrocannabinol/Creatinine [Mass Ratio] in Urine |
19056-1 | Mercury [Presence] in Urine |
19057-9 | ABO and Rh group [Type] in Blood from newborn |
19058-7 | Allergens identified in Serum |
19059-5 | Amphetamines cutoff [Mass/volume] in Urine |
1906-7 | Asparagine [Mass/volume] in Cerebral spinal fluid |
19060-3 | Deprecated Blood group antibodies identified in Serum or Plasma |
19064-5 | Benzodiazepines cutoff [Mass/volume] in Urine |
19065-2 | Benzoylecgonine cutoff [Mass/volume] in Urine |
19066-0 | Blood bank comment |
1907-5 | Asparagine [Presence] in Serum or Plasma |
19071-0 | Blood removed from patient [Volume] |
19072-8 | Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma |
19073-6 | Cannabinoids cutoff [Mass/volume] in Urine |
19074-4 | Carnitine esters [Moles/volume] in Serum or Plasma |
19075-1 | Cells Counted Total [#] in Cerebral spinal fluid |
19076-9 | Cells Counted Total [#] in Unspecified specimen |
19077-7 | Cells identified in Body fluid |
19078-5 | CD23 cells/100 cells in Unspecified specimen |
19079-3 | CD43 cells/100 cells in Unspecified specimen |
1908-3 | Asparagine [Mass/volume] in Serum or Plasma |
19080-1 | Choriogonadotropin [Units/volume] in Serum or Plasma |
19085-0 | Deprecated Collection duration of Urine - time unspecified |
19086-8 | Collection of urine specimen end date |
19087-6 | Collection of urine specimen end time |
19088-4 | Collection of urine specimen start date |
19089-2 | Collection of urine specimen start time |
1909-1 | Asparagine [Mass/volume] in Urine |
19090-0 | Colony count [#/volume] in Urine |
19091-8 | Colony count [#] in Urine by Visual count |
19092-6 | Cotinine cutoff [Mass/volume] in Urine |
19096-7 | Electrolytes - single valence [Interpretation] in 24 hour Urine Narrative |
19098-3 | Erythrocytes [Presence] in Amniotic fluid |
19099-1 | Events counted [#] in Unspecified specimen |
191-7 | Clarithromycin [Susceptibility] by Serum bactericidal titer |
1910-9 | Asparagine [Mass/time] in 24 hour Urine |
19101-5 | Fungus colony count [#/volume] in Unspecified specimen by Culture |
19102-3 | Genetic screen in Unspecified specimen by Molecular genetics method Narrative |
19104-9 | Glucose [Interpretation] in Serum or Plasma--1 hour post dose glucose |
19105-6 | Glucose [Interpretation] in Serum or Plasma--3 hours post dose glucose |
19106-4 | Herpes simplex virus IgG Ab [Presence] in Serum |
19107-2 | Histoplasma capsulatum Ag [Units/volume] in Serum by Radioimmunoassay (RIA) |
19108-0 | Histoplasma capsulatum Ag [Presence] in Serum |
19109-8 | Histoplasma capsulatum Ag [Presence] in Unspecified specimen |
1911-7 | Aspartate [Mass/volume] in Cerebral spinal fluid |
19110-6 | HIV 1 gp41+gp43 Ab [Presence] in Serum by Immunoblot (IB) |
19111-4 | Mother's hospital number |
19113-0 | IgE [Units/volume] in Serum or Plasma |
19114-8 | Lamellar bodies [#/volume] in Amniotic fluid |
1912-5 | Aspartate [Presence] in Serum or Plasma |
19122-1 | CD42 cells/100 cells in Blood |
19123-9 | Magnesium [Mass/volume] in Serum or Plasma |
19124-7 | Magnesium [Mass/volume] in Urine |
19125-4 | Meconium [Presence] in Amniotic fluid |
19126-2 | Bacteria identified in Bone marrow by Aerobe culture |
19127-0 | Bacteria identified in Sputum by Acute Respiratoy Distress (ARDS) culture |
19128-8 | Bacteria identified in Catheter tip by Culture |
19129-6 | Microscopic observation [Identifier] in Tissue by Biopsy culture |
1913-3 | Aspartate [Mass/volume] in Serum or Plasma |
19132-0 | Mother's name |
19133-8 | Neisseria meningitidis A+C+w135+Y Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
19134-6 | Neisseria meningitidis B+Escherichia coli K1 Ag [Presence] in Cerebral spinal fluid by Latex agglutination |
19137-9 | Neuronal nuclear Ab [Units/volume] in Serum by Immunoblot (IB) |
19138-7 | Opiates cutoff [Mass/volume] in Urine |
19139-5 | Pathologist name |
1914-1 | Aspartate [Mass/volume] in Urine |
19140-3 | Phospholipid Ab [Presence] in Serum |
19141-1 | Propoxyphene [Presence] in Urine |
19144-5 | Reason for drug test [Interpretation] |
19145-2 | Reference lab test name |
19146-0 | Reference lab test results |
19147-8 | Reference lab test reference range |
19148-6 | RhoGam candidate (yes/no) |
19149-4 | Rifabutin [Susceptibility] |
1915-8 | Aspartate [Mass/time] in 24 hour Urine |
19150-2 | Specimen creatinine acceptable [Presence] in Urine |
19151-0 | Specimen drawn [Date and time] of Serum or Plasma |
19152-8 | Specimen specific gravity acceptable [Presence] in Urine |
19153-6 | Volume in Urine collected for unspecified duration |
19156-9 | Susceptibility method - Unspecified specimen |
19157-7 | Tube number of Cerebral spinal fluid |